Patent application title: RECOMBINANT BIOTIN CARBOXYLASE DOMAINS FOR IDENTIFICATION OF ACETYL CoA CARBOXYLASE INHIBITORS
Inventors:
Tedd E. Elich (Durham, NC, US)
Sandra L. Volrath (Durham, NC, US)
Stephanie C. Weatherly (Durham, NC, US)
IPC8 Class: AG01N3368FI
USPC Class:
435 78
Class name: Measuring or testing process involving enzymes or micro-organisms; composition or test strip therefore; processes of forming such composition or test strip involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay involving nonmembrane bound receptor binding or protein binding other than antigen-antibody binding
Publication date: 2009-01-08
Patent application number: 20090011433
Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
Usenet FAQ Index |
Documents |
Other FAQs |
Patent application title: RECOMBINANT BIOTIN CARBOXYLASE DOMAINS FOR IDENTIFICATION OF ACETYL CoA CARBOXYLASE INHIBITORS
Inventors:
Tedd E. Elich
Sandra L. Volrath
Stephanie C. Weatherly
Agents:
MYERS BIGEL SIBLEY & SAJOVEC
Assignees:
Origin: RALEIGH, NC US
IPC8 Class: AG01N3368FI
USPC Class:
435 78
Abstract:
A peptide comprising an Acetyl CoA carboxylase (ACCase) having a deleted
biotin binding domain, having a deleted carboxy transferase domain, and
having a functional biotin carboxylase (BC) domain is described. A
nucleic acid that encodes the peptide described above and a recombinant
host cell that contains the nucleic acid and expresses the encoded
peptide is also described. A method of identifying Acetyl CoA carboxylase
inhibitors, fungicides, herbicides and pharmaceuticals is also described
herein.Claims:
1. A peptide comprising an Acetyl CoA carboxylase (ACCase) having a
deleted biotin binding domain, having a deleted carboxy transferase
domain, and having a functional biotin carboxylase domain.
2. The peptide according to claim 1, wherein said ACCase is selected from the group consisting of mammal, insect, yeast, Ascomycota, Basidiomycota, and Oomycota ACCase.
3. The peptide according to claim 1, wherein said carboxylase is Ustilago maydis carboxylase.
4. The peptide according to claim 1, wherein said carboxylase is Phytopthora infestans carboxylase.
5. The peptide according to claim 1, wherein said carboxylase is Magnaporthe grisea carboxylase.
6. The peptide according to claim 1, wherein said carboxylase is Saccaromyces cerevisiae carboxylase.
7. The peptide according to claim 1, wherein said carboxylase is human carboxylase.
8. The peptide according to claim 1 having the amino acid sequence given in SEQ ID NO: 2.
9. The peptide according to claim 1 selected from the group consisting of peptides having an amino acid sequence as given in SEQ ID NO; 4, SEQ ID NO:6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, and SEQ ID NO: 17 through SEQ ID NO: 71.
10. The peptide according to claim 1, wherein said peptide is a monomer.
11. The peptide according to claim 1, wherein said peptide binds to soraphen.
12. The peptide according to claim 1, wherein said peptide binds to soraphen and has a soraphen dissociation constant of from 10.sup.-7 to 10.sup.-14 M.
13. A composition comprising:(a) an aqueous carrier solution; and(b) the peptide of claim 1 solubilized in said aqueous carrier solution; withsaid peptide included in said composition in an amount of from 0.001 nanograms to 20 milligrams per milliliter of aqueous carrier solution;said peptide having a soraphen dissociation constant in said composition of from 10.sup.-7 to 10.sup.-14 M; andsaid composition having a pH of from 5 through 9.
14. A nucleic acid that encodes a peptide according to claim 1.
15. A recombinant host cell that contains a nucleic acid according to claim 14 and expresses the encoded peptide.
16. A method of identifying Acetyl CoA carboxylase inhibitors or activators, comprising:a) combining a peptide according to claim 1 and a compound to be tested for the ability to bind to said biotin carboxylase domain, under conditions that permit binding to said biotin carboxylase domain;b) determining whether or not said compound binds to said biotin carboxylase domain, the presence of binding indicating said compound is or may be an Acetyl CoA carboxylase inhibitor or activator.
17. The method of claim 16, further comprising the steps of:c) employing a compound identified as binding in step (b) in an assay to detect inhibition or enhancement of Acetyl CoA carboxylase activity; andd) selecting a compound identified in step (c) that inhibits or activates Acetyl CoA carboxylase activity.
18. A method of identifying fungicides, comprising:a) combining a peptide according to claim 1 and a compound to be tested for the ability to bind to said biotin carboxylase domain, under conditions that permit binding to said biotin carboxylase domain;b) determining whether or not said compound binds to said biotin carboxylase domain, the presence of binding indicating said compound is or may be a fungicide;c) employing a compound identified as binding in step (b) in an assay to detect inhibition of Acetyl CoA carboxylase activity; andd) selecting a compound identified in step (c) that inhibits Acetyl CoA carboxylase activity.
19. A kit comprising:(a) a first peptide of claim 1; in combination with(b) a second peptide of claim 1,wherein said first and second peptides are from different species.
20. A kit of claim 19, wherein said first peptide is a non-mammalian peptide and said second peptide is a mammalian peptide.
21. A kit comprising:(a) a first peptide of claim 1; in combination with(b) a second peptide comprising an ACCase having a deleted biotin binding domain, having a deleted carboxy transferase domain, and having a non-functional biotin-carboxylase domain;wherein said first and second peptide are from the same species.
22. A kit of claim 19, wherein said first and second peptide are both S. cerivasae peptides.
Description:
RELATED APPLICATIONS
[0001]The present application is a divisional application of U.S. patent application Ser. No. 10/633,835, filed Aug. 4, 2003, which claims the benefit, under 35 U.S.C. 119(e), of U.S. Provisional Patent Application No. 60/401,170, filed Aug. 5, 2002, the contents of which are herein incorporated by reference in their entireties.
FIELD OF THE INVENTION
[0002]The present invention relates to a peptide comprising a biotin carboxylase domain and fragments thereof useful for the identification of Acetyl CoA carboxylase inhibitors, which in turn are useful among other things as fungicides, insecticides, nematicides, herbicides and pharmaceuticals.
BACKGROUND OF THE INVENTION
[0003]Acetyl CoA carboxylase (ACCase) catalyzes the first committed step in fatty acid biosynthesis and has also been chemically validated as an herbicide and fungicide target. Structurally, ACCases are biotinylated, multifunctional enzymes comprised of three domains: a biotin carboxylase domain, a biotin binding site, and a carboxytransferase domain. In prokaryotic ACCases, as well as in the plastidic isoforms of most plant ACCases, the three domains reside on three distinct, dissociable proteins. In contrast, in most eukaryotic ACCases the three domains reside on a single polypeptide of 160 kD to 280 kD. In their native state, the eukaryotic enzymes are typically dimers or tetramers ranging in size from approximately 400-800 kD.
[0004]The ACCase reaction takes place at two catalytic sites via two partial reactions: the ATP dependent carboxylation of the enzyme-bound biotin prosthetic group, and the subsequent transfer of the carboxyl group from biotin to acetyl CoA to form malonyl CoA. The natural product soraphen has been demonstrated to be a broad-spectrum fungicide that acts by inhibiting the biotin carboxylase reaction of ACCase. ACCase's are known to be low abundant and labile proteins. These properties impede the identification of new ACCase inhibitors.
[0005]The present invention provides a peptide comprising a biotin carboxylase domain and fragments thereof useful for the identification of Acetyl CoA carboxylase inhibitors, which in turn are useful among other things as fungicides, insecticides, nematicides, herbicides and pharmaceuticals.
SUMMARY OF THE INVENTION
[0006]According to embodiments of the present invention, the present invention relates to a peptide comprising an Acetyl CoA carboxylase (ACCase) having a deleted biotin binding domain, having a deleted carboxy transferase domain, and having a functional biotin carboxylase (BC) domain (e.g., capable of binding soraphen). In some embodiments of the invention where such BC domains are used as counterselection agents in conjunction with peptides or BC domains as described above, the peptide or BC domain is non-functional.
[0007]"Functional" as used herein refers to a BC domain that binds soraphen with similar affinity as enzymatically active, full length ACCase protein. Thus, "non-functional" as used herein refers to a BC domain that does not bind soraphen. These non-functional BC domains would be functional with respect to enzyme activity/catalytic function when incorporated into an intact ACCase.
[0008]The carboxylase (and corresponding peptide) may be from any suitable source, including plant, animal (e.g., mammalian), insect, yeast, and fungal carboxylases/peptides.
[0009]According to other embodiments of the present invention, the carboxylase (and corresponding peptide) is from Ustilago maydis carboxylase.
[0010]According to still other embodiments of the present invention, the carboxylase (and corresponding peptide) is from Phytophthora infestans carboxylase.
[0011]According to still other embodiments of the present invention, the carboxylase (and corresponding peptide) are from Magnaporthe grisea, Saccharomyces cerevisiae and Homo sapiens.
[0012]According to other embodiments of the present invention, the present invention relates to the molecules described above wherein the respective peptides are each an Acetyl CoA carboxylase (ACCase) having a deleted biotin binding domain, having a deleted carboxy transferase domain, and having a functional biotin carboxylase domain comprising amino acids as detailed in SEQ ID NOS: 2, 4, 6, 8, 10, 12, 14, or 16, and functional fragments thereof.
[0013]According to other embodiments of the present invention, the molecules described above are each a monomer.
[0014]According to still other embodiments of the present invention, the present invention relates to the molecules described above wherein the respective carboxylase domains bind to compounds that modulate Acetyl CoA carboxylase activity.
[0015]According to other embodiments of the present invention, the carboxylase domains bind to competitive inhibitors, noncompetitive inhibitors, and also binds to soraphen.
[0016]According to other embodiments of the present invention, the present invention relates to a nucleic acid that encodes a peptide comprising an Acetyl CoA carboxylase (ACCase) having a deleted biotin binding domain, having a deleted carboxy transferase domain, and having a functional biotin carboxylase domain, such as described above and further hereinbelow.
[0017]According to other embodiments of the present invention, the present invention relates to a recombinant host cell that contains a nucleic acid as described above and expresses the encoded peptide.
[0018]According to other embodiments of the present invention, the present invention relates to a method of identifying Acetyl CoA carboxylase inhibitors, or activators, comprising a) combining a peptide as described above and a compound to be tested for the ability to bind to said biotin carboxylase domain, under conditions that permit binding to said biotin carboxylase domain, and b) determining whether or not said compound binds to said biotin carboxylase domain, the presence of binding indicating said compound is or may be an Acetyl CoA carboxylase inhibitor. Such compounds are candidates for and useful as pesticides, including but not limited to insecticides, nematocides, fungicides, and/or herbicides, and/or also pharmaceuticals, including but not limited to antifungals.
[0019]According to other embodiments of the present invention, the present invention relates to a method of identifying Acetyl CoA carboxylase inhibitors, further comprising the steps of c) employing a compound identified as binding in step (b) in an assay to detect inhibition of Acetyl CoA carboxylase activity; and d) selecting a compound identified in step (c) that inhibits Acetyl CoA carboxylase activity.
[0020]According to still other embodiments of the present invention, the present invention relates to a method of identifying fungicides, comprising a) combining a peptide as described above and a compound to be tested for the ability to bind to said biotin carboxylase domain, under conditions that permit binding to said biotin carboxylase domain, b) determining whether or not said compound binds to said biotin carboxylase domain, the presence of binding indicating said compound is or may be a fungicide, c) employing a compound identified as binding in step (b) in an assay to detect inhibition of Acetyl CoA carboxylase activity, and d) selecting a compound identified in step (c) that inhibits Acetyl CoA carboxylase activity.
[0021]According to still other embodiments of the present invention, the present invention relates to the use of a peptide or compound as described above for carrying out a method as described above.
BRIEF DESCRIPTION OF THE DRAWINGS
[0022]FIG. 1 illustrates full-length ACCase protein from Ustilago maydis (pCS11) with the three functional domains detailed.
[0023]FIG. 2 illustrates soraphen binding to and inhibition of the full-length pCS11 protein.
[0024]FIG. 3 illustrates soraphen binding to the Ustilago BC domain (pCS8) with comparable affinity to full length ACCase (pCS11).
[0025]FIG. 4 illustrates soraphen binding to Phytopthora infestans BC domain.
[0026]FIG. 5 illustrates the biotin carboxylase domain of Ustilago peptide (pCS8) compared to full-length Ustilago ACCase.
[0027]FIG. 6 illustrates the amino acid sequence of Ustilago maydis ACCase BC domain, amino acids 2-560 (pCS8, SEQ ID NO: 2)(Taken from Full Length Amino Acid Sequence for Ustilago maydis ACCase, Accession Number: Z46886; A. Bailey, J. Keon, J. Owen, and J. Hargreaves, ACC1 gene, encoding acetyl-CoA carboxylase, is essential for growth in Ustilago maydis, Mol. Gen. Genet. 249 (2), 191-201 (1995)).
[0028]FIG. 7 illustrates the amino acid sequence of Phytopthora infestans ACCase BC domain, amino acids 1-555 (pCS15, SEQ ID NO: 4).
[0029]FIG. 8 illustrates anion Exchange Chromatography of pCS8 peptide.
[0030]FIG. 9A illustrates spectrophotometric assay absorbance traces for E. coli BC and FIG. 9B shows (i) spectrophotometric and (ii) 14C isotope exchange activity assays on pCS11 protein.
[0031]FIG. 10 illustrates the alignment of Ustilago (SEQ ID NO: 2), Phytophthora (SEQ ID NO: 4), Magnaporthe (SEQ ID NO: 6) and yeast (SEQ ID NO: 8) ACCase BC domains.
[0032]FIG. 11 illustrates soraphen binding to the Magnaporthe BC domain.
[0033]FIG. 12 illustrates soraphen binding to the human ACC1 BC domain.
[0034]FIG. 13 illustrates the alignment of the human ACC1 BC (SEQ ID NO: 10) and ACC2 BC (SEQ ID NO: 12) domains with the Ustilago ACCase BC (SEQ ID NO: 2) domain.
[0035]FIG. 14 illustrates dissociation experiments using [3H]-soraphen to determine the soraphen off rate for Ustilago ACCase BC domain.
[0036]FIG. 15 illustrates the binding of [3H]-soraphen A and soraphen C conjugates to (A) the Ustilago ACCase BC domain and (B) the full-length Ustilago ACCase protein.
[0037]FIG. 16 depicts soraphen binding to wild type and mutant S. cerevisiae ACCase BC domain peptides.
[0038]FIG. 17 illustrates soraphen A binding to wild-type and mutant full-length S. cerevisiae ACCase.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0039]The present invention will now be described more fully hereinafter with reference to the accompanying figures, in which preferred embodiments of the invention are shown. This invention may, however, be embodied in different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. The disclosures of all United States patent references cited herein are to be incorporated by reference herein in their entirety.
[0040]Described herein is the use of recombinant, isolated, biotin carboxylase domains for the discovery of new Acetyl CoA carboxylase (ACCase) inhibitors. A biotin carboxylase (BC) domain from the ACCase gene of the basidiomycete Ustilago maydis was isolated, cloned, expressed, and characterized. The isolated BC domain was shown to have similar high-affinity, soraphen-binding properties as the full-length protein. In contrast to the full-length protein (FIG. 1), however, the BC domain is significantly smaller and can be expressed at higher levels, is more stable, and exists as a monomer. The isolated BC domain is useful for screening new ACCase inhibitors. The BC domain from the oomycete Phytophthora infestans was also cloned. A full-length ACCase sequence from this organism has not been published. The appropriate fragment was cloned utilizing PCR using primers derived from published EST's that showed homology to sequences flanking the soraphen-binding domain that was identified in the Ustilago gene. The recombinantly expressed Phytopthora BC domain exhibited high-affinity soraphen-binding. BC domains from M. grisea, S. cerevisiae, and H. sapiens were also similarly cloned and determined to exhibit high-affinity soraphen-binding, thus demonstrating the applicability of this approach to distantly related organisms.
[0041]The terminology used in the description of the invention herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used in the description of the invention and the appended claims, the singular forms "a", "an" and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise.
[0042]As used herein, an "isolated" nucleic acid (e.g., an "isolated DNA" or an "isolated genomic RNA") means a nucleic acid separated or substantially free from at least some of the other components of the naturally occurring organism or virus, for example, the cell or viral structural components or other polypeptides or nucleic acids commonly found associated with the nucleic acid.
[0043]Likewise, an "isolated" polypeptide means a polypeptide that is separated or substantially free from at least some of the other components of the naturally occurring organism or virus, for example, the cell or viral structural components or other polypeptides or nucleic acids commonly found associated with the polypeptide. As used herein, the terms "polypeptide" and "peptide" have the same meaning.
[0044]As used herein, the terms "deleted" or "deletion" mean either total deletion of the specified segment or the deletion of a sufficient portion of the specified segment to render the segment inoperative or nonfunctional (e.g., does not encode a functional peptide, wherein functional is defined as the ability to bind soraphen), in accordance with common usage. See, e.g. U.S. Pat. No. 6,180,362; U.S. Pat. No. 5,689,039.
[0045]As used herein, the term modulation of Acetyl CoA carboxylase activity refers to the ability of a compound to alter the activity of the enzyme. The alteration may be by enhancing or decreasing the activity of the enzyme, or by causing the enzyme to function in a manner other than that observed in the absence of the compound.
[0046]Also as used herein, the term activator refers to the ability of a compound to initiate and/or enhance Acetyl CoA carboxylase activity (e.g., an agonist).
[0047]The term inhibitor as used herein refers to the ability of a compound to decrease and/or terminate Acetyl CoA carboxylase activity (e.g., an antagonist).
[0048]As used herein, test compounds refer to compounds that may bind the biotin carboxylase domain, under conditions that permit binding to the biotin carboxylase domain. The presence of binding indicating the compound is or may be an Acetyl CoA carboxylase inhibitor. Moreover, binding of the compound to the biotin carboxylase domain may indicate that the compound may be a fungicide, insecticide, nematicide, or herbicide or may be a pharmaceutical (e.g., a compound that reduces, controls, inhibits or otherwise regulates weight gain in a human or animal subject, particularly compounds that are inhibitors of human or mammalian ACC2, and more particularly compounds that preferentially inhibit or antagonize human or mammalian ACC2 and not human or mammalian ACC1, see, e.g., L. Abu-Elheiga et al., Science 291, 2613 (30 Mar. 2001)). Additionally, binding of the test compound refers to specific binding wherein the binding interaction between the BC domain and test compounds is high. The dissociation constant of the BC domain complexes is from about 10-4 M to about 10-14 M, more preferably 10-7 to 10-14, and still more preferably 10-8 to 10-14 and most preferably lower than 2×10-9 M. The test compound may be identified by any available means, including but not limited to the Evolutionary Chemistry process described herein below.
[0049]Amino acid sequences disclosed herein are presented in the amino to carboxy direction, from left to right. The amino and carboxy groups are not presented in the sequence. Nucleotide sequences are presented herein by single strand only, in the 5' to 3' direction, from left to right. Nucleotides and amino acids are represented herein in the manner recommended by the IUPAC-IUB Biochemical Nomenclature Commission, or (for amino acids) by three-letter code, in accordance with 37 C.F.R §1.822 and established usage. See, e.g., Patent In User Manual, 99-102 (November 1990) (U.S. Patent and Trademark Office).
[0050]In general, the term "peptide" refers to a molecular chain of amino acids with a biological activity (e.g., capacity to bind soraphen). If required, it can be modified in vivo and/or in vitro, for example by glycosylation, myristoylation, amidation, carboxylation or phosphorylation; thus inter alia oligopeptides and polypeptides are included. It is understood however that the peptides of the present invention do not extend to native proteins which may contain the disclosed peptides. The peptides disclosed herein may be obtained, for example, by synthetic or recombinant techniques known in the art. It will also be understood that amino acid and nucleic acid sequences may include or exclude additional residues, such as additions or deletions of N- or C-terminal amino acids or 5' or 3' sequences, and yet still be essentially as set forth as disclosed herein, so long as the sequence meets the criteria set forth above, including the maintenance of biological activity (e.g., capacity to bind soraphen). Thus, up to about 10, 20, 30, or about 40 amino acids may be deleted from either, or both, the N- and/or C-terminus of the peptide, so long as a functional biotin carboxylase domain (e.g., soraphen binding) is retained. Examples of such peptides are peptides having the amino acid sequence given in SEQ ID NO: 14, 16 and 17 through 71 herein. Note that, for BC domains of human ACC1 and ACC2, up to 102 and 244 amino acids, respectively may be deleted from the N-terminal end, alone or in combination with the above listed C-terminal deletions, so long as a function biotin carboxylase domain (e.g., soraphen binding) is retained.
[0051]"Nucleic acid sequence" as used herein refers to an oligonucleotide, nucleotide, or polynucleotide, and to DNA or RNA of genomic or synthetic origin which may be single- or double-stranded, and represent the sense or antisense strand. Suitable nucleic acid sequences encoding an ACCase biotin carboxylase (BC) domain (that is, an ACCase having a deleted biotin binding domain and a deleted carboxy transferase domain) include, for example, a nucleic acid encoding a Ustilago maydis BC domain. Examples of such are given as SEQ ID NOS: 1, 3, 5, 7, 9, 11, 13, and 15 herein.
[0052]Polynucleotides of the present invention include those coding for peptides homologous to, and having essentially the same biological properties as, the peptides disclosed herein. For example, the DNA sequences disclosed herein as SEQ ID NOS:1, 3, 5, 7, 9, 11, 13, and 15. This definition is intended to encompass natural allelic sequences thereof. Thus, isolated DNA or cloned genes of the present invention can be of any species of origin. Thus, polynucleotides that hybridize to any one or more of the DNA sequences disclosed herein as SEQ ID NOS: 1, 3, 5, 7, 9, 11, 13, and 15 and which code on expression for an ACCase BC domain, are also an aspect of the invention. Conditions which will permit other polynucleotides that code on expression for a protein or peptide of the present invention to hybridize to the DNA of SEQ ID NOS:1, 3, 5, 7, 9, 11, 13, and 15 herein can be determined in accordance with known techniques.
[0053]For example, hybridization of such sequences may be carried out under conditions of reduced stringency, medium stringency or even stringent conditions (e.g., conditions represented by a wash stringency of 35-40% Formamide with 5×Denhardt's solution, 0.5% SDS and 1×SSPE at 37° C.; conditions represented by a wash stringency of 40-45% Formamide with 5×Denhardt's solution, 0.5% SDS, and 1×SSPE at 42° C.; and conditions represented by a wash stringency of 50% Formamide with 5×Denhardt's solution, 0.5% SDS and 1×SSPE at 42° C., respectively) to DNA of SEQ ID NOS:1, 3, 5, 7, 9, 11, 13, and 15 herein in a standard hybridization assay. See, e.g., J. Sambrook et al., Molecular Cloning, A Laboratory Manual (2d Ed. 1989) (Cold Spring Harbor Laboratory). In general, sequences which code for proteins or peptides of the present invention and which hybridize to the DNA of SEQ ID NOS:1, 3, 5, 7, 9, 11, 13, and 15, for example, will be at least 60% or 75% identical or homologous, 85% identical or homologous, 90% identical or homologous and even 95% identical or homologous, or more with one or more of SEQ ID NOS:1, 3, 5, 7, 9, 11, 13, and 15.
[0054]Mathematical algorithms can be used to determine the percent identity of two sequences. Non-limiting examples of mathematical algorithms are the algorithm of Karlin and Altschul (1990) Proc. Natl. Acad. Sci. USA 87:2264, modified as in Karlin and Altschul (1993) Proc. Natl. Acad. Sci. USA 90:5873-5877; the algorithm of Myers and Miller (1988) CABIOS 4:11-17; the local homology algorithm of Smith et al. (1981) Adv. Appl. Math. 2:482; the homology alignment algorithm of Needleman and Wunsch (1970) J. Mol. Biol. 48:443-453; and the search-for-similarity-method of Pearson and Lipman (1988) Proc. Natl. Acad. Sci. USA 85:2444-2448.
[0055]Various computer implementations based on these mathematical algorithms have been designed to enable the determination of sequence identity. The BLAST programs of Altschul et al. (1990) J. Mol. Biol. 215:403 are based on the algorithm of Karlin and Altschul (1990) supra. Searches to obtain nucleotide sequences that are homologous to nucleotide sequences of the present invention can be performed with the BLASTN program, score=100, wordlength=12. To obtain amino acid sequences homologous to sequences encoding a protein or polypeptide of the current invention, the BLASTX program may be used, score=50, wordlength=3. Gapped alignments may be obtained by using Gapped BLAST as described in Altschul et al. (1997) Nucleic Acids Res. 25:3389. To detect distant relationships between molecules, PSI-BLAST can be used. See Altschul et al. (1997) supra. For all of the BLAST programs, the default parameters of the respective programs can be used.
[0056]Further, polynucleotides that code for proteins or peptides of the present invention, or polynucleotides that hybridize to that as SEQ ID NO:1, 3, 5, 7, 9, 11, 13, and 15, or polynucleotides having sequence identity or homology thereto as described above, for example, but which differ in codon sequence therefrom due to the degeneracy of the genetic code, are also an aspect of this invention. The degeneracy of the genetic code, which allows different nucleic acid sequences to code for the same protein or peptide, is well known in the literature. See, e.g., U.S. Pat. No. 4,757,006 to Toole et al. at Col. 2, Table 1.
[0057]The production of cloned genes, recombinant DNA, vectors, transformed host cells, proteins and protein fragments by genetic engineering is well known. See, e.g., U.S. Pat. No. 4,761,371 to Bell et al. at Col. 6 line 3 to Col. 9 line 65; U.S. Pat. No. 4,877,729 to Clark et al. at Col. 4 line 38 to Col. 7 line 6; U.S. Pat. No. 4,912,038 to Schilling at Col. 3 line 26 to Col. 14 line 12; and U.S. Pat. No. 4,879,224 to Wallner at Col. 6 line 8 to Col. 8 line 59.
[0058]PCR is the polymerase chain reaction--a technique for copying the complementary strands of a target DNA molecule simultaneously for a series of cycles until the desired amount is obtained. First, primers are synthesized that have nucleotide sequences complementary to the DNA that flanks the target region. The DNA is heated to separate the complementary strands and then cooled to let the primers bind to the flanking sequences. A heat-stable DNA polymerase is added, and the reaction is allowed to proceed for a series of replication cycles. Twenty will yield a millionfold amplification; thirty cycles will yield an amplification factor of one billion.
[0059]A vector is a replicable DNA construct. Vectors are used herein either to amplify DNA encoding the proteins or peptides of the present invention or to express the proteins or peptides of the present invention. An expression vector is a replicable DNA construct in which a DNA sequence encoding the proteins of the present invention is operably linked to suitable control sequences capable of effecting the expression of proteins or peptides of the present invention in a suitable host. The need for such control sequences will vary depending upon the host selected and the transformation method chosen. Generally, control sequences include a transcriptional promoter, an optional operator sequence to control transcription, a sequence encoding suitable mRNA ribosomal binding sites, and sequences which control the termination of transcription and translation. Amplification vectors do not require expression control domains. All that is needed is the ability to replicate in a host, usually conferred by an origin of replication, and a selection gene to facilitate recognition of transformants.
[0060]Vectors comprise plasmids, viruses (e.g., adenovirus, cytomegalovirus), phage, retroviruses and integratable DNA fragments (i.e., fragments integratable into the host genome by recombination). The vector replicates and functions independently of the host genome, or may, in some instances, integrate into the genome itself. Expression vectors should contain a promoter and RNA binding sites which are operably linked to the gene to be expressed and are operable in the host organism.
[0061]DNA regions are operably linked or operably associated when they are functionally related to each other. For example, a promoter is operably linked to a coding sequence if it controls the transcription of the sequence; a ribosome binding site is operably linked to a coding sequence if it is positioned so as to permit translation. Generally, operably linked means contiguous and, in the case of leader sequences, contiguous and in reading phase.
[0062]Transformed host cells are cells which have been transformed or transfected with vectors containing DNA coding for proteins or peptides of the present invention and need not express protein or peptide. However, in the present invention, the cells preferably express the protein or peptide.
[0063]Suitable host cells include prokaryotes, yeast cells, or higher eukaryotic organism cells. Prokaryote host cells include gram negative or gram positive organisms, for example Escherichia coli (E. coli) or Bacilli. Higher eukaryotic cells include established cell lines of mammalian origin as described below. Exemplary host cells are E. coli W3110 (ATCC 27,325), E. coli B, E. coli X1776 (ATCC 31,537), E. coli 294 (ATCC 31,446). A broad variety of suitable prokaryotic and microbial vectors are available. E. coli is typically transformed using pBR322. See Bolivar et al., Gene 2, 95 (1977). Promoters most commonly used in recombinant microbial expression vectors include the beta-lactamase (penicillinase) and lactose promoter systems (Chang et al., Nature 275, 615 (1978); and Goeddel et al., Nature 281, 544 (1979), a tryptophan (trp) promoter system (Goeddel et al., Nucleic Acids Res. 8, 4057 (1980) and EPO App. Publ. No. 36,776) and the tac promoter (H. De Boer et al., Proc. Natl. Acad. Sci. USA 80, 21 (1983). The promoter and Shine-Dalgarno sequence (for prokaryotic host expression) are operably linked to the DNA of the present invention, i.e., they are positioned so as to promote transcription of the messenger RNA from the DNA.
[0064]Expression vectors should contain a promoter which is recognized by the host organism. This generally means a promoter obtained from the intended host. Promoters most commonly used in recombinant microbial expression vectors include the beta-lactamase (penicillinase) and lactose promoter systems (Chang et al., Nature 275, 615 (1978); and Goeddel et al., Nature 281, 544 (1979), a tryptophan (trp) promoter system (Goeddel et al., Nucleic Acids Res. 8, 4057 (1980) and EPO App. Publ. No. 36,776) and the tac promoter (H. De Boer et al., Proc. Natl. Acad. Sci. USA 80, 21 (1983). While these are commonly used, other microbial promoters are suitable. Details concerning nucleotide sequences of many have been published, enabling a skilled worker to operably ligate them to DNA encoding the protein in plasmid or viral vectors (Siebenlist et al., Cell 20, 269 (1980). The promoter and Shine-Dalgarno sequence (for prokaryotic host expression) are operably linked to the DNA encoding the desired protein, i.e., they are positioned so as to promote transcription of the protein messenger RNA from the DNA.
[0065]Eukaryotic microbes such as yeast cultures may be transformed with suitable protein-encoding vectors. See e.g., U.S. Pat. No. 4,745,057. Saccharomyces cerevisiae is the most commonly used among lower eukaryotic host microorganisms, although a number of other strains are commonly available. Yeast vectors may contain an origin of replication from the 2 micron yeast plasmid or an autonomously replicating sequence (ARS), a promoter, DNA encoding the desired protein, sequences for polyadenylation and transcription termination, and a selection gene. An exemplary plasmid is YRp7, (Stinchcomb et al., Nature 282, 39 (1979); Kingsman et al., Gene 7, 141 (1979); Tschemper et al., Gene 10, 157 (1980). This plasmid contains the trp1 gene, which provides a selection marker for a mutant strain of yeast lacking the ability to grow in tryptophan, for example ATCC No. 44076 or PEP4-1 (Jones, Genetics 85, 12 (1977). The presence of the trp1 lesion in the yeast host cell genome then provides an effective environment for detecting transformation by growth in the absence of tryptophan.
[0066]Suitable promoting sequences in yeast vectors include the promoters for metallothionein, 3-phospho-glycerate kinase (Hitzeman et al., J. Biol. Chem. 255, 2073 (1980) or other glycolytic enzymes (Hess et al., J. Adv. Enzyme Reg. 7, 149 (1968); and Holland et al., Biochemistry 17, 4900 (1978), such as enolase, glyceraldehyde-3-phosphate dehydrogenase, hexokinase, pyruvate decarboxylase, phosphofructokinase, glucose-6-phosphate isomerase, 3-phosphoglycerate mutase, pyruvate kinase, triosephosphate isomerase, phosphoglucose isomerase, and glucokinase. Suitable vectors and promoters for use in yeast expression are further described in R. Hitzeman et al., EPO Publn. No. 73,657.
[0067]Cultures of cells derived from multicellular organisms are a desirable host for recombinant protein synthesis. In principal, any higher eukaryotic cell culture is workable, whether from vertebrate or invertebrate culture, including insect cells. Propagation of such cells in cell culture has become a routine procedure. See Tissue Culture, Academic Press, Kruse and Patterson, editors (1973). Examples of useful host cell lines are VERO and HeLa cells, Chinese hamster ovary (CHO) cell lines, and W1138, BHK, COS-7, CV, and MDCK cell lines. Expression vectors for such cells ordinarily include (if necessary) an origin of replication, a promoter located upstream from the gene to be expressed, along with a ribosome binding site, RNA splice site (if intron-containing genomic DNA is used), a polyadenylation site, and a transcriptional termination sequence.
[0068]The transcriptional and translational control sequences in expression vectors to be used in transforming vertebrate cells are often provided by viral sources. For example, commonly used promoters are derived from polyoma, Adenovirus 2, and Simian Virus 40 (SV40). See, e.g., U.S. Pat. No. 4,599,308. The early and late promoters are useful because both are obtained easily from the virus as a fragment which also contains the SV40 viral origin of replication. See Fiers et al., Nature 273, 113 (1978). Further, the protein promoter, control and/or signal sequences, may also be used, provided such control sequences are compatible with the host cell chosen.
[0069]An origin of replication may be provided either by construction of the vector to include an exogenous origin, such as may be derived from SV40 or other viral source (e.g. Polyoma, Adenovirus, VSV, or BPV), or may be provided by the host cell chromosomal replication mechanism. If the vector is integrated into the host cell chromosome, the latter may be sufficient.
[0070]Host cells such as insect cells (e.g., cultured Spodoptera frugiperda cells) and expression vectors such as the baculorivus expression vector (e.g., vectors derived from Autographa californica MNPV, Trichoplusia ni MNPV, Rachiplusia ou MNPV, or Galleria ou MNPV) may be employed to make proteins useful in carrying out the present invention, as described in U.S. Pat. Nos. 4,745,051 and 4,879,236 to Smith et al. In general, a baculovirus expression vector comprises a baculovirus genome containing the gene to be expressed inserted into the polyhedrin gene at a position ranging from the polyhedrin transcriptional start signal to the ATG start site and under the transcriptional control of a baculovirus polyhedrin promoter.
[0071]Host cells transformed with nucleotide sequences encoding a protein or peptide of the invention may be cultured under conditions suitable for the expression and recovery of the protein from cell culture. The protein produced by a transformed cell may be secreted or contained intracellularly depending on the sequence and/or the vector used. As will be understood by those of skill in the art, expression vectors containing polynucleotides which encode a protein or peptide of the invention may be designed to contain signal sequences which direct secretion of the protein or peptide through a prokaryotic or eukaryotic cell membrane. Other constructions may be used to join sequences encoding the protein or peptide to nucleotide sequence encoding a polypeptide domain which will facilitate purification of soluble proteins. Such purification facilitating domains include, but are not limited to, metal chelating peptides such as histidine-tryptophan modules that allow purification on immobilized metals, protein A domains that allow purification on immobilized immunoglobulin, and the domain utilized in the FLAGS extension/affinity purification system (Immunex Corp., Seattle, Wash.). The inclusion of cleavable linker sequences such as those specific for Factor XA or enterokinase (Invitrogen, San Diego, Calif.) between the purification domain and the protein or peptide of the invention may be used to facilitate purification. One such expression vector provides for expression of a fusion protein containing a protein or peptide of the invention and a nucleic acid encoding 6 histidine residues preceding a thioredoxin or an enterokinase cleavage site. The histidine residues facilitate purification on IMAC (immobilized metal ion affinity chromatography) as described in Porath, J. et al. (1992, Prot. Exp. Purif. 3: 263-281) while the enterokinase cleavage site provides a means for purifying the protein or peptide of the invention from the fusion protein. A discussion of vectors which contain fusion proteins is provided in Kroll, D. J. et al. (1993; DNA Cell Biol. 12:441-453).
[0072]ACCase activity can be measured spectrophotometrically and also through the isotope exchange technique. ACCase activity was measured spectrophotometrically by coupling the production of ADP to the oxidation of NADH using pyruvate kinase and lactate dehydrogenase. This assay was used to measure overall ACCase activity by supplying acetyl CoA as a substrate. Activity of the full length Ustilago ACCase is detailed in FIG. 2. ACCase activity was measured by way of isotope exchange based upon the fact that ACCase catalyzes the formation of malonyl CoA from acetyl-CoA and bicarbonate. The isotope exchange assay is designed to monitor the incorporation of 14C from bicarbonate into the malonyl CoA product.
[0073]Binding assays were conducted to detect binding to the BC domain, and thus, enabled identification of test compounds. Methods of conducting binding assays are well known in the art. Direct measurement of the binding of radiolabeled ligands is typically performed by incubating numerous concentrations of radioligand with a constant amount of target peptide under equilibrium binding conditions followed by determining the amount of labeled probe specifically bound. "Specifically bound" is defined as total binding minus non-specific binding, where non-specific binding is determined in the presence of excess unlabeled ligand. The strength of the binding interaction between the BC domain and soraphen is high and comparable to binding of soraphen to the full length ACCase (FIGS. 2, 3 and 4). The dissociation constant of the BC domain complexes, for example for soraphen, is from about 10-4 to about 10-14 M, and preferably at 10-7 M to 10-14 M, and more preferably at least 10-8 M to 10-14 M, and still more preferably lower than 2×10-9 M. Complexes can be formed by covalent or noncovalent interactions. Once one possesses a radiolabeled ligand that binds to a target protein, any additional compound that is not radiolabeled can be assayed for binding to the same site using a competition binding assay. A competition binding assay is performed by incubating a constant concentration of target protein and radiolabled ligand with numerous concentrations of test compounds under equilibrium conditions followed by determining the amount of radiolabeled ligand that is specifically bound.
[0074]Thus, a further aspect of the present invention is a composition comprising: (a) an aqueous carrier solution; and (b) the peptide (or ACCase BC domain described herein) solubilized in said aqueous carrier solution. The composition is useful for, among other things, the binding or screening assays described herein. In general, "solubilized" means that the peptide is homogeneously or uniformly dissolved or dispersed in the carrier solution in a manner that makes the peptide in the composition available for participation in the binding events (e.g., soraphen binding) described herein. The carrier solution may be any suitable aqueous solution that comprises, consists of or consists essentially of water, along with other typical optional ingredients such as buffers, agents for adjusting pH, preservatives, etc. In general, the peptide is included in the composition in any suitable amount, for example from 0.001, 0.01 or 0.1 nanograms up to 0.1, 1, 10, or 20 milligrams per milliliter of aqueous carrier solution. The peptide is in a physical form in the composition that renders it suitable for a binding assay and thus has a soraphen dissociation constant in said composition of, for example, from 10-4 Up to 10-14 M. The pH of the composition may be at, or adjusted to be at, a pH suitable for binding studies, such as a pH of 5 through 9. Preferably, the Evolutionary Chemistry process as referenced herein could be utilized to identify test compounds that bind to the BC domain. In such instance, the composition should be comprised of an aqueous carrier solution containing a BC domain peptide, possessing a soraphen dissociation constant of 10-8 to 10-9 M. The BC domain would be utilized at a concentration of 0.02 to 20 milligrams per milliliter at pH 7 incubated in combination with one or more RNA-tethered test compounds for 1 hour to enable equilibrium binding to occur. Depending upon the level of stringency applied, low affinity test compounds would be washed away from the BC domain peptide and high affinity binding compounds would be retained. The retained compounds are potential ACCase inhibitors.
[0075]Alternatively, ACCase inhibitors could be identified in a screen based on the principle of competition binding with soraphen. As mentioned previously, one way to detect competitive binding is by use of radiolabeled soraphen. In such instance, the composition should be comprised of an aqueous carrier solution containing a BC domain peptide, possessing a soraphen dissociation constant of 10-8 to 10-9 M. The BC domain would be utilized at a concentration of 5 nM to 10 nM at pH 7 incubated in combination with 3H-soraphen (with a specific activity greater than 500 cpm per picomole) at a concentration 10% to 90% that of the BC domain, and with one or more test compounds at a concentration of 10-4 M to 10-10 M for 1 hour or more to enable equilibrium binding. The amount of 3H-soraphen that remains bound to the BC domain would then be determined. A reduction in the amount of bound soraphen indicates that the test compound or compounds can bind to the same site on the BC domain and thus represent potential ACCase inhibitors.
[0076]Another preferred method to screen for ACCase inhibitors based on the principle of competitive binding with soraphen is by a fluorescence polarization assay. In this method, a fluorescent soraphen derivative that retained high affinity for BC domains would need to be acquired or prepared through standard synthetic procedures. In such instance, the composition should be comprised of an aqueous carrier solution containing a BC domain peptide, possessing a fluorescent-soraphen derivative dissociation constant of 10-6 M to 10-9 M. The BC domain would be utilized at a concentration approximately equal to the dissociation constant of the fluorescent probe, and incubated in the presence of one or more test compounds at a concentration of 10-4 M to 10-10 M for 1 hour or more to enable equilibrium binding. The fluorescence polarization would then be measured. Since the fluorescence polarization is directly related to the amount of fluorescent-soraphen derivative bound, a reduction in fluorescence polarization indicates that the test compound or compounds can bind to the same site on the BC domain and thus represent potential ACCase inhibitors.
[0077]Evolutionary chemistry (EC) as described herein relates to the process wherein product libraries are formed by combining a pool of first chemical reactants coupled to a nucleic acid with a pool of free chemical reactants. The coupled nucleic acid is capable of mediating the chemical reaction which leads to the product library and further the nucleic acid is amplifiable so a product which has a predetermined desirable characteristic can be enriched for and identified from the product library. In its most general form, a nucleic acid-reactant test mixture is formed by attaching a first reactant (R) to each of the nucleic acids in a test mixture (containing 102 to 1018 nucleic acids with randomized sequences). The nucleic acid-reactant test mixture is treated with other free reactants that will combine with the first reactant (R) to form different products. It is important to note that from the nucleic acid test mixture (NA), discrete nucleic acid sequences will be associated with facilitating the formation of the different shaped products and are denoted, for example, by sequence-A, sequence-B and sequence-C. The products may differ in shape, reactivity or both shape and reactivity. Partitioning of the desirable product shape or reactivity is accomplished by binding to or reaction with a target. Proteins, small molecules, lipids, saccharides, etc., are all examples of targets (T). After binding to or reacting with the target the non-interacting products, which are attached to sequence-B and sequence-C are separated from sequence-A and discarded. The nucleic acid sequence-A is then amplified by a variety of methods known to those experienced in the art. Sequence-A is then used to facilitate the assembly of the desirable product by facilitating the specific reaction to form the selected product on treatment with the mixture of starting reactants. In a typical reaction, Sequence-A can be reattached to the first reactant, however, said reattachment is not always required. This is an idealized case and in many examples the nucleic acid facilitator may assemble more than one product from the starting mixture, but all of the products selected will have the desired properties of binding to or chemical reaction with the target. EC is more fully described in U.S. Pat. Nos. 6,048,698; 6,030,776; 5,858,660; 5,789,160; 5,723,592; and 5,723,289.
[0078]In sum, BC peptide domains, as exemplified by Ustilago pCS8, are expressed at high levels, can be purified to homogeneity, are stable under typical laboratory conditions, and exhibit high affinity soraphen binding comparable to that of full length ACCase (FIG. 5). Therefore, it is an excellent agent for use in target based affinity binding screens and selections, including but not limited to evolutionary chemistry selections, for the identification of ACCase inhibitors.
[0079]In some assays it may be desirable to use a first peptide of the present invention in conjunction (e.g., sequentially or simultaneously) with a second peptide that serves as a counterselection agent. For one embodiment, the counterselection agent may be a peptide of the same species as the first peptide (that is, with substantially the same amino acid sequence as the first peptide), but with a nonfunctional BC domain (for example, by introduction of a deletion or substitution mutation therein), to select against agents that bind non-specifically (e.g., not at the soraphen binding site) to the first peptide. An example would be an S. cerevisiae first peptide and a corresponding S. cerevisiae second peptide in which the second peptide contains a mutation that disrupts soraphen binding (e.g., S77->Y). In another embodiment, the second peptide counterselection agent may be a peptide of a different species as the first peptide, but with a functional BC domain, to detect agents that bind to and act on the first species but not the second species. For example, the first peptide may be non-mammalian, and the second peptide may be ammalian or human (e.g., to select against agents that are active on the mammalian or human ACCase). Where a species contains two different ACCases such as does human, the first and second peptide may be of the same species but a different ACCase (e.g., human ACC1 and human ACC2). In either embodiment, the first and second peptides can be provided together as kits or sets, either per se or as compositions/formulations as described above, which may be stored, utilized and/or packaged together, optionally including instructions for their use in assays as described herein.
[0080]While the present invention has been described primarily with reference to a ACCase BC domains isolated from Ustilago maydis (FIG. 6; SEQ ID NO: 2), Phytophthora infestans (FIG. 7; SEQ ID NO: 4), Magnaporthe grisea (SEQ ID NO: 6), Saccharomyces cerevisiae (SEQ ID NO: 8), and Homo sapiens (SEQ ID NOS: 10, 12, 14, 16), it will be appreciated that distantly related organisms may be substituted for the organisms described herein. For example, peptides of the present invention may be isolated from other fungal, insect, or plant species, such as set forth in Tables 1-3 below, including any other members of the kingdoms, divisions, classes, orders or families set forth therein, as well as nematodes and mammals.
TABLE-US-00001 TABLE 1 Fungal Pests (Kingdom = Fungi if Division is not Oomycota; If Division = Oomycota, then Kingdom = Chromista) Common Major Genus Species Name Family Order Class Division Crop Magnaporthe grisea rice blast Magnaporthaceae Diaporthales Ascomycetes Ascomycota rice Erysiphe graminis powdery Erysiphaceae Erysiphales Ascomycetes Ascomycota wheat tritici mildew Septoria nodorum septoria Leptosphaeriaceae Pleosporales Ascomycetes Ascomycota wheat (Leptosphaeria) and tritici Gaeumannomyces graminis take-all Pythiaceae Pythiales Oomycetes Oomycota wheat Pythium spp Pythiaceae Pythiales Oomycetes Oomycota turf Puccinia sorghi stalk rot/rust Pucciniaceae Uredinales Urediniomycetes Basidiomycota maize Aspergillus flavus Trichocomaceae Eurotiales Ascomycetes Ascomycota maize Phytophthora Infestans late blight Pythiaceae Pythiales Oomycetes Oomycota potatoes Fusarium spp wilt Nectriaceae Hypocreales Ascomycetes Ascomycota potatoes Botrytis spp Clavicipitaceae Hypocreales Ascomycetes Ascomycota tree/vines Alternaria spp Pleosporaceae Pleosporales Ascomycetes Ascomycota Cercospora spp Mycosphaerellaceae Mycosphaerellales Ascomycetes Ascomycota Rhizoctonia spp Platygloeaceae Platygloeales Ustilaginomycetes Basidiomycota Ceratobasidiaceae Ceratobasidiales Basidiomycetes Basidiomycota Peronospora spp Downy Peronosporaceae Peronosporales Oomycetes Oomycota mildew Colletotrichum Glomerella Glomerellaceae Ascomycetes Ascomycota spp Bremia spp Downy Peronosporaceae Peronosporales Oomycetes Oomycota mildew
TABLE-US-00002 TABLE 2 Insect Pests (Kingdom = Animalia; Phylum = Arthropoda) Major Genus Species Common Name Family Order Class Crop Nilaparvata lugens Brown planthopper Delphacidae Hemiptera Insecta rice Mayetiola destructor Hessian fly Cecidomyiidae Diptera Insecta wheat Heliothis zea Corn earworm/ Noctuidae Lepidoptera Insecta maize bollworm Ostrinia nubilalis European cornborer Pyralidae/Crambidae Lepidoptera Insecta maize Diabrotica spp Corn rootworm Chrysomelidae Coleoptera Insecta maize Myzus spp aphid Aphididae Homoptera Insecta potato Leptinotarsa decemlineata Colorado beetle Chrysomelidae Coleoptera Insecta potato Pectinophora gossypiella Pink bollworm Gelechiidae Lepidoptera Insecta cotton Heliothis spp Noctuidae Lepidoptera Insecta cotton whiteflies Aleyrodidae Homoptera Insecta Potato leafhopper Cicadellidae Hemiptera Insecta Plutella xylostella Diamondback moth Plutellidae Lepidoptera Insecta Chaetocnema Flea beetles Chrysomelidae Coleoptera Insecta spp
TABLE-US-00003 TABLE 3 Weedy Pests (Kingdom = Plantae; Division = Magnoliophyta) Major Genus Species Common Name Family Order Class Crop Echinochloa crus-galli Barnyard grass Poaceae Cyperales Liliopsida rice, cotton Echinochloa colonum Poaceae Cyperales Liliopsida maize Avena fatua Wild oats Poaceae Cyperales Liliopsida wheat Polygonum convolvulus black bindweed Polygonaceae Polygonales Magnoliopsida wheat Cyperus rotundus sedge Cyperaceae Cyperales Liliopsida maize, cotton Chenopodium album lambsquarters Chenopodiaceae Caryophyllales Magnoliopsida potato Galium spp bedstraw Rubiaceae Ipomoea spp morningglory Convolvulaceae Solanales Magnoliopsida Amaranthus spp pigweed Amaranthaceae Caryophyllales Magnoliopsida Digitaria spp Crabgrass Poaceae Cyperales Liliopsida Lolium spp ryegrass Poaceae Cyperales Liliopsida Sorghum halepense Johnson grass Poaceae Cyperales Liliopsida Panicum miliaceum Wild proso Poaceae Cyperales Liliopsida millet Senna spp Velvet leaf Fabaceae Fabales Magnoliopsida
[0081]The present invention is explained in greater detail in the following non-limiting Examples and the Figures herein, in which the following abbreviations are used: pCS8--Ustilago maydis, basidomycete, N-terminal His-tag BC domain, 64.6 kDa protein; pCS11--Ustilago maydis, basidomycete, full length ACCase with C-terminal His-tag, 241.4 kDa protein; pCS15-Phytophthora infestans, oomycete C-terminal His-tag BC domain, 63.3 kDa protein; pCS16--Saccharomyces cerevisiae, wild type N-terminal His-tag BC domain, 68.0 kDa protein; pCS16M--Saccharomyces cerevisiae, S77Y mutant, N-terminal His-tag BC domain, 68.0 kDa protein; pCS17-Magnaporthe grisea, ascomycete, N-terminal His-tag BC domain, 68.2 kDa protein; pCS19--Homo sapiens, C-term His-tag ACC1 BC domain, 71.2 kDa protein; pCS20--Homo sapiens, C-term His-tag ACC2 BC domain, 86.7 kDa protein; pCS201-Escherichia coli, N-terminal His-tag BC protein, 51.6 kDa protein; pCS204--Saccharomyces cerevisiae, C-terminal His-tag wild type full length ACCase protein, 254.3 kDa protein; and pCS204M--Saccharomyces cerevisiae, C-terminal His-tag S77Y mutant full length ACCase protein, 254.3 kDa protein.
Example 1
[0082]A. Preparation of BC Domain Peptide. E. coli cultures transformed with protein expression constructs for BC domains with either N or C terminal his-tags (as illustrated in FIG. 5 for pCS8) were induced by the addition of IPTG (0.2 mM) at an OD600=0.5. The cultures were grown overnight at 18° C., harvested and stored at -80° C. The bacterial pellet was resuspended in a buffer containing 50 mM NaH2PO4 (pH8), 300 mM NaCl, 10 mM imidazole, protease inhibitor and 1 mg/mL lysozyme. The lysate was sonicated and nuclease was added. The lysate was then incubated with Ni-NTA resin (Novagen) for 1 hour at 4° C. pCS8 was eluted with a buffer containing 50 mM NaH2PO4 (pH8), 300 mM NaCl, and 250 mM imidazole. Fractions containing pCS8 were combined and ammonium sulfate precipitated (40% ammonium sulfate). The pellet from the ammonium sulfate precipitation was resuspended in SB (SB=200 mM NaH2PO4 pH 7.0, 10% glycerol). Protein concentrations were determined by Bradford analysis. The purified protein was stored at -80° C.
[0083]B. Purification of BC Domain Peptide. A one-step purification of his-tagged BC domain peptides, as exemplified for pCS8, on Ni-NTA-agarose yields protein that is approximately 90-95% pure as judged by SDS-PAGE was utilized. This method is similar to the purification performed with a histidine-tag attached to the amino terminus of a mutant form of the enzyme and nickel affinity chromatography as described in C. Blanchard et al., "Mutations at Four Active Site Residues of Biotin Carboxylase Abolish Substrate-Induced Synergism by Biotin," Biochemistry, vol. 38, pp. 3393-3400 (1999). After elution from the Ni-NTA agarose column, the pCS8 protein was precipitated by adding an equal volume of saturated ammonium sulfate. The precipitated protein was then resuspended in SB to a concentration of 10 to 20 milligrams per milliliter and stored at -80° C. until used. This method is utilized for purification of all BC domains described herein. Because purer preparations may be required for some purposes, an additional polishing step was investigated. For this purpose, a single UNO-Q (Bio-Rad) anion exchange step subsequent to the Ni-NTA-agarose chromatography purified pCS8 to apparent homogeneity with good yield. UNO-Q is a fast flow matrix that is readily amenable to scale-up. See also FIG. 8.
Example 2
[0084]ACCase Activity Assays. The following methods were employed to detect ACCase activity. See also FIGS. 9A and 9B.
[0085]Method 1: Assay-Spectrophotometric. ACCase activity was measured spectrophotometrically by coupling the production of ADP to the oxidation of NADH using pyruvate kinase and lactate dehydrogenase. This assay was used to measure either overall ACCase activity by supplying acetyl CoA as a substrate, or BC activity by supplying free biotin as a substrate (note, however, that this has only been demonstrated with "prokaryotic type" BC's). This assay is best suited for purified protein. This assay would be used to test for enzymatic activity of compounds identified by virtue of their binding to isolated BC domains, including but not limited to the EC process.
[0086]To establish this assay, E. coli biotin carboxylase was first cloned and expressed according to the literature (Biochemistry 38:3393-3400, 1999). As seen in FIG. 9A, the activity of E. coli BC towards a free biotin substrate was readily detectable. Under the conditions of the assay, activity was detected with as little as 40 ng protein, and a maximal velocity was reached between 2 and 20 μg pCS201. In repeated attempts with multiple pCS8 preparations, however, no activity was detected using up to 7 μg protein. We conclude that pCS8 is unable to carboxylate free biotin, as would be expected since such activity has not been detected utilizing eukaryotic BC domains.
[0087]To measure overall ACCase activity, a full-length Ustilago maydis ACCase was cloned, expressed in E. coli with a C-terminal His-tag (pCS11), and purified. As seen in FIG. 9B(i), the time dependent oxidation of NADH, detected by a decrease in absorbance at 340 nm, was dependent on both pCS11 protein as well as acetyl CoA substrate.
[0088]Method 2: Assay-14C Isotope Exchange. ACCase catalyzes the formation of malonyl CoA from acetyl-CoA and bicarbonate. The isotope exchange assay is designed to monitor the incorporation of 14C from bicarbonate into the malonyl CoA product. Malonyl CoA is acid and heat stable so the unreacted H14CO3- can be removed by acidification followed by evaporation. As can be seen in FIG. 9B(ii) and consistent with the spectrophotometric assay, activity (measured as the incorporation of 14C into malonyl CoA) was dependent on both pCS11 protein and acetyl CoA substrate. Because this an endpoint assay, it is less suitable than the spectrophotometric assay for kinetic measurements; however, it is superior for detecting activity in crude preparations. It will also be used to test for enzymatic activity of compounds identified by virtue of their binding to isolated BC domains, including but not limited to the EC process.
Example 3
[0089]Soraphen binding assay. Affinity based screens and selection assays, including but not limited to EC selections, rely on binding of small molecules and not inhibition of enzymatic activity. Therefore, despite the lack of enzymatic activity, pCS8 would be a suitable affinity based screening or selection agent if it retained the high affinity soraphen binding activity of the full-length Ustilago ACCase. Soraphen A was tritium labeled by Sibtech, Inc. (Newington, Conn.) and used for binding experiments with pCS8 protein. Briefly, 6.7 nM purified pCS8 protein was incubated with various concentrations (approximately 0.5-20 nM) of 3H-soraphen in PNT buffer (100 mM NaH2PO4, 150 mM NaCl, 0.01% Triton X-100, pH 7.0) for 45 min at room temperature. pCS8 protein (with bound ligand) was separated from free ligand on NAP-5 desalting columns (Amersham Biosciences) and the amount of bound 3H-soraphen determined by liquid scintillation counting. Non-specific binding was determined with duplicate samples containing 2 μM cold soraphen. The data were fit by non-linear regression to a one site ligand binding equation: Y=Bmax*X/(KD+X) where Y=bound ligand and X=free ligand.
[0090]pCS8 exhibited saturable binding of 3H-Soraphen consistent with a single high affinity binding site (FIG. 3). The data shown for pCS8 are combined from two experiments with independent protein preps demonstrating little prep-to-prep variability. A negative control was provided by pCS201. pCS201 encodes an N-terminal His-tagged enzymatically active E. coli BC that is not inhibited by soraphen. As expected, pCS201 did not exhibit high affinity soraphen binding.
[0091]Non-linear regression fits of the data gave an estimate of 1.5 nM for the KD Of the soraphen-pCS8 interaction (FIG. 4). This is in good agreement with the KD estimate of the soraphen-pCS11 full length ACCase of 1.6 nM (FIG. 2) and is in good agreement with the published value of a 1.4 nM Ki for soraphen inhibition of Ustilago ACCase activity (Heike Behrbohm Ph.D. thesis, Braunschweig Techn. Univ., 1996). As such, the pCS8 is a suitable affinity-based screening and selection agent as it retains high-affinity soraphen binding comparable to full-length Ustilago ACCase.
Example 4
[0092]Additional characterization of pCS8. No protein degradation or loss of soraphen binding was seen after incubation of SB solubilized pCS8 peptide for 24 h at room temperature. No protein degradation or loss of soraphen binding was seen after storage of SB solubilized pCS8 peptide for 5 weeks at -80° C., including multiple freeze thaws.
Example 5
[0093]Partial summary of BC domains generated. A number of biotin carboxylase (BC) domains that have been characterized herein and can be purified in sufficient quantities for use in affinity based screens or selections, including but not limited to selections using Evolutionary Chemistry, and five BC domains are as follows: wild type versions from Ustilago maydis, Phytophthora infestans, Magnaporthe grisea, and Saccharomyces cerevisiae; and the mutated version from Saccharomyces cerevisiae. Amino acid sequence alignments of the expressed domains are shown in FIG. 10. Identical residues are indicated with an asterisk, and the S to Y mutation in S. cerevisiae that abolishes soraphen binding is indicated in bold.
Example 6
[0094]Generation of the Magnaporthe grisea BC domain. A preliminary sequence of the entire genome of Magnaporthe grisea (ascomycete, causal agent of rice blast) was recently released into the public domain by the Whitehead Institute in collaboration with Ralph Dean's lab at North Carolina State University. The full-length M. grisea ACCase gene was PCR amplified from genomic DNA, cloned, and sequenced. One small predicted intron was removed to create a full-length cDNA. The biotin carboxylase domain was subcloned (based on alignment with our pCS8 U. maydis BC domain) and inserted into a pET vector (5'His tag) to make pCS17. pCS17 was expressed in E. coli and the His-tagged BC domain was purified and assayed for soraphen binding. As expected, the Magnaporthe BC domain exhibited high affinity soraphen binding, as demonstrated in FIG. 11.
Example 7
[0095]Cloning and expression of human ACCase genes. There are at least two forms of the acetyl-CoA carboxylase enzyme in humans. ACC1 is a cytosolic enzyme present at high levels in liver and lipogenic tissues, and is the primary species responsible for fatty acid synthesis. ACC2 is a mitochondrial enzyme found primarily in heart and muscle tissue, and is thought to regulate fatty acid oxidation. Biotin carboxylase domains from human ACCases could potentially be useful as counterselection agents with potential to select against mammalian toxicity. Additionally, agonists and inhibitors of human ACCase that can distinguish between ACC1 and ACC2 BC domains may have potential pharmaceutical applications.
[0096]Complete genomic DNA sequences are available for both genes. Their BC domains (based on homology with our pCS8 ustilago clone) were successfully cloned by amplifying small exons from genomic DNA and using PCR to splice them together. The ACC1 BC domain consists of 14 exons, 104 bp to 237 bp in length, which were assembled to make an 1896 bp (SEQ ID NO: 9) BC domain cDNA. The ACC2 BC domain consists of 14 exons, 108-661 bp in length, assembled to make a 2322 bp (SEQ ID NO: 11) BC domain cDNA. Both BC domains were cloned into pET30 to make 3' His-tagged fusion proteins, The ACC1 clone is designated pCS19 and should produce a fusion protein of 71.2 kD. The ACC2 clone is designated pCS20 and should produce a fusion protein of 86.7 kD. Expression analysis showed that the ACC1 fusion protein is expressed at low levels in E. coli and can be purified from the soluble fraction. The purified pCS19 protein exhibited high affinity soraphen binding (see FIG. 12). Alignments of the Ustilago and human ACCase domains are depicted in FIG. 13. Besides being useful in identifying selective agrochemicals, a particularly intriguing use of the human BC domains is to identify specific inhibitors that preferentially target the ACC2 domain, but not the ACC1 domain, since such inhibitors could prove useful in controlling body weight.
Example 8
[0097]This example demonstrates that pCS8 has binding characteristics amenable for use in affinity based screening or selection procedures.
[0098]Soraphen off-rate determination. Kinetic aspects of binding interactions are an important parameter in designing optimal conditions for affinity-based screening and selection assays, including but not limited to EC. Therefore, soraphen dissociation experiments were performed to determine the off-rate for the binding interaction using the Ustilago BC domain (pCS8). 53.6 pmol pCS8 protein was incubated with 30 pmol 3H-soraphen in a volume of 2 ml for 15 min. The protein with bound soraphen was separated from free soraphen on NAP5 columns and eluted in a total of 4 ml. Cold soraphen was added to 2 μM and dissociation of the bound soraphen was followed by removing 0.5 ml aliquots at various times and applying them to NAP 5 columns to again separate bound from free radiolabel. The 3H-soraphen in the eluted fractions was quantified by liquid scintillation counting and the data were fit to the following equation: Y=Ymax*e-kt+NS (FIG. 14).
[0099]This off rate corresponds to 10.7 min half-life. Note that the on-rate can be calculated from this data since Kd=koff/kon; so kon=9.31×105 M-1 s-1. At 10 μM protein, even with very low ligand concentrations, such a binding interaction would approach equilibrium very rapidly.
Example 9
[0100]Competitive Binding Assay. Isolated biotin carboxylase domains and radiolabeled soraphen can be employed in a competitive binding assay to test the ability of any compound to bind to the soraphen binding site. Like soraphen, such compounds are likely to inhibit ACCase activity. To exemplify this assay, we prepared two soraphen derivatives with modifications at the 5-position (soraphen A-conjugate) or 11-position (soraphen C-conjugate). Both derivatives were then tested in competition binding assays with both pCS8 and pCS11 proteins. The proteins were incubated with 3H-soraphen and various concentrations of the 2 conjugates for 1 hr. Bound 3H-soraphen was then separated from unbound on NAP 5 columns and quantified by scintillation counting. To estimate the conjugates Ki's, the resulting data was fit to an equation for heterologous competitive binding with ligand depletion (H. J. Motulsky, Analyzing Data with GraphPad Prism, 1999, GraphPad Software Inc., San Diego Calif., www.graphpad.com):
##EQU00001##
[0101]Representative data are shown in FIG. 15, in which the soraphen A-conjugate is labeled A-conj and the soraphen C-conjugate is labeled C-conj. As expected, there was no significant difference between the affinities of the conjugates for the BC domain (pCS8) (FIG. 15A) and the full-length protein (pCS11) (FIG. 15B). As a positive control for this assay, an experiment using cold soraphen A as the competitor was performed and yielded a Ki estimate of 1.1 nM (data not shown), consistent with direct saturation binding experiments.
Example 10
[0102]Soraphen resistant Saccharomyces cerevisiae ACCase and ACCase BC domain mutants--Counterselection Agents. Mutation of Serine 77 to Tyrosine in the S. cerevisiae ACCase protein has been shown to confer soraphen resistance (European Patent Application 94810710, 1994; and U.S. Pat. No. 5,641,666, 1997).
[0103]This soraphen resistance mutation was introduced into pCS204, a yeast expression vector containing the full-length S. cerevisiae ACCase gene constructed by cloning a PCR-amplified full-length S. cerevisiae ACCase gene into the expression vector pYES2 for inducible overexpression of His-tagged ACCase in S. cerevisiae. The resulting construct was designated pCS204M. The S. cerevisiae biotin carboxylase domains from pCS204 and pCS204M were then subcloned into an E. coli pET expression vector to form pCS16 and pCS16M, respectively. Like pCS8, both of these constructs express their respective BC domains as N-terminal-His-tagged fusion proteins to facilitate purification. Expression analysis demonstrated that both pCS16 and pCS 16M yielded comparable amounts of purified, soluble protein. The products were then analyzed by size exclusion chromatography and, like pCS8 protein, both were found to exist primarily as monomers (>90%). The proteins were then tested for soraphen binding and the results are shown in FIG. 16. pCS16 protein exhibited high-affinity soraphen binding comparable to pCS8 protein. In contrast, soraphen binding by pCS16M was similar to the non-specific control (Data not shown) confinning that introduction of this single amino acid mutation into a BC domain abolishes soraphen binding. Therefore, pCS16M protein would be an excellent counter-selection agent to eliminate non-soraphen-binding-site interactions.
[0104]The effect of the mutation on full-length ACCase was also assessed. pCS204 and pCS204M were overexpressed in S. cerevisiae and purified by Ni-NTA chromatography. Both proteins appeared identical on SDS-PAGE (Data not shown).
[0105]The proteins were then assayed for ACCase activity using the 14C isotope exchange assay. The resulting data were similar to those from a published report (Curr. Genet. 25:95-100 (1994)) comparing the activity of the endogenous protein from wild type and mutant yeast, and demonstrate that pCS204M protein activity is insensitive to soraphen but still sensitive to avidin inhibition (Table 4).
TABLE-US-00004 TABLE 4 Relative Enzymatic Activity (%) Mutant Treatment WT enzyme* enzyme* pCS204 pCS204M Control 100.0 100.0 100.0 100.0 +150 μg/mL 0.8 74.7 7.5 105 soraphen A +1.5 μg/mL 1.0 74.9 11.6 101 soraphen A +1.5 ng/mL 71.8 79.4 92.0 103 soraphen A +250 μg/ml avidin 0.4 0.1 2.1 2.5 - acetyl CoA 0.6 0.2 2.0 2.8 *Data from Curr. Genet. 25: 95-100 (1994).
[0106]Finally, pCS204 and pCS204M were assayed for soraphen A binding and the results are shown in FIG. 17. Full-length pCS204 protein bound soraphen with similar high affinity as the BC domain expressed by pCS16. Soraphen binding by pCS204M, like that of pCS 16M, was comparable to the non-specific control.
[0107]The foregoing is illustrative of the present invention, and is not to be construed as limiting thereof. The invention is defined by the following claims, with equivalents of the claims to be included therein.
Sequence CWU
1
7111677DNAUstilago maydisCDS(1)..(1677)ACCase BC domain (aa 2-560) 1ccg
cct ccg gat cac aag gca gtc agc cag ttt atc ggc ggc aac ccg 48Pro
Pro Pro Asp His Lys Ala Val Ser Gln Phe Ile Gly Gly Asn Pro1
5 10 15ctt gaa acc gct ccc gcc agc
cct gtt gcc gac ttt att cgc aaa cag 96Leu Glu Thr Ala Pro Ala Ser
Pro Val Ala Asp Phe Ile Arg Lys Gln 20 25
30ggt ggt cac agt gtc atc acc aag gtc ctc att tgc aac aac
ggt atc 144Gly Gly His Ser Val Ile Thr Lys Val Leu Ile Cys Asn Asn
Gly Ile 35 40 45gcc gcc gtc aag
gag att cgc tcc atc cga aaa tgg gcc tac gag acc 192Ala Ala Val Lys
Glu Ile Arg Ser Ile Arg Lys Trp Ala Tyr Glu Thr 50 55
60ttt ggc gat gag cgt gcc att gaa ttt acc gtc atg gcc
acc cct gag 240Phe Gly Asp Glu Arg Ala Ile Glu Phe Thr Val Met Ala
Thr Pro Glu65 70 75
80gac ctc aaa gtc aat gcc gac tac atc cgc atg gcc gac caa tac gtc
288Asp Leu Lys Val Asn Ala Asp Tyr Ile Arg Met Ala Asp Gln Tyr Val
85 90 95gag gta ccc ggt ggc tct
aac aac aac aac tac gct aac gtc gac ctc 336Glu Val Pro Gly Gly Ser
Asn Asn Asn Asn Tyr Ala Asn Val Asp Leu 100
105 110atc gtc gat gtc gct gag cga gcc ggc gtt cac gcc
gta tgg gct ggc 384Ile Val Asp Val Ala Glu Arg Ala Gly Val His Ala
Val Trp Ala Gly 115 120 125tgg ggt
cac gcc tcc gag aac cca cgc cta cct gaa tcg ctc gcc gcc 432Trp Gly
His Ala Ser Glu Asn Pro Arg Leu Pro Glu Ser Leu Ala Ala 130
135 140tcc aag cac aag atc atc ttt atc ggt ccc ccc
ggc tcc gcc atg cgc 480Ser Lys His Lys Ile Ile Phe Ile Gly Pro Pro
Gly Ser Ala Met Arg145 150 155
160tcg ctt ggt gac aag atc tcg tcc acc atc gtc gca cag cac gcc gac
528Ser Leu Gly Asp Lys Ile Ser Ser Thr Ile Val Ala Gln His Ala Asp
165 170 175gtg cca tgc atg ccc
tgg tcc ggt acc ggc atc aag gag acc atg atg 576Val Pro Cys Met Pro
Trp Ser Gly Thr Gly Ile Lys Glu Thr Met Met 180
185 190agc gat cag ggt ttc ctg acc gtc tcg gac gac gtc
tac caa cag gcc 624Ser Asp Gln Gly Phe Leu Thr Val Ser Asp Asp Val
Tyr Gln Gln Ala 195 200 205tgc atc
cac acc gct gaa gaa ggt ctt gag aag gcc gaa aag atc ggc 672Cys Ile
His Thr Ala Glu Glu Gly Leu Glu Lys Ala Glu Lys Ile Gly 210
215 220tac ccc gtc atg atc aag gcc tcc gaa ggt gga
gga gga aag ggt atc 720Tyr Pro Val Met Ile Lys Ala Ser Glu Gly Gly
Gly Gly Lys Gly Ile225 230 235
240cga aag tgt acc aac ggc gaa gaa ttc aag cag ctc tac aac gcc gtt
768Arg Lys Cys Thr Asn Gly Glu Glu Phe Lys Gln Leu Tyr Asn Ala Val
245 250 255ctc ggt gaa gtg ccc
ggc tcg ccc gtt ttc gtt atg aaa ctc gcc ggc 816Leu Gly Glu Val Pro
Gly Ser Pro Val Phe Val Met Lys Leu Ala Gly 260
265 270cag gcg cgt cat ctc gag gtg cag ctg ctg gcc gat
cag tac ggc aac 864Gln Ala Arg His Leu Glu Val Gln Leu Leu Ala Asp
Gln Tyr Gly Asn 275 280 285gcc atc
agc atc ttt ggt cgt gac tgc tct gtc cag cgt cgt cac caa 912Ala Ile
Ser Ile Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His Gln 290
295 300aag atc atc gag gag gct cct gtc act atc gct
cct gag gat gcc cgc 960Lys Ile Ile Glu Glu Ala Pro Val Thr Ile Ala
Pro Glu Asp Ala Arg305 310 315
320gag tcc atg gag aag gct gcc gtg cgt ctc gcc aaa ctg gtt ggc tac
1008Glu Ser Met Glu Lys Ala Ala Val Arg Leu Ala Lys Leu Val Gly Tyr
325 330 335gtc tct gcc ggt acc
gtc gaa tgg ctc tac tct ccc gag tcg ggc gag 1056Val Ser Ala Gly Thr
Val Glu Trp Leu Tyr Ser Pro Glu Ser Gly Glu 340
345 350ttt gcc ttc ctc gag ctc aac ccc cgt ctt cag gtc
gag cac cct act 1104Phe Ala Phe Leu Glu Leu Asn Pro Arg Leu Gln Val
Glu His Pro Thr 355 360 365acc gag
atg gtc tcg ggt gtc aac att ccc gct gcc cag ctt cag gtc 1152Thr Glu
Met Val Ser Gly Val Asn Ile Pro Ala Ala Gln Leu Gln Val 370
375 380gcc atg ggt atc cct ctc tac tcg atc cgc gac
atc cga acc ctt tac 1200Ala Met Gly Ile Pro Leu Tyr Ser Ile Arg Asp
Ile Arg Thr Leu Tyr385 390 395
400ggc atg gac cct cgc ggt aat gag gtc atc gac ttt gac ttc tct agc
1248Gly Met Asp Pro Arg Gly Asn Glu Val Ile Asp Phe Asp Phe Ser Ser
405 410 415ccc gag tcg ttc aag
acc cag cgc aag cct cag ccc cag ggc cac gta 1296Pro Glu Ser Phe Lys
Thr Gln Arg Lys Pro Gln Pro Gln Gly His Val 420
425 430gtc gcc tgc cgt atc act gcc gaa aac ccc gac acc
ggc ttc aag cct 1344Val Ala Cys Arg Ile Thr Ala Glu Asn Pro Asp Thr
Gly Phe Lys Pro 435 440 445ggc atg
ggt gcc ctc act gag ctc aac ttc cgc tcc agc acc tcc acc 1392Gly Met
Gly Ala Leu Thr Glu Leu Asn Phe Arg Ser Ser Thr Ser Thr 450
455 460tgg ggt tac ttc tcc gtc ggc acc agc ggt gct
ctc cac gag tac gcc 1440Trp Gly Tyr Phe Ser Val Gly Thr Ser Gly Ala
Leu His Glu Tyr Ala465 470 475
480gat tcg cag ttc gga cac atc ttt gcc tat ggt gcc gac cga tcc gag
1488Asp Ser Gln Phe Gly His Ile Phe Ala Tyr Gly Ala Asp Arg Ser Glu
485 490 495gcg cga aaa cag atg
gtc atc tcg ctc aag gag ctc tcc att cgc ggt 1536Ala Arg Lys Gln Met
Val Ile Ser Leu Lys Glu Leu Ser Ile Arg Gly 500
505 510gac ttc cgt acc acc gtc gaa tac ctc atc aag ttg
ctc gag acc gac 1584Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile Lys Leu
Leu Glu Thr Asp 515 520 525gcc ttc
gag tcc aac aag atc acc act gga tgg ctc gat ggt ctc att 1632Ala Phe
Glu Ser Asn Lys Ile Thr Thr Gly Trp Leu Asp Gly Leu Ile 530
535 540cag gac cgt ctc act gcc gaa cga cct cct gcg
gac ctc gct gtc 1677Gln Asp Arg Leu Thr Ala Glu Arg Pro Pro Ala
Asp Leu Ala Val545 550 5552559PRTUstilago
maydis 2Pro Pro Pro Asp His Lys Ala Val Ser Gln Phe Ile Gly Gly Asn Pro1
5 10 15Leu Glu Thr Ala
Pro Ala Ser Pro Val Ala Asp Phe Ile Arg Lys Gln 20
25 30Gly Gly His Ser Val Ile Thr Lys Val Leu Ile
Cys Asn Asn Gly Ile 35 40 45Ala
Ala Val Lys Glu Ile Arg Ser Ile Arg Lys Trp Ala Tyr Glu Thr 50
55 60Phe Gly Asp Glu Arg Ala Ile Glu Phe Thr
Val Met Ala Thr Pro Glu65 70 75
80Asp Leu Lys Val Asn Ala Asp Tyr Ile Arg Met Ala Asp Gln Tyr
Val 85 90 95Glu Val Pro
Gly Gly Ser Asn Asn Asn Asn Tyr Ala Asn Val Asp Leu 100
105 110Ile Val Asp Val Ala Glu Arg Ala Gly Val
His Ala Val Trp Ala Gly 115 120
125Trp Gly His Ala Ser Glu Asn Pro Arg Leu Pro Glu Ser Leu Ala Ala 130
135 140Ser Lys His Lys Ile Ile Phe Ile
Gly Pro Pro Gly Ser Ala Met Arg145 150
155 160Ser Leu Gly Asp Lys Ile Ser Ser Thr Ile Val Ala
Gln His Ala Asp 165 170
175Val Pro Cys Met Pro Trp Ser Gly Thr Gly Ile Lys Glu Thr Met Met
180 185 190Ser Asp Gln Gly Phe Leu
Thr Val Ser Asp Asp Val Tyr Gln Gln Ala 195 200
205Cys Ile His Thr Ala Glu Glu Gly Leu Glu Lys Ala Glu Lys
Ile Gly 210 215 220Tyr Pro Val Met Ile
Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile225 230
235 240Arg Lys Cys Thr Asn Gly Glu Glu Phe Lys
Gln Leu Tyr Asn Ala Val 245 250
255Leu Gly Glu Val Pro Gly Ser Pro Val Phe Val Met Lys Leu Ala Gly
260 265 270Gln Ala Arg His Leu
Glu Val Gln Leu Leu Ala Asp Gln Tyr Gly Asn 275
280 285Ala Ile Ser Ile Phe Gly Arg Asp Cys Ser Val Gln
Arg Arg His Gln 290 295 300Lys Ile Ile
Glu Glu Ala Pro Val Thr Ile Ala Pro Glu Asp Ala Arg305
310 315 320Glu Ser Met Glu Lys Ala Ala
Val Arg Leu Ala Lys Leu Val Gly Tyr 325
330 335Val Ser Ala Gly Thr Val Glu Trp Leu Tyr Ser Pro
Glu Ser Gly Glu 340 345 350Phe
Ala Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro Thr 355
360 365Thr Glu Met Val Ser Gly Val Asn Ile
Pro Ala Ala Gln Leu Gln Val 370 375
380Ala Met Gly Ile Pro Leu Tyr Ser Ile Arg Asp Ile Arg Thr Leu Tyr385
390 395 400Gly Met Asp Pro
Arg Gly Asn Glu Val Ile Asp Phe Asp Phe Ser Ser 405
410 415Pro Glu Ser Phe Lys Thr Gln Arg Lys Pro
Gln Pro Gln Gly His Val 420 425
430Val Ala Cys Arg Ile Thr Ala Glu Asn Pro Asp Thr Gly Phe Lys Pro
435 440 445Gly Met Gly Ala Leu Thr Glu
Leu Asn Phe Arg Ser Ser Thr Ser Thr 450 455
460Trp Gly Tyr Phe Ser Val Gly Thr Ser Gly Ala Leu His Glu Tyr
Ala465 470 475 480Asp Ser
Gln Phe Gly His Ile Phe Ala Tyr Gly Ala Asp Arg Ser Glu
485 490 495Ala Arg Lys Gln Met Val Ile
Ser Leu Lys Glu Leu Ser Ile Arg Gly 500 505
510Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile Lys Leu Leu Glu
Thr Asp 515 520 525Ala Phe Glu Ser
Asn Lys Ile Thr Thr Gly Trp Leu Asp Gly Leu Ile 530
535 540Gln Asp Arg Leu Thr Ala Glu Arg Pro Pro Ala Asp
Leu Ala Val545 550
55531665DNAPhytophthora infestansCDS(1)..(1665)ACCase BC domain (aa
1-555) 3atg gtg gcc gag gaa gcg ccc ccc gcc gct gat gtt gcg gct tac gcg
48Met Val Ala Glu Glu Ala Pro Pro Ala Ala Asp Val Ala Ala Tyr Ala1
5 10 15gag acg cgc agc gac
agc aac ccg ctg aac tac gcg agc atg gag gag 96Glu Thr Arg Ser Asp
Ser Asn Pro Leu Asn Tyr Ala Ser Met Glu Glu 20
25 30tat gtg cgt ctg cag aag ggt acg cgc ccc att acg
tcc gtt ctg atc 144Tyr Val Arg Leu Gln Lys Gly Thr Arg Pro Ile Thr
Ser Val Leu Ile 35 40 45gcc aac
aac ggt atc tcg gcc gtc aag gcc atc cgc agc atc cgc agc 192Ala Asn
Asn Gly Ile Ser Ala Val Lys Ala Ile Arg Ser Ile Arg Ser 50
55 60tgg agc tac gag atg ttc gct gac gaa cac gtc
gtg acc ttc gtc gtc 240Trp Ser Tyr Glu Met Phe Ala Asp Glu His Val
Val Thr Phe Val Val65 70 75
80atg gct acg ccc gag gat ctt aag gct aat gca gag tac att cgc atg
288Met Ala Thr Pro Glu Asp Leu Lys Ala Asn Ala Glu Tyr Ile Arg Met
85 90 95gcc gaa cac gtc gtc
gaa gtg ccc ggc ggc tcc aac aac cac aac tac 336Ala Glu His Val Val
Glu Val Pro Gly Gly Ser Asn Asn His Asn Tyr 100
105 110gcc aac gta tct ctc atc att gag atc gcc gag cgc
ttc aac gtc gac 384Ala Asn Val Ser Leu Ile Ile Glu Ile Ala Glu Arg
Phe Asn Val Asp 115 120 125gcc gtc
tgg gcc ggc tgg ggc cac gcc tct gag aat ccg ctt ctg ccc 432Ala Val
Trp Ala Gly Trp Gly His Ala Ser Glu Asn Pro Leu Leu Pro 130
135 140gac acg ctc gct cag act gag cgt aag atc gtc
ttt atc ggc ccc ccg 480Asp Thr Leu Ala Gln Thr Glu Arg Lys Ile Val
Phe Ile Gly Pro Pro145 150 155
160ggc aag ccc atg cgt gca ttg ggc gac aag atc ggc tcc act atc atc
528Gly Lys Pro Met Arg Ala Leu Gly Asp Lys Ile Gly Ser Thr Ile Ile
165 170 175gcg cag agc gct aag
gtg cct aca atc gcc tgg aac ggc gac ggc atg 576Ala Gln Ser Ala Lys
Val Pro Thr Ile Ala Trp Asn Gly Asp Gly Met 180
185 190gaa gtc gac tac aag gaa cac gac gga atc ccc gac
gag atc tac aac 624Glu Val Asp Tyr Lys Glu His Asp Gly Ile Pro Asp
Glu Ile Tyr Asn 195 200 205gcc gct
atg ttg cgt gac ggc cag cac tgt ctg gac gaa tgc aaa cgt 672Ala Ala
Met Leu Arg Asp Gly Gln His Cys Leu Asp Glu Cys Lys Arg 210
215 220atc ggc ttc ccc gtc atg att aaa gcc agc gaa
ggc gga ggt ggc aag 720Ile Gly Phe Pro Val Met Ile Lys Ala Ser Glu
Gly Gly Gly Gly Lys225 230 235
240ggt atc cgt atg gtt cac gaa gag tcc cag gtg ctc agt gcc tgg gaa
768Gly Ile Arg Met Val His Glu Glu Ser Gln Val Leu Ser Ala Trp Glu
245 250 255gct gtg cgt ggt gag
atc cct ggg tct cct atc ttc gtc atg aag ctg 816Ala Val Arg Gly Glu
Ile Pro Gly Ser Pro Ile Phe Val Met Lys Leu 260
265 270gca ccc aag tcg cgt cac ttg gaa gtg cag cta ttg
gcg gat acg tac 864Ala Pro Lys Ser Arg His Leu Glu Val Gln Leu Leu
Ala Asp Thr Tyr 275 280 285ggc aat
gcc atc gct ctc agt ggc cgt gat tgc tcc gtg cag cgt cgt 912Gly Asn
Ala Ile Ala Leu Ser Gly Arg Asp Cys Ser Val Gln Arg Arg 290
295 300cac caa aag atc gtc gag gaa ggt ccc gtt ctt
gcg ccc acc caa gaa 960His Gln Lys Ile Val Glu Glu Gly Pro Val Leu
Ala Pro Thr Gln Glu305 310 315
320gtg tgg gag aag atg atg cgc gcc gcc act cgc ctc gct cag gag gtc
1008Val Trp Glu Lys Met Met Arg Ala Ala Thr Arg Leu Ala Gln Glu Val
325 330 335gag tac gtc aac gcc
ggt acc gtc gag tac ctg ttc agt gag ctg ccg 1056Glu Tyr Val Asn Ala
Gly Thr Val Glu Tyr Leu Phe Ser Glu Leu Pro 340
345 350gaa gac aac ggc aac tcg ttc ttc ttc ctg gaa ctc
aac ccg cgt ttg 1104Glu Asp Asn Gly Asn Ser Phe Phe Phe Leu Glu Leu
Asn Pro Arg Leu 355 360 365cag gtg
gaa cac ccc gtc aca gag atg atc act cat gtg aat ctc cca 1152Gln Val
Glu His Pro Val Thr Glu Met Ile Thr His Val Asn Leu Pro 370
375 380gct gct caa ctg caa gtg gct atg ggt att ccg
ctg cac tgc atc ccg 1200Ala Ala Gln Leu Gln Val Ala Met Gly Ile Pro
Leu His Cys Ile Pro385 390 395
400gat gtg cgt cgt ctg tac aac aag gat gcg ttt gag acg aca gtt att
1248Asp Val Arg Arg Leu Tyr Asn Lys Asp Ala Phe Glu Thr Thr Val Ile
405 410 415gac ttc gac gcg gag
aag cag aag cca ccg cat gga cac gtt atc gcc 1296Asp Phe Asp Ala Glu
Lys Gln Lys Pro Pro His Gly His Val Ile Ala 420
425 430gcg cgt att acc gcc gag gat ccg aac gcc ggt ttc
cag cct acc agt 1344Ala Arg Ile Thr Ala Glu Asp Pro Asn Ala Gly Phe
Gln Pro Thr Ser 435 440 445gga gcc
atc cag gag ctt aac ttc cgt agt acg ccc gat gta tgg ggt 1392Gly Ala
Ile Gln Glu Leu Asn Phe Arg Ser Thr Pro Asp Val Trp Gly 450
455 460tac ttc tcg gtg gac tcg tcc gga cag gtg cac
gag ttc gct gac tca 1440Tyr Phe Ser Val Asp Ser Ser Gly Gln Val His
Glu Phe Ala Asp Ser465 470 475
480cag att ggt cac ctg ttc tcg tgg agt ccg act cgt gaa aag gcc cgt
1488Gln Ile Gly His Leu Phe Ser Trp Ser Pro Thr Arg Glu Lys Ala Arg
485 490 495aag aac atg gtt cta
gcg ctc aag gag ttg tcg att cgt ggt gat att 1536Lys Asn Met Val Leu
Ala Leu Lys Glu Leu Ser Ile Arg Gly Asp Ile 500
505 510cac acg acg gtc gag tac atc gtt aac atg atg gag
tct gat gat ttc 1584His Thr Thr Val Glu Tyr Ile Val Asn Met Met Glu
Ser Asp Asp Phe 515 520 525aag tac
aac cgc atc tcc acg tcg tgg ctg gat gag cgt atc tcg cac 1632Lys Tyr
Asn Arg Ile Ser Thr Ser Trp Leu Asp Glu Arg Ile Ser His 530
535 540cac aat gaa gtg cgt cta cag ggt cgg ccg gac
1665His Asn Glu Val Arg Leu Gln Gly Arg Pro Asp545
550 5554555PRTPhytophthora infestans 4Met
Val Ala Glu Glu Ala Pro Pro Ala Ala Asp Val Ala Ala Tyr Ala1
5 10 15Glu Thr Arg Ser Asp Ser Asn
Pro Leu Asn Tyr Ala Ser Met Glu Glu 20 25
30Tyr Val Arg Leu Gln Lys Gly Thr Arg Pro Ile Thr Ser Val
Leu Ile 35 40 45Ala Asn Asn Gly
Ile Ser Ala Val Lys Ala Ile Arg Ser Ile Arg Ser 50 55
60Trp Ser Tyr Glu Met Phe Ala Asp Glu His Val Val Thr
Phe Val Val65 70 75
80Met Ala Thr Pro Glu Asp Leu Lys Ala Asn Ala Glu Tyr Ile Arg Met
85 90 95Ala Glu His Val Val Glu
Val Pro Gly Gly Ser Asn Asn His Asn Tyr 100
105 110Ala Asn Val Ser Leu Ile Ile Glu Ile Ala Glu Arg
Phe Asn Val Asp 115 120 125Ala Val
Trp Ala Gly Trp Gly His Ala Ser Glu Asn Pro Leu Leu Pro 130
135 140Asp Thr Leu Ala Gln Thr Glu Arg Lys Ile Val
Phe Ile Gly Pro Pro145 150 155
160Gly Lys Pro Met Arg Ala Leu Gly Asp Lys Ile Gly Ser Thr Ile Ile
165 170 175Ala Gln Ser Ala
Lys Val Pro Thr Ile Ala Trp Asn Gly Asp Gly Met 180
185 190Glu Val Asp Tyr Lys Glu His Asp Gly Ile Pro
Asp Glu Ile Tyr Asn 195 200 205Ala
Ala Met Leu Arg Asp Gly Gln His Cys Leu Asp Glu Cys Lys Arg 210
215 220Ile Gly Phe Pro Val Met Ile Lys Ala Ser
Glu Gly Gly Gly Gly Lys225 230 235
240Gly Ile Arg Met Val His Glu Glu Ser Gln Val Leu Ser Ala Trp
Glu 245 250 255Ala Val Arg
Gly Glu Ile Pro Gly Ser Pro Ile Phe Val Met Lys Leu 260
265 270Ala Pro Lys Ser Arg His Leu Glu Val Gln
Leu Leu Ala Asp Thr Tyr 275 280
285Gly Asn Ala Ile Ala Leu Ser Gly Arg Asp Cys Ser Val Gln Arg Arg 290
295 300His Gln Lys Ile Val Glu Glu Gly
Pro Val Leu Ala Pro Thr Gln Glu305 310
315 320Val Trp Glu Lys Met Met Arg Ala Ala Thr Arg Leu
Ala Gln Glu Val 325 330
335Glu Tyr Val Asn Ala Gly Thr Val Glu Tyr Leu Phe Ser Glu Leu Pro
340 345 350Glu Asp Asn Gly Asn Ser
Phe Phe Phe Leu Glu Leu Asn Pro Arg Leu 355 360
365Gln Val Glu His Pro Val Thr Glu Met Ile Thr His Val Asn
Leu Pro 370 375 380Ala Ala Gln Leu Gln
Val Ala Met Gly Ile Pro Leu His Cys Ile Pro385 390
395 400Asp Val Arg Arg Leu Tyr Asn Lys Asp Ala
Phe Glu Thr Thr Val Ile 405 410
415Asp Phe Asp Ala Glu Lys Gln Lys Pro Pro His Gly His Val Ile Ala
420 425 430Ala Arg Ile Thr Ala
Glu Asp Pro Asn Ala Gly Phe Gln Pro Thr Ser 435
440 445Gly Ala Ile Gln Glu Leu Asn Phe Arg Ser Thr Pro
Asp Val Trp Gly 450 455 460Tyr Phe Ser
Val Asp Ser Ser Gly Gln Val His Glu Phe Ala Asp Ser465
470 475 480Gln Ile Gly His Leu Phe Ser
Trp Ser Pro Thr Arg Glu Lys Ala Arg 485
490 495Lys Asn Met Val Leu Ala Leu Lys Glu Leu Ser Ile
Arg Gly Asp Ile 500 505 510His
Thr Thr Val Glu Tyr Ile Val Asn Met Met Glu Ser Asp Asp Phe 515
520 525Lys Tyr Asn Arg Ile Ser Thr Ser Trp
Leu Asp Glu Arg Ile Ser His 530 535
540His Asn Glu Val Arg Leu Gln Gly Arg Pro Asp545 550
55551773DNAMagnaporthe griseaCDS(1)..(1773)ACCase BC domain
(aa 2-592) 5act gag aca aat gga acc gct gcg gct gct aac agc tcc cgt cag
cgc 48Thr Glu Thr Asn Gly Thr Ala Ala Ala Ala Asn Ser Ser Arg Gln
Arg1 5 10 15aac ggc gcc
aac ggc gtc acc gtg cct gtg gcc aac ggc aag gct act 96Asn Gly Ala
Asn Gly Val Thr Val Pro Val Ala Asn Gly Lys Ala Thr 20
25 30tac gct cag agg cac aag att gcc gac cac
ttt att ggc ggc aac agg 144Tyr Ala Gln Arg His Lys Ile Ala Asp His
Phe Ile Gly Gly Asn Arg 35 40
45cta gag aat gcc cct ccg tcc aag gtc aag gag tgg gtt gcc gca cac
192Leu Glu Asn Ala Pro Pro Ser Lys Val Lys Glu Trp Val Ala Ala His 50
55 60gac ggc cac aca gtc atc acc aac gtc
ctg att gcc aac aac ggt atc 240Asp Gly His Thr Val Ile Thr Asn Val
Leu Ile Ala Asn Asn Gly Ile65 70 75
80gct gcc gtc aag gag att cga tcc gtg cga aaa tgg gca tac
gag acg 288Ala Ala Val Lys Glu Ile Arg Ser Val Arg Lys Trp Ala Tyr
Glu Thr 85 90 95ttc gga
gac gaa agg gcc att cag ttc act gtg atg gcc act ccc gag 336Phe Gly
Asp Glu Arg Ala Ile Gln Phe Thr Val Met Ala Thr Pro Glu 100
105 110gat ttg caa gca aac gca gac tac att
cgc atg gca gac cac tac gtc 384Asp Leu Gln Ala Asn Ala Asp Tyr Ile
Arg Met Ala Asp His Tyr Val 115 120
125gag gtc cct ggt ggt aca aac aac aac aac tat gcg aac gtc gag ttg
432Glu Val Pro Gly Gly Thr Asn Asn Asn Asn Tyr Ala Asn Val Glu Leu 130
135 140atc gtc gat gtt gcg gag cgc atg
aac gtg cac gcc gtt tgg gcc ggt 480Ile Val Asp Val Ala Glu Arg Met
Asn Val His Ala Val Trp Ala Gly145 150
155 160tgg gga cac gca tcg gag aac cca aag ctc cct gag
tct ctc gct gcc 528Trp Gly His Ala Ser Glu Asn Pro Lys Leu Pro Glu
Ser Leu Ala Ala 165 170
175tcg cct aag aaa att att ttc atc ggc cct ccc ggc tcc gcg atg cgc
576Ser Pro Lys Lys Ile Ile Phe Ile Gly Pro Pro Gly Ser Ala Met Arg
180 185 190tcg ctc ggt gac aag atc
tct tct acc att gtc gct caa cat gcc cag 624Ser Leu Gly Asp Lys Ile
Ser Ser Thr Ile Val Ala Gln His Ala Gln 195 200
205gtc cca tgt atc ccc tgg tcg gga act ggt gtt gat gcg gtc
caa atc 672Val Pro Cys Ile Pro Trp Ser Gly Thr Gly Val Asp Ala Val
Gln Ile 210 215 220gac aag aag gga att
gtc acc gtc gac gac gac act tat gcc aaa gga 720Asp Lys Lys Gly Ile
Val Thr Val Asp Asp Asp Thr Tyr Ala Lys Gly225 230
235 240tgc gtc act tca tgg cag gag ggt ctt gag
aag gcc aga caa att ggt 768Cys Val Thr Ser Trp Gln Glu Gly Leu Glu
Lys Ala Arg Gln Ile Gly 245 250
255ttc ccg gtc atg atc aag gct tct gag ggt ggt ggt ggc aag ggt atc
816Phe Pro Val Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile
260 265 270cgt aag gct gtc tcc gag
gag ggc ttc gag gag ctc tac aag gcc gct 864Arg Lys Ala Val Ser Glu
Glu Gly Phe Glu Glu Leu Tyr Lys Ala Ala 275 280
285gcc agt gaa atc ccc ggt tcg ccc atc ttc atc atg aag ctt
gca ggc 912Ala Ser Glu Ile Pro Gly Ser Pro Ile Phe Ile Met Lys Leu
Ala Gly 290 295 300aac gcc agg cat ttg
gaa gtg cag ctt ctc gct gat cag tac ggc aac 960Asn Ala Arg His Leu
Glu Val Gln Leu Leu Ala Asp Gln Tyr Gly Asn305 310
315 320aac atc tcc ctc ttt ggt cgt gat tgt tcc
gtc cag cga agg cac caa 1008Asn Ile Ser Leu Phe Gly Arg Asp Cys Ser
Val Gln Arg Arg His Gln 325 330
335aag att atc gag gaa gct ccc gtg acc atc gcc aag ccc gac acg ttc
1056Lys Ile Ile Glu Glu Ala Pro Val Thr Ile Ala Lys Pro Asp Thr Phe
340 345 350aag gcc atg gag gag gcc
gct gtt cgt ctt ggt cgt ctt gtc ggt tac 1104Lys Ala Met Glu Glu Ala
Ala Val Arg Leu Gly Arg Leu Val Gly Tyr 355 360
365gtc tct gct ggt acc gtc gag tac ctg tac tcg cac gcc gac
gac aag 1152Val Ser Ala Gly Thr Val Glu Tyr Leu Tyr Ser His Ala Asp
Asp Lys 370 375 380ttc tac ttc ctg gag
ctc aac cct cgt ctt cag gtc gag cat cct acc 1200Phe Tyr Phe Leu Glu
Leu Asn Pro Arg Leu Gln Val Glu His Pro Thr385 390
395 400act gag ggt gtc agt ggt gtc aac ctc ccc
gct tcg cag ctt cag att 1248Thr Glu Gly Val Ser Gly Val Asn Leu Pro
Ala Ser Gln Leu Gln Ile 405 410
415gcc atg ggt atc cct ctc cac agg ata tct gac att agg ctc ctt tac
1296Ala Met Gly Ile Pro Leu His Arg Ile Ser Asp Ile Arg Leu Leu Tyr
420 425 430ggt gtg gac ccc aag ctc
tcg act gag atc gac ttt gac ttc aag aac 1344Gly Val Asp Pro Lys Leu
Ser Thr Glu Ile Asp Phe Asp Phe Lys Asn 435 440
445ccc gac agc gag aag acg cag agg agg cca tcg ccc aaa ggc
cac ctt 1392Pro Asp Ser Glu Lys Thr Gln Arg Arg Pro Ser Pro Lys Gly
His Leu 450 455 460act gcc tgc cgt att
acc tca gag gac cct gga gag ggc ttc aag ccg 1440Thr Ala Cys Arg Ile
Thr Ser Glu Asp Pro Gly Glu Gly Phe Lys Pro465 470
475 480tcc aac ggt gtc atg cac gag ctg aac ttc
cgc agt agt tca aac gtg 1488Ser Asn Gly Val Met His Glu Leu Asn Phe
Arg Ser Ser Ser Asn Val 485 490
495tgg ggt tac ttc tca gtc ggt acg cag ggt gga att cac agt ttc tcc
1536Trp Gly Tyr Phe Ser Val Gly Thr Gln Gly Gly Ile His Ser Phe Ser
500 505 510gac agt cag ttc ggt cac
att ttc gcc tat ggc gag aac cga tcc gcg 1584Asp Ser Gln Phe Gly His
Ile Phe Ala Tyr Gly Glu Asn Arg Ser Ala 515 520
525tca agg aag cac atg gtt atc gcc ttg aag gaa ctt agc att
cgt ggt 1632Ser Arg Lys His Met Val Ile Ala Leu Lys Glu Leu Ser Ile
Arg Gly 530 535 540gat ttc cgc acc acg
gtc gag tac cta atc aag ctt ctg gag acg gag 1680Asp Phe Arg Thr Thr
Val Glu Tyr Leu Ile Lys Leu Leu Glu Thr Glu545 550
555 560gct ttc gag gag aac acc att acc act ggc
tgg ctg gac gag ctt att 1728Ala Phe Glu Glu Asn Thr Ile Thr Thr Gly
Trp Leu Asp Glu Leu Ile 565 570
575tcg aag aag ctc act gcg gag agg ccc gac aag atg ctt gct gtt
1773Ser Lys Lys Leu Thr Ala Glu Arg Pro Asp Lys Met Leu Ala Val
580 585 5906591PRTMagnaporthe grisea
6Thr Glu Thr Asn Gly Thr Ala Ala Ala Ala Asn Ser Ser Arg Gln Arg1
5 10 15Asn Gly Ala Asn Gly Val
Thr Val Pro Val Ala Asn Gly Lys Ala Thr 20 25
30Tyr Ala Gln Arg His Lys Ile Ala Asp His Phe Ile Gly
Gly Asn Arg 35 40 45Leu Glu Asn
Ala Pro Pro Ser Lys Val Lys Glu Trp Val Ala Ala His 50
55 60Asp Gly His Thr Val Ile Thr Asn Val Leu Ile Ala
Asn Asn Gly Ile65 70 75
80Ala Ala Val Lys Glu Ile Arg Ser Val Arg Lys Trp Ala Tyr Glu Thr
85 90 95Phe Gly Asp Glu Arg Ala
Ile Gln Phe Thr Val Met Ala Thr Pro Glu 100
105 110Asp Leu Gln Ala Asn Ala Asp Tyr Ile Arg Met Ala
Asp His Tyr Val 115 120 125Glu Val
Pro Gly Gly Thr Asn Asn Asn Asn Tyr Ala Asn Val Glu Leu 130
135 140Ile Val Asp Val Ala Glu Arg Met Asn Val His
Ala Val Trp Ala Gly145 150 155
160Trp Gly His Ala Ser Glu Asn Pro Lys Leu Pro Glu Ser Leu Ala Ala
165 170 175Ser Pro Lys Lys
Ile Ile Phe Ile Gly Pro Pro Gly Ser Ala Met Arg 180
185 190Ser Leu Gly Asp Lys Ile Ser Ser Thr Ile Val
Ala Gln His Ala Gln 195 200 205Val
Pro Cys Ile Pro Trp Ser Gly Thr Gly Val Asp Ala Val Gln Ile 210
215 220Asp Lys Lys Gly Ile Val Thr Val Asp Asp
Asp Thr Tyr Ala Lys Gly225 230 235
240Cys Val Thr Ser Trp Gln Glu Gly Leu Glu Lys Ala Arg Gln Ile
Gly 245 250 255Phe Pro Val
Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile 260
265 270Arg Lys Ala Val Ser Glu Glu Gly Phe Glu
Glu Leu Tyr Lys Ala Ala 275 280
285Ala Ser Glu Ile Pro Gly Ser Pro Ile Phe Ile Met Lys Leu Ala Gly 290
295 300Asn Ala Arg His Leu Glu Val Gln
Leu Leu Ala Asp Gln Tyr Gly Asn305 310
315 320Asn Ile Ser Leu Phe Gly Arg Asp Cys Ser Val Gln
Arg Arg His Gln 325 330
335Lys Ile Ile Glu Glu Ala Pro Val Thr Ile Ala Lys Pro Asp Thr Phe
340 345 350Lys Ala Met Glu Glu Ala
Ala Val Arg Leu Gly Arg Leu Val Gly Tyr 355 360
365Val Ser Ala Gly Thr Val Glu Tyr Leu Tyr Ser His Ala Asp
Asp Lys 370 375 380Phe Tyr Phe Leu Glu
Leu Asn Pro Arg Leu Gln Val Glu His Pro Thr385 390
395 400Thr Glu Gly Val Ser Gly Val Asn Leu Pro
Ala Ser Gln Leu Gln Ile 405 410
415Ala Met Gly Ile Pro Leu His Arg Ile Ser Asp Ile Arg Leu Leu Tyr
420 425 430Gly Val Asp Pro Lys
Leu Ser Thr Glu Ile Asp Phe Asp Phe Lys Asn 435
440 445Pro Asp Ser Glu Lys Thr Gln Arg Arg Pro Ser Pro
Lys Gly His Leu 450 455 460Thr Ala Cys
Arg Ile Thr Ser Glu Asp Pro Gly Glu Gly Phe Lys Pro465
470 475 480Ser Asn Gly Val Met His Glu
Leu Asn Phe Arg Ser Ser Ser Asn Val 485
490 495Trp Gly Tyr Phe Ser Val Gly Thr Gln Gly Gly Ile
His Ser Phe Ser 500 505 510Asp
Ser Gln Phe Gly His Ile Phe Ala Tyr Gly Glu Asn Arg Ser Ala 515
520 525Ser Arg Lys His Met Val Ile Ala Leu
Lys Glu Leu Ser Ile Arg Gly 530 535
540Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile Lys Leu Leu Glu Thr Glu545
550 555 560Ala Phe Glu Glu
Asn Thr Ile Thr Thr Gly Trp Leu Asp Glu Leu Ile 565
570 575Ser Lys Lys Leu Thr Ala Glu Arg Pro Asp
Lys Met Leu Ala Val 580 585
59071740DNASaccharomyces cerevisiaeCDS(1)..(1740)ACCase BC domain (aa
2-581) 7tct gaa gaa agc tta ttc gag tct tct cca cag aag atg gag tac gaa
48Ser Glu Glu Ser Leu Phe Glu Ser Ser Pro Gln Lys Met Glu Tyr Glu1
5 10 15att aca aac tac tca
gaa aga cat aca gaa ctt cca ggt cat ttc att 96Ile Thr Asn Tyr Ser
Glu Arg His Thr Glu Leu Pro Gly His Phe Ile 20
25 30ggc ctc aat aca gta gat aaa cta gag gag tcc ccg
tta agg gac ttt 144Gly Leu Asn Thr Val Asp Lys Leu Glu Glu Ser Pro
Leu Arg Asp Phe 35 40 45gtt aag
agt cac ggt ggt cac acg gtc ata tcc aag atc ctg ata gca 192Val Lys
Ser His Gly Gly His Thr Val Ile Ser Lys Ile Leu Ile Ala 50
55 60aat aat ggt att gcc gcc gtg aaa gaa att aga
tcc gtc aga aaa tgg 240Asn Asn Gly Ile Ala Ala Val Lys Glu Ile Arg
Ser Val Arg Lys Trp65 70 75
80gca tac gag acg ttc ggc gat gac aga acc gtc caa ttc gtc gcc atg
288Ala Tyr Glu Thr Phe Gly Asp Asp Arg Thr Val Gln Phe Val Ala Met
85 90 95gcc acc cca gaa gat
ctg gag gcc aac gca gaa tat atc cgt atg gcc 336Ala Thr Pro Glu Asp
Leu Glu Ala Asn Ala Glu Tyr Ile Arg Met Ala 100
105 110gat caa tac att gaa gtg cca ggt ggt act aat aat
aac aac tac gct 384Asp Gln Tyr Ile Glu Val Pro Gly Gly Thr Asn Asn
Asn Asn Tyr Ala 115 120 125aac gta
gac ttg atc gta gac atc gcc gaa aga gca gac gta gac gcc 432Asn Val
Asp Leu Ile Val Asp Ile Ala Glu Arg Ala Asp Val Asp Ala 130
135 140gta tgg gct ggc tgg ggt cac gcc tcc gag aat
cca cta ttg cct gaa 480Val Trp Ala Gly Trp Gly His Ala Ser Glu Asn
Pro Leu Leu Pro Glu145 150 155
160aaa ttg tcc cag tct aag agg aaa gtc atc ttt att ggg cct cca ggt
528Lys Leu Ser Gln Ser Lys Arg Lys Val Ile Phe Ile Gly Pro Pro Gly
165 170 175aac gcc atg agg tct
tta ggt gat aaa atc tcc tct acc att gtc gct 576Asn Ala Met Arg Ser
Leu Gly Asp Lys Ile Ser Ser Thr Ile Val Ala 180
185 190caa agt gct aaa gtc cca tgt att cca tgg tct ggt
acc ggt gtt gac 624Gln Ser Ala Lys Val Pro Cys Ile Pro Trp Ser Gly
Thr Gly Val Asp 195 200 205acc gtt
cac gtg gac gag aaa acc ggt ctg gtc tct gtc gac gat gac 672Thr Val
His Val Asp Glu Lys Thr Gly Leu Val Ser Val Asp Asp Asp 210
215 220atc tat caa aag ggt tgt tgt acc tct cct gaa
gat ggt tta caa aag 720Ile Tyr Gln Lys Gly Cys Cys Thr Ser Pro Glu
Asp Gly Leu Gln Lys225 230 235
240gcc aag cgt att ggt ttt cct gtc atg att aag gca tcc gaa ggt ggt
768Ala Lys Arg Ile Gly Phe Pro Val Met Ile Lys Ala Ser Glu Gly Gly
245 250 255ggt ggt aaa ggt atc
aga caa gtt gaa cgt gaa gaa gat ttc atc gct 816Gly Gly Lys Gly Ile
Arg Gln Val Glu Arg Glu Glu Asp Phe Ile Ala 260
265 270tta tac cac cag gca gcc aac gaa att cca ggc tcc
ccc att ttc atc 864Leu Tyr His Gln Ala Ala Asn Glu Ile Pro Gly Ser
Pro Ile Phe Ile 275 280 285atg aag
ttg gcc ggt aga gcg cgt cac ttg gaa gtt caa ctg cta gca 912Met Lys
Leu Ala Gly Arg Ala Arg His Leu Glu Val Gln Leu Leu Ala 290
295 300gat cag tac ggt aca aat att tcc ttg ttc ggt
aga gac tgt tcc gtt 960Asp Gln Tyr Gly Thr Asn Ile Ser Leu Phe Gly
Arg Asp Cys Ser Val305 310 315
320cag aga cgt cat caa aaa att atc gaa gaa gca cca gtt aca att gcc
1008Gln Arg Arg His Gln Lys Ile Ile Glu Glu Ala Pro Val Thr Ile Ala
325 330 335aag gct gaa aca ttt
cac gag atg gaa aag gct gcc gtc aga ctg ggg 1056Lys Ala Glu Thr Phe
His Glu Met Glu Lys Ala Ala Val Arg Leu Gly 340
345 350aaa cta gtc ggt tat gtc tct gcc ggt acc gtg gag
tat cta tat tct 1104Lys Leu Val Gly Tyr Val Ser Ala Gly Thr Val Glu
Tyr Leu Tyr Ser 355 360 365cat gat
gat gga aaa ttc tac ttt tta gaa ttg aac cca aga tta caa 1152His Asp
Asp Gly Lys Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu Gln 370
375 380gtc gag cat cca aca acg gaa atg gtc tcc ggt
gtt aac tta cct gca 1200Val Glu His Pro Thr Thr Glu Met Val Ser Gly
Val Asn Leu Pro Ala385 390 395
400gct caa tta caa atc gct atg ggt atc cct atg cat aga ata agt gac
1248Ala Gln Leu Gln Ile Ala Met Gly Ile Pro Met His Arg Ile Ser Asp
405 410 415att aga act tta tat
ggt atg aat cct cat tct gcc tca gaa atc gat 1296Ile Arg Thr Leu Tyr
Gly Met Asn Pro His Ser Ala Ser Glu Ile Asp 420
425 430ttc gaa ttc aaa act caa gat gcc acc aag aaa caa
aga aga cct att 1344Phe Glu Phe Lys Thr Gln Asp Ala Thr Lys Lys Gln
Arg Arg Pro Ile 435 440 445cca aag
ggt cat tgt acc gct tgt cgt atc aca tca gaa gat cca aac 1392Pro Lys
Gly His Cys Thr Ala Cys Arg Ile Thr Ser Glu Asp Pro Asn 450
455 460gat gga ttc aag cca tcg ggt ggt act ttg cat
gaa cta aac ttc cgt 1440Asp Gly Phe Lys Pro Ser Gly Gly Thr Leu His
Glu Leu Asn Phe Arg465 470 475
480tct tcc tct aat gtt tgg ggt tac ttc tcc gtg ggt aac aat ggt aat
1488Ser Ser Ser Asn Val Trp Gly Tyr Phe Ser Val Gly Asn Asn Gly Asn
485 490 495att cac tcc ttt tcg
gac tct cag ttc ggc cat att ttt gct ttt ggt 1536Ile His Ser Phe Ser
Asp Ser Gln Phe Gly His Ile Phe Ala Phe Gly 500
505 510gaa aat aga caa gct tcc agg aaa cac atg gtt gtt
gcc ctg aag gaa 1584Glu Asn Arg Gln Ala Ser Arg Lys His Met Val Val
Ala Leu Lys Glu 515 520 525ttg tcc
att agg ggt gat ttc aga act act gtg gaa tac ttg atc aaa 1632Leu Ser
Ile Arg Gly Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile Lys 530
535 540ctt ttg gaa act gaa gat ttc gag gat aac act
att acc acc ggt tgg 1680Leu Leu Glu Thr Glu Asp Phe Glu Asp Asn Thr
Ile Thr Thr Gly Trp545 550 555
560ttg gac gat ttg att act cat aaa atg acc gct gaa aag cct gat cca
1728Leu Asp Asp Leu Ile Thr His Lys Met Thr Ala Glu Lys Pro Asp Pro
565 570 575act ctt gcc gtc
1740Thr Leu Ala Val
5808580PRTSaccharomyces cerevisiae 8Ser Glu Glu Ser Leu Phe Glu Ser
Ser Pro Gln Lys Met Glu Tyr Glu1 5 10
15Ile Thr Asn Tyr Ser Glu Arg His Thr Glu Leu Pro Gly His
Phe Ile 20 25 30Gly Leu Asn
Thr Val Asp Lys Leu Glu Glu Ser Pro Leu Arg Asp Phe 35
40 45Val Lys Ser His Gly Gly His Thr Val Ile Ser
Lys Ile Leu Ile Ala 50 55 60Asn Asn
Gly Ile Ala Ala Val Lys Glu Ile Arg Ser Val Arg Lys Trp65
70 75 80Ala Tyr Glu Thr Phe Gly Asp
Asp Arg Thr Val Gln Phe Val Ala Met 85 90
95Ala Thr Pro Glu Asp Leu Glu Ala Asn Ala Glu Tyr Ile
Arg Met Ala 100 105 110Asp Gln
Tyr Ile Glu Val Pro Gly Gly Thr Asn Asn Asn Asn Tyr Ala 115
120 125Asn Val Asp Leu Ile Val Asp Ile Ala Glu
Arg Ala Asp Val Asp Ala 130 135 140Val
Trp Ala Gly Trp Gly His Ala Ser Glu Asn Pro Leu Leu Pro Glu145
150 155 160Lys Leu Ser Gln Ser Lys
Arg Lys Val Ile Phe Ile Gly Pro Pro Gly 165
170 175Asn Ala Met Arg Ser Leu Gly Asp Lys Ile Ser Ser
Thr Ile Val Ala 180 185 190Gln
Ser Ala Lys Val Pro Cys Ile Pro Trp Ser Gly Thr Gly Val Asp 195
200 205Thr Val His Val Asp Glu Lys Thr Gly
Leu Val Ser Val Asp Asp Asp 210 215
220Ile Tyr Gln Lys Gly Cys Cys Thr Ser Pro Glu Asp Gly Leu Gln Lys225
230 235 240Ala Lys Arg Ile
Gly Phe Pro Val Met Ile Lys Ala Ser Glu Gly Gly 245
250 255Gly Gly Lys Gly Ile Arg Gln Val Glu Arg
Glu Glu Asp Phe Ile Ala 260 265
270Leu Tyr His Gln Ala Ala Asn Glu Ile Pro Gly Ser Pro Ile Phe Ile
275 280 285Met Lys Leu Ala Gly Arg Ala
Arg His Leu Glu Val Gln Leu Leu Ala 290 295
300Asp Gln Tyr Gly Thr Asn Ile Ser Leu Phe Gly Arg Asp Cys Ser
Val305 310 315 320Gln Arg
Arg His Gln Lys Ile Ile Glu Glu Ala Pro Val Thr Ile Ala
325 330 335Lys Ala Glu Thr Phe His Glu
Met Glu Lys Ala Ala Val Arg Leu Gly 340 345
350Lys Leu Val Gly Tyr Val Ser Ala Gly Thr Val Glu Tyr Leu
Tyr Ser 355 360 365His Asp Asp Gly
Lys Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu Gln 370
375 380Val Glu His Pro Thr Thr Glu Met Val Ser Gly Val
Asn Leu Pro Ala385 390 395
400Ala Gln Leu Gln Ile Ala Met Gly Ile Pro Met His Arg Ile Ser Asp
405 410 415Ile Arg Thr Leu Tyr
Gly Met Asn Pro His Ser Ala Ser Glu Ile Asp 420
425 430Phe Glu Phe Lys Thr Gln Asp Ala Thr Lys Lys Gln
Arg Arg Pro Ile 435 440 445Pro Lys
Gly His Cys Thr Ala Cys Arg Ile Thr Ser Glu Asp Pro Asn 450
455 460Asp Gly Phe Lys Pro Ser Gly Gly Thr Leu His
Glu Leu Asn Phe Arg465 470 475
480Ser Ser Ser Asn Val Trp Gly Tyr Phe Ser Val Gly Asn Asn Gly Asn
485 490 495Ile His Ser Phe
Ser Asp Ser Gln Phe Gly His Ile Phe Ala Phe Gly 500
505 510Glu Asn Arg Gln Ala Ser Arg Lys His Met Val
Val Ala Leu Lys Glu 515 520 525Leu
Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile Lys 530
535 540Leu Leu Glu Thr Glu Asp Phe Glu Asp Asn
Thr Ile Thr Thr Gly Trp545 550 555
560Leu Asp Asp Leu Ile Thr His Lys Met Thr Ala Glu Lys Pro Asp
Pro 565 570 575Thr Leu Ala
Val 58091896DNAHomo sapiensCDS(1)..(1896)Human ACCase1 (alpha)
BC domain (aa 1-632) 9atg gat gaa cca tct ccc ttg gcc caa cct ctg gag ctg
aac cag cac 48Met Asp Glu Pro Ser Pro Leu Ala Gln Pro Leu Glu Leu
Asn Gln His1 5 10 15tct
cga ttc ata ata ggt tct gtg tct gaa gat aac tca gag gat gag 96Ser
Arg Phe Ile Ile Gly Ser Val Ser Glu Asp Asn Ser Glu Asp Glu 20
25 30atc agc aac ctg gtg aag ttg gac
cta ctg gag gag aag gag ggc tcc 144Ile Ser Asn Leu Val Lys Leu Asp
Leu Leu Glu Glu Lys Glu Gly Ser 35 40
45ttg tca cct gct tct gtt ggc tca gat aca ctc tct gat ttg ggg atc
192Leu Ser Pro Ala Ser Val Gly Ser Asp Thr Leu Ser Asp Leu Gly Ile
50 55 60tct agc cta cag gat ggc ttg gcc
ttg cac ata agg tcc agc atg tct 240Ser Ser Leu Gln Asp Gly Leu Ala
Leu His Ile Arg Ser Ser Met Ser65 70 75
80ggc ttg cac cta gta aag cag ggc cga gac aga aag aaa
ata gat tct 288Gly Leu His Leu Val Lys Gln Gly Arg Asp Arg Lys Lys
Ile Asp Ser 85 90 95caa
cga gat ttc act gtg gct tct cca gca gaa ttt gtt act cgc ttt 336Gln
Arg Asp Phe Thr Val Ala Ser Pro Ala Glu Phe Val Thr Arg Phe
100 105 110ggg gga aat aaa gtg att gag
aag gtt ctt att gct aac aat ggc att 384Gly Gly Asn Lys Val Ile Glu
Lys Val Leu Ile Ala Asn Asn Gly Ile 115 120
125gca gca gtg aaa tgc atg cgg tct atc cgt agg tgg tct tat gaa
atg 432Ala Ala Val Lys Cys Met Arg Ser Ile Arg Arg Trp Ser Tyr Glu
Met 130 135 140ttt cga aat gaa cgt gca
att aga ttc gtt gtc atg gtc aca cct gaa 480Phe Arg Asn Glu Arg Ala
Ile Arg Phe Val Val Met Val Thr Pro Glu145 150
155 160gac ctt aaa gcc aat gca gaa tac att aag atg
gca gat cac tat gtg 528Asp Leu Lys Ala Asn Ala Glu Tyr Ile Lys Met
Ala Asp His Tyr Val 165 170
175cca gtg cct gga gga cca aac aac aac aac tat gca aat gtg gaa tta
576Pro Val Pro Gly Gly Pro Asn Asn Asn Asn Tyr Ala Asn Val Glu Leu
180 185 190att ctt gat att gct aaa
agg atc cca gtg cag gca gtg tgg gct ggc 624Ile Leu Asp Ile Ala Lys
Arg Ile Pro Val Gln Ala Val Trp Ala Gly 195 200
205tgg ggt cat gct tct gag aat ccc aaa cta ccg gaa ctt ctc
ttg aaa 672Trp Gly His Ala Ser Glu Asn Pro Lys Leu Pro Glu Leu Leu
Leu Lys 210 215 220aat ggc att gcc ttc
atg ggt cct cca agc cag gcc atg tgg gct tta 720Asn Gly Ile Ala Phe
Met Gly Pro Pro Ser Gln Ala Met Trp Ala Leu225 230
235 240ggg gat aag att gca tct tcc ata gtg gct
caa act gca ggt atc cca 768Gly Asp Lys Ile Ala Ser Ser Ile Val Ala
Gln Thr Ala Gly Ile Pro 245 250
255act ctt ccc tgg agc ggc agt ggt ctt cgt gtg gac tgg cag gaa aat
816Thr Leu Pro Trp Ser Gly Ser Gly Leu Arg Val Asp Trp Gln Glu Asn
260 265 270gat ttt tca aaa cgt atc
tta aat gtt ccc cag gag cta tat gaa aaa 864Asp Phe Ser Lys Arg Ile
Leu Asn Val Pro Gln Glu Leu Tyr Glu Lys 275 280
285ggt tat gtg aaa gat gtg gat gat ggg cta aag gca gct gag
gaa gtt 912Gly Tyr Val Lys Asp Val Asp Asp Gly Leu Lys Ala Ala Glu
Glu Val 290 295 300gga tat cca gta atg
atc aag gcc tca gag gga gga gga ggg aag gga 960Gly Tyr Pro Val Met
Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly305 310
315 320att aga aaa gtc aac aat gca gat gac ttc
cct aat ctc ttc aga cag 1008Ile Arg Lys Val Asn Asn Ala Asp Asp Phe
Pro Asn Leu Phe Arg Gln 325 330
335gtt caa gct gaa gtt cct gga tct ccc ata ttt gtg atg aga cta gcc
1056Val Gln Ala Glu Val Pro Gly Ser Pro Ile Phe Val Met Arg Leu Ala
340 345 350aaa caa tct cgt cat ctg
gag gtg cag atc tta gcg gac caa tat ggc 1104Lys Gln Ser Arg His Leu
Glu Val Gln Ile Leu Ala Asp Gln Tyr Gly 355 360
365aat gct atc tct ttg ttt ggt cgt gat tgc tct gta caa cgc
agg cat 1152Asn Ala Ile Ser Leu Phe Gly Arg Asp Cys Ser Val Gln Arg
Arg His 370 375 380cag aag att att gaa
gaa gca cct gct act att gct act cca gca gta 1200Gln Lys Ile Ile Glu
Glu Ala Pro Ala Thr Ile Ala Thr Pro Ala Val385 390
395 400ttt gaa cac atg gaa cag tgt gcg gtg aaa
ctt gcc aaa atg gtg ggt 1248Phe Glu His Met Glu Gln Cys Ala Val Lys
Leu Ala Lys Met Val Gly 405 410
415tat gtg agt gct ggg act gtg gaa tac ctg tac agc cag gat ggc agc
1296Tyr Val Ser Ala Gly Thr Val Glu Tyr Leu Tyr Ser Gln Asp Gly Ser
420 425 430ttc tac ttt ctg gaa ttg
aat cct cgg ctg cag gta gag cac cct tgt 1344Phe Tyr Phe Leu Glu Leu
Asn Pro Arg Leu Gln Val Glu His Pro Cys 435 440
445aca gag atg gtg gct gat gtc aat ctc cct gca gca cag ctc
cag att 1392Thr Glu Met Val Ala Asp Val Asn Leu Pro Ala Ala Gln Leu
Gln Ile 450 455 460gcc atg ggg att cct
cta tat aga atc aag gat atc cgt atg atg tat 1440Ala Met Gly Ile Pro
Leu Tyr Arg Ile Lys Asp Ile Arg Met Met Tyr465 470
475 480ggg gta tct ccc tgg ggt gat tct ccc att
gat ttt gaa gat tct gca 1488Gly Val Ser Pro Trp Gly Asp Ser Pro Ile
Asp Phe Glu Asp Ser Ala 485 490
495cac gtt cct tgt cca agg ggc cat gtt att gct gct cgg atc act agt
1536His Val Pro Cys Pro Arg Gly His Val Ile Ala Ala Arg Ile Thr Ser
500 505 510gaa aat cca gat gag ggt
ttt aag ccc agc tca gga aca gtt cag gag 1584Glu Asn Pro Asp Glu Gly
Phe Lys Pro Ser Ser Gly Thr Val Gln Glu 515 520
525cta aat ttc cgc agc aat aag aat gtt tgg gga tat ttc agt
gtt gct 1632Leu Asn Phe Arg Ser Asn Lys Asn Val Trp Gly Tyr Phe Ser
Val Ala 530 535 540gct gca ggg gga ctt
cat gaa ttt gct gat tct cag ttt ggt cac tgc 1680Ala Ala Gly Gly Leu
His Glu Phe Ala Asp Ser Gln Phe Gly His Cys545 550
555 560ttt tct tgg gga gaa aac aga gaa gag gca
att tca aac atg gtg gtg 1728Phe Ser Trp Gly Glu Asn Arg Glu Glu Ala
Ile Ser Asn Met Val Val 565 570
575gct ttg aag gag ctg tct att cgg ggt gac ttt cga act aca gtt gaa
1776Ala Leu Lys Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu
580 585 590tac ctg atc aaa ttg tta
gag act gaa agc ttt cag atg aac aga att 1824Tyr Leu Ile Lys Leu Leu
Glu Thr Glu Ser Phe Gln Met Asn Arg Ile 595 600
605gat act ggc tgg ctg gac aga ctg ata gca gaa aaa gta cag
gct gag 1872Asp Thr Gly Trp Leu Asp Arg Leu Ile Ala Glu Lys Val Gln
Ala Glu 610 615 620cga cct gac acc atg
ttg ggg gtt 1896Arg Pro Asp Thr Met
Leu Gly Val625 63010632PRTHomo sapiens 10Met Asp Glu Pro
Ser Pro Leu Ala Gln Pro Leu Glu Leu Asn Gln His1 5
10 15Ser Arg Phe Ile Ile Gly Ser Val Ser Glu
Asp Asn Ser Glu Asp Glu 20 25
30Ile Ser Asn Leu Val Lys Leu Asp Leu Leu Glu Glu Lys Glu Gly Ser
35 40 45Leu Ser Pro Ala Ser Val Gly Ser
Asp Thr Leu Ser Asp Leu Gly Ile 50 55
60Ser Ser Leu Gln Asp Gly Leu Ala Leu His Ile Arg Ser Ser Met Ser65
70 75 80Gly Leu His Leu Val
Lys Gln Gly Arg Asp Arg Lys Lys Ile Asp Ser 85
90 95Gln Arg Asp Phe Thr Val Ala Ser Pro Ala Glu
Phe Val Thr Arg Phe 100 105
110Gly Gly Asn Lys Val Ile Glu Lys Val Leu Ile Ala Asn Asn Gly Ile
115 120 125Ala Ala Val Lys Cys Met Arg
Ser Ile Arg Arg Trp Ser Tyr Glu Met 130 135
140Phe Arg Asn Glu Arg Ala Ile Arg Phe Val Val Met Val Thr Pro
Glu145 150 155 160Asp Leu
Lys Ala Asn Ala Glu Tyr Ile Lys Met Ala Asp His Tyr Val
165 170 175Pro Val Pro Gly Gly Pro Asn
Asn Asn Asn Tyr Ala Asn Val Glu Leu 180 185
190Ile Leu Asp Ile Ala Lys Arg Ile Pro Val Gln Ala Val Trp
Ala Gly 195 200 205Trp Gly His Ala
Ser Glu Asn Pro Lys Leu Pro Glu Leu Leu Leu Lys 210
215 220Asn Gly Ile Ala Phe Met Gly Pro Pro Ser Gln Ala
Met Trp Ala Leu225 230 235
240Gly Asp Lys Ile Ala Ser Ser Ile Val Ala Gln Thr Ala Gly Ile Pro
245 250 255Thr Leu Pro Trp Ser
Gly Ser Gly Leu Arg Val Asp Trp Gln Glu Asn 260
265 270Asp Phe Ser Lys Arg Ile Leu Asn Val Pro Gln Glu
Leu Tyr Glu Lys 275 280 285Gly Tyr
Val Lys Asp Val Asp Asp Gly Leu Lys Ala Ala Glu Glu Val 290
295 300Gly Tyr Pro Val Met Ile Lys Ala Ser Glu Gly
Gly Gly Gly Lys Gly305 310 315
320Ile Arg Lys Val Asn Asn Ala Asp Asp Phe Pro Asn Leu Phe Arg Gln
325 330 335Val Gln Ala Glu
Val Pro Gly Ser Pro Ile Phe Val Met Arg Leu Ala 340
345 350Lys Gln Ser Arg His Leu Glu Val Gln Ile Leu
Ala Asp Gln Tyr Gly 355 360 365Asn
Ala Ile Ser Leu Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His 370
375 380Gln Lys Ile Ile Glu Glu Ala Pro Ala Thr
Ile Ala Thr Pro Ala Val385 390 395
400Phe Glu His Met Glu Gln Cys Ala Val Lys Leu Ala Lys Met Val
Gly 405 410 415Tyr Val Ser
Ala Gly Thr Val Glu Tyr Leu Tyr Ser Gln Asp Gly Ser 420
425 430Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu
Gln Val Glu His Pro Cys 435 440
445Thr Glu Met Val Ala Asp Val Asn Leu Pro Ala Ala Gln Leu Gln Ile 450
455 460Ala Met Gly Ile Pro Leu Tyr Arg
Ile Lys Asp Ile Arg Met Met Tyr465 470
475 480Gly Val Ser Pro Trp Gly Asp Ser Pro Ile Asp Phe
Glu Asp Ser Ala 485 490
495His Val Pro Cys Pro Arg Gly His Val Ile Ala Ala Arg Ile Thr Ser
500 505 510Glu Asn Pro Asp Glu Gly
Phe Lys Pro Ser Ser Gly Thr Val Gln Glu 515 520
525Leu Asn Phe Arg Ser Asn Lys Asn Val Trp Gly Tyr Phe Ser
Val Ala 530 535 540Ala Ala Gly Gly Leu
His Glu Phe Ala Asp Ser Gln Phe Gly His Cys545 550
555 560Phe Ser Trp Gly Glu Asn Arg Glu Glu Ala
Ile Ser Asn Met Val Val 565 570
575Ala Leu Lys Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu
580 585 590Tyr Leu Ile Lys Leu
Leu Glu Thr Glu Ser Phe Gln Met Asn Arg Ile 595
600 605Asp Thr Gly Trp Leu Asp Arg Leu Ile Ala Glu Lys
Val Gln Ala Glu 610 615 620Arg Pro Asp
Thr Met Leu Gly Val625 630112322DNAHomo
sapiensCDS(1)..(2322)Human ACCase2 (beta) BC domain (aa 1-774) 11atg gtc
ttg ctt ctt tgt cta tct tgt ctg att ttc tcc tgt ctg acc 48Met Val
Leu Leu Leu Cys Leu Ser Cys Leu Ile Phe Ser Cys Leu Thr1 5
10 15ttt tcc tgg tta aaa atc tgg ggg
aaa atg acg gac tcc aag ccg atc 96Phe Ser Trp Leu Lys Ile Trp Gly
Lys Met Thr Asp Ser Lys Pro Ile 20 25
30acc aag agt aaa tca gaa gca aac ctc atc ccg agc cag gag ccc
ttt 144Thr Lys Ser Lys Ser Glu Ala Asn Leu Ile Pro Ser Gln Glu Pro
Phe 35 40 45cca gcc tct gat aac
tca ggg gag aca ccg cag aga aat ggg gag ggc 192Pro Ala Ser Asp Asn
Ser Gly Glu Thr Pro Gln Arg Asn Gly Glu Gly 50 55
60cac act ctg ccc aag aca ccc agc cag gcc gag cca gcc tcc
cac aaa 240His Thr Leu Pro Lys Thr Pro Ser Gln Ala Glu Pro Ala Ser
His Lys65 70 75 80ggc
ccc aaa gat gcc ggt cgg cgg aga aac tcc cta cca ccc tcc cac 288Gly
Pro Lys Asp Ala Gly Arg Arg Arg Asn Ser Leu Pro Pro Ser His
85 90 95cag aag ccc cca aga aac ccc
ctt tct tcc agt gac gca gca ccc tcc 336Gln Lys Pro Pro Arg Asn Pro
Leu Ser Ser Ser Asp Ala Ala Pro Ser 100 105
110cca gag ctt caa gcc aac ggg act ggg aca caa ggt ctg gag
gcc aca 384Pro Glu Leu Gln Ala Asn Gly Thr Gly Thr Gln Gly Leu Glu
Ala Thr 115 120 125gat acc aat ggc
ctg tcc tcc tca gcc agg ccc cag ggc cag caa gct 432Asp Thr Asn Gly
Leu Ser Ser Ser Ala Arg Pro Gln Gly Gln Gln Ala 130
135 140ggc tcc ccc tcc aaa gaa gac aag aag cag gca aac
atc aag agg cag 480Gly Ser Pro Ser Lys Glu Asp Lys Lys Gln Ala Asn
Ile Lys Arg Gln145 150 155
160ctg atg acc aac ttc atc ctg ggc tct ttt gat gac tac tcc tct gac
528Leu Met Thr Asn Phe Ile Leu Gly Ser Phe Asp Asp Tyr Ser Ser Asp
165 170 175gag gac tct gtt gct
ggc tca tct cgt gag tct acc cgg aag ggc agc 576Glu Asp Ser Val Ala
Gly Ser Ser Arg Glu Ser Thr Arg Lys Gly Ser 180
185 190cgg gcc agc ttg ggg gcc ctg tcc ctg gag gct tat
ctg acc aca ggt 624Arg Ala Ser Leu Gly Ala Leu Ser Leu Glu Ala Tyr
Leu Thr Thr Gly 195 200 205gaa gct
gag acc cgc gtc ccc act atg agg ccg agc atg tcg gga ctc 672Glu Ala
Glu Thr Arg Val Pro Thr Met Arg Pro Ser Met Ser Gly Leu 210
215 220cac ctg gtg aag agg gga cgg gaa cac aag aag
ctg gac ctg cac aga 720His Leu Val Lys Arg Gly Arg Glu His Lys Lys
Leu Asp Leu His Arg225 230 235
240gac ttt acc gtg gct tct ccc gct gag ttt gtc aca cgc ttt ggg ggg
768Asp Phe Thr Val Ala Ser Pro Ala Glu Phe Val Thr Arg Phe Gly Gly
245 250 255gat cgg gtc atc gag
aag gtg ctt att gcc aac aac ggg att gcc gcc 816Asp Arg Val Ile Glu
Lys Val Leu Ile Ala Asn Asn Gly Ile Ala Ala 260
265 270gtg aag tgc atg cgc tcc atc cgc agg tgg gcc tat
gag atg ttc cgc 864Val Lys Cys Met Arg Ser Ile Arg Arg Trp Ala Tyr
Glu Met Phe Arg 275 280 285aac gag
cgg gcc atc cgg ttt gtt gtg atg gtg acc ccc gag gac ctt 912Asn Glu
Arg Ala Ile Arg Phe Val Val Met Val Thr Pro Glu Asp Leu 290
295 300aag gcc aac gca gag tac atc aag atg gcg gat
cat tac gtc ccc gtc 960Lys Ala Asn Ala Glu Tyr Ile Lys Met Ala Asp
His Tyr Val Pro Val305 310 315
320cca gga ggg ccc aat aac aac aac tat gcc aac gtg gag ctg att gtg
1008Pro Gly Gly Pro Asn Asn Asn Asn Tyr Ala Asn Val Glu Leu Ile Val
325 330 335gac att gcc aag aga
att cct ttg cag gcg gtg tgg gct ggc tgg ggc 1056Asp Ile Ala Lys Arg
Ile Pro Leu Gln Ala Val Trp Ala Gly Trp Gly 340
345 350cat gct tca gaa aac cct aaa ctt ccg gag ctg ctg
tgc aag aat gga 1104His Ala Ser Glu Asn Pro Lys Leu Pro Glu Leu Leu
Cys Lys Asn Gly 355 360 365gtt gct
ttc tta ggc cct ccc agt gag gcc atg tgg gcc tta gga gat 1152Val Ala
Phe Leu Gly Pro Pro Ser Glu Ala Met Trp Ala Leu Gly Asp 370
375 380aag atc gcc tcc acc gtt gtc gcc cag acg cta
cag gtc cca acc ctg 1200Lys Ile Ala Ser Thr Val Val Ala Gln Thr Leu
Gln Val Pro Thr Leu385 390 395
400ccc agg agt gga agc ggc ctg aca gtg gag tgg aca gaa gat gat ctg
1248Pro Arg Ser Gly Ser Gly Leu Thr Val Glu Trp Thr Glu Asp Asp Leu
405 410 415cag cag gga aaa aga
atc agt gtc cca gaa gat gtt tat gac aag ggt 1296Gln Gln Gly Lys Arg
Ile Ser Val Pro Glu Asp Val Tyr Asp Lys Gly 420
425 430tgc gtg aaa gac gta gat gag ggc ttg gag gca gca
gaa aga att ggt 1344Cys Val Lys Asp Val Asp Glu Gly Leu Glu Ala Ala
Glu Arg Ile Gly 435 440 445ttt cca
ttg atg atc aaa gct tct gaa ggt ggc gga ggg aag gga atc 1392Phe Pro
Leu Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile 450
455 460cgg aag gct gag agt gcg gag gac ttc ccg atc
ctt ttc aga caa gta 1440Arg Lys Ala Glu Ser Ala Glu Asp Phe Pro Ile
Leu Phe Arg Gln Val465 470 475
480cag agt gag atc cca ggc tcg ccc atc ttt ctc atg aag ctg gcc cag
1488Gln Ser Glu Ile Pro Gly Ser Pro Ile Phe Leu Met Lys Leu Ala Gln
485 490 495cac gcc cgt cac ctg
gaa gtt cag atc ctc gct gac cag tat ggg aat 1536His Ala Arg His Leu
Glu Val Gln Ile Leu Ala Asp Gln Tyr Gly Asn 500
505 510gct gtg tct ctg ttt ggt cgc gac tgc tcc atc cag
cgg cgg cat cag 1584Ala Val Ser Leu Phe Gly Arg Asp Cys Ser Ile Gln
Arg Arg His Gln 515 520 525aag atc
gtt gag gaa gca ccg gcc acc atc gcc ccg ctg gcc ata ttc 1632Lys Ile
Val Glu Glu Ala Pro Ala Thr Ile Ala Pro Leu Ala Ile Phe 530
535 540gag ttc atg gag cag tgt gcc atc cgc ctg gcc
aag acc gtg ggc tat 1680Glu Phe Met Glu Gln Cys Ala Ile Arg Leu Ala
Lys Thr Val Gly Tyr545 550 555
560gtg agt gca ggg aca gtg gaa tac ctc tat agt cag gat ggc agc ttc
1728Val Ser Ala Gly Thr Val Glu Tyr Leu Tyr Ser Gln Asp Gly Ser Phe
565 570 575cac ttc ttg gag ctg
aat cct cgc ttg cag gtg gaa cat ccc tgc aca 1776His Phe Leu Glu Leu
Asn Pro Arg Leu Gln Val Glu His Pro Cys Thr 580
585 590gaa atg att gct gat gtt aat ctg ccg gcc gcc cag
cta cag atc gcc 1824Glu Met Ile Ala Asp Val Asn Leu Pro Ala Ala Gln
Leu Gln Ile Ala 595 600 605atg ggc
gtg cca ctg cac cgg ctg aag gat atc cgg ctt ctg tat gga 1872Met Gly
Val Pro Leu His Arg Leu Lys Asp Ile Arg Leu Leu Tyr Gly 610
615 620gag tca cca tgg gga gtg act ccc att tct ttt
gaa acc ccc tca aac 1920Glu Ser Pro Trp Gly Val Thr Pro Ile Ser Phe
Glu Thr Pro Ser Asn625 630 635
640cct ccc ctc gcc cga ggc cac gtc att gcc gcc aga atc acc agc gaa
1968Pro Pro Leu Ala Arg Gly His Val Ile Ala Ala Arg Ile Thr Ser Glu
645 650 655aac cca gac gag ggt
ttt aag ccg agc tcc ggg act gtc cag gaa ctg 2016Asn Pro Asp Glu Gly
Phe Lys Pro Ser Ser Gly Thr Val Gln Glu Leu 660
665 670aat ttc cgg agc agc aag aac gtg tgg ggt tac ttc
agc gtg gcc gct 2064Asn Phe Arg Ser Ser Lys Asn Val Trp Gly Tyr Phe
Ser Val Ala Ala 675 680 685act gga
ggc ctg cac gag ttt gcg gat tcc caa ttt ggg cac tgc ttc 2112Thr Gly
Gly Leu His Glu Phe Ala Asp Ser Gln Phe Gly His Cys Phe 690
695 700tcc tgg gga gag aac cgg aaa gag gcc att tcg
aac atg gtg gtg gct 2160Ser Trp Gly Glu Asn Arg Lys Glu Ala Ile Ser
Asn Met Val Val Ala705 710 715
720ttg aag gaa ctg tcc atc cga ggt gac ttt agg act acc gtg gaa tac
2208Leu Lys Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu Tyr
725 730 735ctc att aac ctc ctg
gag acc gag agc ttc cag aac aac gac atc gac 2256Leu Ile Asn Leu Leu
Glu Thr Glu Ser Phe Gln Asn Asn Asp Ile Asp 740
745 750acc ggg tgg ttg gac tac ctc att gct gag aaa gtg
cag gag aaa ccg 2304Thr Gly Trp Leu Asp Tyr Leu Ile Ala Glu Lys Val
Gln Glu Lys Pro 755 760 765gat atc
atg ctt ggg gtg 2322Asp Ile
Met Leu Gly Val 77012774PRTHomo sapiens 12Met Val Leu Leu Leu Cys Leu
Ser Cys Leu Ile Phe Ser Cys Leu Thr1 5 10
15Phe Ser Trp Leu Lys Ile Trp Gly Lys Met Thr Asp Ser
Lys Pro Ile 20 25 30Thr Lys
Ser Lys Ser Glu Ala Asn Leu Ile Pro Ser Gln Glu Pro Phe 35
40 45Pro Ala Ser Asp Asn Ser Gly Glu Thr Pro
Gln Arg Asn Gly Glu Gly 50 55 60His
Thr Leu Pro Lys Thr Pro Ser Gln Ala Glu Pro Ala Ser His Lys65
70 75 80Gly Pro Lys Asp Ala Gly
Arg Arg Arg Asn Ser Leu Pro Pro Ser His 85
90 95Gln Lys Pro Pro Arg Asn Pro Leu Ser Ser Ser Asp
Ala Ala Pro Ser 100 105 110Pro
Glu Leu Gln Ala Asn Gly Thr Gly Thr Gln Gly Leu Glu Ala Thr 115
120 125Asp Thr Asn Gly Leu Ser Ser Ser Ala
Arg Pro Gln Gly Gln Gln Ala 130 135
140Gly Ser Pro Ser Lys Glu Asp Lys Lys Gln Ala Asn Ile Lys Arg Gln145
150 155 160Leu Met Thr Asn
Phe Ile Leu Gly Ser Phe Asp Asp Tyr Ser Ser Asp 165
170 175Glu Asp Ser Val Ala Gly Ser Ser Arg Glu
Ser Thr Arg Lys Gly Ser 180 185
190Arg Ala Ser Leu Gly Ala Leu Ser Leu Glu Ala Tyr Leu Thr Thr Gly
195 200 205Glu Ala Glu Thr Arg Val Pro
Thr Met Arg Pro Ser Met Ser Gly Leu 210 215
220His Leu Val Lys Arg Gly Arg Glu His Lys Lys Leu Asp Leu His
Arg225 230 235 240Asp Phe
Thr Val Ala Ser Pro Ala Glu Phe Val Thr Arg Phe Gly Gly
245 250 255Asp Arg Val Ile Glu Lys Val
Leu Ile Ala Asn Asn Gly Ile Ala Ala 260 265
270Val Lys Cys Met Arg Ser Ile Arg Arg Trp Ala Tyr Glu Met
Phe Arg 275 280 285Asn Glu Arg Ala
Ile Arg Phe Val Val Met Val Thr Pro Glu Asp Leu 290
295 300Lys Ala Asn Ala Glu Tyr Ile Lys Met Ala Asp His
Tyr Val Pro Val305 310 315
320Pro Gly Gly Pro Asn Asn Asn Asn Tyr Ala Asn Val Glu Leu Ile Val
325 330 335Asp Ile Ala Lys Arg
Ile Pro Leu Gln Ala Val Trp Ala Gly Trp Gly 340
345 350His Ala Ser Glu Asn Pro Lys Leu Pro Glu Leu Leu
Cys Lys Asn Gly 355 360 365Val Ala
Phe Leu Gly Pro Pro Ser Glu Ala Met Trp Ala Leu Gly Asp 370
375 380Lys Ile Ala Ser Thr Val Val Ala Gln Thr Leu
Gln Val Pro Thr Leu385 390 395
400Pro Arg Ser Gly Ser Gly Leu Thr Val Glu Trp Thr Glu Asp Asp Leu
405 410 415Gln Gln Gly Lys
Arg Ile Ser Val Pro Glu Asp Val Tyr Asp Lys Gly 420
425 430Cys Val Lys Asp Val Asp Glu Gly Leu Glu Ala
Ala Glu Arg Ile Gly 435 440 445Phe
Pro Leu Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile 450
455 460Arg Lys Ala Glu Ser Ala Glu Asp Phe Pro
Ile Leu Phe Arg Gln Val465 470 475
480Gln Ser Glu Ile Pro Gly Ser Pro Ile Phe Leu Met Lys Leu Ala
Gln 485 490 495His Ala Arg
His Leu Glu Val Gln Ile Leu Ala Asp Gln Tyr Gly Asn 500
505 510Ala Val Ser Leu Phe Gly Arg Asp Cys Ser
Ile Gln Arg Arg His Gln 515 520
525Lys Ile Val Glu Glu Ala Pro Ala Thr Ile Ala Pro Leu Ala Ile Phe 530
535 540Glu Phe Met Glu Gln Cys Ala Ile
Arg Leu Ala Lys Thr Val Gly Tyr545 550
555 560Val Ser Ala Gly Thr Val Glu Tyr Leu Tyr Ser Gln
Asp Gly Ser Phe 565 570
575His Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro Cys Thr
580 585 590Glu Met Ile Ala Asp Val
Asn Leu Pro Ala Ala Gln Leu Gln Ile Ala 595 600
605Met Gly Val Pro Leu His Arg Leu Lys Asp Ile Arg Leu Leu
Tyr Gly 610 615 620Glu Ser Pro Trp Gly
Val Thr Pro Ile Ser Phe Glu Thr Pro Ser Asn625 630
635 640Pro Pro Leu Ala Arg Gly His Val Ile Ala
Ala Arg Ile Thr Ser Glu 645 650
655Asn Pro Asp Glu Gly Phe Lys Pro Ser Ser Gly Thr Val Gln Glu Leu
660 665 670Asn Phe Arg Ser Ser
Lys Asn Val Trp Gly Tyr Phe Ser Val Ala Ala 675
680 685Thr Gly Gly Leu His Glu Phe Ala Asp Ser Gln Phe
Gly His Cys Phe 690 695 700Ser Trp Gly
Glu Asn Arg Lys Glu Ala Ile Ser Asn Met Val Val Ala705
710 715 720Leu Lys Glu Leu Ser Ile Arg
Gly Asp Phe Arg Thr Thr Val Glu Tyr 725
730 735Leu Ile Asn Leu Leu Glu Thr Glu Ser Phe Gln Asn
Asn Asp Ile Asp 740 745 750Thr
Gly Trp Leu Asp Tyr Leu Ile Ala Glu Lys Val Gln Glu Lys Pro 755
760 765Asp Ile Met Leu Gly Val
770131596DNAHomo sapiensCDS(1)..(1596)N-terminal deleted Human ACCase1 BC
domain (AAs 102-632) 13atg gtg gct tct cca gca gaa ttt gtt act cgc
ttt ggg gga aat aaa 48Met Val Ala Ser Pro Ala Glu Phe Val Thr Arg
Phe Gly Gly Asn Lys1 5 10
15gtg att gag aag gtt ctt att gct aac aat ggc att gca gca gtg aaa
96Val Ile Glu Lys Val Leu Ile Ala Asn Asn Gly Ile Ala Ala Val Lys
20 25 30tgc atg cgg tct atc cgt agg
tgg tct tat gaa atg ttt cga aat gaa 144Cys Met Arg Ser Ile Arg Arg
Trp Ser Tyr Glu Met Phe Arg Asn Glu 35 40
45cgt gca att aga ttc gtt gtc atg gtc aca cct gaa gac ctt aaa
gcc 192Arg Ala Ile Arg Phe Val Val Met Val Thr Pro Glu Asp Leu Lys
Ala 50 55 60aat gca gaa tac att aag
atg gca gat cac tat gtg cca gtg cct gga 240Asn Ala Glu Tyr Ile Lys
Met Ala Asp His Tyr Val Pro Val Pro Gly65 70
75 80gga cca aac aac aac aac tat gca aat gtg gaa
tta att ctt gat att 288Gly Pro Asn Asn Asn Asn Tyr Ala Asn Val Glu
Leu Ile Leu Asp Ile 85 90
95gct aaa agg atc cca gtg cag gca gtg tgg gct ggc tgg ggt cat gct
336Ala Lys Arg Ile Pro Val Gln Ala Val Trp Ala Gly Trp Gly His Ala
100 105 110tct gag aat ccc aaa cta
ccg gaa ctt ctc ttg aaa aat ggc att gcc 384Ser Glu Asn Pro Lys Leu
Pro Glu Leu Leu Leu Lys Asn Gly Ile Ala 115 120
125ttc atg ggt cct cca agc cag gcc atg tgg gct tta ggg gat
aag att 432Phe Met Gly Pro Pro Ser Gln Ala Met Trp Ala Leu Gly Asp
Lys Ile 130 135 140gca tct tcc ata gtg
gct caa act gca ggt atc cca act ctt ccc tgg 480Ala Ser Ser Ile Val
Ala Gln Thr Ala Gly Ile Pro Thr Leu Pro Trp145 150
155 160agc ggc agt ggt ctt cgt gtg gac tgg cag
gaa aat gat ttt tca aaa 528Ser Gly Ser Gly Leu Arg Val Asp Trp Gln
Glu Asn Asp Phe Ser Lys 165 170
175cgt atc tta aat gtt ccc cag gag cta tat gaa aaa ggt tat gtg aaa
576Arg Ile Leu Asn Val Pro Gln Glu Leu Tyr Glu Lys Gly Tyr Val Lys
180 185 190gat gtg gat gat ggg cta
aag gca gct gag gaa gtt gga tat cca gta 624Asp Val Asp Asp Gly Leu
Lys Ala Ala Glu Glu Val Gly Tyr Pro Val 195 200
205atg atc aag gcc tca gag gga gga gga ggg aag gga att aga
aaa gtc 672Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile Arg
Lys Val 210 215 220aac aat gca gat gac
ttc cct aat ctc ttc aga cag gtt caa gct gaa 720Asn Asn Ala Asp Asp
Phe Pro Asn Leu Phe Arg Gln Val Gln Ala Glu225 230
235 240gtt cct gga tct ccc ata ttt gtg atg aga
cta gcc aaa caa tct cgt 768Val Pro Gly Ser Pro Ile Phe Val Met Arg
Leu Ala Lys Gln Ser Arg 245 250
255cat ctg gag gtg cag atc tta gcg gac caa tat ggc aat gct atc tct
816His Leu Glu Val Gln Ile Leu Ala Asp Gln Tyr Gly Asn Ala Ile Ser
260 265 270ttg ttt ggt cgt gat tgc
tct gta caa cgc agg cat cag aag att att 864Leu Phe Gly Arg Asp Cys
Ser Val Gln Arg Arg His Gln Lys Ile Ile 275 280
285gaa gaa gca cct gct act att gct act cca gca gta ttt gaa
cac atg 912Glu Glu Ala Pro Ala Thr Ile Ala Thr Pro Ala Val Phe Glu
His Met 290 295 300gaa cag tgt gcg gtg
aaa ctt gcc aaa atg gtg ggt tat gtg agt gct 960Glu Gln Cys Ala Val
Lys Leu Ala Lys Met Val Gly Tyr Val Ser Ala305 310
315 320ggg act gtg gaa tac ctg tac agc cag gat
ggc agc ttc tac ttt ctg 1008Gly Thr Val Glu Tyr Leu Tyr Ser Gln Asp
Gly Ser Phe Tyr Phe Leu 325 330
335gaa ttg aat cct cgg ctg cag gta gag cac cct tgt aca gag atg gtg
1056Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro Cys Thr Glu Met Val
340 345 350gct gat gtc aat ctc cct
gca gca cag ctc cag att gcc atg ggg att 1104Ala Asp Val Asn Leu Pro
Ala Ala Gln Leu Gln Ile Ala Met Gly Ile 355 360
365cct cta tat aga atc aag gat atc cgt atg atg tat ggg gta
tct ccc 1152Pro Leu Tyr Arg Ile Lys Asp Ile Arg Met Met Tyr Gly Val
Ser Pro 370 375 380tgg ggt gat tct ccc
att gat ttt gaa gat tct gca cac gtt cct tgt 1200Trp Gly Asp Ser Pro
Ile Asp Phe Glu Asp Ser Ala His Val Pro Cys385 390
395 400cca agg ggc cat gtt att gct gct cgg atc
act agt gaa aat cca gat 1248Pro Arg Gly His Val Ile Ala Ala Arg Ile
Thr Ser Glu Asn Pro Asp 405 410
415gag ggt ttt aag ccc agc tca gga aca gtt cag gag cta aat ttc cgc
1296Glu Gly Phe Lys Pro Ser Ser Gly Thr Val Gln Glu Leu Asn Phe Arg
420 425 430agc aat aag aat gtt tgg
gga tat ttc agt gtt gct gct gca ggg gga 1344Ser Asn Lys Asn Val Trp
Gly Tyr Phe Ser Val Ala Ala Ala Gly Gly 435 440
445ctt cat gaa ttt gct gat tct cag ttt ggt cac tgc ttt tct
tgg gga 1392Leu His Glu Phe Ala Asp Ser Gln Phe Gly His Cys Phe Ser
Trp Gly 450 455 460gaa aac aga gaa gag
gca att tca aac atg gtg gtg gct ttg aag gag 1440Glu Asn Arg Glu Glu
Ala Ile Ser Asn Met Val Val Ala Leu Lys Glu465 470
475 480ctg tct att cgg ggt gac ttt cga act aca
gtt gaa tac ctg atc aaa 1488Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr
Val Glu Tyr Leu Ile Lys 485 490
495ttg tta gag act gaa agc ttt cag atg aac aga att gat act ggc tgg
1536Leu Leu Glu Thr Glu Ser Phe Gln Met Asn Arg Ile Asp Thr Gly Trp
500 505 510ctg gac aga ctg ata gca
gaa aaa gta cag gct gag cga cct gac acc 1584Leu Asp Arg Leu Ile Ala
Glu Lys Val Gln Ala Glu Arg Pro Asp Thr 515 520
525atg ttg ggg gtt
1596Met Leu Gly Val 53014532PRTHomo sapiens 14Met Val Ala
Ser Pro Ala Glu Phe Val Thr Arg Phe Gly Gly Asn Lys1 5
10 15Val Ile Glu Lys Val Leu Ile Ala Asn
Asn Gly Ile Ala Ala Val Lys 20 25
30Cys Met Arg Ser Ile Arg Arg Trp Ser Tyr Glu Met Phe Arg Asn Glu
35 40 45Arg Ala Ile Arg Phe Val Val
Met Val Thr Pro Glu Asp Leu Lys Ala 50 55
60Asn Ala Glu Tyr Ile Lys Met Ala Asp His Tyr Val Pro Val Pro Gly65
70 75 80Gly Pro Asn Asn
Asn Asn Tyr Ala Asn Val Glu Leu Ile Leu Asp Ile 85
90 95Ala Lys Arg Ile Pro Val Gln Ala Val Trp
Ala Gly Trp Gly His Ala 100 105
110Ser Glu Asn Pro Lys Leu Pro Glu Leu Leu Leu Lys Asn Gly Ile Ala
115 120 125Phe Met Gly Pro Pro Ser Gln
Ala Met Trp Ala Leu Gly Asp Lys Ile 130 135
140Ala Ser Ser Ile Val Ala Gln Thr Ala Gly Ile Pro Thr Leu Pro
Trp145 150 155 160Ser Gly
Ser Gly Leu Arg Val Asp Trp Gln Glu Asn Asp Phe Ser Lys
165 170 175Arg Ile Leu Asn Val Pro Gln
Glu Leu Tyr Glu Lys Gly Tyr Val Lys 180 185
190Asp Val Asp Asp Gly Leu Lys Ala Ala Glu Glu Val Gly Tyr
Pro Val 195 200 205Met Ile Lys Ala
Ser Glu Gly Gly Gly Gly Lys Gly Ile Arg Lys Val 210
215 220Asn Asn Ala Asp Asp Phe Pro Asn Leu Phe Arg Gln
Val Gln Ala Glu225 230 235
240Val Pro Gly Ser Pro Ile Phe Val Met Arg Leu Ala Lys Gln Ser Arg
245 250 255His Leu Glu Val Gln
Ile Leu Ala Asp Gln Tyr Gly Asn Ala Ile Ser 260
265 270Leu Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His
Gln Lys Ile Ile 275 280 285Glu Glu
Ala Pro Ala Thr Ile Ala Thr Pro Ala Val Phe Glu His Met 290
295 300Glu Gln Cys Ala Val Lys Leu Ala Lys Met Val
Gly Tyr Val Ser Ala305 310 315
320Gly Thr Val Glu Tyr Leu Tyr Ser Gln Asp Gly Ser Phe Tyr Phe Leu
325 330 335Glu Leu Asn Pro
Arg Leu Gln Val Glu His Pro Cys Thr Glu Met Val 340
345 350Ala Asp Val Asn Leu Pro Ala Ala Gln Leu Gln
Ile Ala Met Gly Ile 355 360 365Pro
Leu Tyr Arg Ile Lys Asp Ile Arg Met Met Tyr Gly Val Ser Pro 370
375 380Trp Gly Asp Ser Pro Ile Asp Phe Glu Asp
Ser Ala His Val Pro Cys385 390 395
400Pro Arg Gly His Val Ile Ala Ala Arg Ile Thr Ser Glu Asn Pro
Asp 405 410 415Glu Gly Phe
Lys Pro Ser Ser Gly Thr Val Gln Glu Leu Asn Phe Arg 420
425 430Ser Asn Lys Asn Val Trp Gly Tyr Phe Ser
Val Ala Ala Ala Gly Gly 435 440
445Leu His Glu Phe Ala Asp Ser Gln Phe Gly His Cys Phe Ser Trp Gly 450
455 460Glu Asn Arg Glu Glu Ala Ile Ser
Asn Met Val Val Ala Leu Lys Glu465 470
475 480Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu
Tyr Leu Ile Lys 485 490
495Leu Leu Glu Thr Glu Ser Phe Gln Met Asn Arg Ile Asp Thr Gly Trp
500 505 510Leu Asp Arg Leu Ile Ala
Glu Lys Val Gln Ala Glu Arg Pro Asp Thr 515 520
525Met Leu Gly Val 530151596DNAHomo
sapiensCDS(1)..(1596)N-terminal deleted Human ACCase2 BC domain
(AAs 244-774) 15atg gtg gct tct ccc gct gag ttt gtc aca cgc ttt ggg ggg
gat cgg 48Met Val Ala Ser Pro Ala Glu Phe Val Thr Arg Phe Gly Gly
Asp Arg1 5 10 15gtc atc
gag aag gtg ctt att gcc aac aac ggg att gcc gcc gtg aag 96Val Ile
Glu Lys Val Leu Ile Ala Asn Asn Gly Ile Ala Ala Val Lys 20
25 30tgc atg cgc tcc atc cgc agg tgg gcc
tat gag atg ttc cgc aac gag 144Cys Met Arg Ser Ile Arg Arg Trp Ala
Tyr Glu Met Phe Arg Asn Glu 35 40
45cgg gcc atc cgg ttt gtt gtg atg gtg acc ccc gag gac ctt aag gcc
192Arg Ala Ile Arg Phe Val Val Met Val Thr Pro Glu Asp Leu Lys Ala 50
55 60aac gca gag tac atc aag atg gcg gat
cat tac gtc ccc gtc cca gga 240Asn Ala Glu Tyr Ile Lys Met Ala Asp
His Tyr Val Pro Val Pro Gly65 70 75
80ggg ccc aat aac aac aac tat gcc aac gtg gag ctg att gtg
gac att 288Gly Pro Asn Asn Asn Asn Tyr Ala Asn Val Glu Leu Ile Val
Asp Ile 85 90 95gcc aag
aga att cct ttg cag gcg gtg tgg gct ggc tgg ggc cat gct 336Ala Lys
Arg Ile Pro Leu Gln Ala Val Trp Ala Gly Trp Gly His Ala 100
105 110tca gaa aac cct aaa ctt ccg gag ctg
ctg tgc aag aat gga gtt gct 384Ser Glu Asn Pro Lys Leu Pro Glu Leu
Leu Cys Lys Asn Gly Val Ala 115 120
125ttc tta ggc cct ccc agt gag gcc atg tgg gcc tta gga gat aag atc
432Phe Leu Gly Pro Pro Ser Glu Ala Met Trp Ala Leu Gly Asp Lys Ile 130
135 140gcc tcc acc gtt gtc gcc cag acg
cta cag gtc cca acc ctg ccc agg 480Ala Ser Thr Val Val Ala Gln Thr
Leu Gln Val Pro Thr Leu Pro Arg145 150
155 160agt gga agc ggc ctg aca gtg gag tgg aca gaa gat
gat ctg cag cag 528Ser Gly Ser Gly Leu Thr Val Glu Trp Thr Glu Asp
Asp Leu Gln Gln 165 170
175gga aaa aga atc agt gtc cca gaa gat gtt tat gac aag ggt tgc gtg
576Gly Lys Arg Ile Ser Val Pro Glu Asp Val Tyr Asp Lys Gly Cys Val
180 185 190aaa gac gta gat gag ggc
ttg gag gca gca gaa aga att ggt ttt cca 624Lys Asp Val Asp Glu Gly
Leu Glu Ala Ala Glu Arg Ile Gly Phe Pro 195 200
205ttg atg atc aaa gct tct gaa ggt ggc gga ggg aag gga atc
cgg aag 672Leu Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile
Arg Lys 210 215 220gct gag agt gcg gag
gac ttc ccg atc ctt ttc aga caa gta cag agt 720Ala Glu Ser Ala Glu
Asp Phe Pro Ile Leu Phe Arg Gln Val Gln Ser225 230
235 240gag atc cca ggc tcg ccc atc ttt ctc atg
aag ctg gcc cag cac gcc 768Glu Ile Pro Gly Ser Pro Ile Phe Leu Met
Lys Leu Ala Gln His Ala 245 250
255cgt cac ctg gaa gtt cag atc ctc gct gac cag tat ggg aat gct gtg
816Arg His Leu Glu Val Gln Ile Leu Ala Asp Gln Tyr Gly Asn Ala Val
260 265 270tct ctg ttt ggt cgc gac
tgc tcc atc cag cgg cgg cat cag aag atc 864Ser Leu Phe Gly Arg Asp
Cys Ser Ile Gln Arg Arg His Gln Lys Ile 275 280
285gtt gag gaa gca ccg gcc acc atc gcc ccg ctg gcc ata ttc
gag ttc 912Val Glu Glu Ala Pro Ala Thr Ile Ala Pro Leu Ala Ile Phe
Glu Phe 290 295 300atg gag cag tgt gcc
atc cgc ctg gcc aag acc gtg ggc tat gtg agt 960Met Glu Gln Cys Ala
Ile Arg Leu Ala Lys Thr Val Gly Tyr Val Ser305 310
315 320gca ggg aca gtg gaa tac ctc tat agt cag
gat ggc agc ttc cac ttc 1008Ala Gly Thr Val Glu Tyr Leu Tyr Ser Gln
Asp Gly Ser Phe His Phe 325 330
335ttg gag ctg aat cct cgc ttg cag gtg gaa cat ccc tgc aca gaa atg
1056Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro Cys Thr Glu Met
340 345 350att gct gat gtt aat ctg
ccg gcc gcc cag cta cag atc gcc atg ggc 1104Ile Ala Asp Val Asn Leu
Pro Ala Ala Gln Leu Gln Ile Ala Met Gly 355 360
365gtg cca ctg cac cgg ctg aag gat atc cgg ctt ctg tat gga
gag tca 1152Val Pro Leu His Arg Leu Lys Asp Ile Arg Leu Leu Tyr Gly
Glu Ser 370 375 380cca tgg gga gtg act
ccc att tct ttt gaa acc ccc tca aac cct ccc 1200Pro Trp Gly Val Thr
Pro Ile Ser Phe Glu Thr Pro Ser Asn Pro Pro385 390
395 400ctc gcc cga ggc cac gtc att gcc gcc aga
atc acc agc gaa aac cca 1248Leu Ala Arg Gly His Val Ile Ala Ala Arg
Ile Thr Ser Glu Asn Pro 405 410
415gac gag ggt ttt aag ccg agc tcc ggg act gtc cag gaa ctg aat ttc
1296Asp Glu Gly Phe Lys Pro Ser Ser Gly Thr Val Gln Glu Leu Asn Phe
420 425 430cgg agc agc aag aac gtg
tgg ggt tac ttc agc gtg gcc gct act gga 1344Arg Ser Ser Lys Asn Val
Trp Gly Tyr Phe Ser Val Ala Ala Thr Gly 435 440
445ggc ctg cac gag ttt gcg gat tcc caa ttt ggg cac tgc ttc
tcc tgg 1392Gly Leu His Glu Phe Ala Asp Ser Gln Phe Gly His Cys Phe
Ser Trp 450 455 460gga gag aac cgg aaa
gag gcc att tcg aac atg gtg gtg gct ttg aag 1440Gly Glu Asn Arg Lys
Glu Ala Ile Ser Asn Met Val Val Ala Leu Lys465 470
475 480gaa ctg tcc atc cga ggt gac ttt agg act
acc gtg gaa tac ctc att 1488Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr
Thr Val Glu Tyr Leu Ile 485 490
495aac ctc ctg gag acc gag agc ttc cag aac aac gac atc gac acc ggg
1536Asn Leu Leu Glu Thr Glu Ser Phe Gln Asn Asn Asp Ile Asp Thr Gly
500 505 510tgg ttg gac tac ctc att
gct gag aaa gtg cag gag aaa ccg gat atc 1584Trp Leu Asp Tyr Leu Ile
Ala Glu Lys Val Gln Glu Lys Pro Asp Ile 515 520
525atg ctt ggg gtg
1596Met Leu Gly Val 53016532PRTHomo sapiens 16Met Val Ala
Ser Pro Ala Glu Phe Val Thr Arg Phe Gly Gly Asp Arg1 5
10 15Val Ile Glu Lys Val Leu Ile Ala Asn
Asn Gly Ile Ala Ala Val Lys 20 25
30Cys Met Arg Ser Ile Arg Arg Trp Ala Tyr Glu Met Phe Arg Asn Glu
35 40 45Arg Ala Ile Arg Phe Val Val
Met Val Thr Pro Glu Asp Leu Lys Ala 50 55
60Asn Ala Glu Tyr Ile Lys Met Ala Asp His Tyr Val Pro Val Pro Gly65
70 75 80Gly Pro Asn Asn
Asn Asn Tyr Ala Asn Val Glu Leu Ile Val Asp Ile 85
90 95Ala Lys Arg Ile Pro Leu Gln Ala Val Trp
Ala Gly Trp Gly His Ala 100 105
110Ser Glu Asn Pro Lys Leu Pro Glu Leu Leu Cys Lys Asn Gly Val Ala
115 120 125Phe Leu Gly Pro Pro Ser Glu
Ala Met Trp Ala Leu Gly Asp Lys Ile 130 135
140Ala Ser Thr Val Val Ala Gln Thr Leu Gln Val Pro Thr Leu Pro
Arg145 150 155 160Ser Gly
Ser Gly Leu Thr Val Glu Trp Thr Glu Asp Asp Leu Gln Gln
165 170 175Gly Lys Arg Ile Ser Val Pro
Glu Asp Val Tyr Asp Lys Gly Cys Val 180 185
190Lys Asp Val Asp Glu Gly Leu Glu Ala Ala Glu Arg Ile Gly
Phe Pro 195 200 205Leu Met Ile Lys
Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile Arg Lys 210
215 220Ala Glu Ser Ala Glu Asp Phe Pro Ile Leu Phe Arg
Gln Val Gln Ser225 230 235
240Glu Ile Pro Gly Ser Pro Ile Phe Leu Met Lys Leu Ala Gln His Ala
245 250 255Arg His Leu Glu Val
Gln Ile Leu Ala Asp Gln Tyr Gly Asn Ala Val 260
265 270Ser Leu Phe Gly Arg Asp Cys Ser Ile Gln Arg Arg
His Gln Lys Ile 275 280 285Val Glu
Glu Ala Pro Ala Thr Ile Ala Pro Leu Ala Ile Phe Glu Phe 290
295 300Met Glu Gln Cys Ala Ile Arg Leu Ala Lys Thr
Val Gly Tyr Val Ser305 310 315
320Ala Gly Thr Val Glu Tyr Leu Tyr Ser Gln Asp Gly Ser Phe His Phe
325 330 335Leu Glu Leu Asn
Pro Arg Leu Gln Val Glu His Pro Cys Thr Glu Met 340
345 350Ile Ala Asp Val Asn Leu Pro Ala Ala Gln Leu
Gln Ile Ala Met Gly 355 360 365Val
Pro Leu His Arg Leu Lys Asp Ile Arg Leu Leu Tyr Gly Glu Ser 370
375 380Pro Trp Gly Val Thr Pro Ile Ser Phe Glu
Thr Pro Ser Asn Pro Pro385 390 395
400Leu Ala Arg Gly His Val Ile Ala Ala Arg Ile Thr Ser Glu Asn
Pro 405 410 415Asp Glu Gly
Phe Lys Pro Ser Ser Gly Thr Val Gln Glu Leu Asn Phe 420
425 430Arg Ser Ser Lys Asn Val Trp Gly Tyr Phe
Ser Val Ala Ala Thr Gly 435 440
445Gly Leu His Glu Phe Ala Asp Ser Gln Phe Gly His Cys Phe Ser Trp 450
455 460Gly Glu Asn Arg Lys Glu Ala Ile
Ser Asn Met Val Val Ala Leu Lys465 470
475 480Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val
Glu Tyr Leu Ile 485 490
495Asn Leu Leu Glu Thr Glu Ser Phe Gln Asn Asn Asp Ile Asp Thr Gly
500 505 510Trp Leu Asp Tyr Leu Ile
Ala Glu Lys Val Gln Glu Lys Pro Asp Ile 515 520
525Met Leu Gly Val 53017554PRTUstilago
maydisMISC_FEATURE(1)..(554)N-terminal deleted Ustilago ACCase BC domain
(AAs 7-560) 17Lys Ala Val Ser Gln Phe Ile Gly Gly Asn Pro Leu Glu
Thr Ala Pro1 5 10 15Ala
Ser Pro Val Ala Asp Phe Ile Arg Lys Gln Gly Gly His Ser Val 20
25 30Ile Thr Lys Val Leu Ile Cys Asn
Asn Gly Ile Ala Ala Val Lys Glu 35 40
45Ile Arg Ser Ile Arg Lys Trp Ala Tyr Glu Thr Phe Gly Asp Glu Arg
50 55 60Ala Ile Glu Phe Thr Val Met Ala
Thr Pro Glu Asp Leu Lys Val Asn65 70 75
80Ala Asp Tyr Ile Arg Met Ala Asp Gln Tyr Val Glu Val
Pro Gly Gly 85 90 95Ser
Asn Asn Asn Asn Tyr Ala Asn Val Asp Leu Ile Val Asp Val Ala
100 105 110Glu Arg Ala Gly Val His Ala
Val Trp Ala Gly Trp Gly His Ala Ser 115 120
125Glu Asn Pro Arg Leu Pro Glu Ser Leu Ala Ala Ser Lys His Lys
Ile 130 135 140Ile Phe Ile Gly Pro Pro
Gly Ser Ala Met Arg Ser Leu Gly Asp Lys145 150
155 160Ile Ser Ser Thr Ile Val Ala Gln His Ala Asp
Val Pro Cys Met Pro 165 170
175Trp Ser Gly Thr Gly Ile Lys Glu Thr Met Met Ser Asp Gln Gly Phe
180 185 190Leu Thr Val Ser Asp Asp
Val Tyr Gln Gln Ala Cys Ile His Thr Ala 195 200
205Glu Glu Gly Leu Glu Lys Ala Glu Lys Ile Gly Tyr Pro Val
Met Ile 210 215 220Lys Ala Ser Glu Gly
Gly Gly Gly Lys Gly Ile Arg Lys Cys Thr Asn225 230
235 240Gly Glu Glu Phe Lys Gln Leu Tyr Asn Ala
Val Leu Gly Glu Val Pro 245 250
255Gly Ser Pro Val Phe Val Met Lys Leu Ala Gly Gln Ala Arg His Leu
260 265 270Glu Val Gln Leu Leu
Ala Asp Gln Tyr Gly Asn Ala Ile Ser Ile Phe 275
280 285Gly Arg Asp Cys Ser Val Gln Arg Arg His Gln Lys
Ile Ile Glu Glu 290 295 300Ala Pro Val
Thr Ile Ala Pro Glu Asp Ala Arg Glu Ser Met Glu Lys305
310 315 320Ala Ala Val Arg Leu Ala Lys
Leu Val Gly Tyr Val Ser Ala Gly Thr 325
330 335Val Glu Trp Leu Tyr Ser Pro Glu Ser Gly Glu Phe
Ala Phe Leu Glu 340 345 350Leu
Asn Pro Arg Leu Gln Val Glu His Pro Thr Thr Glu Met Val Ser 355
360 365Gly Val Asn Ile Pro Ala Ala Gln Leu
Gln Val Ala Met Gly Ile Pro 370 375
380Leu Tyr Ser Ile Arg Asp Ile Arg Thr Leu Tyr Gly Met Asp Pro Arg385
390 395 400Gly Asn Glu Val
Ile Asp Phe Asp Phe Ser Ser Pro Glu Ser Phe Lys 405
410 415Thr Gln Arg Lys Pro Gln Pro Gln Gly His
Val Val Ala Cys Arg Ile 420 425
430Thr Ala Glu Asn Pro Asp Thr Gly Phe Lys Pro Gly Met Gly Ala Leu
435 440 445Thr Glu Leu Asn Phe Arg Ser
Ser Thr Ser Thr Trp Gly Tyr Phe Ser 450 455
460Val Gly Thr Ser Gly Ala Leu His Glu Tyr Ala Asp Ser Gln Phe
Gly465 470 475 480His Ile
Phe Ala Tyr Gly Ala Asp Arg Ser Glu Ala Arg Lys Gln Met
485 490 495Val Ile Ser Leu Lys Glu Leu
Ser Ile Arg Gly Asp Phe Arg Thr Thr 500 505
510Val Glu Tyr Leu Ile Lys Leu Leu Glu Thr Asp Ala Phe Glu
Ser Asn 515 520 525Lys Ile Thr Thr
Gly Trp Leu Asp Gly Leu Ile Gln Asp Arg Leu Thr 530
535 540Ala Glu Arg Pro Pro Ala Asp Leu Ala Val545
55018549PRTUstilago maydisMISC_FEATURE(1)..(549)N-terminal
deleted Ustilago ACCase BC domain (AAs 12-560) 18Phe Ile Gly Gly
Asn Pro Leu Glu Thr Ala Pro Ala Ser Pro Val Ala1 5
10 15Asp Phe Ile Arg Lys Gln Gly Gly His Ser
Val Ile Thr Lys Val Leu 20 25
30Ile Cys Asn Asn Gly Ile Ala Ala Val Lys Glu Ile Arg Ser Ile Arg
35 40 45Lys Trp Ala Tyr Glu Thr Phe Gly
Asp Glu Arg Ala Ile Glu Phe Thr 50 55
60Val Met Ala Thr Pro Glu Asp Leu Lys Val Asn Ala Asp Tyr Ile Arg65
70 75 80Met Ala Asp Gln Tyr
Val Glu Val Pro Gly Gly Ser Asn Asn Asn Asn 85
90 95Tyr Ala Asn Val Asp Leu Ile Val Asp Val Ala
Glu Arg Ala Gly Val 100 105
110His Ala Val Trp Ala Gly Trp Gly His Ala Ser Glu Asn Pro Arg Leu
115 120 125Pro Glu Ser Leu Ala Ala Ser
Lys His Lys Ile Ile Phe Ile Gly Pro 130 135
140Pro Gly Ser Ala Met Arg Ser Leu Gly Asp Lys Ile Ser Ser Thr
Ile145 150 155 160Val Ala
Gln His Ala Asp Val Pro Cys Met Pro Trp Ser Gly Thr Gly
165 170 175Ile Lys Glu Thr Met Met Ser
Asp Gln Gly Phe Leu Thr Val Ser Asp 180 185
190Asp Val Tyr Gln Gln Ala Cys Ile His Thr Ala Glu Glu Gly
Leu Glu 195 200 205Lys Ala Glu Lys
Ile Gly Tyr Pro Val Met Ile Lys Ala Ser Glu Gly 210
215 220Gly Gly Gly Lys Gly Ile Arg Lys Cys Thr Asn Gly
Glu Glu Phe Lys225 230 235
240Gln Leu Tyr Asn Ala Val Leu Gly Glu Val Pro Gly Ser Pro Val Phe
245 250 255Val Met Lys Leu Ala
Gly Gln Ala Arg His Leu Glu Val Gln Leu Leu 260
265 270Ala Asp Gln Tyr Gly Asn Ala Ile Ser Ile Phe Gly
Arg Asp Cys Ser 275 280 285Val Gln
Arg Arg His Gln Lys Ile Ile Glu Glu Ala Pro Val Thr Ile 290
295 300Ala Pro Glu Asp Ala Arg Glu Ser Met Glu Lys
Ala Ala Val Arg Leu305 310 315
320Ala Lys Leu Val Gly Tyr Val Ser Ala Gly Thr Val Glu Trp Leu Tyr
325 330 335Ser Pro Glu Ser
Gly Glu Phe Ala Phe Leu Glu Leu Asn Pro Arg Leu 340
345 350Gln Val Glu His Pro Thr Thr Glu Met Val Ser
Gly Val Asn Ile Pro 355 360 365Ala
Ala Gln Leu Gln Val Ala Met Gly Ile Pro Leu Tyr Ser Ile Arg 370
375 380Asp Ile Arg Thr Leu Tyr Gly Met Asp Pro
Arg Gly Asn Glu Val Ile385 390 395
400Asp Phe Asp Phe Ser Ser Pro Glu Ser Phe Lys Thr Gln Arg Lys
Pro 405 410 415Gln Pro Gln
Gly His Val Val Ala Cys Arg Ile Thr Ala Glu Asn Pro 420
425 430Asp Thr Gly Phe Lys Pro Gly Met Gly Ala
Leu Thr Glu Leu Asn Phe 435 440
445Arg Ser Ser Thr Ser Thr Trp Gly Tyr Phe Ser Val Gly Thr Ser Gly 450
455 460Ala Leu His Glu Tyr Ala Asp Ser
Gln Phe Gly His Ile Phe Ala Tyr465 470
475 480Gly Ala Asp Arg Ser Glu Ala Arg Lys Gln Met Val
Ile Ser Leu Lys 485 490
495Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile
500 505 510Lys Leu Leu Glu Thr Asp
Ala Phe Glu Ser Asn Lys Ile Thr Thr Gly 515 520
525Trp Leu Asp Gly Leu Ile Gln Asp Arg Leu Thr Ala Glu Arg
Pro Pro 530 535 540Ala Asp Leu Ala
Val54519539PRTUstilago maydisMISC_FEATURE(1)..(539)N-terminal deleted
Ustilago ACCse BC domain (AAs 22-560) 19Pro Ala Ser Pro Val Ala Asp
Phe Ile Arg Lys Gln Gly Gly His Ser1 5 10
15Val Ile Thr Lys Val Leu Ile Cys Asn Asn Gly Ile Ala
Ala Val Lys 20 25 30Glu Ile
Arg Ser Ile Arg Lys Trp Ala Tyr Glu Thr Phe Gly Asp Glu 35
40 45Arg Ala Ile Glu Phe Thr Val Met Ala Thr
Pro Glu Asp Leu Lys Val 50 55 60Asn
Ala Asp Tyr Ile Arg Met Ala Asp Gln Tyr Val Glu Val Pro Gly65
70 75 80Gly Ser Asn Asn Asn Asn
Tyr Ala Asn Val Asp Leu Ile Val Asp Val 85
90 95Ala Glu Arg Ala Gly Val His Ala Val Trp Ala Gly
Trp Gly His Ala 100 105 110Ser
Glu Asn Pro Arg Leu Pro Glu Ser Leu Ala Ala Ser Lys His Lys 115
120 125Ile Ile Phe Ile Gly Pro Pro Gly Ser
Ala Met Arg Ser Leu Gly Asp 130 135
140Lys Ile Ser Ser Thr Ile Val Ala Gln His Ala Asp Val Pro Cys Met145
150 155 160Pro Trp Ser Gly
Thr Gly Ile Lys Glu Thr Met Met Ser Asp Gln Gly 165
170 175Phe Leu Thr Val Ser Asp Asp Val Tyr Gln
Gln Ala Cys Ile His Thr 180 185
190Ala Glu Glu Gly Leu Glu Lys Ala Glu Lys Ile Gly Tyr Pro Val Met
195 200 205Ile Lys Ala Ser Glu Gly Gly
Gly Gly Lys Gly Ile Arg Lys Cys Thr 210 215
220Asn Gly Glu Glu Phe Lys Gln Leu Tyr Asn Ala Val Leu Gly Glu
Val225 230 235 240Pro Gly
Ser Pro Val Phe Val Met Lys Leu Ala Gly Gln Ala Arg His
245 250 255Leu Glu Val Gln Leu Leu Ala
Asp Gln Tyr Gly Asn Ala Ile Ser Ile 260 265
270Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His Gln Lys Ile
Ile Glu 275 280 285Glu Ala Pro Val
Thr Ile Ala Pro Glu Asp Ala Arg Glu Ser Met Glu 290
295 300Lys Ala Ala Val Arg Leu Ala Lys Leu Val Gly Tyr
Val Ser Ala Gly305 310 315
320Thr Val Glu Trp Leu Tyr Ser Pro Glu Ser Gly Glu Phe Ala Phe Leu
325 330 335Glu Leu Asn Pro Arg
Leu Gln Val Glu His Pro Thr Thr Glu Met Val 340
345 350Ser Gly Val Asn Ile Pro Ala Ala Gln Leu Gln Val
Ala Met Gly Ile 355 360 365Pro Leu
Tyr Ser Ile Arg Asp Ile Arg Thr Leu Tyr Gly Met Asp Pro 370
375 380Arg Gly Asn Glu Val Ile Asp Phe Asp Phe Ser
Ser Pro Glu Ser Phe385 390 395
400Lys Thr Gln Arg Lys Pro Gln Pro Gln Gly His Val Val Ala Cys Arg
405 410 415Ile Thr Ala Glu
Asn Pro Asp Thr Gly Phe Lys Pro Gly Met Gly Ala 420
425 430Leu Thr Glu Leu Asn Phe Arg Ser Ser Thr Ser
Thr Trp Gly Tyr Phe 435 440 445Ser
Val Gly Thr Ser Gly Ala Leu His Glu Tyr Ala Asp Ser Gln Phe 450
455 460Gly His Ile Phe Ala Tyr Gly Ala Asp Arg
Ser Glu Ala Arg Lys Gln465 470 475
480Met Val Ile Ser Leu Lys Glu Leu Ser Ile Arg Gly Asp Phe Arg
Thr 485 490 495Thr Val Glu
Tyr Leu Ile Lys Leu Leu Glu Thr Asp Ala Phe Glu Ser 500
505 510Asn Lys Ile Thr Thr Gly Trp Leu Asp Gly
Leu Ile Gln Asp Arg Leu 515 520
525Thr Ala Glu Arg Pro Pro Ala Asp Leu Ala Val 530
53520529PRTUstilago maydisMISC_FEATURE(1)..(529)N-terminal deleted
Ustilago ACCase BC domain (AAs 32-560) 20Lys Gln Gly Gly His Ser
Val Ile Thr Lys Val Leu Ile Cys Asn Asn1 5
10 15Gly Ile Ala Ala Val Lys Glu Ile Arg Ser Ile Arg
Lys Trp Ala Tyr 20 25 30Glu
Thr Phe Gly Asp Glu Arg Ala Ile Glu Phe Thr Val Met Ala Thr 35
40 45Pro Glu Asp Leu Lys Val Asn Ala Asp
Tyr Ile Arg Met Ala Asp Gln 50 55
60Tyr Val Glu Val Pro Gly Gly Ser Asn Asn Asn Asn Tyr Ala Asn Val65
70 75 80Asp Leu Ile Val Asp
Val Ala Glu Arg Ala Gly Val His Ala Val Trp 85
90 95Ala Gly Trp Gly His Ala Ser Glu Asn Pro Arg
Leu Pro Glu Ser Leu 100 105
110Ala Ala Ser Lys His Lys Ile Ile Phe Ile Gly Pro Pro Gly Ser Ala
115 120 125Met Arg Ser Leu Gly Asp Lys
Ile Ser Ser Thr Ile Val Ala Gln His 130 135
140Ala Asp Val Pro Cys Met Pro Trp Ser Gly Thr Gly Ile Lys Glu
Thr145 150 155 160Met Met
Ser Asp Gln Gly Phe Leu Thr Val Ser Asp Asp Val Tyr Gln
165 170 175Gln Ala Cys Ile His Thr Ala
Glu Glu Gly Leu Glu Lys Ala Glu Lys 180 185
190Ile Gly Tyr Pro Val Met Ile Lys Ala Ser Glu Gly Gly Gly
Gly Lys 195 200 205Gly Ile Arg Lys
Cys Thr Asn Gly Glu Glu Phe Lys Gln Leu Tyr Asn 210
215 220Ala Val Leu Gly Glu Val Pro Gly Ser Pro Val Phe
Val Met Lys Leu225 230 235
240Ala Gly Gln Ala Arg His Leu Glu Val Gln Leu Leu Ala Asp Gln Tyr
245 250 255Gly Asn Ala Ile Ser
Ile Phe Gly Arg Asp Cys Ser Val Gln Arg Arg 260
265 270His Gln Lys Ile Ile Glu Glu Ala Pro Val Thr Ile
Ala Pro Glu Asp 275 280 285Ala Arg
Glu Ser Met Glu Lys Ala Ala Val Arg Leu Ala Lys Leu Val 290
295 300Gly Tyr Val Ser Ala Gly Thr Val Glu Trp Leu
Tyr Ser Pro Glu Ser305 310 315
320Gly Glu Phe Ala Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His
325 330 335Pro Thr Thr Glu
Met Val Ser Gly Val Asn Ile Pro Ala Ala Gln Leu 340
345 350Gln Val Ala Met Gly Ile Pro Leu Tyr Ser Ile
Arg Asp Ile Arg Thr 355 360 365Leu
Tyr Gly Met Asp Pro Arg Gly Asn Glu Val Ile Asp Phe Asp Phe 370
375 380Ser Ser Pro Glu Ser Phe Lys Thr Gln Arg
Lys Pro Gln Pro Gln Gly385 390 395
400His Val Val Ala Cys Arg Ile Thr Ala Glu Asn Pro Asp Thr Gly
Phe 405 410 415Lys Pro Gly
Met Gly Ala Leu Thr Glu Leu Asn Phe Arg Ser Ser Thr 420
425 430Ser Thr Trp Gly Tyr Phe Ser Val Gly Thr
Ser Gly Ala Leu His Glu 435 440
445Tyr Ala Asp Ser Gln Phe Gly His Ile Phe Ala Tyr Gly Ala Asp Arg 450
455 460Ser Glu Ala Arg Lys Gln Met Val
Ile Ser Leu Lys Glu Leu Ser Ile465 470
475 480Arg Gly Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile
Lys Leu Leu Glu 485 490
495Thr Asp Ala Phe Glu Ser Asn Lys Ile Thr Thr Gly Trp Leu Asp Gly
500 505 510Leu Ile Gln Asp Arg Leu
Thr Ala Glu Arg Pro Pro Ala Asp Leu Ala 515 520
525Val21519PRTUstilago
maydisMISC_FEATURE(1)..(519)N-terminal deleted Ustilago ACCase BC domain
(AAs 42-560) 21Val Leu Ile Cys Asn Asn Gly Ile Ala Ala Val Lys Glu
Ile Arg Ser1 5 10 15Ile
Arg Lys Trp Ala Tyr Glu Thr Phe Gly Asp Glu Arg Ala Ile Glu 20
25 30Phe Thr Val Met Ala Thr Pro Glu
Asp Leu Lys Val Asn Ala Asp Tyr 35 40
45Ile Arg Met Ala Asp Gln Tyr Val Glu Val Pro Gly Gly Ser Asn Asn
50 55 60Asn Asn Tyr Ala Asn Val Asp Leu
Ile Val Asp Val Ala Glu Arg Ala65 70 75
80Gly Val His Ala Val Trp Ala Gly Trp Gly His Ala Ser
Glu Asn Pro 85 90 95Arg
Leu Pro Glu Ser Leu Ala Ala Ser Lys His Lys Ile Ile Phe Ile
100 105 110Gly Pro Pro Gly Ser Ala Met
Arg Ser Leu Gly Asp Lys Ile Ser Ser 115 120
125Thr Ile Val Ala Gln His Ala Asp Val Pro Cys Met Pro Trp Ser
Gly 130 135 140Thr Gly Ile Lys Glu Thr
Met Met Ser Asp Gln Gly Phe Leu Thr Val145 150
155 160Ser Asp Asp Val Tyr Gln Gln Ala Cys Ile His
Thr Ala Glu Glu Gly 165 170
175Leu Glu Lys Ala Glu Lys Ile Gly Tyr Pro Val Met Ile Lys Ala Ser
180 185 190Glu Gly Gly Gly Gly Lys
Gly Ile Arg Lys Cys Thr Asn Gly Glu Glu 195 200
205Phe Lys Gln Leu Tyr Asn Ala Val Leu Gly Glu Val Pro Gly
Ser Pro 210 215 220Val Phe Val Met Lys
Leu Ala Gly Gln Ala Arg His Leu Glu Val Gln225 230
235 240Leu Leu Ala Asp Gln Tyr Gly Asn Ala Ile
Ser Ile Phe Gly Arg Asp 245 250
255Cys Ser Val Gln Arg Arg His Gln Lys Ile Ile Glu Glu Ala Pro Val
260 265 270Thr Ile Ala Pro Glu
Asp Ala Arg Glu Ser Met Glu Lys Ala Ala Val 275
280 285Arg Leu Ala Lys Leu Val Gly Tyr Val Ser Ala Gly
Thr Val Glu Trp 290 295 300Leu Tyr Ser
Pro Glu Ser Gly Glu Phe Ala Phe Leu Glu Leu Asn Pro305
310 315 320Arg Leu Gln Val Glu His Pro
Thr Thr Glu Met Val Ser Gly Val Asn 325
330 335Ile Pro Ala Ala Gln Leu Gln Val Ala Met Gly Ile
Pro Leu Tyr Ser 340 345 350Ile
Arg Asp Ile Arg Thr Leu Tyr Gly Met Asp Pro Arg Gly Asn Glu 355
360 365Val Ile Asp Phe Asp Phe Ser Ser Pro
Glu Ser Phe Lys Thr Gln Arg 370 375
380Lys Pro Gln Pro Gln Gly His Val Val Ala Cys Arg Ile Thr Ala Glu385
390 395 400Asn Pro Asp Thr
Gly Phe Lys Pro Gly Met Gly Ala Leu Thr Glu Leu 405
410 415Asn Phe Arg Ser Ser Thr Ser Thr Trp Gly
Tyr Phe Ser Val Gly Thr 420 425
430Ser Gly Ala Leu His Glu Tyr Ala Asp Ser Gln Phe Gly His Ile Phe
435 440 445Ala Tyr Gly Ala Asp Arg Ser
Glu Ala Arg Lys Gln Met Val Ile Ser 450 455
460Leu Lys Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu
Tyr465 470 475 480Leu Ile
Lys Leu Leu Glu Thr Asp Ala Phe Glu Ser Asn Lys Ile Thr
485 490 495Thr Gly Trp Leu Asp Gly Leu
Ile Gln Asp Arg Leu Thr Ala Glu Arg 500 505
510Pro Pro Ala Asp Leu Ala Val 51522554PRTUstilago
maydisMISC_FEATURE(1)..(554)C-terminal deleted Ustilago ACCase BC domain
(AAs 2-555) 22Pro Pro Pro Asp His Lys Ala Val Ser Gln Phe Ile Gly
Gly Asn Pro1 5 10 15Leu
Glu Thr Ala Pro Ala Ser Pro Val Ala Asp Phe Ile Arg Lys Gln 20
25 30Gly Gly His Ser Val Ile Thr Lys
Val Leu Ile Cys Asn Asn Gly Ile 35 40
45Ala Ala Val Lys Glu Ile Arg Ser Ile Arg Lys Trp Ala Tyr Glu Thr
50 55 60Phe Gly Asp Glu Arg Ala Ile Glu
Phe Thr Val Met Ala Thr Pro Glu65 70 75
80Asp Leu Lys Val Asn Ala Asp Tyr Ile Arg Met Ala Asp
Gln Tyr Val 85 90 95Glu
Val Pro Gly Gly Ser Asn Asn Asn Asn Tyr Ala Asn Val Asp Leu
100 105 110Ile Val Asp Val Ala Glu Arg
Ala Gly Val His Ala Val Trp Ala Gly 115 120
125Trp Gly His Ala Ser Glu Asn Pro Arg Leu Pro Glu Ser Leu Ala
Ala 130 135 140Ser Lys His Lys Ile Ile
Phe Ile Gly Pro Pro Gly Ser Ala Met Arg145 150
155 160Ser Leu Gly Asp Lys Ile Ser Ser Thr Ile Val
Ala Gln His Ala Asp 165 170
175Val Pro Cys Met Pro Trp Ser Gly Thr Gly Ile Lys Glu Thr Met Met
180 185 190Ser Asp Gln Gly Phe Leu
Thr Val Ser Asp Asp Val Tyr Gln Gln Ala 195 200
205Cys Ile His Thr Ala Glu Glu Gly Leu Glu Lys Ala Glu Lys
Ile Gly 210 215 220Tyr Pro Val Met Ile
Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile225 230
235 240Arg Lys Cys Thr Asn Gly Glu Glu Phe Lys
Gln Leu Tyr Asn Ala Val 245 250
255Leu Gly Glu Val Pro Gly Ser Pro Val Phe Val Met Lys Leu Ala Gly
260 265 270Gln Ala Arg His Leu
Glu Val Gln Leu Leu Ala Asp Gln Tyr Gly Asn 275
280 285Ala Ile Ser Ile Phe Gly Arg Asp Cys Ser Val Gln
Arg Arg His Gln 290 295 300Lys Ile Ile
Glu Glu Ala Pro Val Thr Ile Ala Pro Glu Asp Ala Arg305
310 315 320Glu Ser Met Glu Lys Ala Ala
Val Arg Leu Ala Lys Leu Val Gly Tyr 325
330 335Val Ser Ala Gly Thr Val Glu Trp Leu Tyr Ser Pro
Glu Ser Gly Glu 340 345 350Phe
Ala Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro Thr 355
360 365Thr Glu Met Val Ser Gly Val Asn Ile
Pro Ala Ala Gln Leu Gln Val 370 375
380Ala Met Gly Ile Pro Leu Tyr Ser Ile Arg Asp Ile Arg Thr Leu Tyr385
390 395 400Gly Met Asp Pro
Arg Gly Asn Glu Val Ile Asp Phe Asp Phe Ser Ser 405
410 415Pro Glu Ser Phe Lys Thr Gln Arg Lys Pro
Gln Pro Gln Gly His Val 420 425
430Val Ala Cys Arg Ile Thr Ala Glu Asn Pro Asp Thr Gly Phe Lys Pro
435 440 445Gly Met Gly Ala Leu Thr Glu
Leu Asn Phe Arg Ser Ser Thr Ser Thr 450 455
460Trp Gly Tyr Phe Ser Val Gly Thr Ser Gly Ala Leu His Glu Tyr
Ala465 470 475 480Asp Ser
Gln Phe Gly His Ile Phe Ala Tyr Gly Ala Asp Arg Ser Glu
485 490 495Ala Arg Lys Gln Met Val Ile
Ser Leu Lys Glu Leu Ser Ile Arg Gly 500 505
510Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile Lys Leu Leu Glu
Thr Asp 515 520 525Ala Phe Glu Ser
Asn Lys Ile Thr Thr Gly Trp Leu Asp Gly Leu Ile 530
535 540Gln Asp Arg Leu Thr Ala Glu Arg Pro Pro545
55023549PRTUstilago maydisMISC_FEATURE(1)..(549)C-terminal
deleted Ustilago ACCase BC domain (AAs 2-550) 23Pro Pro Pro Asp His
Lys Ala Val Ser Gln Phe Ile Gly Gly Asn Pro1 5
10 15Leu Glu Thr Ala Pro Ala Ser Pro Val Ala Asp
Phe Ile Arg Lys Gln 20 25
30Gly Gly His Ser Val Ile Thr Lys Val Leu Ile Cys Asn Asn Gly Ile
35 40 45Ala Ala Val Lys Glu Ile Arg Ser
Ile Arg Lys Trp Ala Tyr Glu Thr 50 55
60Phe Gly Asp Glu Arg Ala Ile Glu Phe Thr Val Met Ala Thr Pro Glu65
70 75 80Asp Leu Lys Val Asn
Ala Asp Tyr Ile Arg Met Ala Asp Gln Tyr Val 85
90 95Glu Val Pro Gly Gly Ser Asn Asn Asn Asn Tyr
Ala Asn Val Asp Leu 100 105
110Ile Val Asp Val Ala Glu Arg Ala Gly Val His Ala Val Trp Ala Gly
115 120 125Trp Gly His Ala Ser Glu Asn
Pro Arg Leu Pro Glu Ser Leu Ala Ala 130 135
140Ser Lys His Lys Ile Ile Phe Ile Gly Pro Pro Gly Ser Ala Met
Arg145 150 155 160Ser Leu
Gly Asp Lys Ile Ser Ser Thr Ile Val Ala Gln His Ala Asp
165 170 175Val Pro Cys Met Pro Trp Ser
Gly Thr Gly Ile Lys Glu Thr Met Met 180 185
190Ser Asp Gln Gly Phe Leu Thr Val Ser Asp Asp Val Tyr Gln
Gln Ala 195 200 205Cys Ile His Thr
Ala Glu Glu Gly Leu Glu Lys Ala Glu Lys Ile Gly 210
215 220Tyr Pro Val Met Ile Lys Ala Ser Glu Gly Gly Gly
Gly Lys Gly Ile225 230 235
240Arg Lys Cys Thr Asn Gly Glu Glu Phe Lys Gln Leu Tyr Asn Ala Val
245 250 255Leu Gly Glu Val Pro
Gly Ser Pro Val Phe Val Met Lys Leu Ala Gly 260
265 270Gln Ala Arg His Leu Glu Val Gln Leu Leu Ala Asp
Gln Tyr Gly Asn 275 280 285Ala Ile
Ser Ile Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His Gln 290
295 300Lys Ile Ile Glu Glu Ala Pro Val Thr Ile Ala
Pro Glu Asp Ala Arg305 310 315
320Glu Ser Met Glu Lys Ala Ala Val Arg Leu Ala Lys Leu Val Gly Tyr
325 330 335Val Ser Ala Gly
Thr Val Glu Trp Leu Tyr Ser Pro Glu Ser Gly Glu 340
345 350Phe Ala Phe Leu Glu Leu Asn Pro Arg Leu Gln
Val Glu His Pro Thr 355 360 365Thr
Glu Met Val Ser Gly Val Asn Ile Pro Ala Ala Gln Leu Gln Val 370
375 380Ala Met Gly Ile Pro Leu Tyr Ser Ile Arg
Asp Ile Arg Thr Leu Tyr385 390 395
400Gly Met Asp Pro Arg Gly Asn Glu Val Ile Asp Phe Asp Phe Ser
Ser 405 410 415Pro Glu Ser
Phe Lys Thr Gln Arg Lys Pro Gln Pro Gln Gly His Val 420
425 430Val Ala Cys Arg Ile Thr Ala Glu Asn Pro
Asp Thr Gly Phe Lys Pro 435 440
445Gly Met Gly Ala Leu Thr Glu Leu Asn Phe Arg Ser Ser Thr Ser Thr 450
455 460Trp Gly Tyr Phe Ser Val Gly Thr
Ser Gly Ala Leu His Glu Tyr Ala465 470
475 480Asp Ser Gln Phe Gly His Ile Phe Ala Tyr Gly Ala
Asp Arg Ser Glu 485 490
495Ala Arg Lys Gln Met Val Ile Ser Leu Lys Glu Leu Ser Ile Arg Gly
500 505 510Asp Phe Arg Thr Thr Val
Glu Tyr Leu Ile Lys Leu Leu Glu Thr Asp 515 520
525Ala Phe Glu Ser Asn Lys Ile Thr Thr Gly Trp Leu Asp Gly
Leu Ile 530 535 540Gln Asp Arg Leu
Thr54524539PRTUstilago maydisMISC_FEATURE(1)..(539)C-terminal deleted
Ustilago ACCase BC domain (AAs 2-540) 24Pro Pro Pro Asp His Lys Ala
Val Ser Gln Phe Ile Gly Gly Asn Pro1 5 10
15Leu Glu Thr Ala Pro Ala Ser Pro Val Ala Asp Phe Ile
Arg Lys Gln 20 25 30Gly Gly
His Ser Val Ile Thr Lys Val Leu Ile Cys Asn Asn Gly Ile 35
40 45Ala Ala Val Lys Glu Ile Arg Ser Ile Arg
Lys Trp Ala Tyr Glu Thr 50 55 60Phe
Gly Asp Glu Arg Ala Ile Glu Phe Thr Val Met Ala Thr Pro Glu65
70 75 80Asp Leu Lys Val Asn Ala
Asp Tyr Ile Arg Met Ala Asp Gln Tyr Val 85
90 95Glu Val Pro Gly Gly Ser Asn Asn Asn Asn Tyr Ala
Asn Val Asp Leu 100 105 110Ile
Val Asp Val Ala Glu Arg Ala Gly Val His Ala Val Trp Ala Gly 115
120 125Trp Gly His Ala Ser Glu Asn Pro Arg
Leu Pro Glu Ser Leu Ala Ala 130 135
140Ser Lys His Lys Ile Ile Phe Ile Gly Pro Pro Gly Ser Ala Met Arg145
150 155 160Ser Leu Gly Asp
Lys Ile Ser Ser Thr Ile Val Ala Gln His Ala Asp 165
170 175Val Pro Cys Met Pro Trp Ser Gly Thr Gly
Ile Lys Glu Thr Met Met 180 185
190Ser Asp Gln Gly Phe Leu Thr Val Ser Asp Asp Val Tyr Gln Gln Ala
195 200 205Cys Ile His Thr Ala Glu Glu
Gly Leu Glu Lys Ala Glu Lys Ile Gly 210 215
220Tyr Pro Val Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly
Ile225 230 235 240Arg Lys
Cys Thr Asn Gly Glu Glu Phe Lys Gln Leu Tyr Asn Ala Val
245 250 255Leu Gly Glu Val Pro Gly Ser
Pro Val Phe Val Met Lys Leu Ala Gly 260 265
270Gln Ala Arg His Leu Glu Val Gln Leu Leu Ala Asp Gln Tyr
Gly Asn 275 280 285Ala Ile Ser Ile
Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His Gln 290
295 300Lys Ile Ile Glu Glu Ala Pro Val Thr Ile Ala Pro
Glu Asp Ala Arg305 310 315
320Glu Ser Met Glu Lys Ala Ala Val Arg Leu Ala Lys Leu Val Gly Tyr
325 330 335Val Ser Ala Gly Thr
Val Glu Trp Leu Tyr Ser Pro Glu Ser Gly Glu 340
345 350Phe Ala Phe Leu Glu Leu Asn Pro Arg Leu Gln Val
Glu His Pro Thr 355 360 365Thr Glu
Met Val Ser Gly Val Asn Ile Pro Ala Ala Gln Leu Gln Val 370
375 380Ala Met Gly Ile Pro Leu Tyr Ser Ile Arg Asp
Ile Arg Thr Leu Tyr385 390 395
400Gly Met Asp Pro Arg Gly Asn Glu Val Ile Asp Phe Asp Phe Ser Ser
405 410 415Pro Glu Ser Phe
Lys Thr Gln Arg Lys Pro Gln Pro Gln Gly His Val 420
425 430Val Ala Cys Arg Ile Thr Ala Glu Asn Pro Asp
Thr Gly Phe Lys Pro 435 440 445Gly
Met Gly Ala Leu Thr Glu Leu Asn Phe Arg Ser Ser Thr Ser Thr 450
455 460Trp Gly Tyr Phe Ser Val Gly Thr Ser Gly
Ala Leu His Glu Tyr Ala465 470 475
480Asp Ser Gln Phe Gly His Ile Phe Ala Tyr Gly Ala Asp Arg Ser
Glu 485 490 495Ala Arg Lys
Gln Met Val Ile Ser Leu Lys Glu Leu Ser Ile Arg Gly 500
505 510Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile
Lys Leu Leu Glu Thr Asp 515 520
525Ala Phe Glu Ser Asn Lys Ile Thr Thr Gly Trp 530
53525529PRTUstilago maydisMISC_FEATURE(1)..(529)C-terminal deleted
Ustilago ACCase BC domain (AAs 2-530) 25Pro Pro Pro Asp His Lys Ala
Val Ser Gln Phe Ile Gly Gly Asn Pro1 5 10
15Leu Glu Thr Ala Pro Ala Ser Pro Val Ala Asp Phe Ile
Arg Lys Gln 20 25 30Gly Gly
His Ser Val Ile Thr Lys Val Leu Ile Cys Asn Asn Gly Ile 35
40 45Ala Ala Val Lys Glu Ile Arg Ser Ile Arg
Lys Trp Ala Tyr Glu Thr 50 55 60Phe
Gly Asp Glu Arg Ala Ile Glu Phe Thr Val Met Ala Thr Pro Glu65
70 75 80Asp Leu Lys Val Asn Ala
Asp Tyr Ile Arg Met Ala Asp Gln Tyr Val 85
90 95Glu Val Pro Gly Gly Ser Asn Asn Asn Asn Tyr Ala
Asn Val Asp Leu 100 105 110Ile
Val Asp Val Ala Glu Arg Ala Gly Val His Ala Val Trp Ala Gly 115
120 125Trp Gly His Ala Ser Glu Asn Pro Arg
Leu Pro Glu Ser Leu Ala Ala 130 135
140Ser Lys His Lys Ile Ile Phe Ile Gly Pro Pro Gly Ser Ala Met Arg145
150 155 160Ser Leu Gly Asp
Lys Ile Ser Ser Thr Ile Val Ala Gln His Ala Asp 165
170 175Val Pro Cys Met Pro Trp Ser Gly Thr Gly
Ile Lys Glu Thr Met Met 180 185
190Ser Asp Gln Gly Phe Leu Thr Val Ser Asp Asp Val Tyr Gln Gln Ala
195 200 205Cys Ile His Thr Ala Glu Glu
Gly Leu Glu Lys Ala Glu Lys Ile Gly 210 215
220Tyr Pro Val Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly
Ile225 230 235 240Arg Lys
Cys Thr Asn Gly Glu Glu Phe Lys Gln Leu Tyr Asn Ala Val
245 250 255Leu Gly Glu Val Pro Gly Ser
Pro Val Phe Val Met Lys Leu Ala Gly 260 265
270Gln Ala Arg His Leu Glu Val Gln Leu Leu Ala Asp Gln Tyr
Gly Asn 275 280 285Ala Ile Ser Ile
Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His Gln 290
295 300Lys Ile Ile Glu Glu Ala Pro Val Thr Ile Ala Pro
Glu Asp Ala Arg305 310 315
320Glu Ser Met Glu Lys Ala Ala Val Arg Leu Ala Lys Leu Val Gly Tyr
325 330 335Val Ser Ala Gly Thr
Val Glu Trp Leu Tyr Ser Pro Glu Ser Gly Glu 340
345 350Phe Ala Phe Leu Glu Leu Asn Pro Arg Leu Gln Val
Glu His Pro Thr 355 360 365Thr Glu
Met Val Ser Gly Val Asn Ile Pro Ala Ala Gln Leu Gln Val 370
375 380Ala Met Gly Ile Pro Leu Tyr Ser Ile Arg Asp
Ile Arg Thr Leu Tyr385 390 395
400Gly Met Asp Pro Arg Gly Asn Glu Val Ile Asp Phe Asp Phe Ser Ser
405 410 415Pro Glu Ser Phe
Lys Thr Gln Arg Lys Pro Gln Pro Gln Gly His Val 420
425 430Val Ala Cys Arg Ile Thr Ala Glu Asn Pro Asp
Thr Gly Phe Lys Pro 435 440 445Gly
Met Gly Ala Leu Thr Glu Leu Asn Phe Arg Ser Ser Thr Ser Thr 450
455 460Trp Gly Tyr Phe Ser Val Gly Thr Ser Gly
Ala Leu His Glu Tyr Ala465 470 475
480Asp Ser Gln Phe Gly His Ile Phe Ala Tyr Gly Ala Asp Arg Ser
Glu 485 490 495Ala Arg Lys
Gln Met Val Ile Ser Leu Lys Glu Leu Ser Ile Arg Gly 500
505 510Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile
Lys Leu Leu Glu Thr Asp 515 520
525Ala26519PRTUstilago maydisMISC_FEATURE(1)..(519)C-terminal deleted
Ustilago ACCase BC domain (AAs2-520) 26Pro Pro Pro Asp His Lys Ala
Val Ser Gln Phe Ile Gly Gly Asn Pro1 5 10
15Leu Glu Thr Ala Pro Ala Ser Pro Val Ala Asp Phe Ile
Arg Lys Gln 20 25 30Gly Gly
His Ser Val Ile Thr Lys Val Leu Ile Cys Asn Asn Gly Ile 35
40 45Ala Ala Val Lys Glu Ile Arg Ser Ile Arg
Lys Trp Ala Tyr Glu Thr 50 55 60Phe
Gly Asp Glu Arg Ala Ile Glu Phe Thr Val Met Ala Thr Pro Glu65
70 75 80Asp Leu Lys Val Asn Ala
Asp Tyr Ile Arg Met Ala Asp Gln Tyr Val 85
90 95Glu Val Pro Gly Gly Ser Asn Asn Asn Asn Tyr Ala
Asn Val Asp Leu 100 105 110Ile
Val Asp Val Ala Glu Arg Ala Gly Val His Ala Val Trp Ala Gly 115
120 125Trp Gly His Ala Ser Glu Asn Pro Arg
Leu Pro Glu Ser Leu Ala Ala 130 135
140Ser Lys His Lys Ile Ile Phe Ile Gly Pro Pro Gly Ser Ala Met Arg145
150 155 160Ser Leu Gly Asp
Lys Ile Ser Ser Thr Ile Val Ala Gln His Ala Asp 165
170 175Val Pro Cys Met Pro Trp Ser Gly Thr Gly
Ile Lys Glu Thr Met Met 180 185
190Ser Asp Gln Gly Phe Leu Thr Val Ser Asp Asp Val Tyr Gln Gln Ala
195 200 205Cys Ile His Thr Ala Glu Glu
Gly Leu Glu Lys Ala Glu Lys Ile Gly 210 215
220Tyr Pro Val Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly
Ile225 230 235 240Arg Lys
Cys Thr Asn Gly Glu Glu Phe Lys Gln Leu Tyr Asn Ala Val
245 250 255Leu Gly Glu Val Pro Gly Ser
Pro Val Phe Val Met Lys Leu Ala Gly 260 265
270Gln Ala Arg His Leu Glu Val Gln Leu Leu Ala Asp Gln Tyr
Gly Asn 275 280 285Ala Ile Ser Ile
Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His Gln 290
295 300Lys Ile Ile Glu Glu Ala Pro Val Thr Ile Ala Pro
Glu Asp Ala Arg305 310 315
320Glu Ser Met Glu Lys Ala Ala Val Arg Leu Ala Lys Leu Val Gly Tyr
325 330 335Val Ser Ala Gly Thr
Val Glu Trp Leu Tyr Ser Pro Glu Ser Gly Glu 340
345 350Phe Ala Phe Leu Glu Leu Asn Pro Arg Leu Gln Val
Glu His Pro Thr 355 360 365Thr Glu
Met Val Ser Gly Val Asn Ile Pro Ala Ala Gln Leu Gln Val 370
375 380Ala Met Gly Ile Pro Leu Tyr Ser Ile Arg Asp
Ile Arg Thr Leu Tyr385 390 395
400Gly Met Asp Pro Arg Gly Asn Glu Val Ile Asp Phe Asp Phe Ser Ser
405 410 415Pro Glu Ser Phe
Lys Thr Gln Arg Lys Pro Gln Pro Gln Gly His Val 420
425 430Val Ala Cys Arg Ile Thr Ala Glu Asn Pro Asp
Thr Gly Phe Lys Pro 435 440 445Gly
Met Gly Ala Leu Thr Glu Leu Asn Phe Arg Ser Ser Thr Ser Thr 450
455 460Trp Gly Tyr Phe Ser Val Gly Thr Ser Gly
Ala Leu His Glu Tyr Ala465 470 475
480Asp Ser Gln Phe Gly His Ile Phe Ala Tyr Gly Ala Asp Arg Ser
Glu 485 490 495Ala Arg Lys
Gln Met Val Ile Ser Leu Lys Glu Leu Ser Ile Arg Gly 500
505 510Asp Phe Arg Thr Thr Val Glu
51527554PRTUstilago maydisMISC_FEATURE(1)..(554)N- and C-terminal deleted
Ustilago ACCase BC domain (AAs 4-547) 27Pro Asp His Lys Ala Val Ser
Gln Phe Ile Gly Gly Asn Pro Leu Glu1 5 10
15Thr Ala Pro Ala Ser Pro Val Ala Asp Phe Ile Arg Lys
Gln Gly Gly 20 25 30His Ser
Val Ile Thr Lys Val Leu Ile Cys Asn Asn Gly Ile Ala Ala 35
40 45Val Lys Glu Ile Arg Ser Ile Arg Lys Trp
Ala Tyr Glu Thr Phe Gly 50 55 60Asp
Glu Arg Ala Ile Glu Phe Thr Val Met Ala Thr Pro Glu Asp Leu65
70 75 80Lys Val Asn Ala Asp Tyr
Ile Arg Met Ala Asp Gln Tyr Val Glu Val 85
90 95Pro Gly Gly Ser Asn Asn Asn Asn Tyr Ala Asn Val
Asp Leu Ile Val 100 105 110Asp
Val Ala Glu Arg Ala Gly Val His Ala Val Trp Ala Gly Trp Gly 115
120 125His Ala Ser Glu Asn Pro Arg Leu Pro
Glu Ser Leu Ala Ala Ser Lys 130 135
140His Lys Ile Ile Phe Ile Gly Pro Pro Gly Ser Ala Met Arg Ser Leu145
150 155 160Gly Asp Lys Ile
Ser Ser Thr Ile Val Ala Gln His Ala Asp Val Pro 165
170 175Cys Met Pro Trp Ser Gly Thr Gly Ile Lys
Glu Thr Met Met Ser Asp 180 185
190Gln Gly Phe Leu Thr Val Ser Asp Asp Val Tyr Gln Gln Ala Cys Ile
195 200 205His Thr Ala Glu Glu Gly Leu
Glu Lys Ala Glu Lys Ile Gly Tyr Pro 210 215
220Val Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile Arg
Lys225 230 235 240Cys Thr
Asn Gly Glu Glu Phe Lys Gln Leu Tyr Asn Ala Val Leu Gly
245 250 255Glu Val Pro Gly Ser Pro Val
Phe Val Met Lys Leu Ala Gly Gln Ala 260 265
270Arg His Leu Glu Val Gln Leu Leu Ala Asp Gln Tyr Gly Asn
Ala Ile 275 280 285Ser Ile Phe Gly
Arg Asp Cys Ser Val Gln Arg Arg His Gln Lys Ile 290
295 300Ile Glu Glu Ala Pro Val Thr Ile Ala Pro Glu Asp
Ala Arg Glu Ser305 310 315
320Met Glu Lys Ala Ala Val Arg Leu Ala Lys Leu Val Gly Tyr Val Ser
325 330 335Ala Gly Thr Val Glu
Trp Leu Tyr Ser Pro Glu Ser Gly Glu Phe Ala 340
345 350Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His
Pro Thr Thr Glu 355 360 365Met Val
Ser Gly Val Asn Ile Pro Ala Ala Gln Leu Gln Val Ala Met 370
375 380Gly Ile Pro Leu Tyr Ser Ile Arg Asp Ile Arg
Thr Leu Tyr Gly Met385 390 395
400Asp Pro Arg Gly Asn Glu Val Ile Asp Phe Asp Phe Ser Ser Pro Glu
405 410 415Ser Phe Lys Thr
Gln Arg Lys Pro Gln Pro Gln Gly His Val Val Ala 420
425 430Cys Arg Ile Thr Ala Glu Asn Pro Asp Thr Gly
Phe Lys Pro Gly Met 435 440 445Gly
Ala Leu Thr Glu Leu Asn Phe Arg Ser Ser Thr Ser Thr Trp Gly 450
455 460Tyr Phe Ser Val Gly Thr Ser Gly Ala Leu
His Glu Tyr Ala Asp Ser465 470 475
480Gln Phe Gly His Ile Phe Ala Tyr Gly Ala Asp Arg Ser Glu Ala
Arg 485 490 495Lys Gln Met
Val Ile Ser Leu Lys Glu Leu Ser Ile Arg Gly Asp Phe 500
505 510Arg Thr Thr Val Glu Tyr Leu Ile Lys Leu
Leu Glu Thr Asp Ala Phe 515 520
525Glu Ser Asn Lys Ile Thr Thr Gly Trp Leu Asp Gly Leu Ile Gln Asp 530
535 540Arg Leu Thr Ala Glu Arg Pro Pro
Ala Asp545 55028549PRTUstilago
maydisMISC_FEATURE(1)..(549)N- and C-terminal deleted Ustilago ACCase BC
domain (AAs 7-555) 28Lys Ala Val Ser Gln Phe Ile Gly Gly Asn Pro Leu
Glu Thr Ala Pro1 5 10
15Ala Ser Pro Val Ala Asp Phe Ile Arg Lys Gln Gly Gly His Ser Val
20 25 30Ile Thr Lys Val Leu Ile Cys
Asn Asn Gly Ile Ala Ala Val Lys Glu 35 40
45Ile Arg Ser Ile Arg Lys Trp Ala Tyr Glu Thr Phe Gly Asp Glu
Arg 50 55 60Ala Ile Glu Phe Thr Val
Met Ala Thr Pro Glu Asp Leu Lys Val Asn65 70
75 80Ala Asp Tyr Ile Arg Met Ala Asp Gln Tyr Val
Glu Val Pro Gly Gly 85 90
95Ser Asn Asn Asn Asn Tyr Ala Asn Val Asp Leu Ile Val Asp Val Ala
100 105 110Glu Arg Ala Gly Val His
Ala Val Trp Ala Gly Trp Gly His Ala Ser 115 120
125Glu Asn Pro Arg Leu Pro Glu Ser Leu Ala Ala Ser Lys His
Lys Ile 130 135 140Ile Phe Ile Gly Pro
Pro Gly Ser Ala Met Arg Ser Leu Gly Asp Lys145 150
155 160Ile Ser Ser Thr Ile Val Ala Gln His Ala
Asp Val Pro Cys Met Pro 165 170
175Trp Ser Gly Thr Gly Ile Lys Glu Thr Met Met Ser Asp Gln Gly Phe
180 185 190Leu Thr Val Ser Asp
Asp Val Tyr Gln Gln Ala Cys Ile His Thr Ala 195
200 205Glu Glu Gly Leu Glu Lys Ala Glu Lys Ile Gly Tyr
Pro Val Met Ile 210 215 220Lys Ala Ser
Glu Gly Gly Gly Gly Lys Gly Ile Arg Lys Cys Thr Asn225
230 235 240Gly Glu Glu Phe Lys Gln Leu
Tyr Asn Ala Val Leu Gly Glu Val Pro 245
250 255Gly Ser Pro Val Phe Val Met Lys Leu Ala Gly Gln
Ala Arg His Leu 260 265 270Glu
Val Gln Leu Leu Ala Asp Gln Tyr Gly Asn Ala Ile Ser Ile Phe 275
280 285Gly Arg Asp Cys Ser Val Gln Arg Arg
His Gln Lys Ile Ile Glu Glu 290 295
300Ala Pro Val Thr Ile Ala Pro Glu Asp Ala Arg Glu Ser Met Glu Lys305
310 315 320Ala Ala Val Arg
Leu Ala Lys Leu Val Gly Tyr Val Ser Ala Gly Thr 325
330 335Val Glu Trp Leu Tyr Ser Pro Glu Ser Gly
Glu Phe Ala Phe Leu Glu 340 345
350Leu Asn Pro Arg Leu Gln Val Glu His Pro Thr Thr Glu Met Val Ser
355 360 365Gly Val Asn Ile Pro Ala Ala
Gln Leu Gln Val Ala Met Gly Ile Pro 370 375
380Leu Tyr Ser Ile Arg Asp Ile Arg Thr Leu Tyr Gly Met Asp Pro
Arg385 390 395 400Gly Asn
Glu Val Ile Asp Phe Asp Phe Ser Ser Pro Glu Ser Phe Lys
405 410 415Thr Gln Arg Lys Pro Gln Pro
Gln Gly His Val Val Ala Cys Arg Ile 420 425
430Thr Ala Glu Asn Pro Asp Thr Gly Phe Lys Pro Gly Met Gly
Ala Leu 435 440 445Thr Glu Leu Asn
Phe Arg Ser Ser Thr Ser Thr Trp Gly Tyr Phe Ser 450
455 460Val Gly Thr Ser Gly Ala Leu His Glu Tyr Ala Asp
Ser Gln Phe Gly465 470 475
480His Ile Phe Ala Tyr Gly Ala Asp Arg Ser Glu Ala Arg Lys Gln Met
485 490 495Val Ile Ser Leu Lys
Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr 500
505 510Val Glu Tyr Leu Ile Lys Leu Leu Glu Thr Asp Ala
Phe Glu Ser Asn 515 520 525Lys Ile
Thr Thr Gly Trp Leu Asp Gly Leu Ile Gln Asp Arg Leu Thr 530
535 540Ala Glu Arg Pro Pro54529539PRTUstilago
maydisMISC_FEATURE(1)..(539)N- and C-terminal deleted Ustilago ACCase BC
domain (AAs 12-550) 29Phe Ile Gly Gly Asn Pro Leu Glu Thr Ala Pro
Ala Ser Pro Val Ala1 5 10
15Asp Phe Ile Arg Lys Gln Gly Gly His Ser Val Ile Thr Lys Val Leu
20 25 30Ile Cys Asn Asn Gly Ile Ala
Ala Val Lys Glu Ile Arg Ser Ile Arg 35 40
45Lys Trp Ala Tyr Glu Thr Phe Gly Asp Glu Arg Ala Ile Glu Phe
Thr 50 55 60Val Met Ala Thr Pro Glu
Asp Leu Lys Val Asn Ala Asp Tyr Ile Arg65 70
75 80Met Ala Asp Gln Tyr Val Glu Val Pro Gly Gly
Ser Asn Asn Asn Asn 85 90
95Tyr Ala Asn Val Asp Leu Ile Val Asp Val Ala Glu Arg Ala Gly Val
100 105 110His Ala Val Trp Ala Gly
Trp Gly His Ala Ser Glu Asn Pro Arg Leu 115 120
125Pro Glu Ser Leu Ala Ala Ser Lys His Lys Ile Ile Phe Ile
Gly Pro 130 135 140Pro Gly Ser Ala Met
Arg Ser Leu Gly Asp Lys Ile Ser Ser Thr Ile145 150
155 160Val Ala Gln His Ala Asp Val Pro Cys Met
Pro Trp Ser Gly Thr Gly 165 170
175Ile Lys Glu Thr Met Met Ser Asp Gln Gly Phe Leu Thr Val Ser Asp
180 185 190Asp Val Tyr Gln Gln
Ala Cys Ile His Thr Ala Glu Glu Gly Leu Glu 195
200 205Lys Ala Glu Lys Ile Gly Tyr Pro Val Met Ile Lys
Ala Ser Glu Gly 210 215 220Gly Gly Gly
Lys Gly Ile Arg Lys Cys Thr Asn Gly Glu Glu Phe Lys225
230 235 240Gln Leu Tyr Asn Ala Val Leu
Gly Glu Val Pro Gly Ser Pro Val Phe 245
250 255Val Met Lys Leu Ala Gly Gln Ala Arg His Leu Glu
Val Gln Leu Leu 260 265 270Ala
Asp Gln Tyr Gly Asn Ala Ile Ser Ile Phe Gly Arg Asp Cys Ser 275
280 285Val Gln Arg Arg His Gln Lys Ile Ile
Glu Glu Ala Pro Val Thr Ile 290 295
300Ala Pro Glu Asp Ala Arg Glu Ser Met Glu Lys Ala Ala Val Arg Leu305
310 315 320Ala Lys Leu Val
Gly Tyr Val Ser Ala Gly Thr Val Glu Trp Leu Tyr 325
330 335Ser Pro Glu Ser Gly Glu Phe Ala Phe Leu
Glu Leu Asn Pro Arg Leu 340 345
350Gln Val Glu His Pro Thr Thr Glu Met Val Ser Gly Val Asn Ile Pro
355 360 365Ala Ala Gln Leu Gln Val Ala
Met Gly Ile Pro Leu Tyr Ser Ile Arg 370 375
380Asp Ile Arg Thr Leu Tyr Gly Met Asp Pro Arg Gly Asn Glu Val
Ile385 390 395 400Asp Phe
Asp Phe Ser Ser Pro Glu Ser Phe Lys Thr Gln Arg Lys Pro
405 410 415Gln Pro Gln Gly His Val Val
Ala Cys Arg Ile Thr Ala Glu Asn Pro 420 425
430Asp Thr Gly Phe Lys Pro Gly Met Gly Ala Leu Thr Glu Leu
Asn Phe 435 440 445Arg Ser Ser Thr
Ser Thr Trp Gly Tyr Phe Ser Val Gly Thr Ser Gly 450
455 460Ala Leu His Glu Tyr Ala Asp Ser Gln Phe Gly His
Ile Phe Ala Tyr465 470 475
480Gly Ala Asp Arg Ser Glu Ala Arg Lys Gln Met Val Ile Ser Leu Lys
485 490 495Glu Leu Ser Ile Arg
Gly Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile 500
505 510Lys Leu Leu Glu Thr Asp Ala Phe Glu Ser Asn Lys
Ile Thr Thr Gly 515 520 525Trp Leu
Asp Gly Leu Ile Gln Asp Arg Leu Thr 530
53530529PRTUstilago maydisMISC_FEATURE(1)..(529)N- and C-terminal deleted
Ustilago ACCase BC domain (AAs 17-545) 30Pro Leu Glu Thr Ala Pro
Ala Ser Pro Val Ala Asp Phe Ile Arg Lys1 5
10 15Gln Gly Gly His Ser Val Ile Thr Lys Val Leu Ile
Cys Asn Asn Gly 20 25 30Ile
Ala Ala Val Lys Glu Ile Arg Ser Ile Arg Lys Trp Ala Tyr Glu 35
40 45Thr Phe Gly Asp Glu Arg Ala Ile Glu
Phe Thr Val Met Ala Thr Pro 50 55
60Glu Asp Leu Lys Val Asn Ala Asp Tyr Ile Arg Met Ala Asp Gln Tyr65
70 75 80Val Glu Val Pro Gly
Gly Ser Asn Asn Asn Asn Tyr Ala Asn Val Asp 85
90 95Leu Ile Val Asp Val Ala Glu Arg Ala Gly Val
His Ala Val Trp Ala 100 105
110Gly Trp Gly His Ala Ser Glu Asn Pro Arg Leu Pro Glu Ser Leu Ala
115 120 125Ala Ser Lys His Lys Ile Ile
Phe Ile Gly Pro Pro Gly Ser Ala Met 130 135
140Arg Ser Leu Gly Asp Lys Ile Ser Ser Thr Ile Val Ala Gln His
Ala145 150 155 160Asp Val
Pro Cys Met Pro Trp Ser Gly Thr Gly Ile Lys Glu Thr Met
165 170 175Met Ser Asp Gln Gly Phe Leu
Thr Val Ser Asp Asp Val Tyr Gln Gln 180 185
190Ala Cys Ile His Thr Ala Glu Glu Gly Leu Glu Lys Ala Glu
Lys Ile 195 200 205Gly Tyr Pro Val
Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly 210
215 220Ile Arg Lys Cys Thr Asn Gly Glu Glu Phe Lys Gln
Leu Tyr Asn Ala225 230 235
240Val Leu Gly Glu Val Pro Gly Ser Pro Val Phe Val Met Lys Leu Ala
245 250 255Gly Gln Ala Arg His
Leu Glu Val Gln Leu Leu Ala Asp Gln Tyr Gly 260
265 270Asn Ala Ile Ser Ile Phe Gly Arg Asp Cys Ser Val
Gln Arg Arg His 275 280 285Gln Lys
Ile Ile Glu Glu Ala Pro Val Thr Ile Ala Pro Glu Asp Ala 290
295 300Arg Glu Ser Met Glu Lys Ala Ala Val Arg Leu
Ala Lys Leu Val Gly305 310 315
320Tyr Val Ser Ala Gly Thr Val Glu Trp Leu Tyr Ser Pro Glu Ser Gly
325 330 335Glu Phe Ala Phe
Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro 340
345 350Thr Thr Glu Met Val Ser Gly Val Asn Ile Pro
Ala Ala Gln Leu Gln 355 360 365Val
Ala Met Gly Ile Pro Leu Tyr Ser Ile Arg Asp Ile Arg Thr Leu 370
375 380Tyr Gly Met Asp Pro Arg Gly Asn Glu Val
Ile Asp Phe Asp Phe Ser385 390 395
400Ser Pro Glu Ser Phe Lys Thr Gln Arg Lys Pro Gln Pro Gln Gly
His 405 410 415Val Val Ala
Cys Arg Ile Thr Ala Glu Asn Pro Asp Thr Gly Phe Lys 420
425 430Pro Gly Met Gly Ala Leu Thr Glu Leu Asn
Phe Arg Ser Ser Thr Ser 435 440
445Thr Trp Gly Tyr Phe Ser Val Gly Thr Ser Gly Ala Leu His Glu Tyr 450
455 460Ala Asp Ser Gln Phe Gly His Ile
Phe Ala Tyr Gly Ala Asp Arg Ser465 470
475 480Glu Ala Arg Lys Gln Met Val Ile Ser Leu Lys Glu
Leu Ser Ile Arg 485 490
495Gly Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile Lys Leu Leu Glu Thr
500 505 510Asp Ala Phe Glu Ser Asn
Lys Ile Thr Thr Gly Trp Leu Asp Gly Leu 515 520
525Ile31519PRTUstilago maydisMISC_FEATURE(1)..(519)N- and
C-terminal deleted Ustilago ACCase BC domain (AAs 22-540) 31Pro Ala
Ser Pro Val Ala Asp Phe Ile Arg Lys Gln Gly Gly His Ser1 5
10 15Val Ile Thr Lys Val Leu Ile Cys
Asn Asn Gly Ile Ala Ala Val Lys 20 25
30Glu Ile Arg Ser Ile Arg Lys Trp Ala Tyr Glu Thr Phe Gly Asp
Glu 35 40 45Arg Ala Ile Glu Phe
Thr Val Met Ala Thr Pro Glu Asp Leu Lys Val 50 55
60Asn Ala Asp Tyr Ile Arg Met Ala Asp Gln Tyr Val Glu Val
Pro Gly65 70 75 80Gly
Ser Asn Asn Asn Asn Tyr Ala Asn Val Asp Leu Ile Val Asp Val
85 90 95Ala Glu Arg Ala Gly Val His
Ala Val Trp Ala Gly Trp Gly His Ala 100 105
110Ser Glu Asn Pro Arg Leu Pro Glu Ser Leu Ala Ala Ser Lys
His Lys 115 120 125Ile Ile Phe Ile
Gly Pro Pro Gly Ser Ala Met Arg Ser Leu Gly Asp 130
135 140Lys Ile Ser Ser Thr Ile Val Ala Gln His Ala Asp
Val Pro Cys Met145 150 155
160Pro Trp Ser Gly Thr Gly Ile Lys Glu Thr Met Met Ser Asp Gln Gly
165 170 175Phe Leu Thr Val Ser
Asp Asp Val Tyr Gln Gln Ala Cys Ile His Thr 180
185 190Ala Glu Glu Gly Leu Glu Lys Ala Glu Lys Ile Gly
Tyr Pro Val Met 195 200 205Ile Lys
Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile Arg Lys Cys Thr 210
215 220Asn Gly Glu Glu Phe Lys Gln Leu Tyr Asn Ala
Val Leu Gly Glu Val225 230 235
240Pro Gly Ser Pro Val Phe Val Met Lys Leu Ala Gly Gln Ala Arg His
245 250 255Leu Glu Val Gln
Leu Leu Ala Asp Gln Tyr Gly Asn Ala Ile Ser Ile 260
265 270Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His
Gln Lys Ile Ile Glu 275 280 285Glu
Ala Pro Val Thr Ile Ala Pro Glu Asp Ala Arg Glu Ser Met Glu 290
295 300Lys Ala Ala Val Arg Leu Ala Lys Leu Val
Gly Tyr Val Ser Ala Gly305 310 315
320Thr Val Glu Trp Leu Tyr Ser Pro Glu Ser Gly Glu Phe Ala Phe
Leu 325 330 335Glu Leu Asn
Pro Arg Leu Gln Val Glu His Pro Thr Thr Glu Met Val 340
345 350Ser Gly Val Asn Ile Pro Ala Ala Gln Leu
Gln Val Ala Met Gly Ile 355 360
365Pro Leu Tyr Ser Ile Arg Asp Ile Arg Thr Leu Tyr Gly Met Asp Pro 370
375 380Arg Gly Asn Glu Val Ile Asp Phe
Asp Phe Ser Ser Pro Glu Ser Phe385 390
395 400Lys Thr Gln Arg Lys Pro Gln Pro Gln Gly His Val
Val Ala Cys Arg 405 410
415Ile Thr Ala Glu Asn Pro Asp Thr Gly Phe Lys Pro Gly Met Gly Ala
420 425 430Leu Thr Glu Leu Asn Phe
Arg Ser Ser Thr Ser Thr Trp Gly Tyr Phe 435 440
445Ser Val Gly Thr Ser Gly Ala Leu His Glu Tyr Ala Asp Ser
Gln Phe 450 455 460Gly His Ile Phe Ala
Tyr Gly Ala Asp Arg Ser Glu Ala Arg Lys Gln465 470
475 480Met Val Ile Ser Leu Lys Glu Leu Ser Ile
Arg Gly Asp Phe Arg Thr 485 490
495Thr Val Glu Tyr Leu Ile Lys Leu Leu Glu Thr Asp Ala Phe Glu Ser
500 505 510Asn Lys Ile Thr Thr
Gly Trp 51532580PRTSaccharomyces
cerevisiaeMISC_FEATURE(76)..(76)Saccharomyces cerevisiae ACCase BC domain
S77Y mutation 32Ser Glu Glu Ser Leu Phe Glu Ser Ser Pro Gln Lys Met
Glu Tyr Glu1 5 10 15Ile
Thr Asn Tyr Ser Glu Arg His Thr Glu Leu Pro Gly His Phe Ile 20
25 30Gly Leu Asn Thr Val Asp Lys Leu
Glu Glu Ser Pro Leu Arg Asp Phe 35 40
45Val Lys Ser His Gly Gly His Thr Val Ile Ser Lys Ile Leu Ile Ala
50 55 60Asn Asn Gly Ile Ala Ala Val Lys
Glu Ile Arg Tyr Val Arg Lys Trp65 70 75
80Ala Tyr Glu Thr Phe Gly Asp Asp Arg Thr Val Gln Phe
Val Ala Met 85 90 95Ala
Thr Pro Glu Asp Leu Glu Ala Asn Ala Glu Tyr Ile Arg Met Ala
100 105 110Asp Gln Tyr Ile Glu Val Pro
Gly Gly Thr Asn Asn Asn Asn Tyr Ala 115 120
125Asn Val Asp Leu Ile Val Asp Ile Ala Glu Arg Ala Asp Val Asp
Ala 130 135 140Val Trp Ala Gly Trp Gly
His Ala Ser Glu Asn Pro Leu Leu Pro Glu145 150
155 160Lys Leu Ser Gln Ser Lys Arg Lys Val Ile Phe
Ile Gly Pro Pro Gly 165 170
175Asn Ala Met Arg Ser Leu Gly Asp Lys Ile Ser Ser Thr Ile Val Ala
180 185 190Gln Ser Ala Lys Val Pro
Cys Ile Pro Trp Ser Gly Thr Gly Val Asp 195 200
205Thr Val His Val Asp Glu Lys Thr Gly Leu Val Ser Val Asp
Asp Asp 210 215 220Ile Tyr Gln Lys Gly
Cys Cys Thr Ser Pro Glu Asp Gly Leu Gln Lys225 230
235 240Ala Lys Arg Ile Gly Phe Pro Val Met Ile
Lys Ala Ser Glu Gly Gly 245 250
255Gly Gly Lys Gly Ile Arg Gln Val Glu Arg Glu Glu Asp Phe Ile Ala
260 265 270Leu Tyr His Gln Ala
Ala Asn Glu Ile Pro Gly Ser Pro Ile Phe Ile 275
280 285Met Lys Leu Ala Gly Arg Ala Arg His Leu Glu Val
Gln Leu Leu Ala 290 295 300Asp Gln Tyr
Gly Thr Asn Ile Ser Leu Phe Gly Arg Asp Cys Ser Val305
310 315 320Gln Arg Arg His Gln Lys Ile
Ile Glu Glu Ala Pro Val Thr Ile Ala 325
330 335Lys Ala Glu Thr Phe His Glu Met Glu Lys Ala Ala
Val Arg Leu Gly 340 345 350Lys
Leu Val Gly Tyr Val Ser Ala Gly Thr Val Glu Tyr Leu Tyr Ser 355
360 365His Asp Asp Gly Lys Phe Tyr Phe Leu
Glu Leu Asn Pro Arg Leu Gln 370 375
380Val Glu His Pro Thr Thr Glu Met Val Ser Gly Val Asn Leu Pro Ala385
390 395 400Ala Gln Leu Gln
Ile Ala Met Gly Ile Pro Met His Arg Ile Ser Asp 405
410 415Ile Arg Thr Leu Tyr Gly Met Asn Pro His
Ser Ala Ser Glu Ile Asp 420 425
430Phe Glu Phe Lys Thr Gln Asp Ala Thr Lys Lys Gln Arg Arg Pro Ile
435 440 445Pro Lys Gly His Cys Thr Ala
Cys Arg Ile Thr Ser Glu Asp Pro Asn 450 455
460Asp Gly Phe Lys Pro Ser Gly Gly Thr Leu His Glu Leu Asn Phe
Arg465 470 475 480Ser Ser
Ser Asn Val Trp Gly Tyr Phe Ser Val Gly Asn Asn Gly Asn
485 490 495Ile His Ser Phe Ser Asp Ser
Gln Phe Gly His Ile Phe Ala Phe Gly 500 505
510Glu Asn Arg Gln Ala Ser Arg Lys His Met Val Val Ala Leu
Lys Glu 515 520 525Leu Ser Ile Arg
Gly Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile Lys 530
535 540Leu Leu Glu Thr Glu Asp Phe Glu Asp Asn Thr Ile
Thr Thr Gly Trp545 550 555
560Leu Asp Asp Leu Ile Thr His Lys Met Thr Ala Glu Lys Pro Asp Pro
565 570 575Thr Leu Ala Val
58033575PRTSaccharomyces cerevisiaeMISC_FEATURE(1)..(575)N-terminal
deleted Saccharomyces cerevisiae ACCase BC domain (AAs 7-581) 33Phe
Glu Ser Ser Pro Gln Lys Met Glu Tyr Glu Ile Thr Asn Tyr Ser1
5 10 15Glu Arg His Thr Glu Leu Pro
Gly His Phe Ile Gly Leu Asn Thr Val 20 25
30Asp Lys Leu Glu Glu Ser Pro Leu Arg Asp Phe Val Lys Ser
His Gly 35 40 45Gly His Thr Val
Ile Ser Lys Ile Leu Ile Ala Asn Asn Gly Ile Ala 50 55
60Ala Val Lys Glu Ile Arg Ser Val Arg Lys Trp Ala Tyr
Glu Thr Phe65 70 75
80Gly Asp Asp Arg Thr Val Gln Phe Val Ala Met Ala Thr Pro Glu Asp
85 90 95Leu Glu Ala Asn Ala Glu
Tyr Ile Arg Met Ala Asp Gln Tyr Ile Glu 100
105 110Val Pro Gly Gly Thr Asn Asn Asn Asn Tyr Ala Asn
Val Asp Leu Ile 115 120 125Val Asp
Ile Ala Glu Arg Ala Asp Val Asp Ala Val Trp Ala Gly Trp 130
135 140Gly His Ala Ser Glu Asn Pro Leu Leu Pro Glu
Lys Leu Ser Gln Ser145 150 155
160Lys Arg Lys Val Ile Phe Ile Gly Pro Pro Gly Asn Ala Met Arg Ser
165 170 175Leu Gly Asp Lys
Ile Ser Ser Thr Ile Val Ala Gln Ser Ala Lys Val 180
185 190Pro Cys Ile Pro Trp Ser Gly Thr Gly Val Asp
Thr Val His Val Asp 195 200 205Glu
Lys Thr Gly Leu Val Ser Val Asp Asp Asp Ile Tyr Gln Lys Gly 210
215 220Cys Cys Thr Ser Pro Glu Asp Gly Leu Gln
Lys Ala Lys Arg Ile Gly225 230 235
240Phe Pro Val Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly
Ile 245 250 255Arg Gln Val
Glu Arg Glu Glu Asp Phe Ile Ala Leu Tyr His Gln Ala 260
265 270Ala Asn Glu Ile Pro Gly Ser Pro Ile Phe
Ile Met Lys Leu Ala Gly 275 280
285Arg Ala Arg His Leu Glu Val Gln Leu Leu Ala Asp Gln Tyr Gly Thr 290
295 300Asn Ile Ser Leu Phe Gly Arg Asp
Cys Ser Val Gln Arg Arg His Gln305 310
315 320Lys Ile Ile Glu Glu Ala Pro Val Thr Ile Ala Lys
Ala Glu Thr Phe 325 330
335His Glu Met Glu Lys Ala Ala Val Arg Leu Gly Lys Leu Val Gly Tyr
340 345 350Val Ser Ala Gly Thr Val
Glu Tyr Leu Tyr Ser His Asp Asp Gly Lys 355 360
365Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His
Pro Thr 370 375 380Thr Glu Met Val Ser
Gly Val Asn Leu Pro Ala Ala Gln Leu Gln Ile385 390
395 400Ala Met Gly Ile Pro Met His Arg Ile Ser
Asp Ile Arg Thr Leu Tyr 405 410
415Gly Met Asn Pro His Ser Ala Ser Glu Ile Asp Phe Glu Phe Lys Thr
420 425 430Gln Asp Ala Thr Lys
Lys Gln Arg Arg Pro Ile Pro Lys Gly His Cys 435
440 445Thr Ala Cys Arg Ile Thr Ser Glu Asp Pro Asn Asp
Gly Phe Lys Pro 450 455 460Ser Gly Gly
Thr Leu His Glu Leu Asn Phe Arg Ser Ser Ser Asn Val465
470 475 480Trp Gly Tyr Phe Ser Val Gly
Asn Asn Gly Asn Ile His Ser Phe Ser 485
490 495Asp Ser Gln Phe Gly His Ile Phe Ala Phe Gly Glu
Asn Arg Gln Ala 500 505 510Ser
Arg Lys His Met Val Val Ala Leu Lys Glu Leu Ser Ile Arg Gly 515
520 525Asp Phe Arg Thr Thr Val Glu Tyr Leu
Ile Lys Leu Leu Glu Thr Glu 530 535
540Asp Phe Glu Asp Asn Thr Ile Thr Thr Gly Trp Leu Asp Asp Leu Ile545
550 555 560Thr His Lys Met
Thr Ala Glu Lys Pro Asp Pro Thr Leu Ala Val 565
570 57534570PRTSaccharomyces
cerevisiaeMISC_FEATURE(1)..(570)N-terminal deleted Saccharomyces
cerevisiae ACCase BC domain (AAs 12-581) 34Gln Lys Met Glu Tyr Glu
Ile Thr Asn Tyr Ser Glu Arg His Thr Glu1 5
10 15Leu Pro Gly His Phe Ile Gly Leu Asn Thr Val Asp
Lys Leu Glu Glu 20 25 30Ser
Pro Leu Arg Asp Phe Val Lys Ser His Gly Gly His Thr Val Ile 35
40 45Ser Lys Ile Leu Ile Ala Asn Asn Gly
Ile Ala Ala Val Lys Glu Ile 50 55
60Arg Ser Val Arg Lys Trp Ala Tyr Glu Thr Phe Gly Asp Asp Arg Thr65
70 75 80Val Gln Phe Val Ala
Met Ala Thr Pro Glu Asp Leu Glu Ala Asn Ala 85
90 95Glu Tyr Ile Arg Met Ala Asp Gln Tyr Ile Glu
Val Pro Gly Gly Thr 100 105
110Asn Asn Asn Asn Tyr Ala Asn Val Asp Leu Ile Val Asp Ile Ala Glu
115 120 125Arg Ala Asp Val Asp Ala Val
Trp Ala Gly Trp Gly His Ala Ser Glu 130 135
140Asn Pro Leu Leu Pro Glu Lys Leu Ser Gln Ser Lys Arg Lys Val
Ile145 150 155 160Phe Ile
Gly Pro Pro Gly Asn Ala Met Arg Ser Leu Gly Asp Lys Ile
165 170 175Ser Ser Thr Ile Val Ala Gln
Ser Ala Lys Val Pro Cys Ile Pro Trp 180 185
190Ser Gly Thr Gly Val Asp Thr Val His Val Asp Glu Lys Thr
Gly Leu 195 200 205Val Ser Val Asp
Asp Asp Ile Tyr Gln Lys Gly Cys Cys Thr Ser Pro 210
215 220Glu Asp Gly Leu Gln Lys Ala Lys Arg Ile Gly Phe
Pro Val Met Ile225 230 235
240Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile Arg Gln Val Glu Arg
245 250 255Glu Glu Asp Phe Ile
Ala Leu Tyr His Gln Ala Ala Asn Glu Ile Pro 260
265 270Gly Ser Pro Ile Phe Ile Met Lys Leu Ala Gly Arg
Ala Arg His Leu 275 280 285Glu Val
Gln Leu Leu Ala Asp Gln Tyr Gly Thr Asn Ile Ser Leu Phe 290
295 300Gly Arg Asp Cys Ser Val Gln Arg Arg His Gln
Lys Ile Ile Glu Glu305 310 315
320Ala Pro Val Thr Ile Ala Lys Ala Glu Thr Phe His Glu Met Glu Lys
325 330 335Ala Ala Val Arg
Leu Gly Lys Leu Val Gly Tyr Val Ser Ala Gly Thr 340
345 350Val Glu Tyr Leu Tyr Ser His Asp Asp Gly Lys
Phe Tyr Phe Leu Glu 355 360 365Leu
Asn Pro Arg Leu Gln Val Glu His Pro Thr Thr Glu Met Val Ser 370
375 380Gly Val Asn Leu Pro Ala Ala Gln Leu Gln
Ile Ala Met Gly Ile Pro385 390 395
400Met His Arg Ile Ser Asp Ile Arg Thr Leu Tyr Gly Met Asn Pro
His 405 410 415Ser Ala Ser
Glu Ile Asp Phe Glu Phe Lys Thr Gln Asp Ala Thr Lys 420
425 430Lys Gln Arg Arg Pro Ile Pro Lys Gly His
Cys Thr Ala Cys Arg Ile 435 440
445Thr Ser Glu Asp Pro Asn Asp Gly Phe Lys Pro Ser Gly Gly Thr Leu 450
455 460His Glu Leu Asn Phe Arg Ser Ser
Ser Asn Val Trp Gly Tyr Phe Ser465 470
475 480Val Gly Asn Asn Gly Asn Ile His Ser Phe Ser Asp
Ser Gln Phe Gly 485 490
495His Ile Phe Ala Phe Gly Glu Asn Arg Gln Ala Ser Arg Lys His Met
500 505 510Val Val Ala Leu Lys Glu
Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr 515 520
525Val Glu Tyr Leu Ile Lys Leu Leu Glu Thr Glu Asp Phe Glu
Asp Asn 530 535 540Thr Ile Thr Thr Gly
Trp Leu Asp Asp Leu Ile Thr His Lys Met Thr545 550
555 560Ala Glu Lys Pro Asp Pro Thr Leu Ala Val
565 57035560PRTSaccharomyces
cerevisiaeMISC_FEATURE(1)..(560)N-terminal deleted Saccharomyces
cerevisiae ACCase BC domain (AAs 22-581) 35Ser Glu Arg His Thr Glu
Leu Pro Gly His Phe Ile Gly Leu Asn Thr1 5
10 15Val Asp Lys Leu Glu Glu Ser Pro Leu Arg Asp Phe
Val Lys Ser His 20 25 30Gly
Gly His Thr Val Ile Ser Lys Ile Leu Ile Ala Asn Asn Gly Ile 35
40 45Ala Ala Val Lys Glu Ile Arg Ser Val
Arg Lys Trp Ala Tyr Glu Thr 50 55
60Phe Gly Asp Asp Arg Thr Val Gln Phe Val Ala Met Ala Thr Pro Glu65
70 75 80Asp Leu Glu Ala Asn
Ala Glu Tyr Ile Arg Met Ala Asp Gln Tyr Ile 85
90 95Glu Val Pro Gly Gly Thr Asn Asn Asn Asn Tyr
Ala Asn Val Asp Leu 100 105
110Ile Val Asp Ile Ala Glu Arg Ala Asp Val Asp Ala Val Trp Ala Gly
115 120 125Trp Gly His Ala Ser Glu Asn
Pro Leu Leu Pro Glu Lys Leu Ser Gln 130 135
140Ser Lys Arg Lys Val Ile Phe Ile Gly Pro Pro Gly Asn Ala Met
Arg145 150 155 160Ser Leu
Gly Asp Lys Ile Ser Ser Thr Ile Val Ala Gln Ser Ala Lys
165 170 175Val Pro Cys Ile Pro Trp Ser
Gly Thr Gly Val Asp Thr Val His Val 180 185
190Asp Glu Lys Thr Gly Leu Val Ser Val Asp Asp Asp Ile Tyr
Gln Lys 195 200 205Gly Cys Cys Thr
Ser Pro Glu Asp Gly Leu Gln Lys Ala Lys Arg Ile 210
215 220Gly Phe Pro Val Met Ile Lys Ala Ser Glu Gly Gly
Gly Gly Lys Gly225 230 235
240Ile Arg Gln Val Glu Arg Glu Glu Asp Phe Ile Ala Leu Tyr His Gln
245 250 255Ala Ala Asn Glu Ile
Pro Gly Ser Pro Ile Phe Ile Met Lys Leu Ala 260
265 270Gly Arg Ala Arg His Leu Glu Val Gln Leu Leu Ala
Asp Gln Tyr Gly 275 280 285Thr Asn
Ile Ser Leu Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His 290
295 300Gln Lys Ile Ile Glu Glu Ala Pro Val Thr Ile
Ala Lys Ala Glu Thr305 310 315
320Phe His Glu Met Glu Lys Ala Ala Val Arg Leu Gly Lys Leu Val Gly
325 330 335Tyr Val Ser Ala
Gly Thr Val Glu Tyr Leu Tyr Ser His Asp Asp Gly 340
345 350Lys Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu
Gln Val Glu His Pro 355 360 365Thr
Thr Glu Met Val Ser Gly Val Asn Leu Pro Ala Ala Gln Leu Gln 370
375 380Ile Ala Met Gly Ile Pro Met His Arg Ile
Ser Asp Ile Arg Thr Leu385 390 395
400Tyr Gly Met Asn Pro His Ser Ala Ser Glu Ile Asp Phe Glu Phe
Lys 405 410 415Thr Gln Asp
Ala Thr Lys Lys Gln Arg Arg Pro Ile Pro Lys Gly His 420
425 430Cys Thr Ala Cys Arg Ile Thr Ser Glu Asp
Pro Asn Asp Gly Phe Lys 435 440
445Pro Ser Gly Gly Thr Leu His Glu Leu Asn Phe Arg Ser Ser Ser Asn 450
455 460Val Trp Gly Tyr Phe Ser Val Gly
Asn Asn Gly Asn Ile His Ser Phe465 470
475 480Ser Asp Ser Gln Phe Gly His Ile Phe Ala Phe Gly
Glu Asn Arg Gln 485 490
495Ala Ser Arg Lys His Met Val Val Ala Leu Lys Glu Leu Ser Ile Arg
500 505 510Gly Asp Phe Arg Thr Thr
Val Glu Tyr Leu Ile Lys Leu Leu Glu Thr 515 520
525Glu Asp Phe Glu Asp Asn Thr Ile Thr Thr Gly Trp Leu Asp
Asp Leu 530 535 540Ile Thr His Lys Met
Thr Ala Glu Lys Pro Asp Pro Thr Leu Ala Val545 550
555 56036550PRTSaccharomyces
cerevisiaeMISC_FEATURE(1)..(550)N-terminal deleted Saccharomyces
cerevisiae ACCase BC domain (AAs 32-581 36Phe Ile Gly Leu Asn Thr
Val Asp Lys Leu Glu Glu Ser Pro Leu Arg1 5
10 15Asp Phe Val Lys Ser His Gly Gly His Thr Val Ile
Ser Lys Ile Leu 20 25 30Ile
Ala Asn Asn Gly Ile Ala Ala Val Lys Glu Ile Arg Ser Val Arg 35
40 45Lys Trp Ala Tyr Glu Thr Phe Gly Asp
Asp Arg Thr Val Gln Phe Val 50 55
60Ala Met Ala Thr Pro Glu Asp Leu Glu Ala Asn Ala Glu Tyr Ile Arg65
70 75 80Met Ala Asp Gln Tyr
Ile Glu Val Pro Gly Gly Thr Asn Asn Asn Asn 85
90 95Tyr Ala Asn Val Asp Leu Ile Val Asp Ile Ala
Glu Arg Ala Asp Val 100 105
110Asp Ala Val Trp Ala Gly Trp Gly His Ala Ser Glu Asn Pro Leu Leu
115 120 125Pro Glu Lys Leu Ser Gln Ser
Lys Arg Lys Val Ile Phe Ile Gly Pro 130 135
140Pro Gly Asn Ala Met Arg Ser Leu Gly Asp Lys Ile Ser Ser Thr
Ile145 150 155 160Val Ala
Gln Ser Ala Lys Val Pro Cys Ile Pro Trp Ser Gly Thr Gly
165 170 175Val Asp Thr Val His Val Asp
Glu Lys Thr Gly Leu Val Ser Val Asp 180 185
190Asp Asp Ile Tyr Gln Lys Gly Cys Cys Thr Ser Pro Glu Asp
Gly Leu 195 200 205Gln Lys Ala Lys
Arg Ile Gly Phe Pro Val Met Ile Lys Ala Ser Glu 210
215 220Gly Gly Gly Gly Lys Gly Ile Arg Gln Val Glu Arg
Glu Glu Asp Phe225 230 235
240Ile Ala Leu Tyr His Gln Ala Ala Asn Glu Ile Pro Gly Ser Pro Ile
245 250 255Phe Ile Met Lys Leu
Ala Gly Arg Ala Arg His Leu Glu Val Gln Leu 260
265 270Leu Ala Asp Gln Tyr Gly Thr Asn Ile Ser Leu Phe
Gly Arg Asp Cys 275 280 285Ser Val
Gln Arg Arg His Gln Lys Ile Ile Glu Glu Ala Pro Val Thr 290
295 300Ile Ala Lys Ala Glu Thr Phe His Glu Met Glu
Lys Ala Ala Val Arg305 310 315
320Leu Gly Lys Leu Val Gly Tyr Val Ser Ala Gly Thr Val Glu Tyr Leu
325 330 335Tyr Ser His Asp
Asp Gly Lys Phe Tyr Phe Leu Glu Leu Asn Pro Arg 340
345 350Leu Gln Val Glu His Pro Thr Thr Glu Met Val
Ser Gly Val Asn Leu 355 360 365Pro
Ala Ala Gln Leu Gln Ile Ala Met Gly Ile Pro Met His Arg Ile 370
375 380Ser Asp Ile Arg Thr Leu Tyr Gly Met Asn
Pro His Ser Ala Ser Glu385 390 395
400Ile Asp Phe Glu Phe Lys Thr Gln Asp Ala Thr Lys Lys Gln Arg
Arg 405 410 415Pro Ile Pro
Lys Gly His Cys Thr Ala Cys Arg Ile Thr Ser Glu Asp 420
425 430Pro Asn Asp Gly Phe Lys Pro Ser Gly Gly
Thr Leu His Glu Leu Asn 435 440
445Phe Arg Ser Ser Ser Asn Val Trp Gly Tyr Phe Ser Val Gly Asn Asn 450
455 460Gly Asn Ile His Ser Phe Ser Asp
Ser Gln Phe Gly His Ile Phe Ala465 470
475 480Phe Gly Glu Asn Arg Gln Ala Ser Arg Lys His Met
Val Val Ala Leu 485 490
495Lys Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu Tyr Leu
500 505 510Ile Lys Leu Leu Glu Thr
Glu Asp Phe Glu Asp Asn Thr Ile Thr Thr 515 520
525Gly Trp Leu Asp Asp Leu Ile Thr His Lys Met Thr Ala Glu
Lys Pro 530 535 540Asp Pro Thr Leu Ala
Val545 55037540PRTSaccharomyces
cerevisiaeMISC_FEATURE(1)..(540)N-terminal deleted Saccharomyces
cerevisiae ACCase BC domain (AAs 42-581) 37Glu Glu Ser Pro Leu Arg
Asp Phe Val Lys Ser His Gly Gly His Thr1 5
10 15Val Ile Ser Lys Ile Leu Ile Ala Asn Asn Gly Ile
Ala Ala Val Lys 20 25 30Glu
Ile Arg Ser Val Arg Lys Trp Ala Tyr Glu Thr Phe Gly Asp Asp 35
40 45Arg Thr Val Gln Phe Val Ala Met Ala
Thr Pro Glu Asp Leu Glu Ala 50 55
60Asn Ala Glu Tyr Ile Arg Met Ala Asp Gln Tyr Ile Glu Val Pro Gly65
70 75 80Gly Thr Asn Asn Asn
Asn Tyr Ala Asn Val Asp Leu Ile Val Asp Ile 85
90 95Ala Glu Arg Ala Asp Val Asp Ala Val Trp Ala
Gly Trp Gly His Ala 100 105
110Ser Glu Asn Pro Leu Leu Pro Glu Lys Leu Ser Gln Ser Lys Arg Lys
115 120 125Val Ile Phe Ile Gly Pro Pro
Gly Asn Ala Met Arg Ser Leu Gly Asp 130 135
140Lys Ile Ser Ser Thr Ile Val Ala Gln Ser Ala Lys Val Pro Cys
Ile145 150 155 160Pro Trp
Ser Gly Thr Gly Val Asp Thr Val His Val Asp Glu Lys Thr
165 170 175Gly Leu Val Ser Val Asp Asp
Asp Ile Tyr Gln Lys Gly Cys Cys Thr 180 185
190Ser Pro Glu Asp Gly Leu Gln Lys Ala Lys Arg Ile Gly Phe
Pro Val 195 200 205Met Ile Lys Ala
Ser Glu Gly Gly Gly Gly Lys Gly Ile Arg Gln Val 210
215 220Glu Arg Glu Glu Asp Phe Ile Ala Leu Tyr His Gln
Ala Ala Asn Glu225 230 235
240Ile Pro Gly Ser Pro Ile Phe Ile Met Lys Leu Ala Gly Arg Ala Arg
245 250 255His Leu Glu Val Gln
Leu Leu Ala Asp Gln Tyr Gly Thr Asn Ile Ser 260
265 270Leu Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His
Gln Lys Ile Ile 275 280 285Glu Glu
Ala Pro Val Thr Ile Ala Lys Ala Glu Thr Phe His Glu Met 290
295 300Glu Lys Ala Ala Val Arg Leu Gly Lys Leu Val
Gly Tyr Val Ser Ala305 310 315
320Gly Thr Val Glu Tyr Leu Tyr Ser His Asp Asp Gly Lys Phe Tyr Phe
325 330 335Leu Glu Leu Asn
Pro Arg Leu Gln Val Glu His Pro Thr Thr Glu Met 340
345 350Val Ser Gly Val Asn Leu Pro Ala Ala Gln Leu
Gln Ile Ala Met Gly 355 360 365Ile
Pro Met His Arg Ile Ser Asp Ile Arg Thr Leu Tyr Gly Met Asn 370
375 380Pro His Ser Ala Ser Glu Ile Asp Phe Glu
Phe Lys Thr Gln Asp Ala385 390 395
400Thr Lys Lys Gln Arg Arg Pro Ile Pro Lys Gly His Cys Thr Ala
Cys 405 410 415Arg Ile Thr
Ser Glu Asp Pro Asn Asp Gly Phe Lys Pro Ser Gly Gly 420
425 430Thr Leu His Glu Leu Asn Phe Arg Ser Ser
Ser Asn Val Trp Gly Tyr 435 440
445Phe Ser Val Gly Asn Asn Gly Asn Ile His Ser Phe Ser Asp Ser Gln 450
455 460Phe Gly His Ile Phe Ala Phe Gly
Glu Asn Arg Gln Ala Ser Arg Lys465 470
475 480His Met Val Val Ala Leu Lys Glu Leu Ser Ile Arg
Gly Asp Phe Arg 485 490
495Thr Thr Val Glu Tyr Leu Ile Lys Leu Leu Glu Thr Glu Asp Phe Glu
500 505 510Asp Asn Thr Ile Thr Thr
Gly Trp Leu Asp Asp Leu Ile Thr His Lys 515 520
525Met Thr Ala Glu Lys Pro Asp Pro Thr Leu Ala Val 530
535 54038575PRTSaccharomyces
cerevisiaeMISC_FEATURE(1)..(575)C-terminal deleted Saccharomyces
cerevisiae ACCase BC domain (AAs 2-576) 38Ser Glu Glu Ser Leu Phe
Glu Ser Ser Pro Gln Lys Met Glu Tyr Glu1 5
10 15Ile Thr Asn Tyr Ser Glu Arg His Thr Glu Leu Pro
Gly His Phe Ile 20 25 30Gly
Leu Asn Thr Val Asp Lys Leu Glu Glu Ser Pro Leu Arg Asp Phe 35
40 45Val Lys Ser His Gly Gly His Thr Val
Ile Ser Lys Ile Leu Ile Ala 50 55
60Asn Asn Gly Ile Ala Ala Val Lys Glu Ile Arg Ser Val Arg Lys Trp65
70 75 80Ala Tyr Glu Thr Phe
Gly Asp Asp Arg Thr Val Gln Phe Val Ala Met 85
90 95Ala Thr Pro Glu Asp Leu Glu Ala Asn Ala Glu
Tyr Ile Arg Met Ala 100 105
110Asp Gln Tyr Ile Glu Val Pro Gly Gly Thr Asn Asn Asn Asn Tyr Ala
115 120 125Asn Val Asp Leu Ile Val Asp
Ile Ala Glu Arg Ala Asp Val Asp Ala 130 135
140Val Trp Ala Gly Trp Gly His Ala Ser Glu Asn Pro Leu Leu Pro
Glu145 150 155 160Lys Leu
Ser Gln Ser Lys Arg Lys Val Ile Phe Ile Gly Pro Pro Gly
165 170 175Asn Ala Met Arg Ser Leu Gly
Asp Lys Ile Ser Ser Thr Ile Val Ala 180 185
190Gln Ser Ala Lys Val Pro Cys Ile Pro Trp Ser Gly Thr Gly
Val Asp 195 200 205Thr Val His Val
Asp Glu Lys Thr Gly Leu Val Ser Val Asp Asp Asp 210
215 220Ile Tyr Gln Lys Gly Cys Cys Thr Ser Pro Glu Asp
Gly Leu Gln Lys225 230 235
240Ala Lys Arg Ile Gly Phe Pro Val Met Ile Lys Ala Ser Glu Gly Gly
245 250 255Gly Gly Lys Gly Ile
Arg Gln Val Glu Arg Glu Glu Asp Phe Ile Ala 260
265 270Leu Tyr His Gln Ala Ala Asn Glu Ile Pro Gly Ser
Pro Ile Phe Ile 275 280 285Met Lys
Leu Ala Gly Arg Ala Arg His Leu Glu Val Gln Leu Leu Ala 290
295 300Asp Gln Tyr Gly Thr Asn Ile Ser Leu Phe Gly
Arg Asp Cys Ser Val305 310 315
320Gln Arg Arg His Gln Lys Ile Ile Glu Glu Ala Pro Val Thr Ile Ala
325 330 335Lys Ala Glu Thr
Phe His Glu Met Glu Lys Ala Ala Val Arg Leu Gly 340
345 350Lys Leu Val Gly Tyr Val Ser Ala Gly Thr Val
Glu Tyr Leu Tyr Ser 355 360 365His
Asp Asp Gly Lys Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu Gln 370
375 380Val Glu His Pro Thr Thr Glu Met Val Ser
Gly Val Asn Leu Pro Ala385 390 395
400Ala Gln Leu Gln Ile Ala Met Gly Ile Pro Met His Arg Ile Ser
Asp 405 410 415Ile Arg Thr
Leu Tyr Gly Met Asn Pro His Ser Ala Ser Glu Ile Asp 420
425 430Phe Glu Phe Lys Thr Gln Asp Ala Thr Lys
Lys Gln Arg Arg Pro Ile 435 440
445Pro Lys Gly His Cys Thr Ala Cys Arg Ile Thr Ser Glu Asp Pro Asn 450
455 460Asp Gly Phe Lys Pro Ser Gly Gly
Thr Leu His Glu Leu Asn Phe Arg465 470
475 480Ser Ser Ser Asn Val Trp Gly Tyr Phe Ser Val Gly
Asn Asn Gly Asn 485 490
495Ile His Ser Phe Ser Asp Ser Gln Phe Gly His Ile Phe Ala Phe Gly
500 505 510Glu Asn Arg Gln Ala Ser
Arg Lys His Met Val Val Ala Leu Lys Glu 515 520
525Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu Tyr Leu
Ile Lys 530 535 540Leu Leu Glu Thr Glu
Asp Phe Glu Asp Asn Thr Ile Thr Thr Gly Trp545 550
555 560Leu Asp Asp Leu Ile Thr His Lys Met Thr
Ala Glu Lys Pro Asp 565 570
57539570PRTSaccharomyces cerevisiaeMISC_FEATURE(1)..(570)C-terminal
deleted Saccharomyces cerevisiae ACCase BC domain (AAs 2-571) 39Ser
Glu Glu Ser Leu Phe Glu Ser Ser Pro Gln Lys Met Glu Tyr Glu1
5 10 15Ile Thr Asn Tyr Ser Glu Arg
His Thr Glu Leu Pro Gly His Phe Ile 20 25
30Gly Leu Asn Thr Val Asp Lys Leu Glu Glu Ser Pro Leu Arg
Asp Phe 35 40 45Val Lys Ser His
Gly Gly His Thr Val Ile Ser Lys Ile Leu Ile Ala 50 55
60Asn Asn Gly Ile Ala Ala Val Lys Glu Ile Arg Ser Val
Arg Lys Trp65 70 75
80Ala Tyr Glu Thr Phe Gly Asp Asp Arg Thr Val Gln Phe Val Ala Met
85 90 95Ala Thr Pro Glu Asp Leu
Glu Ala Asn Ala Glu Tyr Ile Arg Met Ala 100
105 110Asp Gln Tyr Ile Glu Val Pro Gly Gly Thr Asn Asn
Asn Asn Tyr Ala 115 120 125Asn Val
Asp Leu Ile Val Asp Ile Ala Glu Arg Ala Asp Val Asp Ala 130
135 140Val Trp Ala Gly Trp Gly His Ala Ser Glu Asn
Pro Leu Leu Pro Glu145 150 155
160Lys Leu Ser Gln Ser Lys Arg Lys Val Ile Phe Ile Gly Pro Pro Gly
165 170 175Asn Ala Met Arg
Ser Leu Gly Asp Lys Ile Ser Ser Thr Ile Val Ala 180
185 190Gln Ser Ala Lys Val Pro Cys Ile Pro Trp Ser
Gly Thr Gly Val Asp 195 200 205Thr
Val His Val Asp Glu Lys Thr Gly Leu Val Ser Val Asp Asp Asp 210
215 220Ile Tyr Gln Lys Gly Cys Cys Thr Ser Pro
Glu Asp Gly Leu Gln Lys225 230 235
240Ala Lys Arg Ile Gly Phe Pro Val Met Ile Lys Ala Ser Glu Gly
Gly 245 250 255Gly Gly Lys
Gly Ile Arg Gln Val Glu Arg Glu Glu Asp Phe Ile Ala 260
265 270Leu Tyr His Gln Ala Ala Asn Glu Ile Pro
Gly Ser Pro Ile Phe Ile 275 280
285Met Lys Leu Ala Gly Arg Ala Arg His Leu Glu Val Gln Leu Leu Ala 290
295 300Asp Gln Tyr Gly Thr Asn Ile Ser
Leu Phe Gly Arg Asp Cys Ser Val305 310
315 320Gln Arg Arg His Gln Lys Ile Ile Glu Glu Ala Pro
Val Thr Ile Ala 325 330
335Lys Ala Glu Thr Phe His Glu Met Glu Lys Ala Ala Val Arg Leu Gly
340 345 350Lys Leu Val Gly Tyr Val
Ser Ala Gly Thr Val Glu Tyr Leu Tyr Ser 355 360
365His Asp Asp Gly Lys Phe Tyr Phe Leu Glu Leu Asn Pro Arg
Leu Gln 370 375 380Val Glu His Pro Thr
Thr Glu Met Val Ser Gly Val Asn Leu Pro Ala385 390
395 400Ala Gln Leu Gln Ile Ala Met Gly Ile Pro
Met His Arg Ile Ser Asp 405 410
415Ile Arg Thr Leu Tyr Gly Met Asn Pro His Ser Ala Ser Glu Ile Asp
420 425 430Phe Glu Phe Lys Thr
Gln Asp Ala Thr Lys Lys Gln Arg Arg Pro Ile 435
440 445Pro Lys Gly His Cys Thr Ala Cys Arg Ile Thr Ser
Glu Asp Pro Asn 450 455 460Asp Gly Phe
Lys Pro Ser Gly Gly Thr Leu His Glu Leu Asn Phe Arg465
470 475 480Ser Ser Ser Asn Val Trp Gly
Tyr Phe Ser Val Gly Asn Asn Gly Asn 485
490 495Ile His Ser Phe Ser Asp Ser Gln Phe Gly His Ile
Phe Ala Phe Gly 500 505 510Glu
Asn Arg Gln Ala Ser Arg Lys His Met Val Val Ala Leu Lys Glu 515
520 525Leu Ser Ile Arg Gly Asp Phe Arg Thr
Thr Val Glu Tyr Leu Ile Lys 530 535
540Leu Leu Glu Thr Glu Asp Phe Glu Asp Asn Thr Ile Thr Thr Gly Trp545
550 555 560Leu Asp Asp Leu
Ile Thr His Lys Met Thr 565
57040560PRTSaccharomyces cerevisiaeMISC_FEATURE(1)..(560)C-terminal
deleted Saccharomyces cerevisiae ACCase BC domain (AAs 2-561) 40Ser
Glu Glu Ser Leu Phe Glu Ser Ser Pro Gln Lys Met Glu Tyr Glu1
5 10 15Ile Thr Asn Tyr Ser Glu Arg
His Thr Glu Leu Pro Gly His Phe Ile 20 25
30Gly Leu Asn Thr Val Asp Lys Leu Glu Glu Ser Pro Leu Arg
Asp Phe 35 40 45Val Lys Ser His
Gly Gly His Thr Val Ile Ser Lys Ile Leu Ile Ala 50 55
60Asn Asn Gly Ile Ala Ala Val Lys Glu Ile Arg Ser Val
Arg Lys Trp65 70 75
80Ala Tyr Glu Thr Phe Gly Asp Asp Arg Thr Val Gln Phe Val Ala Met
85 90 95Ala Thr Pro Glu Asp Leu
Glu Ala Asn Ala Glu Tyr Ile Arg Met Ala 100
105 110Asp Gln Tyr Ile Glu Val Pro Gly Gly Thr Asn Asn
Asn Asn Tyr Ala 115 120 125Asn Val
Asp Leu Ile Val Asp Ile Ala Glu Arg Ala Asp Val Asp Ala 130
135 140Val Trp Ala Gly Trp Gly His Ala Ser Glu Asn
Pro Leu Leu Pro Glu145 150 155
160Lys Leu Ser Gln Ser Lys Arg Lys Val Ile Phe Ile Gly Pro Pro Gly
165 170 175Asn Ala Met Arg
Ser Leu Gly Asp Lys Ile Ser Ser Thr Ile Val Ala 180
185 190Gln Ser Ala Lys Val Pro Cys Ile Pro Trp Ser
Gly Thr Gly Val Asp 195 200 205Thr
Val His Val Asp Glu Lys Thr Gly Leu Val Ser Val Asp Asp Asp 210
215 220Ile Tyr Gln Lys Gly Cys Cys Thr Ser Pro
Glu Asp Gly Leu Gln Lys225 230 235
240Ala Lys Arg Ile Gly Phe Pro Val Met Ile Lys Ala Ser Glu Gly
Gly 245 250 255Gly Gly Lys
Gly Ile Arg Gln Val Glu Arg Glu Glu Asp Phe Ile Ala 260
265 270Leu Tyr His Gln Ala Ala Asn Glu Ile Pro
Gly Ser Pro Ile Phe Ile 275 280
285Met Lys Leu Ala Gly Arg Ala Arg His Leu Glu Val Gln Leu Leu Ala 290
295 300Asp Gln Tyr Gly Thr Asn Ile Ser
Leu Phe Gly Arg Asp Cys Ser Val305 310
315 320Gln Arg Arg His Gln Lys Ile Ile Glu Glu Ala Pro
Val Thr Ile Ala 325 330
335Lys Ala Glu Thr Phe His Glu Met Glu Lys Ala Ala Val Arg Leu Gly
340 345 350Lys Leu Val Gly Tyr Val
Ser Ala Gly Thr Val Glu Tyr Leu Tyr Ser 355 360
365His Asp Asp Gly Lys Phe Tyr Phe Leu Glu Leu Asn Pro Arg
Leu Gln 370 375 380Val Glu His Pro Thr
Thr Glu Met Val Ser Gly Val Asn Leu Pro Ala385 390
395 400Ala Gln Leu Gln Ile Ala Met Gly Ile Pro
Met His Arg Ile Ser Asp 405 410
415Ile Arg Thr Leu Tyr Gly Met Asn Pro His Ser Ala Ser Glu Ile Asp
420 425 430Phe Glu Phe Lys Thr
Gln Asp Ala Thr Lys Lys Gln Arg Arg Pro Ile 435
440 445Pro Lys Gly His Cys Thr Ala Cys Arg Ile Thr Ser
Glu Asp Pro Asn 450 455 460Asp Gly Phe
Lys Pro Ser Gly Gly Thr Leu His Glu Leu Asn Phe Arg465
470 475 480Ser Ser Ser Asn Val Trp Gly
Tyr Phe Ser Val Gly Asn Asn Gly Asn 485
490 495Ile His Ser Phe Ser Asp Ser Gln Phe Gly His Ile
Phe Ala Phe Gly 500 505 510Glu
Asn Arg Gln Ala Ser Arg Lys His Met Val Val Ala Leu Lys Glu 515
520 525Leu Ser Ile Arg Gly Asp Phe Arg Thr
Thr Val Glu Tyr Leu Ile Lys 530 535
540Leu Leu Glu Thr Glu Asp Phe Glu Asp Asn Thr Ile Thr Thr Gly Trp545
550 555
56041550PRTSaccharomyces cerevisiaeMISC_FEATURE(1)..(550)C-terminal
deleted Saccharomyces cerevisiae ACCase BC domain (AAs 2-551) 41Ser
Glu Glu Ser Leu Phe Glu Ser Ser Pro Gln Lys Met Glu Tyr Glu1
5 10 15Ile Thr Asn Tyr Ser Glu Arg
His Thr Glu Leu Pro Gly His Phe Ile 20 25
30Gly Leu Asn Thr Val Asp Lys Leu Glu Glu Ser Pro Leu Arg
Asp Phe 35 40 45Val Lys Ser His
Gly Gly His Thr Val Ile Ser Lys Ile Leu Ile Ala 50 55
60Asn Asn Gly Ile Ala Ala Val Lys Glu Ile Arg Ser Val
Arg Lys Trp65 70 75
80Ala Tyr Glu Thr Phe Gly Asp Asp Arg Thr Val Gln Phe Val Ala Met
85 90 95Ala Thr Pro Glu Asp Leu
Glu Ala Asn Ala Glu Tyr Ile Arg Met Ala 100
105 110Asp Gln Tyr Ile Glu Val Pro Gly Gly Thr Asn Asn
Asn Asn Tyr Ala 115 120 125Asn Val
Asp Leu Ile Val Asp Ile Ala Glu Arg Ala Asp Val Asp Ala 130
135 140Val Trp Ala Gly Trp Gly His Ala Ser Glu Asn
Pro Leu Leu Pro Glu145 150 155
160Lys Leu Ser Gln Ser Lys Arg Lys Val Ile Phe Ile Gly Pro Pro Gly
165 170 175Asn Ala Met Arg
Ser Leu Gly Asp Lys Ile Ser Ser Thr Ile Val Ala 180
185 190Gln Ser Ala Lys Val Pro Cys Ile Pro Trp Ser
Gly Thr Gly Val Asp 195 200 205Thr
Val His Val Asp Glu Lys Thr Gly Leu Val Ser Val Asp Asp Asp 210
215 220Ile Tyr Gln Lys Gly Cys Cys Thr Ser Pro
Glu Asp Gly Leu Gln Lys225 230 235
240Ala Lys Arg Ile Gly Phe Pro Val Met Ile Lys Ala Ser Glu Gly
Gly 245 250 255Gly Gly Lys
Gly Ile Arg Gln Val Glu Arg Glu Glu Asp Phe Ile Ala 260
265 270Leu Tyr His Gln Ala Ala Asn Glu Ile Pro
Gly Ser Pro Ile Phe Ile 275 280
285Met Lys Leu Ala Gly Arg Ala Arg His Leu Glu Val Gln Leu Leu Ala 290
295 300Asp Gln Tyr Gly Thr Asn Ile Ser
Leu Phe Gly Arg Asp Cys Ser Val305 310
315 320Gln Arg Arg His Gln Lys Ile Ile Glu Glu Ala Pro
Val Thr Ile Ala 325 330
335Lys Ala Glu Thr Phe His Glu Met Glu Lys Ala Ala Val Arg Leu Gly
340 345 350Lys Leu Val Gly Tyr Val
Ser Ala Gly Thr Val Glu Tyr Leu Tyr Ser 355 360
365His Asp Asp Gly Lys Phe Tyr Phe Leu Glu Leu Asn Pro Arg
Leu Gln 370 375 380Val Glu His Pro Thr
Thr Glu Met Val Ser Gly Val Asn Leu Pro Ala385 390
395 400Ala Gln Leu Gln Ile Ala Met Gly Ile Pro
Met His Arg Ile Ser Asp 405 410
415Ile Arg Thr Leu Tyr Gly Met Asn Pro His Ser Ala Ser Glu Ile Asp
420 425 430Phe Glu Phe Lys Thr
Gln Asp Ala Thr Lys Lys Gln Arg Arg Pro Ile 435
440 445Pro Lys Gly His Cys Thr Ala Cys Arg Ile Thr Ser
Glu Asp Pro Asn 450 455 460Asp Gly Phe
Lys Pro Ser Gly Gly Thr Leu His Glu Leu Asn Phe Arg465
470 475 480Ser Ser Ser Asn Val Trp Gly
Tyr Phe Ser Val Gly Asn Asn Gly Asn 485
490 495Ile His Ser Phe Ser Asp Ser Gln Phe Gly His Ile
Phe Ala Phe Gly 500 505 510Glu
Asn Arg Gln Ala Ser Arg Lys His Met Val Val Ala Leu Lys Glu 515
520 525Leu Ser Ile Arg Gly Asp Phe Arg Thr
Thr Val Glu Tyr Leu Ile Lys 530 535
540Leu Leu Glu Thr Glu Asp545 55042540PRTSaccharomyces
cerevisiaeMISC_FEATURE(1)..(540)C-terminal deleted Saccharomyces
cerevisiae ACCase BC domain (AAs 2-541) 42Ser Glu Glu Ser Leu Phe
Glu Ser Ser Pro Gln Lys Met Glu Tyr Glu1 5
10 15Ile Thr Asn Tyr Ser Glu Arg His Thr Glu Leu Pro
Gly His Phe Ile 20 25 30Gly
Leu Asn Thr Val Asp Lys Leu Glu Glu Ser Pro Leu Arg Asp Phe 35
40 45Val Lys Ser His Gly Gly His Thr Val
Ile Ser Lys Ile Leu Ile Ala 50 55
60Asn Asn Gly Ile Ala Ala Val Lys Glu Ile Arg Ser Val Arg Lys Trp65
70 75 80Ala Tyr Glu Thr Phe
Gly Asp Asp Arg Thr Val Gln Phe Val Ala Met 85
90 95Ala Thr Pro Glu Asp Leu Glu Ala Asn Ala Glu
Tyr Ile Arg Met Ala 100 105
110Asp Gln Tyr Ile Glu Val Pro Gly Gly Thr Asn Asn Asn Asn Tyr Ala
115 120 125Asn Val Asp Leu Ile Val Asp
Ile Ala Glu Arg Ala Asp Val Asp Ala 130 135
140Val Trp Ala Gly Trp Gly His Ala Ser Glu Asn Pro Leu Leu Pro
Glu145 150 155 160Lys Leu
Ser Gln Ser Lys Arg Lys Val Ile Phe Ile Gly Pro Pro Gly
165 170 175Asn Ala Met Arg Ser Leu Gly
Asp Lys Ile Ser Ser Thr Ile Val Ala 180 185
190Gln Ser Ala Lys Val Pro Cys Ile Pro Trp Ser Gly Thr Gly
Val Asp 195 200 205Thr Val His Val
Asp Glu Lys Thr Gly Leu Val Ser Val Asp Asp Asp 210
215 220Ile Tyr Gln Lys Gly Cys Cys Thr Ser Pro Glu Asp
Gly Leu Gln Lys225 230 235
240Ala Lys Arg Ile Gly Phe Pro Val Met Ile Lys Ala Ser Glu Gly Gly
245 250 255Gly Gly Lys Gly Ile
Arg Gln Val Glu Arg Glu Glu Asp Phe Ile Ala 260
265 270Leu Tyr His Gln Ala Ala Asn Glu Ile Pro Gly Ser
Pro Ile Phe Ile 275 280 285Met Lys
Leu Ala Gly Arg Ala Arg His Leu Glu Val Gln Leu Leu Ala 290
295 300Asp Gln Tyr Gly Thr Asn Ile Ser Leu Phe Gly
Arg Asp Cys Ser Val305 310 315
320Gln Arg Arg His Gln Lys Ile Ile Glu Glu Ala Pro Val Thr Ile Ala
325 330 335Lys Ala Glu Thr
Phe His Glu Met Glu Lys Ala Ala Val Arg Leu Gly 340
345 350Lys Leu Val Gly Tyr Val Ser Ala Gly Thr Val
Glu Tyr Leu Tyr Ser 355 360 365His
Asp Asp Gly Lys Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu Gln 370
375 380Val Glu His Pro Thr Thr Glu Met Val Ser
Gly Val Asn Leu Pro Ala385 390 395
400Ala Gln Leu Gln Ile Ala Met Gly Ile Pro Met His Arg Ile Ser
Asp 405 410 415Ile Arg Thr
Leu Tyr Gly Met Asn Pro His Ser Ala Ser Glu Ile Asp 420
425 430Phe Glu Phe Lys Thr Gln Asp Ala Thr Lys
Lys Gln Arg Arg Pro Ile 435 440
445Pro Lys Gly His Cys Thr Ala Cys Arg Ile Thr Ser Glu Asp Pro Asn 450
455 460Asp Gly Phe Lys Pro Ser Gly Gly
Thr Leu His Glu Leu Asn Phe Arg465 470
475 480Ser Ser Ser Asn Val Trp Gly Tyr Phe Ser Val Gly
Asn Asn Gly Asn 485 490
495Ile His Ser Phe Ser Asp Ser Gln Phe Gly His Ile Phe Ala Phe Gly
500 505 510Glu Asn Arg Gln Ala Ser
Arg Lys His Met Val Val Ala Leu Lys Glu 515 520
525Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu 530
535 54043575PRTSaccharomyces
cerevisiaeMISC_FEATURE(1)..(575)N- and C-terminal deleted Saccharomyces
cerevisiae ACCase BC domain (AAs 4-578) 43Glu Ser Leu Phe Glu Ser Ser
Pro Gln Lys Met Glu Tyr Glu Ile Thr1 5 10
15Asn Tyr Ser Glu Arg His Thr Glu Leu Pro Gly His Phe
Ile Gly Leu 20 25 30Asn Thr
Val Asp Lys Leu Glu Glu Ser Pro Leu Arg Asp Phe Val Lys 35
40 45Ser His Gly Gly His Thr Val Ile Ser Lys
Ile Leu Ile Ala Asn Asn 50 55 60Gly
Ile Ala Ala Val Lys Glu Ile Arg Ser Val Arg Lys Trp Ala Tyr65
70 75 80Glu Thr Phe Gly Asp Asp
Arg Thr Val Gln Phe Val Ala Met Ala Thr 85
90 95Pro Glu Asp Leu Glu Ala Asn Ala Glu Tyr Ile Arg
Met Ala Asp Gln 100 105 110Tyr
Ile Glu Val Pro Gly Gly Thr Asn Asn Asn Asn Tyr Ala Asn Val 115
120 125Asp Leu Ile Val Asp Ile Ala Glu Arg
Ala Asp Val Asp Ala Val Trp 130 135
140Ala Gly Trp Gly His Ala Ser Glu Asn Pro Leu Leu Pro Glu Lys Leu145
150 155 160Ser Gln Ser Lys
Arg Lys Val Ile Phe Ile Gly Pro Pro Gly Asn Ala 165
170 175Met Arg Ser Leu Gly Asp Lys Ile Ser Ser
Thr Ile Val Ala Gln Ser 180 185
190Ala Lys Val Pro Cys Ile Pro Trp Ser Gly Thr Gly Val Asp Thr Val
195 200 205His Val Asp Glu Lys Thr Gly
Leu Val Ser Val Asp Asp Asp Ile Tyr 210 215
220Gln Lys Gly Cys Cys Thr Ser Pro Glu Asp Gly Leu Gln Lys Ala
Lys225 230 235 240Arg Ile
Gly Phe Pro Val Met Ile Lys Ala Ser Glu Gly Gly Gly Gly
245 250 255Lys Gly Ile Arg Gln Val Glu
Arg Glu Glu Asp Phe Ile Ala Leu Tyr 260 265
270His Gln Ala Ala Asn Glu Ile Pro Gly Ser Pro Ile Phe Ile
Met Lys 275 280 285Leu Ala Gly Arg
Ala Arg His Leu Glu Val Gln Leu Leu Ala Asp Gln 290
295 300Tyr Gly Thr Asn Ile Ser Leu Phe Gly Arg Asp Cys
Ser Val Gln Arg305 310 315
320Arg His Gln Lys Ile Ile Glu Glu Ala Pro Val Thr Ile Ala Lys Ala
325 330 335Glu Thr Phe His Glu
Met Glu Lys Ala Ala Val Arg Leu Gly Lys Leu 340
345 350Val Gly Tyr Val Ser Ala Gly Thr Val Glu Tyr Leu
Tyr Ser His Asp 355 360 365Asp Gly
Lys Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu 370
375 380His Pro Thr Thr Glu Met Val Ser Gly Val Asn
Leu Pro Ala Ala Gln385 390 395
400Leu Gln Ile Ala Met Gly Ile Pro Met His Arg Ile Ser Asp Ile Arg
405 410 415Thr Leu Tyr Gly
Met Asn Pro His Ser Ala Ser Glu Ile Asp Phe Glu 420
425 430Phe Lys Thr Gln Asp Ala Thr Lys Lys Gln Arg
Arg Pro Ile Pro Lys 435 440 445Gly
His Cys Thr Ala Cys Arg Ile Thr Ser Glu Asp Pro Asn Asp Gly 450
455 460Phe Lys Pro Ser Gly Gly Thr Leu His Glu
Leu Asn Phe Arg Ser Ser465 470 475
480Ser Asn Val Trp Gly Tyr Phe Ser Val Gly Asn Asn Gly Asn Ile
His 485 490 495Ser Phe Ser
Asp Ser Gln Phe Gly His Ile Phe Ala Phe Gly Glu Asn 500
505 510Arg Gln Ala Ser Arg Lys His Met Val Val
Ala Leu Lys Glu Leu Ser 515 520
525Ile Arg Gly Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile Lys Leu Leu 530
535 540Glu Thr Glu Asp Phe Glu Asp Asn
Thr Ile Thr Thr Gly Trp Leu Asp545 550
555 560Asp Leu Ile Thr His Lys Met Thr Ala Glu Lys Pro
Asp Pro Thr 565 570
57544570PRTSaccharomyces cerevisiaeMISC_FEATURE(1)..(570)N- and
C-terminal deleted Saccharomyces cerevisiae ACCase BC domain (AAs
7-576) 44Phe Glu Ser Ser Pro Gln Lys Met Glu Tyr Glu Ile Thr Asn Tyr Ser1
5 10 15Glu Arg His Thr
Glu Leu Pro Gly His Phe Ile Gly Leu Asn Thr Val 20
25 30Asp Lys Leu Glu Glu Ser Pro Leu Arg Asp Phe
Val Lys Ser His Gly 35 40 45Gly
His Thr Val Ile Ser Lys Ile Leu Ile Ala Asn Asn Gly Ile Ala 50
55 60Ala Val Lys Glu Ile Arg Ser Val Arg Lys
Trp Ala Tyr Glu Thr Phe65 70 75
80Gly Asp Asp Arg Thr Val Gln Phe Val Ala Met Ala Thr Pro Glu
Asp 85 90 95Leu Glu Ala
Asn Ala Glu Tyr Ile Arg Met Ala Asp Gln Tyr Ile Glu 100
105 110Val Pro Gly Gly Thr Asn Asn Asn Asn Tyr
Ala Asn Val Asp Leu Ile 115 120
125Val Asp Ile Ala Glu Arg Ala Asp Val Asp Ala Val Trp Ala Gly Trp 130
135 140Gly His Ala Ser Glu Asn Pro Leu
Leu Pro Glu Lys Leu Ser Gln Ser145 150
155 160Lys Arg Lys Val Ile Phe Ile Gly Pro Pro Gly Asn
Ala Met Arg Ser 165 170
175Leu Gly Asp Lys Ile Ser Ser Thr Ile Val Ala Gln Ser Ala Lys Val
180 185 190Pro Cys Ile Pro Trp Ser
Gly Thr Gly Val Asp Thr Val His Val Asp 195 200
205Glu Lys Thr Gly Leu Val Ser Val Asp Asp Asp Ile Tyr Gln
Lys Gly 210 215 220Cys Cys Thr Ser Pro
Glu Asp Gly Leu Gln Lys Ala Lys Arg Ile Gly225 230
235 240Phe Pro Val Met Ile Lys Ala Ser Glu Gly
Gly Gly Gly Lys Gly Ile 245 250
255Arg Gln Val Glu Arg Glu Glu Asp Phe Ile Ala Leu Tyr His Gln Ala
260 265 270Ala Asn Glu Ile Pro
Gly Ser Pro Ile Phe Ile Met Lys Leu Ala Gly 275
280 285Arg Ala Arg His Leu Glu Val Gln Leu Leu Ala Asp
Gln Tyr Gly Thr 290 295 300Asn Ile Ser
Leu Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His Gln305
310 315 320Lys Ile Ile Glu Glu Ala Pro
Val Thr Ile Ala Lys Ala Glu Thr Phe 325
330 335His Glu Met Glu Lys Ala Ala Val Arg Leu Gly Lys
Leu Val Gly Tyr 340 345 350Val
Ser Ala Gly Thr Val Glu Tyr Leu Tyr Ser His Asp Asp Gly Lys 355
360 365Phe Tyr Phe Leu Glu Leu Asn Pro Arg
Leu Gln Val Glu His Pro Thr 370 375
380Thr Glu Met Val Ser Gly Val Asn Leu Pro Ala Ala Gln Leu Gln Ile385
390 395 400Ala Met Gly Ile
Pro Met His Arg Ile Ser Asp Ile Arg Thr Leu Tyr 405
410 415Gly Met Asn Pro His Ser Ala Ser Glu Ile
Asp Phe Glu Phe Lys Thr 420 425
430Gln Asp Ala Thr Lys Lys Gln Arg Arg Pro Ile Pro Lys Gly His Cys
435 440 445Thr Ala Cys Arg Ile Thr Ser
Glu Asp Pro Asn Asp Gly Phe Lys Pro 450 455
460Ser Gly Gly Thr Leu His Glu Leu Asn Phe Arg Ser Ser Ser Asn
Val465 470 475 480Trp Gly
Tyr Phe Ser Val Gly Asn Asn Gly Asn Ile His Ser Phe Ser
485 490 495Asp Ser Gln Phe Gly His Ile
Phe Ala Phe Gly Glu Asn Arg Gln Ala 500 505
510Ser Arg Lys His Met Val Val Ala Leu Lys Glu Leu Ser Ile
Arg Gly 515 520 525Asp Phe Arg Thr
Thr Val Glu Tyr Leu Ile Lys Leu Leu Glu Thr Glu 530
535 540Asp Phe Glu Asp Asn Thr Ile Thr Thr Gly Trp Leu
Asp Asp Leu Ile545 550 555
560Thr His Lys Met Thr Ala Glu Lys Pro Asp 565
57045560PRTSaccharomyces cerevisiaeMISC_FEATURE(1)..(560)N- and
C-terminal deleted Saccharomyces cerevisiae ACCase BC domain (AAs
12-571) 45Gln Lys Met Glu Tyr Glu Ile Thr Asn Tyr Ser Glu Arg His Thr
Glu1 5 10 15Leu Pro Gly
His Phe Ile Gly Leu Asn Thr Val Asp Lys Leu Glu Glu 20
25 30Ser Pro Leu Arg Asp Phe Val Lys Ser His
Gly Gly His Thr Val Ile 35 40
45Ser Lys Ile Leu Ile Ala Asn Asn Gly Ile Ala Ala Val Lys Glu Ile 50
55 60Arg Ser Val Arg Lys Trp Ala Tyr Glu
Thr Phe Gly Asp Asp Arg Thr65 70 75
80Val Gln Phe Val Ala Met Ala Thr Pro Glu Asp Leu Glu Ala
Asn Ala 85 90 95Glu Tyr
Ile Arg Met Ala Asp Gln Tyr Ile Glu Val Pro Gly Gly Thr 100
105 110Asn Asn Asn Asn Tyr Ala Asn Val Asp
Leu Ile Val Asp Ile Ala Glu 115 120
125Arg Ala Asp Val Asp Ala Val Trp Ala Gly Trp Gly His Ala Ser Glu
130 135 140Asn Pro Leu Leu Pro Glu Lys
Leu Ser Gln Ser Lys Arg Lys Val Ile145 150
155 160Phe Ile Gly Pro Pro Gly Asn Ala Met Arg Ser Leu
Gly Asp Lys Ile 165 170
175Ser Ser Thr Ile Val Ala Gln Ser Ala Lys Val Pro Cys Ile Pro Trp
180 185 190Ser Gly Thr Gly Val Asp
Thr Val His Val Asp Glu Lys Thr Gly Leu 195 200
205Val Ser Val Asp Asp Asp Ile Tyr Gln Lys Gly Cys Cys Thr
Ser Pro 210 215 220Glu Asp Gly Leu Gln
Lys Ala Lys Arg Ile Gly Phe Pro Val Met Ile225 230
235 240Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly
Ile Arg Gln Val Glu Arg 245 250
255Glu Glu Asp Phe Ile Ala Leu Tyr His Gln Ala Ala Asn Glu Ile Pro
260 265 270Gly Ser Pro Ile Phe
Ile Met Lys Leu Ala Gly Arg Ala Arg His Leu 275
280 285Glu Val Gln Leu Leu Ala Asp Gln Tyr Gly Thr Asn
Ile Ser Leu Phe 290 295 300Gly Arg Asp
Cys Ser Val Gln Arg Arg His Gln Lys Ile Ile Glu Glu305
310 315 320Ala Pro Val Thr Ile Ala Lys
Ala Glu Thr Phe His Glu Met Glu Lys 325
330 335Ala Ala Val Arg Leu Gly Lys Leu Val Gly Tyr Val
Ser Ala Gly Thr 340 345 350Val
Glu Tyr Leu Tyr Ser His Asp Asp Gly Lys Phe Tyr Phe Leu Glu 355
360 365Leu Asn Pro Arg Leu Gln Val Glu His
Pro Thr Thr Glu Met Val Ser 370 375
380Gly Val Asn Leu Pro Ala Ala Gln Leu Gln Ile Ala Met Gly Ile Pro385
390 395 400Met His Arg Ile
Ser Asp Ile Arg Thr Leu Tyr Gly Met Asn Pro His 405
410 415Ser Ala Ser Glu Ile Asp Phe Glu Phe Lys
Thr Gln Asp Ala Thr Lys 420 425
430Lys Gln Arg Arg Pro Ile Pro Lys Gly His Cys Thr Ala Cys Arg Ile
435 440 445Thr Ser Glu Asp Pro Asn Asp
Gly Phe Lys Pro Ser Gly Gly Thr Leu 450 455
460His Glu Leu Asn Phe Arg Ser Ser Ser Asn Val Trp Gly Tyr Phe
Ser465 470 475 480Val Gly
Asn Asn Gly Asn Ile His Ser Phe Ser Asp Ser Gln Phe Gly
485 490 495His Ile Phe Ala Phe Gly Glu
Asn Arg Gln Ala Ser Arg Lys His Met 500 505
510Val Val Ala Leu Lys Glu Leu Ser Ile Arg Gly Asp Phe Arg
Thr Thr 515 520 525Val Glu Tyr Leu
Ile Lys Leu Leu Glu Thr Glu Asp Phe Glu Asp Asn 530
535 540Thr Ile Thr Thr Gly Trp Leu Asp Asp Leu Ile Thr
His Lys Met Thr545 550 555
56046550PRTSaccharomyces cerevisiaeMISC_FEATURE(1)..(550)N- and
C-terminal deleted Saccharomyces cerevisiae ACCase BC domain (AAs
17-566) 46Glu Ile Thr Asn Tyr Ser Glu Arg His Thr Glu Leu Pro Gly His
Phe1 5 10 15Ile Gly Leu
Asn Thr Val Asp Lys Leu Glu Glu Ser Pro Leu Arg Asp 20
25 30Phe Val Lys Ser His Gly Gly His Thr Val
Ile Ser Lys Ile Leu Ile 35 40
45Ala Asn Asn Gly Ile Ala Ala Val Lys Glu Ile Arg Ser Val Arg Lys 50
55 60Trp Ala Tyr Glu Thr Phe Gly Asp Asp
Arg Thr Val Gln Phe Val Ala65 70 75
80Met Ala Thr Pro Glu Asp Leu Glu Ala Asn Ala Glu Tyr Ile
Arg Met 85 90 95Ala Asp
Gln Tyr Ile Glu Val Pro Gly Gly Thr Asn Asn Asn Asn Tyr 100
105 110Ala Asn Val Asp Leu Ile Val Asp Ile
Ala Glu Arg Ala Asp Val Asp 115 120
125Ala Val Trp Ala Gly Trp Gly His Ala Ser Glu Asn Pro Leu Leu Pro
130 135 140Glu Lys Leu Ser Gln Ser Lys
Arg Lys Val Ile Phe Ile Gly Pro Pro145 150
155 160Gly Asn Ala Met Arg Ser Leu Gly Asp Lys Ile Ser
Ser Thr Ile Val 165 170
175Ala Gln Ser Ala Lys Val Pro Cys Ile Pro Trp Ser Gly Thr Gly Val
180 185 190Asp Thr Val His Val Asp
Glu Lys Thr Gly Leu Val Ser Val Asp Asp 195 200
205Asp Ile Tyr Gln Lys Gly Cys Cys Thr Ser Pro Glu Asp Gly
Leu Gln 210 215 220Lys Ala Lys Arg Ile
Gly Phe Pro Val Met Ile Lys Ala Ser Glu Gly225 230
235 240Gly Gly Gly Lys Gly Ile Arg Gln Val Glu
Arg Glu Glu Asp Phe Ile 245 250
255Ala Leu Tyr His Gln Ala Ala Asn Glu Ile Pro Gly Ser Pro Ile Phe
260 265 270Ile Met Lys Leu Ala
Gly Arg Ala Arg His Leu Glu Val Gln Leu Leu 275
280 285Ala Asp Gln Tyr Gly Thr Asn Ile Ser Leu Phe Gly
Arg Asp Cys Ser 290 295 300Val Gln Arg
Arg His Gln Lys Ile Ile Glu Glu Ala Pro Val Thr Ile305
310 315 320Ala Lys Ala Glu Thr Phe His
Glu Met Glu Lys Ala Ala Val Arg Leu 325
330 335Gly Lys Leu Val Gly Tyr Val Ser Ala Gly Thr Val
Glu Tyr Leu Tyr 340 345 350Ser
His Asp Asp Gly Lys Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu 355
360 365Gln Val Glu His Pro Thr Thr Glu Met
Val Ser Gly Val Asn Leu Pro 370 375
380Ala Ala Gln Leu Gln Ile Ala Met Gly Ile Pro Met His Arg Ile Ser385
390 395 400Asp Ile Arg Thr
Leu Tyr Gly Met Asn Pro His Ser Ala Ser Glu Ile 405
410 415Asp Phe Glu Phe Lys Thr Gln Asp Ala Thr
Lys Lys Gln Arg Arg Pro 420 425
430Ile Pro Lys Gly His Cys Thr Ala Cys Arg Ile Thr Ser Glu Asp Pro
435 440 445Asn Asp Gly Phe Lys Pro Ser
Gly Gly Thr Leu His Glu Leu Asn Phe 450 455
460Arg Ser Ser Ser Asn Val Trp Gly Tyr Phe Ser Val Gly Asn Asn
Gly465 470 475 480Asn Ile
His Ser Phe Ser Asp Ser Gln Phe Gly His Ile Phe Ala Phe
485 490 495Gly Glu Asn Arg Gln Ala Ser
Arg Lys His Met Val Val Ala Leu Lys 500 505
510Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu Tyr
Leu Ile 515 520 525Lys Leu Leu Glu
Thr Glu Asp Phe Glu Asp Asn Thr Ile Thr Thr Gly 530
535 540Trp Leu Asp Asp Leu Ile545
55047540PRTSaccharomyces cerevisiaeMISC_FEATURE(1)..(540)N- and
C-terminal deleted Saccharomyces cerevisiae ACCase BC domain (AAs
22-561) 47Ser Glu Arg His Thr Glu Leu Pro Gly His Phe Ile Gly Leu Asn
Thr1 5 10 15Val Asp Lys
Leu Glu Glu Ser Pro Leu Arg Asp Phe Val Lys Ser His 20
25 30Gly Gly His Thr Val Ile Ser Lys Ile Leu
Ile Ala Asn Asn Gly Ile 35 40
45Ala Ala Val Lys Glu Ile Arg Ser Val Arg Lys Trp Ala Tyr Glu Thr 50
55 60Phe Gly Asp Asp Arg Thr Val Gln Phe
Val Ala Met Ala Thr Pro Glu65 70 75
80Asp Leu Glu Ala Asn Ala Glu Tyr Ile Arg Met Ala Asp Gln
Tyr Ile 85 90 95Glu Val
Pro Gly Gly Thr Asn Asn Asn Asn Tyr Ala Asn Val Asp Leu 100
105 110Ile Val Asp Ile Ala Glu Arg Ala Asp
Val Asp Ala Val Trp Ala Gly 115 120
125Trp Gly His Ala Ser Glu Asn Pro Leu Leu Pro Glu Lys Leu Ser Gln
130 135 140Ser Lys Arg Lys Val Ile Phe
Ile Gly Pro Pro Gly Asn Ala Met Arg145 150
155 160Ser Leu Gly Asp Lys Ile Ser Ser Thr Ile Val Ala
Gln Ser Ala Lys 165 170
175Val Pro Cys Ile Pro Trp Ser Gly Thr Gly Val Asp Thr Val His Val
180 185 190Asp Glu Lys Thr Gly Leu
Val Ser Val Asp Asp Asp Ile Tyr Gln Lys 195 200
205Gly Cys Cys Thr Ser Pro Glu Asp Gly Leu Gln Lys Ala Lys
Arg Ile 210 215 220Gly Phe Pro Val Met
Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly225 230
235 240Ile Arg Gln Val Glu Arg Glu Glu Asp Phe
Ile Ala Leu Tyr His Gln 245 250
255Ala Ala Asn Glu Ile Pro Gly Ser Pro Ile Phe Ile Met Lys Leu Ala
260 265 270Gly Arg Ala Arg His
Leu Glu Val Gln Leu Leu Ala Asp Gln Tyr Gly 275
280 285Thr Asn Ile Ser Leu Phe Gly Arg Asp Cys Ser Val
Gln Arg Arg His 290 295 300Gln Lys Ile
Ile Glu Glu Ala Pro Val Thr Ile Ala Lys Ala Glu Thr305
310 315 320Phe His Glu Met Glu Lys Ala
Ala Val Arg Leu Gly Lys Leu Val Gly 325
330 335Tyr Val Ser Ala Gly Thr Val Glu Tyr Leu Tyr Ser
His Asp Asp Gly 340 345 350Lys
Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro 355
360 365Thr Thr Glu Met Val Ser Gly Val Asn
Leu Pro Ala Ala Gln Leu Gln 370 375
380Ile Ala Met Gly Ile Pro Met His Arg Ile Ser Asp Ile Arg Thr Leu385
390 395 400Tyr Gly Met Asn
Pro His Ser Ala Ser Glu Ile Asp Phe Glu Phe Lys 405
410 415Thr Gln Asp Ala Thr Lys Lys Gln Arg Arg
Pro Ile Pro Lys Gly His 420 425
430Cys Thr Ala Cys Arg Ile Thr Ser Glu Asp Pro Asn Asp Gly Phe Lys
435 440 445Pro Ser Gly Gly Thr Leu His
Glu Leu Asn Phe Arg Ser Ser Ser Asn 450 455
460Val Trp Gly Tyr Phe Ser Val Gly Asn Asn Gly Asn Ile His Ser
Phe465 470 475 480Ser Asp
Ser Gln Phe Gly His Ile Phe Ala Phe Gly Glu Asn Arg Gln
485 490 495Ala Ser Arg Lys His Met Val
Val Ala Leu Lys Glu Leu Ser Ile Arg 500 505
510Gly Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile Lys Leu Leu
Glu Thr 515 520 525Glu Asp Phe Glu
Asp Asn Thr Ile Thr Thr Gly Trp 530 535
54048545PRTPhytophthora infestansMISC_FEATURE(1)..(545)N-terminal
deleted Phytophthora ACCase BC domain (AAs 11-555) 48Asp Val Ala
Ala Tyr Ala Glu Thr Arg Ser Asp Ser Asn Pro Leu Asn1 5
10 15Tyr Ala Ser Met Glu Glu Tyr Val Arg
Leu Gln Lys Gly Thr Arg Pro 20 25
30Ile Thr Ser Val Leu Ile Ala Asn Asn Gly Ile Ser Ala Val Lys Ala
35 40 45Ile Arg Ser Ile Arg Ser Trp
Ser Tyr Glu Met Phe Ala Asp Glu His 50 55
60Val Val Thr Phe Val Val Met Ala Thr Pro Glu Asp Leu Lys Ala Asn65
70 75 80Ala Glu Tyr Ile
Arg Met Ala Glu His Val Val Glu Val Pro Gly Gly 85
90 95Ser Asn Asn His Asn Tyr Ala Asn Val Ser
Leu Ile Ile Glu Ile Ala 100 105
110Glu Arg Phe Asn Val Asp Ala Val Trp Ala Gly Trp Gly His Ala Ser
115 120 125Glu Asn Pro Leu Leu Pro Asp
Thr Leu Ala Gln Thr Glu Arg Lys Ile 130 135
140Val Phe Ile Gly Pro Pro Gly Lys Pro Met Arg Ala Leu Gly Asp
Lys145 150 155 160Ile Gly
Ser Thr Ile Ile Ala Gln Ser Ala Lys Val Pro Thr Ile Ala
165 170 175Trp Asn Gly Asp Gly Met Glu
Val Asp Tyr Lys Glu His Asp Gly Ile 180 185
190Pro Asp Glu Ile Tyr Asn Ala Ala Met Leu Arg Asp Gly Gln
His Cys 195 200 205Leu Asp Glu Cys
Lys Arg Ile Gly Phe Pro Val Met Ile Lys Ala Ser 210
215 220Glu Gly Gly Gly Gly Lys Gly Ile Arg Met Val His
Glu Glu Ser Gln225 230 235
240Val Leu Ser Ala Trp Glu Ala Val Arg Gly Glu Ile Pro Gly Ser Pro
245 250 255Ile Phe Val Met Lys
Leu Ala Pro Lys Ser Arg His Leu Glu Val Gln 260
265 270Leu Leu Ala Asp Thr Tyr Gly Asn Ala Ile Ala Leu
Ser Gly Arg Asp 275 280 285Cys Ser
Val Gln Arg Arg His Gln Lys Ile Val Glu Glu Gly Pro Val 290
295 300Leu Ala Pro Thr Gln Glu Val Trp Glu Lys Met
Met Arg Ala Ala Thr305 310 315
320Arg Leu Ala Gln Glu Val Glu Tyr Val Asn Ala Gly Thr Val Glu Tyr
325 330 335Leu Phe Ser Glu
Leu Pro Glu Asp Asn Gly Asn Ser Phe Phe Phe Leu 340
345 350Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro
Val Thr Glu Met Ile 355 360 365Thr
His Val Asn Leu Pro Ala Ala Gln Leu Gln Val Ala Met Gly Ile 370
375 380Pro Leu His Cys Ile Pro Asp Val Arg Arg
Leu Tyr Asn Lys Asp Ala385 390 395
400Phe Glu Thr Thr Val Ile Asp Phe Asp Ala Glu Lys Gln Lys Pro
Pro 405 410 415His Gly His
Val Ile Ala Ala Arg Ile Thr Ala Glu Asp Pro Asn Ala 420
425 430Gly Phe Gln Pro Thr Ser Gly Ala Ile Gln
Glu Leu Asn Phe Arg Ser 435 440
445Thr Pro Asp Val Trp Gly Tyr Phe Ser Val Asp Ser Ser Gly Gln Val 450
455 460His Glu Phe Ala Asp Ser Gln Ile
Gly His Leu Phe Ser Trp Ser Pro465 470
475 480Thr Arg Glu Lys Ala Arg Lys Asn Met Val Leu Ala
Leu Lys Glu Leu 485 490
495Ser Ile Arg Gly Asp Ile His Thr Thr Val Glu Tyr Ile Val Asn Met
500 505 510Met Glu Ser Asp Asp Phe
Lys Tyr Asn Arg Ile Ser Thr Ser Trp Leu 515 520
525Asp Glu Arg Ile Ser His His Asn Glu Val Arg Leu Gln Gly
Arg Pro 530 535
540Asp54549535PRTPhytophthora infestansMISC_FEATURE(1)..(535)N-terminal
deleted Phytophthora ACCase BC domain (AAs 21-555) 49Asp Ser Asn
Pro Leu Asn Tyr Ala Ser Met Glu Glu Tyr Val Arg Leu1 5
10 15Gln Lys Gly Thr Arg Pro Ile Thr Ser
Val Leu Ile Ala Asn Asn Gly 20 25
30Ile Ser Ala Val Lys Ala Ile Arg Ser Ile Arg Ser Trp Ser Tyr Glu
35 40 45Met Phe Ala Asp Glu His Val
Val Thr Phe Val Val Met Ala Thr Pro 50 55
60Glu Asp Leu Lys Ala Asn Ala Glu Tyr Ile Arg Met Ala Glu His Val65
70 75 80Val Glu Val Pro
Gly Gly Ser Asn Asn His Asn Tyr Ala Asn Val Ser 85
90 95Leu Ile Ile Glu Ile Ala Glu Arg Phe Asn
Val Asp Ala Val Trp Ala 100 105
110Gly Trp Gly His Ala Ser Glu Asn Pro Leu Leu Pro Asp Thr Leu Ala
115 120 125Gln Thr Glu Arg Lys Ile Val
Phe Ile Gly Pro Pro Gly Lys Pro Met 130 135
140Arg Ala Leu Gly Asp Lys Ile Gly Ser Thr Ile Ile Ala Gln Ser
Ala145 150 155 160Lys Val
Pro Thr Ile Ala Trp Asn Gly Asp Gly Met Glu Val Asp Tyr
165 170 175Lys Glu His Asp Gly Ile Pro
Asp Glu Ile Tyr Asn Ala Ala Met Leu 180 185
190Arg Asp Gly Gln His Cys Leu Asp Glu Cys Lys Arg Ile Gly
Phe Pro 195 200 205Val Met Ile Lys
Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile Arg Met 210
215 220Val His Glu Glu Ser Gln Val Leu Ser Ala Trp Glu
Ala Val Arg Gly225 230 235
240Glu Ile Pro Gly Ser Pro Ile Phe Val Met Lys Leu Ala Pro Lys Ser
245 250 255Arg His Leu Glu Val
Gln Leu Leu Ala Asp Thr Tyr Gly Asn Ala Ile 260
265 270Ala Leu Ser Gly Arg Asp Cys Ser Val Gln Arg Arg
His Gln Lys Ile 275 280 285Val Glu
Glu Gly Pro Val Leu Ala Pro Thr Gln Glu Val Trp Glu Lys 290
295 300Met Met Arg Ala Ala Thr Arg Leu Ala Gln Glu
Val Glu Tyr Val Asn305 310 315
320Ala Gly Thr Val Glu Tyr Leu Phe Ser Glu Leu Pro Glu Asp Asn Gly
325 330 335Asn Ser Phe Phe
Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His 340
345 350Pro Val Thr Glu Met Ile Thr His Val Asn Leu
Pro Ala Ala Gln Leu 355 360 365Gln
Val Ala Met Gly Ile Pro Leu His Cys Ile Pro Asp Val Arg Arg 370
375 380Leu Tyr Asn Lys Asp Ala Phe Glu Thr Thr
Val Ile Asp Phe Asp Ala385 390 395
400Glu Lys Gln Lys Pro Pro His Gly His Val Ile Ala Ala Arg Ile
Thr 405 410 415Ala Glu Asp
Pro Asn Ala Gly Phe Gln Pro Thr Ser Gly Ala Ile Gln 420
425 430Glu Leu Asn Phe Arg Ser Thr Pro Asp Val
Trp Gly Tyr Phe Ser Val 435 440
445Asp Ser Ser Gly Gln Val His Glu Phe Ala Asp Ser Gln Ile Gly His 450
455 460Leu Phe Ser Trp Ser Pro Thr Arg
Glu Lys Ala Arg Lys Asn Met Val465 470
475 480Leu Ala Leu Lys Glu Leu Ser Ile Arg Gly Asp Ile
His Thr Thr Val 485 490
495Glu Tyr Ile Val Asn Met Met Glu Ser Asp Asp Phe Lys Tyr Asn Arg
500 505 510Ile Ser Thr Ser Trp Leu
Asp Glu Arg Ile Ser His His Asn Glu Val 515 520
525Arg Leu Gln Gly Arg Pro Asp 530
53550545PRTPhytophthora infestansMISC_FEATURE(1)..(545)C-terminal deleted
Phytophthora ACCase BC domain (AAs 1-545) 50Met Val Ala Glu Glu Ala
Pro Pro Ala Ala Asp Val Ala Ala Tyr Ala1 5
10 15Glu Thr Arg Ser Asp Ser Asn Pro Leu Asn Tyr Ala
Ser Met Glu Glu 20 25 30Tyr
Val Arg Leu Gln Lys Gly Thr Arg Pro Ile Thr Ser Val Leu Ile 35
40 45Ala Asn Asn Gly Ile Ser Ala Val Lys
Ala Ile Arg Ser Ile Arg Ser 50 55
60Trp Ser Tyr Glu Met Phe Ala Asp Glu His Val Val Thr Phe Val Val65
70 75 80Met Ala Thr Pro Glu
Asp Leu Lys Ala Asn Ala Glu Tyr Ile Arg Met 85
90 95Ala Glu His Val Val Glu Val Pro Gly Gly Ser
Asn Asn His Asn Tyr 100 105
110Ala Asn Val Ser Leu Ile Ile Glu Ile Ala Glu Arg Phe Asn Val Asp
115 120 125Ala Val Trp Ala Gly Trp Gly
His Ala Ser Glu Asn Pro Leu Leu Pro 130 135
140Asp Thr Leu Ala Gln Thr Glu Arg Lys Ile Val Phe Ile Gly Pro
Pro145 150 155 160Gly Lys
Pro Met Arg Ala Leu Gly Asp Lys Ile Gly Ser Thr Ile Ile
165 170 175Ala Gln Ser Ala Lys Val Pro
Thr Ile Ala Trp Asn Gly Asp Gly Met 180 185
190Glu Val Asp Tyr Lys Glu His Asp Gly Ile Pro Asp Glu Ile
Tyr Asn 195 200 205Ala Ala Met Leu
Arg Asp Gly Gln His Cys Leu Asp Glu Cys Lys Arg 210
215 220Ile Gly Phe Pro Val Met Ile Lys Ala Ser Glu Gly
Gly Gly Gly Lys225 230 235
240Gly Ile Arg Met Val His Glu Glu Ser Gln Val Leu Ser Ala Trp Glu
245 250 255Ala Val Arg Gly Glu
Ile Pro Gly Ser Pro Ile Phe Val Met Lys Leu 260
265 270Ala Pro Lys Ser Arg His Leu Glu Val Gln Leu Leu
Ala Asp Thr Tyr 275 280 285Gly Asn
Ala Ile Ala Leu Ser Gly Arg Asp Cys Ser Val Gln Arg Arg 290
295 300His Gln Lys Ile Val Glu Glu Gly Pro Val Leu
Ala Pro Thr Gln Glu305 310 315
320Val Trp Glu Lys Met Met Arg Ala Ala Thr Arg Leu Ala Gln Glu Val
325 330 335Glu Tyr Val Asn
Ala Gly Thr Val Glu Tyr Leu Phe Ser Glu Leu Pro 340
345 350Glu Asp Asn Gly Asn Ser Phe Phe Phe Leu Glu
Leu Asn Pro Arg Leu 355 360 365Gln
Val Glu His Pro Val Thr Glu Met Ile Thr His Val Asn Leu Pro 370
375 380Ala Ala Gln Leu Gln Val Ala Met Gly Ile
Pro Leu His Cys Ile Pro385 390 395
400Asp Val Arg Arg Leu Tyr Asn Lys Asp Ala Phe Glu Thr Thr Val
Ile 405 410 415Asp Phe Asp
Ala Glu Lys Gln Lys Pro Pro His Gly His Val Ile Ala 420
425 430Ala Arg Ile Thr Ala Glu Asp Pro Asn Ala
Gly Phe Gln Pro Thr Ser 435 440
445Gly Ala Ile Gln Glu Leu Asn Phe Arg Ser Thr Pro Asp Val Trp Gly 450
455 460Tyr Phe Ser Val Asp Ser Ser Gly
Gln Val His Glu Phe Ala Asp Ser465 470
475 480Gln Ile Gly His Leu Phe Ser Trp Ser Pro Thr Arg
Glu Lys Ala Arg 485 490
495Lys Asn Met Val Leu Ala Leu Lys Glu Leu Ser Ile Arg Gly Asp Ile
500 505 510His Thr Thr Val Glu Tyr
Ile Val Asn Met Met Glu Ser Asp Asp Phe 515 520
525Lys Tyr Asn Arg Ile Ser Thr Ser Trp Leu Asp Glu Arg Ile
Ser His 530 535
540His54551535PRTPhytophthora infestansMISC_FEATURE(1)..(535)C-terminal
deleted Phytophthora ACCase BC domain (AAs 1-535) 51Met Val Ala Glu
Glu Ala Pro Pro Ala Ala Asp Val Ala Ala Tyr Ala1 5
10 15Glu Thr Arg Ser Asp Ser Asn Pro Leu Asn
Tyr Ala Ser Met Glu Glu 20 25
30Tyr Val Arg Leu Gln Lys Gly Thr Arg Pro Ile Thr Ser Val Leu Ile
35 40 45Ala Asn Asn Gly Ile Ser Ala Val
Lys Ala Ile Arg Ser Ile Arg Ser 50 55
60Trp Ser Tyr Glu Met Phe Ala Asp Glu His Val Val Thr Phe Val Val65
70 75 80Met Ala Thr Pro Glu
Asp Leu Lys Ala Asn Ala Glu Tyr Ile Arg Met 85
90 95Ala Glu His Val Val Glu Val Pro Gly Gly Ser
Asn Asn His Asn Tyr 100 105
110Ala Asn Val Ser Leu Ile Ile Glu Ile Ala Glu Arg Phe Asn Val Asp
115 120 125Ala Val Trp Ala Gly Trp Gly
His Ala Ser Glu Asn Pro Leu Leu Pro 130 135
140Asp Thr Leu Ala Gln Thr Glu Arg Lys Ile Val Phe Ile Gly Pro
Pro145 150 155 160Gly Lys
Pro Met Arg Ala Leu Gly Asp Lys Ile Gly Ser Thr Ile Ile
165 170 175Ala Gln Ser Ala Lys Val Pro
Thr Ile Ala Trp Asn Gly Asp Gly Met 180 185
190Glu Val Asp Tyr Lys Glu His Asp Gly Ile Pro Asp Glu Ile
Tyr Asn 195 200 205Ala Ala Met Leu
Arg Asp Gly Gln His Cys Leu Asp Glu Cys Lys Arg 210
215 220Ile Gly Phe Pro Val Met Ile Lys Ala Ser Glu Gly
Gly Gly Gly Lys225 230 235
240Gly Ile Arg Met Val His Glu Glu Ser Gln Val Leu Ser Ala Trp Glu
245 250 255Ala Val Arg Gly Glu
Ile Pro Gly Ser Pro Ile Phe Val Met Lys Leu 260
265 270Ala Pro Lys Ser Arg His Leu Glu Val Gln Leu Leu
Ala Asp Thr Tyr 275 280 285Gly Asn
Ala Ile Ala Leu Ser Gly Arg Asp Cys Ser Val Gln Arg Arg 290
295 300His Gln Lys Ile Val Glu Glu Gly Pro Val Leu
Ala Pro Thr Gln Glu305 310 315
320Val Trp Glu Lys Met Met Arg Ala Ala Thr Arg Leu Ala Gln Glu Val
325 330 335Glu Tyr Val Asn
Ala Gly Thr Val Glu Tyr Leu Phe Ser Glu Leu Pro 340
345 350Glu Asp Asn Gly Asn Ser Phe Phe Phe Leu Glu
Leu Asn Pro Arg Leu 355 360 365Gln
Val Glu His Pro Val Thr Glu Met Ile Thr His Val Asn Leu Pro 370
375 380Ala Ala Gln Leu Gln Val Ala Met Gly Ile
Pro Leu His Cys Ile Pro385 390 395
400Asp Val Arg Arg Leu Tyr Asn Lys Asp Ala Phe Glu Thr Thr Val
Ile 405 410 415Asp Phe Asp
Ala Glu Lys Gln Lys Pro Pro His Gly His Val Ile Ala 420
425 430Ala Arg Ile Thr Ala Glu Asp Pro Asn Ala
Gly Phe Gln Pro Thr Ser 435 440
445Gly Ala Ile Gln Glu Leu Asn Phe Arg Ser Thr Pro Asp Val Trp Gly 450
455 460Tyr Phe Ser Val Asp Ser Ser Gly
Gln Val His Glu Phe Ala Asp Ser465 470
475 480Gln Ile Gly His Leu Phe Ser Trp Ser Pro Thr Arg
Glu Lys Ala Arg 485 490
495Lys Asn Met Val Leu Ala Leu Lys Glu Leu Ser Ile Arg Gly Asp Ile
500 505 510His Thr Thr Val Glu Tyr
Ile Val Asn Met Met Glu Ser Asp Asp Phe 515 520
525Lys Tyr Asn Arg Ile Ser Thr 530
53552581PRTMagnaporthe griseaMISC_FEATURE(1)..(581)N-terminal deleted
Magnaporthe ACCase BC domain (AAs 12-592 52Asn Ser Ser Arg Gln Arg
Asn Gly Ala Asn Gly Val Thr Val Pro Val1 5
10 15Ala Asn Gly Lys Ala Thr Tyr Ala Gln Arg His Lys
Ile Ala Asp His 20 25 30Phe
Ile Gly Gly Asn Arg Leu Glu Asn Ala Pro Pro Ser Lys Val Lys 35
40 45Glu Trp Val Ala Ala His Asp Gly His
Thr Val Ile Thr Asn Val Leu 50 55
60Ile Ala Asn Asn Gly Ile Ala Ala Val Lys Glu Ile Arg Ser Val Arg65
70 75 80Lys Trp Ala Tyr Glu
Thr Phe Gly Asp Glu Arg Ala Ile Gln Phe Thr 85
90 95Val Met Ala Thr Pro Glu Asp Leu Gln Ala Asn
Ala Asp Tyr Ile Arg 100 105
110Met Ala Asp His Tyr Val Glu Val Pro Gly Gly Thr Asn Asn Asn Asn
115 120 125Tyr Ala Asn Val Glu Leu Ile
Val Asp Val Ala Glu Arg Met Asn Val 130 135
140His Ala Val Trp Ala Gly Trp Gly His Ala Ser Glu Asn Pro Lys
Leu145 150 155 160Pro Glu
Ser Leu Ala Ala Ser Pro Lys Lys Ile Ile Phe Ile Gly Pro
165 170 175Pro Gly Ser Ala Met Arg Ser
Leu Gly Asp Lys Ile Ser Ser Thr Ile 180 185
190Val Ala Gln His Ala Gln Val Pro Cys Ile Pro Trp Ser Gly
Thr Gly 195 200 205Val Asp Ala Val
Gln Ile Asp Lys Lys Gly Ile Val Thr Val Asp Asp 210
215 220Asp Thr Tyr Ala Lys Gly Cys Val Thr Ser Trp Gln
Glu Gly Leu Glu225 230 235
240Lys Ala Arg Gln Ile Gly Phe Pro Val Met Ile Lys Ala Ser Glu Gly
245 250 255Gly Gly Gly Lys Gly
Ile Arg Lys Ala Val Ser Glu Glu Gly Phe Glu 260
265 270Glu Leu Tyr Lys Ala Ala Ala Ser Glu Ile Pro Gly
Ser Pro Ile Phe 275 280 285Ile Met
Lys Leu Ala Gly Asn Ala Arg His Leu Glu Val Gln Leu Leu 290
295 300Ala Asp Gln Tyr Gly Asn Asn Ile Ser Leu Phe
Gly Arg Asp Cys Ser305 310 315
320Val Gln Arg Arg His Gln Lys Ile Ile Glu Glu Ala Pro Val Thr Ile
325 330 335Ala Lys Pro Asp
Thr Phe Lys Ala Met Glu Glu Ala Ala Val Arg Leu 340
345 350Gly Arg Leu Val Gly Tyr Val Ser Ala Gly Thr
Val Glu Tyr Leu Tyr 355 360 365Ser
His Ala Asp Asp Lys Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu 370
375 380Gln Val Glu His Pro Thr Thr Glu Gly Val
Ser Gly Val Asn Leu Pro385 390 395
400Ala Ser Gln Leu Gln Ile Ala Met Gly Ile Pro Leu His Arg Ile
Ser 405 410 415Asp Ile Arg
Leu Leu Tyr Gly Val Asp Pro Lys Leu Ser Thr Glu Ile 420
425 430Asp Phe Asp Phe Lys Asn Pro Asp Ser Glu
Lys Thr Gln Arg Arg Pro 435 440
445Ser Pro Lys Gly His Leu Thr Ala Cys Arg Ile Thr Ser Glu Asp Pro 450
455 460Gly Glu Gly Phe Lys Pro Ser Asn
Gly Val Met His Glu Leu Asn Phe465 470
475 480Arg Ser Ser Ser Asn Val Trp Gly Tyr Phe Ser Val
Gly Thr Gln Gly 485 490
495Gly Ile His Ser Phe Ser Asp Ser Gln Phe Gly His Ile Phe Ala Tyr
500 505 510Gly Glu Asn Arg Ser Ala
Ser Arg Lys His Met Val Ile Ala Leu Lys 515 520
525Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu Tyr
Leu Ile 530 535 540Lys Leu Leu Glu Thr
Glu Ala Phe Glu Glu Asn Thr Ile Thr Thr Gly545 550
555 560Trp Leu Asp Glu Leu Ile Ser Lys Lys Leu
Thr Ala Glu Arg Pro Asp 565 570
575Lys Met Leu Ala Val 58053571PRTMagnaporthe
griseaMISC_FEATURE(1)..(571)N-terminal deleted Magnaporthe ACCase BC
domain (AAs 22-591) 53Gly Val Thr Val Pro Val Ala Asn Gly Lys Ala Thr
Tyr Ala Gln Arg1 5 10
15His Lys Ile Ala Asp His Phe Ile Gly Gly Asn Arg Leu Glu Asn Ala
20 25 30Pro Pro Ser Lys Val Lys Glu
Trp Val Ala Ala His Asp Gly His Thr 35 40
45Val Ile Thr Asn Val Leu Ile Ala Asn Asn Gly Ile Ala Ala Val
Lys 50 55 60Glu Ile Arg Ser Val Arg
Lys Trp Ala Tyr Glu Thr Phe Gly Asp Glu65 70
75 80Arg Ala Ile Gln Phe Thr Val Met Ala Thr Pro
Glu Asp Leu Gln Ala 85 90
95Asn Ala Asp Tyr Ile Arg Met Ala Asp His Tyr Val Glu Val Pro Gly
100 105 110Gly Thr Asn Asn Asn Asn
Tyr Ala Asn Val Glu Leu Ile Val Asp Val 115 120
125Ala Glu Arg Met Asn Val His Ala Val Trp Ala Gly Trp Gly
His Ala 130 135 140Ser Glu Asn Pro Lys
Leu Pro Glu Ser Leu Ala Ala Ser Pro Lys Lys145 150
155 160Ile Ile Phe Ile Gly Pro Pro Gly Ser Ala
Met Arg Ser Leu Gly Asp 165 170
175Lys Ile Ser Ser Thr Ile Val Ala Gln His Ala Gln Val Pro Cys Ile
180 185 190Pro Trp Ser Gly Thr
Gly Val Asp Ala Val Gln Ile Asp Lys Lys Gly 195
200 205Ile Val Thr Val Asp Asp Asp Thr Tyr Ala Lys Gly
Cys Val Thr Ser 210 215 220Trp Gln Glu
Gly Leu Glu Lys Ala Arg Gln Ile Gly Phe Pro Val Met225
230 235 240Ile Lys Ala Ser Glu Gly Gly
Gly Gly Lys Gly Ile Arg Lys Ala Val 245
250 255Ser Glu Glu Gly Phe Glu Glu Leu Tyr Lys Ala Ala
Ala Ser Glu Ile 260 265 270Pro
Gly Ser Pro Ile Phe Ile Met Lys Leu Ala Gly Asn Ala Arg His 275
280 285Leu Glu Val Gln Leu Leu Ala Asp Gln
Tyr Gly Asn Asn Ile Ser Leu 290 295
300Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His Gln Lys Ile Ile Glu305
310 315 320Glu Ala Pro Val
Thr Ile Ala Lys Pro Asp Thr Phe Lys Ala Met Glu 325
330 335Glu Ala Ala Val Arg Leu Gly Arg Leu Val
Gly Tyr Val Ser Ala Gly 340 345
350Thr Val Glu Tyr Leu Tyr Ser His Ala Asp Asp Lys Phe Tyr Phe Leu
355 360 365Glu Leu Asn Pro Arg Leu Gln
Val Glu His Pro Thr Thr Glu Gly Val 370 375
380Ser Gly Val Asn Leu Pro Ala Ser Gln Leu Gln Ile Ala Met Gly
Ile385 390 395 400Pro Leu
His Arg Ile Ser Asp Ile Arg Leu Leu Tyr Gly Val Asp Pro
405 410 415Lys Leu Ser Thr Glu Ile Asp
Phe Asp Phe Lys Asn Pro Asp Ser Glu 420 425
430Lys Thr Gln Arg Arg Pro Ser Pro Lys Gly His Leu Thr Ala
Cys Arg 435 440 445Ile Thr Ser Glu
Asp Pro Gly Glu Gly Phe Lys Pro Ser Asn Gly Val 450
455 460Met His Glu Leu Asn Phe Arg Ser Ser Ser Asn Val
Trp Gly Tyr Phe465 470 475
480Ser Val Gly Thr Gln Gly Gly Ile His Ser Phe Ser Asp Ser Gln Phe
485 490 495Gly His Ile Phe Ala
Tyr Gly Glu Asn Arg Ser Ala Ser Arg Lys His 500
505 510Met Val Ile Ala Leu Lys Glu Leu Ser Ile Arg Gly
Asp Phe Arg Thr 515 520 525Thr Val
Glu Tyr Leu Ile Lys Leu Leu Glu Thr Glu Ala Phe Glu Glu 530
535 540Asn Thr Ile Thr Thr Gly Trp Leu Asp Glu Leu
Ile Ser Lys Lys Leu545 550 555
560Thr Ala Glu Arg Pro Asp Lys Met Leu Ala Val 565
57054581PRTMagnaporthe
griseaMISC_FEATURE(1)..(581)C-terminal deleted Magnaporthe ACCase
(AAs 2-582) 54Thr Glu Thr Asn Gly Thr Ala Ala Ala Ala Asn Ser Ser Arg Gln
Arg1 5 10 15Asn Gly Ala
Asn Gly Val Thr Val Pro Val Ala Asn Gly Lys Ala Thr 20
25 30Tyr Ala Gln Arg His Lys Ile Ala Asp His
Phe Ile Gly Gly Asn Arg 35 40
45Leu Glu Asn Ala Pro Pro Ser Lys Val Lys Glu Trp Val Ala Ala His 50
55 60Asp Gly His Thr Val Ile Thr Asn Val
Leu Ile Ala Asn Asn Gly Ile65 70 75
80Ala Ala Val Lys Glu Ile Arg Ser Val Arg Lys Trp Ala Tyr
Glu Thr 85 90 95Phe Gly
Asp Glu Arg Ala Ile Gln Phe Thr Val Met Ala Thr Pro Glu 100
105 110Asp Leu Gln Ala Asn Ala Asp Tyr Ile
Arg Met Ala Asp His Tyr Val 115 120
125Glu Val Pro Gly Gly Thr Asn Asn Asn Asn Tyr Ala Asn Val Glu Leu
130 135 140Ile Val Asp Val Ala Glu Arg
Met Asn Val His Ala Val Trp Ala Gly145 150
155 160Trp Gly His Ala Ser Glu Asn Pro Lys Leu Pro Glu
Ser Leu Ala Ala 165 170
175Ser Pro Lys Lys Ile Ile Phe Ile Gly Pro Pro Gly Ser Ala Met Arg
180 185 190Ser Leu Gly Asp Lys Ile
Ser Ser Thr Ile Val Ala Gln His Ala Gln 195 200
205Val Pro Cys Ile Pro Trp Ser Gly Thr Gly Val Asp Ala Val
Gln Ile 210 215 220Asp Lys Lys Gly Ile
Val Thr Val Asp Asp Asp Thr Tyr Ala Lys Gly225 230
235 240Cys Val Thr Ser Trp Gln Glu Gly Leu Glu
Lys Ala Arg Gln Ile Gly 245 250
255Phe Pro Val Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile
260 265 270Arg Lys Ala Val Ser
Glu Glu Gly Phe Glu Glu Leu Tyr Lys Ala Ala 275
280 285Ala Ser Glu Ile Pro Gly Ser Pro Ile Phe Ile Met
Lys Leu Ala Gly 290 295 300Asn Ala Arg
His Leu Glu Val Gln Leu Leu Ala Asp Gln Tyr Gly Asn305
310 315 320Asn Ile Ser Leu Phe Gly Arg
Asp Cys Ser Val Gln Arg Arg His Gln 325
330 335Lys Ile Ile Glu Glu Ala Pro Val Thr Ile Ala Lys
Pro Asp Thr Phe 340 345 350Lys
Ala Met Glu Glu Ala Ala Val Arg Leu Gly Arg Leu Val Gly Tyr 355
360 365Val Ser Ala Gly Thr Val Glu Tyr Leu
Tyr Ser His Ala Asp Asp Lys 370 375
380Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro Thr385
390 395 400Thr Glu Gly Val
Ser Gly Val Asn Leu Pro Ala Ser Gln Leu Gln Ile 405
410 415Ala Met Gly Ile Pro Leu His Arg Ile Ser
Asp Ile Arg Leu Leu Tyr 420 425
430Gly Val Asp Pro Lys Leu Ser Thr Glu Ile Asp Phe Asp Phe Lys Asn
435 440 445Pro Asp Ser Glu Lys Thr Gln
Arg Arg Pro Ser Pro Lys Gly His Leu 450 455
460Thr Ala Cys Arg Ile Thr Ser Glu Asp Pro Gly Glu Gly Phe Lys
Pro465 470 475 480Ser Asn
Gly Val Met His Glu Leu Asn Phe Arg Ser Ser Ser Asn Val
485 490 495Trp Gly Tyr Phe Ser Val Gly
Thr Gln Gly Gly Ile His Ser Phe Ser 500 505
510Asp Ser Gln Phe Gly His Ile Phe Ala Tyr Gly Glu Asn Arg
Ser Ala 515 520 525Ser Arg Lys His
Met Val Ile Ala Leu Lys Glu Leu Ser Ile Arg Gly 530
535 540Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile Lys Leu
Leu Glu Thr Glu545 550 555
560Ala Phe Glu Glu Asn Thr Ile Thr Thr Gly Trp Leu Asp Glu Leu Ile
565 570 575Ser Lys Lys Leu Thr
58055571PRTMagnaporthe griseaMISC_FEATURE(1)..(571)C-terminal
deleted Magnaporthe ACCase BC domain (AAs 2-572) 55Thr Glu Thr Asn
Gly Thr Ala Ala Ala Ala Asn Ser Ser Arg Gln Arg1 5
10 15Asn Gly Ala Asn Gly Val Thr Val Pro Val
Ala Asn Gly Lys Ala Thr 20 25
30Tyr Ala Gln Arg His Lys Ile Ala Asp His Phe Ile Gly Gly Asn Arg
35 40 45Leu Glu Asn Ala Pro Pro Ser Lys
Val Lys Glu Trp Val Ala Ala His 50 55
60Asp Gly His Thr Val Ile Thr Asn Val Leu Ile Ala Asn Asn Gly Ile65
70 75 80Ala Ala Val Lys Glu
Ile Arg Ser Val Arg Lys Trp Ala Tyr Glu Thr 85
90 95Phe Gly Asp Glu Arg Ala Ile Gln Phe Thr Val
Met Ala Thr Pro Glu 100 105
110Asp Leu Gln Ala Asn Ala Asp Tyr Ile Arg Met Ala Asp His Tyr Val
115 120 125Glu Val Pro Gly Gly Thr Asn
Asn Asn Asn Tyr Ala Asn Val Glu Leu 130 135
140Ile Val Asp Val Ala Glu Arg Met Asn Val His Ala Val Trp Ala
Gly145 150 155 160Trp Gly
His Ala Ser Glu Asn Pro Lys Leu Pro Glu Ser Leu Ala Ala
165 170 175Ser Pro Lys Lys Ile Ile Phe
Ile Gly Pro Pro Gly Ser Ala Met Arg 180 185
190Ser Leu Gly Asp Lys Ile Ser Ser Thr Ile Val Ala Gln His
Ala Gln 195 200 205Val Pro Cys Ile
Pro Trp Ser Gly Thr Gly Val Asp Ala Val Gln Ile 210
215 220Asp Lys Lys Gly Ile Val Thr Val Asp Asp Asp Thr
Tyr Ala Lys Gly225 230 235
240Cys Val Thr Ser Trp Gln Glu Gly Leu Glu Lys Ala Arg Gln Ile Gly
245 250 255Phe Pro Val Met Ile
Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile 260
265 270Arg Lys Ala Val Ser Glu Glu Gly Phe Glu Glu Leu
Tyr Lys Ala Ala 275 280 285Ala Ser
Glu Ile Pro Gly Ser Pro Ile Phe Ile Met Lys Leu Ala Gly 290
295 300Asn Ala Arg His Leu Glu Val Gln Leu Leu Ala
Asp Gln Tyr Gly Asn305 310 315
320Asn Ile Ser Leu Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His Gln
325 330 335Lys Ile Ile Glu
Glu Ala Pro Val Thr Ile Ala Lys Pro Asp Thr Phe 340
345 350Lys Ala Met Glu Glu Ala Ala Val Arg Leu Gly
Arg Leu Val Gly Tyr 355 360 365Val
Ser Ala Gly Thr Val Glu Tyr Leu Tyr Ser His Ala Asp Asp Lys 370
375 380Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu
Gln Val Glu His Pro Thr385 390 395
400Thr Glu Gly Val Ser Gly Val Asn Leu Pro Ala Ser Gln Leu Gln
Ile 405 410 415Ala Met Gly
Ile Pro Leu His Arg Ile Ser Asp Ile Arg Leu Leu Tyr 420
425 430Gly Val Asp Pro Lys Leu Ser Thr Glu Ile
Asp Phe Asp Phe Lys Asn 435 440
445Pro Asp Ser Glu Lys Thr Gln Arg Arg Pro Ser Pro Lys Gly His Leu 450
455 460Thr Ala Cys Arg Ile Thr Ser Glu
Asp Pro Gly Glu Gly Phe Lys Pro465 470
475 480Ser Asn Gly Val Met His Glu Leu Asn Phe Arg Ser
Ser Ser Asn Val 485 490
495Trp Gly Tyr Phe Ser Val Gly Thr Gln Gly Gly Ile His Ser Phe Ser
500 505 510Asp Ser Gln Phe Gly His
Ile Phe Ala Tyr Gly Glu Asn Arg Ser Ala 515 520
525Ser Arg Lys His Met Val Ile Ala Leu Lys Glu Leu Ser Ile
Arg Gly 530 535 540Asp Phe Arg Thr Thr
Val Glu Tyr Leu Ile Lys Leu Leu Glu Thr Glu545 550
555 560Ala Phe Glu Glu Asn Thr Ile Thr Thr Gly
Trp 565 57056622PRTHomo
sapiensMISC_FEATURE(1)..(622)C-terminal deleted Human ACCase1 BC domain
(AAs 1-622) 56Met Asp Glu Pro Ser Pro Leu Ala Gln Pro Leu Glu Leu Asn
Gln His1 5 10 15Ser Arg
Phe Ile Ile Gly Ser Val Ser Glu Asp Asn Ser Glu Asp Glu 20
25 30Ile Ser Asn Leu Val Lys Leu Asp Leu
Leu Glu Glu Lys Glu Gly Ser 35 40
45Leu Ser Pro Ala Ser Val Gly Ser Asp Thr Leu Ser Asp Leu Gly Ile 50
55 60Ser Ser Leu Gln Asp Gly Leu Ala Leu
His Ile Arg Ser Ser Met Ser65 70 75
80Gly Leu His Leu Val Lys Gln Gly Arg Asp Arg Lys Lys Ile
Asp Ser 85 90 95Gln Arg
Asp Phe Thr Val Ala Ser Pro Ala Glu Phe Val Thr Arg Phe 100
105 110Gly Gly Asn Lys Val Ile Glu Lys Val
Leu Ile Ala Asn Asn Gly Ile 115 120
125Ala Ala Val Lys Cys Met Arg Ser Ile Arg Arg Trp Ser Tyr Glu Met
130 135 140Phe Arg Asn Glu Arg Ala Ile
Arg Phe Val Val Met Val Thr Pro Glu145 150
155 160Asp Leu Lys Ala Asn Ala Glu Tyr Ile Lys Met Ala
Asp His Tyr Val 165 170
175Pro Val Pro Gly Gly Pro Asn Asn Asn Asn Tyr Ala Asn Val Glu Leu
180 185 190Ile Leu Asp Ile Ala Lys
Arg Ile Pro Val Gln Ala Val Trp Ala Gly 195 200
205Trp Gly His Ala Ser Glu Asn Pro Lys Leu Pro Glu Leu Leu
Leu Lys 210 215 220Asn Gly Ile Ala Phe
Met Gly Pro Pro Ser Gln Ala Met Trp Ala Leu225 230
235 240Gly Asp Lys Ile Ala Ser Ser Ile Val Ala
Gln Thr Ala Gly Ile Pro 245 250
255Thr Leu Pro Trp Ser Gly Ser Gly Leu Arg Val Asp Trp Gln Glu Asn
260 265 270Asp Phe Ser Lys Arg
Ile Leu Asn Val Pro Gln Glu Leu Tyr Glu Lys 275
280 285Gly Tyr Val Lys Asp Val Asp Asp Gly Leu Lys Ala
Ala Glu Glu Val 290 295 300Gly Tyr Pro
Val Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly305
310 315 320Ile Arg Lys Val Asn Asn Ala
Asp Asp Phe Pro Asn Leu Phe Arg Gln 325
330 335Val Gln Ala Glu Val Pro Gly Ser Pro Ile Phe Val
Met Arg Leu Ala 340 345 350Lys
Gln Ser Arg His Leu Glu Val Gln Ile Leu Ala Asp Gln Tyr Gly 355
360 365Asn Ala Ile Ser Leu Phe Gly Arg Asp
Cys Ser Val Gln Arg Arg His 370 375
380Gln Lys Ile Ile Glu Glu Ala Pro Ala Thr Ile Ala Thr Pro Ala Val385
390 395 400Phe Glu His Met
Glu Gln Cys Ala Val Lys Leu Ala Lys Met Val Gly 405
410 415Tyr Val Ser Ala Gly Thr Val Glu Tyr Leu
Tyr Ser Gln Asp Gly Ser 420 425
430Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro Cys
435 440 445Thr Glu Met Val Ala Asp Val
Asn Leu Pro Ala Ala Gln Leu Gln Ile 450 455
460Ala Met Gly Ile Pro Leu Tyr Arg Ile Lys Asp Ile Arg Met Met
Tyr465 470 475 480Gly Val
Ser Pro Trp Gly Asp Ser Pro Ile Asp Phe Glu Asp Ser Ala
485 490 495His Val Pro Cys Pro Arg Gly
His Val Ile Ala Ala Arg Ile Thr Ser 500 505
510Glu Asn Pro Asp Glu Gly Phe Lys Pro Ser Ser Gly Thr Val
Gln Glu 515 520 525Leu Asn Phe Arg
Ser Asn Lys Asn Val Trp Gly Tyr Phe Ser Val Ala 530
535 540Ala Ala Gly Gly Leu His Glu Phe Ala Asp Ser Gln
Phe Gly His Cys545 550 555
560Phe Ser Trp Gly Glu Asn Arg Glu Glu Ala Ile Ser Asn Met Val Val
565 570 575Ala Leu Lys Glu Leu
Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu 580
585 590Tyr Leu Ile Lys Leu Leu Glu Thr Glu Ser Phe Gln
Met Asn Arg Ile 595 600 605Asp Thr
Gly Trp Leu Asp Arg Leu Ile Ala Glu Lys Val Gln 610
615 62057612PRTHomo
sapiensMISC_FEATURE(1)..(612)C-terminal deleted Human ACCase1 BC domain
(AAs 1-612) 57Met Asp Glu Pro Ser Pro Leu Ala Gln Pro Leu Glu Leu Asn
Gln His1 5 10 15Ser Arg
Phe Ile Ile Gly Ser Val Ser Glu Asp Asn Ser Glu Asp Glu 20
25 30Ile Ser Asn Leu Val Lys Leu Asp Leu
Leu Glu Glu Lys Glu Gly Ser 35 40
45Leu Ser Pro Ala Ser Val Gly Ser Asp Thr Leu Ser Asp Leu Gly Ile 50
55 60Ser Ser Leu Gln Asp Gly Leu Ala Leu
His Ile Arg Ser Ser Met Ser65 70 75
80Gly Leu His Leu Val Lys Gln Gly Arg Asp Arg Lys Lys Ile
Asp Ser 85 90 95Gln Arg
Asp Phe Thr Val Ala Ser Pro Ala Glu Phe Val Thr Arg Phe 100
105 110Gly Gly Asn Lys Val Ile Glu Lys Val
Leu Ile Ala Asn Asn Gly Ile 115 120
125Ala Ala Val Lys Cys Met Arg Ser Ile Arg Arg Trp Ser Tyr Glu Met
130 135 140Phe Arg Asn Glu Arg Ala Ile
Arg Phe Val Val Met Val Thr Pro Glu145 150
155 160Asp Leu Lys Ala Asn Ala Glu Tyr Ile Lys Met Ala
Asp His Tyr Val 165 170
175Pro Val Pro Gly Gly Pro Asn Asn Asn Asn Tyr Ala Asn Val Glu Leu
180 185 190Ile Leu Asp Ile Ala Lys
Arg Ile Pro Val Gln Ala Val Trp Ala Gly 195 200
205Trp Gly His Ala Ser Glu Asn Pro Lys Leu Pro Glu Leu Leu
Leu Lys 210 215 220Asn Gly Ile Ala Phe
Met Gly Pro Pro Ser Gln Ala Met Trp Ala Leu225 230
235 240Gly Asp Lys Ile Ala Ser Ser Ile Val Ala
Gln Thr Ala Gly Ile Pro 245 250
255Thr Leu Pro Trp Ser Gly Ser Gly Leu Arg Val Asp Trp Gln Glu Asn
260 265 270Asp Phe Ser Lys Arg
Ile Leu Asn Val Pro Gln Glu Leu Tyr Glu Lys 275
280 285Gly Tyr Val Lys Asp Val Asp Asp Gly Leu Lys Ala
Ala Glu Glu Val 290 295 300Gly Tyr Pro
Val Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly305
310 315 320Ile Arg Lys Val Asn Asn Ala
Asp Asp Phe Pro Asn Leu Phe Arg Gln 325
330 335Val Gln Ala Glu Val Pro Gly Ser Pro Ile Phe Val
Met Arg Leu Ala 340 345 350Lys
Gln Ser Arg His Leu Glu Val Gln Ile Leu Ala Asp Gln Tyr Gly 355
360 365Asn Ala Ile Ser Leu Phe Gly Arg Asp
Cys Ser Val Gln Arg Arg His 370 375
380Gln Lys Ile Ile Glu Glu Ala Pro Ala Thr Ile Ala Thr Pro Ala Val385
390 395 400Phe Glu His Met
Glu Gln Cys Ala Val Lys Leu Ala Lys Met Val Gly 405
410 415Tyr Val Ser Ala Gly Thr Val Glu Tyr Leu
Tyr Ser Gln Asp Gly Ser 420 425
430Phe Tyr Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro Cys
435 440 445Thr Glu Met Val Ala Asp Val
Asn Leu Pro Ala Ala Gln Leu Gln Ile 450 455
460Ala Met Gly Ile Pro Leu Tyr Arg Ile Lys Asp Ile Arg Met Met
Tyr465 470 475 480Gly Val
Ser Pro Trp Gly Asp Ser Pro Ile Asp Phe Glu Asp Ser Ala
485 490 495His Val Pro Cys Pro Arg Gly
His Val Ile Ala Ala Arg Ile Thr Ser 500 505
510Glu Asn Pro Asp Glu Gly Phe Lys Pro Ser Ser Gly Thr Val
Gln Glu 515 520 525Leu Asn Phe Arg
Ser Asn Lys Asn Val Trp Gly Tyr Phe Ser Val Ala 530
535 540Ala Ala Gly Gly Leu His Glu Phe Ala Asp Ser Gln
Phe Gly His Cys545 550 555
560Phe Ser Trp Gly Glu Asn Arg Glu Glu Ala Ile Ser Asn Met Val Val
565 570 575Ala Leu Lys Glu Leu
Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu 580
585 590Tyr Leu Ile Lys Leu Leu Glu Thr Glu Ser Phe Gln
Met Asn Arg Ile 595 600 605Asp Thr
Gly Trp 61058522PRTHomo sapiensMISC_FEATURE(2)..(632)N- and C-terminal
deleted Human ACCase1 (AAs 102-622) 58Met Val Ala Ser Pro Ala Glu
Phe Val Thr Arg Phe Gly Gly Asn Lys1 5 10
15Val Ile Glu Lys Val Leu Ile Ala Asn Asn Gly Ile Ala
Ala Val Lys 20 25 30Cys Met
Arg Ser Ile Arg Arg Trp Ser Tyr Glu Met Phe Arg Asn Glu 35
40 45Arg Ala Ile Arg Phe Val Val Met Val Thr
Pro Glu Asp Leu Lys Ala 50 55 60Asn
Ala Glu Tyr Ile Lys Met Ala Asp His Tyr Val Pro Val Pro Gly65
70 75 80Gly Pro Asn Asn Asn Asn
Tyr Ala Asn Val Glu Leu Ile Leu Asp Ile 85
90 95Ala Lys Arg Ile Pro Val Gln Ala Val Trp Ala Gly
Trp Gly His Ala 100 105 110Ser
Glu Asn Pro Lys Leu Pro Glu Leu Leu Leu Lys Asn Gly Ile Ala 115
120 125Phe Met Gly Pro Pro Ser Gln Ala Met
Trp Ala Leu Gly Asp Lys Ile 130 135
140Ala Ser Ser Ile Val Ala Gln Thr Ala Gly Ile Pro Thr Leu Pro Trp145
150 155 160Ser Gly Ser Gly
Leu Arg Val Asp Trp Gln Glu Asn Asp Phe Ser Lys 165
170 175Arg Ile Leu Asn Val Pro Gln Glu Leu Tyr
Glu Lys Gly Tyr Val Lys 180 185
190Asp Val Asp Asp Gly Leu Lys Ala Ala Glu Glu Val Gly Tyr Pro Val
195 200 205Met Ile Lys Ala Ser Glu Gly
Gly Gly Gly Lys Gly Ile Arg Lys Val 210 215
220Asn Asn Ala Asp Asp Phe Pro Asn Leu Phe Arg Gln Val Gln Ala
Glu225 230 235 240Val Pro
Gly Ser Pro Ile Phe Val Met Arg Leu Ala Lys Gln Ser Arg
245 250 255His Leu Glu Val Gln Ile Leu
Ala Asp Gln Tyr Gly Asn Ala Ile Ser 260 265
270Leu Phe Gly Arg Asp Cys Ser Val Gln Arg Arg His Gln Lys
Ile Ile 275 280 285Glu Glu Ala Pro
Ala Thr Ile Ala Thr Pro Ala Val Phe Glu His Met 290
295 300Glu Gln Cys Ala Val Lys Leu Ala Lys Met Val Gly
Tyr Val Ser Ala305 310 315
320Gly Thr Val Glu Tyr Leu Tyr Ser Gln Asp Gly Ser Phe Tyr Phe Leu
325 330 335Glu Leu Asn Pro Arg
Leu Gln Val Glu His Pro Cys Thr Glu Met Val 340
345 350Ala Asp Val Asn Leu Pro Ala Ala Gln Leu Gln Ile
Ala Met Gly Ile 355 360 365Pro Leu
Tyr Arg Ile Lys Asp Ile Arg Met Met Tyr Gly Val Ser Pro 370
375 380Trp Gly Asp Ser Pro Ile Asp Phe Glu Asp Ser
Ala His Val Pro Cys385 390 395
400Pro Arg Gly His Val Ile Ala Ala Arg Ile Thr Ser Glu Asn Pro Asp
405 410 415Glu Gly Phe Lys
Pro Ser Ser Gly Thr Val Gln Glu Leu Asn Phe Arg 420
425 430Ser Asn Lys Asn Val Trp Gly Tyr Phe Ser Val
Ala Ala Ala Gly Gly 435 440 445Leu
His Glu Phe Ala Asp Ser Gln Phe Gly His Cys Phe Ser Trp Gly 450
455 460Glu Asn Arg Glu Glu Ala Ile Ser Asn Met
Val Val Ala Leu Lys Glu465 470 475
480Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile
Lys 485 490 495Leu Leu Glu
Thr Glu Ser Phe Gln Met Asn Arg Ile Asp Thr Gly Trp 500
505 510Leu Asp Arg Leu Ile Ala Glu Lys Val Gln
515 52059512PRTHomo sapiensMISC_FEATURE(2)..(512)N-
and C-terminal deleted Human ACCase1 BC domain (AAs 102-512) 59Met
Val Ala Ser Pro Ala Glu Phe Val Thr Arg Phe Gly Gly Asn Lys1
5 10 15Val Ile Glu Lys Val Leu Ile
Ala Asn Asn Gly Ile Ala Ala Val Lys 20 25
30Cys Met Arg Ser Ile Arg Arg Trp Ser Tyr Glu Met Phe Arg
Asn Glu 35 40 45Arg Ala Ile Arg
Phe Val Val Met Val Thr Pro Glu Asp Leu Lys Ala 50 55
60Asn Ala Glu Tyr Ile Lys Met Ala Asp His Tyr Val Pro
Val Pro Gly65 70 75
80Gly Pro Asn Asn Asn Asn Tyr Ala Asn Val Glu Leu Ile Leu Asp Ile
85 90 95Ala Lys Arg Ile Pro Val
Gln Ala Val Trp Ala Gly Trp Gly His Ala 100
105 110Ser Glu Asn Pro Lys Leu Pro Glu Leu Leu Leu Lys
Asn Gly Ile Ala 115 120 125Phe Met
Gly Pro Pro Ser Gln Ala Met Trp Ala Leu Gly Asp Lys Ile 130
135 140Ala Ser Ser Ile Val Ala Gln Thr Ala Gly Ile
Pro Thr Leu Pro Trp145 150 155
160Ser Gly Ser Gly Leu Arg Val Asp Trp Gln Glu Asn Asp Phe Ser Lys
165 170 175Arg Ile Leu Asn
Val Pro Gln Glu Leu Tyr Glu Lys Gly Tyr Val Lys 180
185 190Asp Val Asp Asp Gly Leu Lys Ala Ala Glu Glu
Val Gly Tyr Pro Val 195 200 205Met
Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile Arg Lys Val 210
215 220Asn Asn Ala Asp Asp Phe Pro Asn Leu Phe
Arg Gln Val Gln Ala Glu225 230 235
240Val Pro Gly Ser Pro Ile Phe Val Met Arg Leu Ala Lys Gln Ser
Arg 245 250 255His Leu Glu
Val Gln Ile Leu Ala Asp Gln Tyr Gly Asn Ala Ile Ser 260
265 270Leu Phe Gly Arg Asp Cys Ser Val Gln Arg
Arg His Gln Lys Ile Ile 275 280
285Glu Glu Ala Pro Ala Thr Ile Ala Thr Pro Ala Val Phe Glu His Met 290
295 300Glu Gln Cys Ala Val Lys Leu Ala
Lys Met Val Gly Tyr Val Ser Ala305 310
315 320Gly Thr Val Glu Tyr Leu Tyr Ser Gln Asp Gly Ser
Phe Tyr Phe Leu 325 330
335Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro Cys Thr Glu Met Val
340 345 350Ala Asp Val Asn Leu Pro
Ala Ala Gln Leu Gln Ile Ala Met Gly Ile 355 360
365Pro Leu Tyr Arg Ile Lys Asp Ile Arg Met Met Tyr Gly Val
Ser Pro 370 375 380Trp Gly Asp Ser Pro
Ile Asp Phe Glu Asp Ser Ala His Val Pro Cys385 390
395 400Pro Arg Gly His Val Ile Ala Ala Arg Ile
Thr Ser Glu Asn Pro Asp 405 410
415Glu Gly Phe Lys Pro Ser Ser Gly Thr Val Gln Glu Leu Asn Phe Arg
420 425 430Ser Asn Lys Asn Val
Trp Gly Tyr Phe Ser Val Ala Ala Ala Gly Gly 435
440 445Leu His Glu Phe Ala Asp Ser Gln Phe Gly His Cys
Phe Ser Trp Gly 450 455 460Glu Asn Arg
Glu Glu Ala Ile Ser Asn Met Val Val Ala Leu Lys Glu465
470 475 480Leu Ser Ile Arg Gly Asp Phe
Arg Thr Thr Val Glu Tyr Leu Ile Lys 485
490 495Leu Leu Glu Thr Glu Ser Phe Gln Met Asn Arg Ile
Asp Thr Gly Trp 500 505
51060764PRTHomo sapiensMISC_FEATURE(1)..(764)C-terminal deleted Human
ACCase2 BC domain (AAs 1-764) 60Met Val Leu Leu Leu Cys Leu Ser Cys
Leu Ile Phe Ser Cys Leu Thr1 5 10
15Phe Ser Trp Leu Lys Ile Trp Gly Lys Met Thr Asp Ser Lys Pro
Ile 20 25 30Thr Lys Ser Lys
Ser Glu Ala Asn Leu Ile Pro Ser Gln Glu Pro Phe 35
40 45Pro Ala Ser Asp Asn Ser Gly Glu Thr Pro Gln Arg
Asn Gly Glu Gly 50 55 60His Thr Leu
Pro Lys Thr Pro Ser Gln Ala Glu Pro Ala Ser His Lys65 70
75 80Gly Pro Lys Asp Ala Gly Arg Arg
Arg Asn Ser Leu Pro Pro Ser His 85 90
95Gln Lys Pro Pro Arg Asn Pro Leu Ser Ser Ser Asp Ala Ala
Pro Ser 100 105 110Pro Glu Leu
Gln Ala Asn Gly Thr Gly Thr Gln Gly Leu Glu Ala Thr 115
120 125Asp Thr Asn Gly Leu Ser Ser Ser Ala Arg Pro
Gln Gly Gln Gln Ala 130 135 140Gly Ser
Pro Ser Lys Glu Asp Lys Lys Gln Ala Asn Ile Lys Arg Gln145
150 155 160Leu Met Thr Asn Phe Ile Leu
Gly Ser Phe Asp Asp Tyr Ser Ser Asp 165
170 175Glu Asp Ser Val Ala Gly Ser Ser Arg Glu Ser Thr
Arg Lys Gly Ser 180 185 190Arg
Ala Ser Leu Gly Ala Leu Ser Leu Glu Ala Tyr Leu Thr Thr Gly 195
200 205Glu Ala Glu Thr Arg Val Pro Thr Met
Arg Pro Ser Met Ser Gly Leu 210 215
220His Leu Val Lys Arg Gly Arg Glu His Lys Lys Leu Asp Leu His Arg225
230 235 240Asp Phe Thr Val
Ala Ser Pro Ala Glu Phe Val Thr Arg Phe Gly Gly 245
250 255Asp Arg Val Ile Glu Lys Val Leu Ile Ala
Asn Asn Gly Ile Ala Ala 260 265
270Val Lys Cys Met Arg Ser Ile Arg Arg Trp Ala Tyr Glu Met Phe Arg
275 280 285Asn Glu Arg Ala Ile Arg Phe
Val Val Met Val Thr Pro Glu Asp Leu 290 295
300Lys Ala Asn Ala Glu Tyr Ile Lys Met Ala Asp His Tyr Val Pro
Val305 310 315 320Pro Gly
Gly Pro Asn Asn Asn Asn Tyr Ala Asn Val Glu Leu Ile Val
325 330 335Asp Ile Ala Lys Arg Ile Pro
Leu Gln Ala Val Trp Ala Gly Trp Gly 340 345
350His Ala Ser Glu Asn Pro Lys Leu Pro Glu Leu Leu Cys Lys
Asn Gly 355 360 365Val Ala Phe Leu
Gly Pro Pro Ser Glu Ala Met Trp Ala Leu Gly Asp 370
375 380Lys Ile Ala Ser Thr Val Val Ala Gln Thr Leu Gln
Val Pro Thr Leu385 390 395
400Pro Arg Ser Gly Ser Gly Leu Thr Val Glu Trp Thr Glu Asp Asp Leu
405 410 415Gln Gln Gly Lys Arg
Ile Ser Val Pro Glu Asp Val Tyr Asp Lys Gly 420
425 430Cys Val Lys Asp Val Asp Glu Gly Leu Glu Ala Ala
Glu Arg Ile Gly 435 440 445Phe Pro
Leu Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile 450
455 460Arg Lys Ala Glu Ser Ala Glu Asp Phe Pro Ile
Leu Phe Arg Gln Val465 470 475
480Gln Ser Glu Ile Pro Gly Ser Pro Ile Phe Leu Met Lys Leu Ala Gln
485 490 495His Ala Arg His
Leu Glu Val Gln Ile Leu Ala Asp Gln Tyr Gly Asn 500
505 510Ala Val Ser Leu Phe Gly Arg Asp Cys Ser Ile
Gln Arg Arg His Gln 515 520 525Lys
Ile Val Glu Glu Ala Pro Ala Thr Ile Ala Pro Leu Ala Ile Phe 530
535 540Glu Phe Met Glu Gln Cys Ala Ile Arg Leu
Ala Lys Thr Val Gly Tyr545 550 555
560Val Ser Ala Gly Thr Val Glu Tyr Leu Tyr Ser Gln Asp Gly Ser
Phe 565 570 575His Phe Leu
Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro Cys Thr 580
585 590Glu Met Ile Ala Asp Val Asn Leu Pro Ala
Ala Gln Leu Gln Ile Ala 595 600
605Met Gly Val Pro Leu His Arg Leu Lys Asp Ile Arg Leu Leu Tyr Gly 610
615 620Glu Ser Pro Trp Gly Val Thr Pro
Ile Ser Phe Glu Thr Pro Ser Asn625 630
635 640Pro Pro Leu Ala Arg Gly His Val Ile Ala Ala Arg
Ile Thr Ser Glu 645 650
655Asn Pro Asp Glu Gly Phe Lys Pro Ser Ser Gly Thr Val Gln Glu Leu
660 665 670Asn Phe Arg Ser Ser Lys
Asn Val Trp Gly Tyr Phe Ser Val Ala Ala 675 680
685Thr Gly Gly Leu His Glu Phe Ala Asp Ser Gln Phe Gly His
Cys Phe 690 695 700Ser Trp Gly Glu Asn
Arg Lys Glu Ala Ile Ser Asn Met Val Val Ala705 710
715 720Leu Lys Glu Leu Ser Ile Arg Gly Asp Phe
Arg Thr Thr Val Glu Tyr 725 730
735Leu Ile Asn Leu Leu Glu Thr Glu Ser Phe Gln Asn Asn Asp Ile Asp
740 745 750Thr Gly Trp Leu Asp
Tyr Leu Ile Ala Glu Lys Val 755 76061754PRTHomo
sapiensMISC_FEATURE(1)..(754)C-terminal deleted Human ACCase2 BC domain
(AAs 1-754) 61Met Val Leu Leu Leu Cys Leu Ser Cys Leu Ile Phe Ser Cys
Leu Thr1 5 10 15Phe Ser
Trp Leu Lys Ile Trp Gly Lys Met Thr Asp Ser Lys Pro Ile 20
25 30Thr Lys Ser Lys Ser Glu Ala Asn Leu
Ile Pro Ser Gln Glu Pro Phe 35 40
45Pro Ala Ser Asp Asn Ser Gly Glu Thr Pro Gln Arg Asn Gly Glu Gly 50
55 60His Thr Leu Pro Lys Thr Pro Ser Gln
Ala Glu Pro Ala Ser His Lys65 70 75
80Gly Pro Lys Asp Ala Gly Arg Arg Arg Asn Ser Leu Pro Pro
Ser His 85 90 95Gln Lys
Pro Pro Arg Asn Pro Leu Ser Ser Ser Asp Ala Ala Pro Ser 100
105 110Pro Glu Leu Gln Ala Asn Gly Thr Gly
Thr Gln Gly Leu Glu Ala Thr 115 120
125Asp Thr Asn Gly Leu Ser Ser Ser Ala Arg Pro Gln Gly Gln Gln Ala
130 135 140Gly Ser Pro Ser Lys Glu Asp
Lys Lys Gln Ala Asn Ile Lys Arg Gln145 150
155 160Leu Met Thr Asn Phe Ile Leu Gly Ser Phe Asp Asp
Tyr Ser Ser Asp 165 170
175Glu Asp Ser Val Ala Gly Ser Ser Arg Glu Ser Thr Arg Lys Gly Ser
180 185 190Arg Ala Ser Leu Gly Ala
Leu Ser Leu Glu Ala Tyr Leu Thr Thr Gly 195 200
205Glu Ala Glu Thr Arg Val Pro Thr Met Arg Pro Ser Met Ser
Gly Leu 210 215 220His Leu Val Lys Arg
Gly Arg Glu His Lys Lys Leu Asp Leu His Arg225 230
235 240Asp Phe Thr Val Ala Ser Pro Ala Glu Phe
Val Thr Arg Phe Gly Gly 245 250
255Asp Arg Val Ile Glu Lys Val Leu Ile Ala Asn Asn Gly Ile Ala Ala
260 265 270Val Lys Cys Met Arg
Ser Ile Arg Arg Trp Ala Tyr Glu Met Phe Arg 275
280 285Asn Glu Arg Ala Ile Arg Phe Val Val Met Val Thr
Pro Glu Asp Leu 290 295 300Lys Ala Asn
Ala Glu Tyr Ile Lys Met Ala Asp His Tyr Val Pro Val305
310 315 320Pro Gly Gly Pro Asn Asn Asn
Asn Tyr Ala Asn Val Glu Leu Ile Val 325
330 335Asp Ile Ala Lys Arg Ile Pro Leu Gln Ala Val Trp
Ala Gly Trp Gly 340 345 350His
Ala Ser Glu Asn Pro Lys Leu Pro Glu Leu Leu Cys Lys Asn Gly 355
360 365Val Ala Phe Leu Gly Pro Pro Ser Glu
Ala Met Trp Ala Leu Gly Asp 370 375
380Lys Ile Ala Ser Thr Val Val Ala Gln Thr Leu Gln Val Pro Thr Leu385
390 395 400Pro Arg Ser Gly
Ser Gly Leu Thr Val Glu Trp Thr Glu Asp Asp Leu 405
410 415Gln Gln Gly Lys Arg Ile Ser Val Pro Glu
Asp Val Tyr Asp Lys Gly 420 425
430Cys Val Lys Asp Val Asp Glu Gly Leu Glu Ala Ala Glu Arg Ile Gly
435 440 445Phe Pro Leu Met Ile Lys Ala
Ser Glu Gly Gly Gly Gly Lys Gly Ile 450 455
460Arg Lys Ala Glu Ser Ala Glu Asp Phe Pro Ile Leu Phe Arg Gln
Val465 470 475 480Gln Ser
Glu Ile Pro Gly Ser Pro Ile Phe Leu Met Lys Leu Ala Gln
485 490 495His Ala Arg His Leu Glu Val
Gln Ile Leu Ala Asp Gln Tyr Gly Asn 500 505
510Ala Val Ser Leu Phe Gly Arg Asp Cys Ser Ile Gln Arg Arg
His Gln 515 520 525Lys Ile Val Glu
Glu Ala Pro Ala Thr Ile Ala Pro Leu Ala Ile Phe 530
535 540Glu Phe Met Glu Gln Cys Ala Ile Arg Leu Ala Lys
Thr Val Gly Tyr545 550 555
560Val Ser Ala Gly Thr Val Glu Tyr Leu Tyr Ser Gln Asp Gly Ser Phe
565 570 575His Phe Leu Glu Leu
Asn Pro Arg Leu Gln Val Glu His Pro Cys Thr 580
585 590Glu Met Ile Ala Asp Val Asn Leu Pro Ala Ala Gln
Leu Gln Ile Ala 595 600 605Met Gly
Val Pro Leu His Arg Leu Lys Asp Ile Arg Leu Leu Tyr Gly 610
615 620Glu Ser Pro Trp Gly Val Thr Pro Ile Ser Phe
Glu Thr Pro Ser Asn625 630 635
640Pro Pro Leu Ala Arg Gly His Val Ile Ala Ala Arg Ile Thr Ser Glu
645 650 655Asn Pro Asp Glu
Gly Phe Lys Pro Ser Ser Gly Thr Val Gln Glu Leu 660
665 670Asn Phe Arg Ser Ser Lys Asn Val Trp Gly Tyr
Phe Ser Val Ala Ala 675 680 685Thr
Gly Gly Leu His Glu Phe Ala Asp Ser Gln Phe Gly His Cys Phe 690
695 700Ser Trp Gly Glu Asn Arg Lys Glu Ala Ile
Ser Asn Met Val Val Ala705 710 715
720Leu Lys Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu
Tyr 725 730 735Leu Ile Asn
Leu Leu Glu Thr Glu Ser Phe Gln Asn Asn Asp Ile Asp 740
745 750Thr Gly62522PRTHomo
sapiensMISC_FEATURE(2)..(522)N- and C-terminal Human ACCase2 BC domain
(AAs 224-764) 62Met Val Ala Ser Pro Ala Glu Phe Val Thr Arg Phe Gly
Gly Asp Arg1 5 10 15Val
Ile Glu Lys Val Leu Ile Ala Asn Asn Gly Ile Ala Ala Val Lys 20
25 30Cys Met Arg Ser Ile Arg Arg Trp
Ala Tyr Glu Met Phe Arg Asn Glu 35 40
45Arg Ala Ile Arg Phe Val Val Met Val Thr Pro Glu Asp Leu Lys Ala
50 55 60Asn Ala Glu Tyr Ile Lys Met Ala
Asp His Tyr Val Pro Val Pro Gly65 70 75
80Gly Pro Asn Asn Asn Asn Tyr Ala Asn Val Glu Leu Ile
Val Asp Ile 85 90 95Ala
Lys Arg Ile Pro Leu Gln Ala Val Trp Ala Gly Trp Gly His Ala
100 105 110Ser Glu Asn Pro Lys Leu Pro
Glu Leu Leu Cys Lys Asn Gly Val Ala 115 120
125Phe Leu Gly Pro Pro Ser Glu Ala Met Trp Ala Leu Gly Asp Lys
Ile 130 135 140Ala Ser Thr Val Val Ala
Gln Thr Leu Gln Val Pro Thr Leu Pro Arg145 150
155 160Ser Gly Ser Gly Leu Thr Val Glu Trp Thr Glu
Asp Asp Leu Gln Gln 165 170
175Gly Lys Arg Ile Ser Val Pro Glu Asp Val Tyr Asp Lys Gly Cys Val
180 185 190Lys Asp Val Asp Glu Gly
Leu Glu Ala Ala Glu Arg Ile Gly Phe Pro 195 200
205Leu Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile
Arg Lys 210 215 220Ala Glu Ser Ala Glu
Asp Phe Pro Ile Leu Phe Arg Gln Val Gln Ser225 230
235 240Glu Ile Pro Gly Ser Pro Ile Phe Leu Met
Lys Leu Ala Gln His Ala 245 250
255Arg His Leu Glu Val Gln Ile Leu Ala Asp Gln Tyr Gly Asn Ala Val
260 265 270Ser Leu Phe Gly Arg
Asp Cys Ser Ile Gln Arg Arg His Gln Lys Ile 275
280 285Val Glu Glu Ala Pro Ala Thr Ile Ala Pro Leu Ala
Ile Phe Glu Phe 290 295 300Met Glu Gln
Cys Ala Ile Arg Leu Ala Lys Thr Val Gly Tyr Val Ser305
310 315 320Ala Gly Thr Val Glu Tyr Leu
Tyr Ser Gln Asp Gly Ser Phe His Phe 325
330 335Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro
Cys Thr Glu Met 340 345 350Ile
Ala Asp Val Asn Leu Pro Ala Ala Gln Leu Gln Ile Ala Met Gly 355
360 365Val Pro Leu His Arg Leu Lys Asp Ile
Arg Leu Leu Tyr Gly Glu Ser 370 375
380Pro Trp Gly Val Thr Pro Ile Ser Phe Glu Thr Pro Ser Asn Pro Pro385
390 395 400Leu Ala Arg Gly
His Val Ile Ala Ala Arg Ile Thr Ser Glu Asn Pro 405
410 415Asp Glu Gly Phe Lys Pro Ser Ser Gly Thr
Val Gln Glu Leu Asn Phe 420 425
430Arg Ser Ser Lys Asn Val Trp Gly Tyr Phe Ser Val Ala Ala Thr Gly
435 440 445Gly Leu His Glu Phe Ala Asp
Ser Gln Phe Gly His Cys Phe Ser Trp 450 455
460Gly Glu Asn Arg Lys Glu Ala Ile Ser Asn Met Val Val Ala Leu
Lys465 470 475 480Glu Leu
Ser Ile Arg Gly Asp Phe Arg Thr Thr Val Glu Tyr Leu Ile
485 490 495Asn Leu Leu Glu Thr Glu Ser
Phe Gln Asn Asn Asp Ile Asp Thr Gly 500 505
510Trp Leu Asp Tyr Leu Ile Ala Glu Lys Val 515
52063512PRTHomo sapiensMIC_FEATURE(2)..(512)N- and C-terminal
deleted Human ACCase2 BC domain (AAs 224-754) 63Met Val Ala Ser Pro
Ala Glu Phe Val Thr Arg Phe Gly Gly Asp Arg1 5
10 15Val Ile Glu Lys Val Leu Ile Ala Asn Asn Gly
Ile Ala Ala Val Lys 20 25
30Cys Met Arg Ser Ile Arg Arg Trp Ala Tyr Glu Met Phe Arg Asn Glu
35 40 45Arg Ala Ile Arg Phe Val Val Met
Val Thr Pro Glu Asp Leu Lys Ala 50 55
60Asn Ala Glu Tyr Ile Lys Met Ala Asp His Tyr Val Pro Val Pro Gly65
70 75 80Gly Pro Asn Asn Asn
Asn Tyr Ala Asn Val Glu Leu Ile Val Asp Ile 85
90 95Ala Lys Arg Ile Pro Leu Gln Ala Val Trp Ala
Gly Trp Gly His Ala 100 105
110Ser Glu Asn Pro Lys Leu Pro Glu Leu Leu Cys Lys Asn Gly Val Ala
115 120 125Phe Leu Gly Pro Pro Ser Glu
Ala Met Trp Ala Leu Gly Asp Lys Ile 130 135
140Ala Ser Thr Val Val Ala Gln Thr Leu Gln Val Pro Thr Leu Pro
Arg145 150 155 160Ser Gly
Ser Gly Leu Thr Val Glu Trp Thr Glu Asp Asp Leu Gln Gln
165 170 175Gly Lys Arg Ile Ser Val Pro
Glu Asp Val Tyr Asp Lys Gly Cys Val 180 185
190Lys Asp Val Asp Glu Gly Leu Glu Ala Ala Glu Arg Ile Gly
Phe Pro 195 200 205Leu Met Ile Lys
Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile Arg Lys 210
215 220Ala Glu Ser Ala Glu Asp Phe Pro Ile Leu Phe Arg
Gln Val Gln Ser225 230 235
240Glu Ile Pro Gly Ser Pro Ile Phe Leu Met Lys Leu Ala Gln His Ala
245 250 255Arg His Leu Glu Val
Gln Ile Leu Ala Asp Gln Tyr Gly Asn Ala Val 260
265 270Ser Leu Phe Gly Arg Asp Cys Ser Ile Gln Arg Arg
His Gln Lys Ile 275 280 285Val Glu
Glu Ala Pro Ala Thr Ile Ala Pro Leu Ala Ile Phe Glu Phe 290
295 300Met Glu Gln Cys Ala Ile Arg Leu Ala Lys Thr
Val Gly Tyr Val Ser305 310 315
320Ala Gly Thr Val Glu Tyr Leu Tyr Ser Gln Asp Gly Ser Phe His Phe
325 330 335Leu Glu Leu Asn
Pro Arg Leu Gln Val Glu His Pro Cys Thr Glu Met 340
345 350Ile Ala Asp Val Asn Leu Pro Ala Ala Gln Leu
Gln Ile Ala Met Gly 355 360 365Val
Pro Leu His Arg Leu Lys Asp Ile Arg Leu Leu Tyr Gly Glu Ser 370
375 380Pro Trp Gly Val Thr Pro Ile Ser Phe Glu
Thr Pro Ser Asn Pro Pro385 390 395
400Leu Ala Arg Gly His Val Ile Ala Ala Arg Ile Thr Ser Glu Asn
Pro 405 410 415Asp Glu Gly
Phe Lys Pro Ser Ser Gly Thr Val Gln Glu Leu Asn Phe 420
425 430Arg Ser Ser Lys Asn Val Trp Gly Tyr Phe
Ser Val Ala Ala Thr Gly 435 440
445Gly Leu His Glu Phe Ala Asp Ser Gln Phe Gly His Cys Phe Ser Trp 450
455 460Gly Glu Asn Arg Lys Glu Ala Ile
Ser Asn Met Val Val Ala Leu Lys465 470
475 480Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val
Glu Tyr Leu Ile 485 490
495Asn Leu Leu Glu Thr Glu Ser Phe Gln Asn Asn Asp Ile Asp Thr Gly
500 505 51064521PRTMagnaporthe
griseaMISC_FEATURE(1)..(521)N-terminal deleted Magnaporthe ACCase BC
domain (AAs 72-592) 64Thr Asn Val Leu Ile Ala Asn Asn Gly Ile Ala Ala
Val Lys Glu Ile1 5 10
15Arg Ser Val Arg Lys Trp Ala Tyr Glu Thr Phe Gly Asp Glu Arg Ala
20 25 30Ile Gln Phe Thr Val Met Ala
Thr Pro Glu Asp Leu Gln Ala Asn Ala 35 40
45Asp Tyr Ile Arg Met Ala Asp His Tyr Val Glu Val Pro Gly Gly
Thr 50 55 60Asn Asn Asn Asn Tyr Ala
Asn Val Glu Leu Ile Val Asp Val Ala Glu65 70
75 80Arg Met Asn Val His Ala Val Trp Ala Gly Trp
Gly His Ala Ser Glu 85 90
95Asn Pro Lys Leu Pro Glu Ser Leu Ala Ala Ser Pro Lys Lys Ile Ile
100 105 110Phe Ile Gly Pro Pro Gly
Ser Ala Met Arg Ser Leu Gly Asp Lys Ile 115 120
125Ser Ser Thr Ile Val Ala Gln His Ala Gln Val Pro Cys Ile
Pro Trp 130 135 140Ser Gly Thr Gly Val
Asp Ala Val Gln Ile Asp Lys Lys Gly Ile Val145 150
155 160Thr Val Asp Asp Asp Thr Tyr Ala Lys Gly
Cys Val Thr Ser Trp Gln 165 170
175Glu Gly Leu Glu Lys Ala Arg Gln Ile Gly Phe Pro Val Met Ile Lys
180 185 190Ala Ser Glu Gly Gly
Gly Gly Lys Gly Ile Arg Lys Ala Val Ser Glu 195
200 205Glu Gly Phe Glu Glu Leu Tyr Lys Ala Ala Ala Ser
Glu Ile Pro Gly 210 215 220Ser Pro Ile
Phe Ile Met Lys Leu Ala Gly Asn Ala Arg His Leu Glu225
230 235 240Val Gln Leu Leu Ala Asp Gln
Tyr Gly Asn Asn Ile Ser Leu Phe Gly 245
250 255Arg Asp Cys Ser Val Gln Arg Arg His Gln Lys Ile
Ile Glu Glu Ala 260 265 270Pro
Val Thr Ile Ala Lys Pro Asp Thr Phe Lys Ala Met Glu Glu Ala 275
280 285Ala Val Arg Leu Gly Arg Leu Val Gly
Tyr Val Ser Ala Gly Thr Val 290 295
300Glu Tyr Leu Tyr Ser His Ala Asp Asp Lys Phe Tyr Phe Leu Glu Leu305
310 315 320Asn Pro Arg Leu
Gln Val Glu His Pro Thr Thr Glu Gly Val Ser Gly 325
330 335Val Asn Leu Pro Ala Ser Gln Leu Gln Ile
Ala Met Gly Ile Pro Leu 340 345
350His Arg Ile Ser Asp Ile Arg Leu Leu Tyr Gly Val Asp Pro Lys Leu
355 360 365Ser Thr Glu Ile Asp Phe Asp
Phe Lys Asn Pro Asp Ser Glu Lys Thr 370 375
380Gln Arg Arg Pro Ser Pro Lys Gly His Leu Thr Ala Cys Arg Ile
Thr385 390 395 400Ser Glu
Asp Pro Gly Glu Gly Phe Lys Pro Ser Asn Gly Val Met His
405 410 415Glu Leu Asn Phe Arg Ser Ser
Ser Asn Val Trp Gly Tyr Phe Ser Val 420 425
430Gly Thr Gln Gly Gly Ile His Ser Phe Ser Asp Ser Gln Phe
Gly His 435 440 445Ile Phe Ala Tyr
Gly Glu Asn Arg Ser Ala Ser Arg Lys His Met Val 450
455 460Ile Ala Leu Lys Glu Leu Ser Ile Arg Gly Asp Phe
Arg Thr Thr Val465 470 475
480Glu Tyr Leu Ile Lys Leu Leu Glu Thr Glu Ala Phe Glu Glu Asn Thr
485 490 495Ile Thr Thr Gly Trp
Leu Asp Glu Leu Ile Ser Lys Lys Leu Thr Ala 500
505 510Glu Arg Pro Asp Lys Met Leu Ala Val 515
52065511PRTMagnaporthe griseaMISC_FEATURE(1)..(511)N- and
C-terminal deleted Magnaporthe ACCase BC domain (AAs 72-582) 65Thr
Asn Val Leu Ile Ala Asn Asn Gly Ile Ala Ala Val Lys Glu Ile1
5 10 15Arg Ser Val Arg Lys Trp Ala
Tyr Glu Thr Phe Gly Asp Glu Arg Ala 20 25
30Ile Gln Phe Thr Val Met Ala Thr Pro Glu Asp Leu Gln Ala
Asn Ala 35 40 45Asp Tyr Ile Arg
Met Ala Asp His Tyr Val Glu Val Pro Gly Gly Thr 50 55
60Asn Asn Asn Asn Tyr Ala Asn Val Glu Leu Ile Val Asp
Val Ala Glu65 70 75
80Arg Met Asn Val His Ala Val Trp Ala Gly Trp Gly His Ala Ser Glu
85 90 95Asn Pro Lys Leu Pro Glu
Ser Leu Ala Ala Ser Pro Lys Lys Ile Ile 100
105 110Phe Ile Gly Pro Pro Gly Ser Ala Met Arg Ser Leu
Gly Asp Lys Ile 115 120 125Ser Ser
Thr Ile Val Ala Gln His Ala Gln Val Pro Cys Ile Pro Trp 130
135 140Ser Gly Thr Gly Val Asp Ala Val Gln Ile Asp
Lys Lys Gly Ile Val145 150 155
160Thr Val Asp Asp Asp Thr Tyr Ala Lys Gly Cys Val Thr Ser Trp Gln
165 170 175Glu Gly Leu Glu
Lys Ala Arg Gln Ile Gly Phe Pro Val Met Ile Lys 180
185 190Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile Arg
Lys Ala Val Ser Glu 195 200 205Glu
Gly Phe Glu Glu Leu Tyr Lys Ala Ala Ala Ser Glu Ile Pro Gly 210
215 220Ser Pro Ile Phe Ile Met Lys Leu Ala Gly
Asn Ala Arg His Leu Glu225 230 235
240Val Gln Leu Leu Ala Asp Gln Tyr Gly Asn Asn Ile Ser Leu Phe
Gly 245 250 255Arg Asp Cys
Ser Val Gln Arg Arg His Gln Lys Ile Ile Glu Glu Ala 260
265 270Pro Val Thr Ile Ala Lys Pro Asp Thr Phe
Lys Ala Met Glu Glu Ala 275 280
285Ala Val Arg Leu Gly Arg Leu Val Gly Tyr Val Ser Ala Gly Thr Val 290
295 300Glu Tyr Leu Tyr Ser His Ala Asp
Asp Lys Phe Tyr Phe Leu Glu Leu305 310
315 320Asn Pro Arg Leu Gln Val Glu His Pro Thr Thr Glu
Gly Val Ser Gly 325 330
335Val Asn Leu Pro Ala Ser Gln Leu Gln Ile Ala Met Gly Ile Pro Leu
340 345 350His Arg Ile Ser Asp Ile
Arg Leu Leu Tyr Gly Val Asp Pro Lys Leu 355 360
365Ser Thr Glu Ile Asp Phe Asp Phe Lys Asn Pro Asp Ser Glu
Lys Thr 370 375 380Gln Arg Arg Pro Ser
Pro Lys Gly His Leu Thr Ala Cys Arg Ile Thr385 390
395 400Ser Glu Asp Pro Gly Glu Gly Phe Lys Pro
Ser Asn Gly Val Met His 405 410
415Glu Leu Asn Phe Arg Ser Ser Ser Asn Val Trp Gly Tyr Phe Ser Val
420 425 430Gly Thr Gln Gly Gly
Ile His Ser Phe Ser Asp Ser Gln Phe Gly His 435
440 445Ile Phe Ala Tyr Gly Glu Asn Arg Ser Ala Ser Arg
Lys His Met Val 450 455 460Ile Ala Leu
Lys Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr Val465
470 475 480Glu Tyr Leu Ile Lys Leu Leu
Glu Thr Glu Ala Phe Glu Glu Asn Thr 485
490 495Ile Thr Thr Gly Trp Leu Asp Glu Leu Ile Ser Lys
Lys Leu Thr 500 505
51066501PRTMagnaporthe griseamisc_featureN- and C-terminal deleted
Magnaporthe ACCase BC domain (AAs 72-572) 66Thr Asn Val Leu Ile Ala
Asn Asn Gly Ile Ala Ala Val Lys Glu Ile1 5
10 15Arg Ser Val Arg Lys Trp Ala Tyr Glu Thr Phe Gly
Asp Glu Arg Ala 20 25 30Ile
Gln Phe Thr Val Met Ala Thr Pro Glu Asp Leu Gln Ala Asn Ala 35
40 45Asp Tyr Ile Arg Met Ala Asp His Tyr
Val Glu Val Pro Gly Gly Thr 50 55
60Asn Asn Asn Asn Tyr Ala Asn Val Glu Leu Ile Val Asp Val Ala Glu65
70 75 80Arg Met Asn Val His
Ala Val Trp Ala Gly Trp Gly His Ala Ser Glu 85
90 95Asn Pro Lys Leu Pro Glu Ser Leu Ala Ala Ser
Pro Lys Lys Ile Ile 100 105
110Phe Ile Gly Pro Pro Gly Ser Ala Met Arg Ser Leu Gly Asp Lys Ile
115 120 125Ser Ser Thr Ile Val Ala Gln
His Ala Gln Val Pro Cys Ile Pro Trp 130 135
140Ser Gly Thr Gly Val Asp Ala Val Gln Ile Asp Lys Lys Gly Ile
Val145 150 155 160Thr Val
Asp Asp Asp Thr Tyr Ala Lys Gly Cys Val Thr Ser Trp Gln
165 170 175Glu Gly Leu Glu Lys Ala Arg
Gln Ile Gly Phe Pro Val Met Ile Lys 180 185
190Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile Arg Lys Ala Val
Ser Glu 195 200 205Glu Gly Phe Glu
Glu Leu Tyr Lys Ala Ala Ala Ser Glu Ile Pro Gly 210
215 220Ser Pro Ile Phe Ile Met Lys Leu Ala Gly Asn Ala
Arg His Leu Glu225 230 235
240Val Gln Leu Leu Ala Asp Gln Tyr Gly Asn Asn Ile Ser Leu Phe Gly
245 250 255Arg Asp Cys Ser Val
Gln Arg Arg His Gln Lys Ile Ile Glu Glu Ala 260
265 270Pro Val Thr Ile Ala Lys Pro Asp Thr Phe Lys Ala
Met Glu Glu Ala 275 280 285Ala Val
Arg Leu Gly Arg Leu Val Gly Tyr Val Ser Ala Gly Thr Val 290
295 300Glu Tyr Leu Tyr Ser His Ala Asp Asp Lys Phe
Tyr Phe Leu Glu Leu305 310 315
320Asn Pro Arg Leu Gln Val Glu His Pro Thr Thr Glu Gly Val Ser Gly
325 330 335Val Asn Leu Pro
Ala Ser Gln Leu Gln Ile Ala Met Gly Ile Pro Leu 340
345 350His Arg Ile Ser Asp Ile Arg Leu Leu Tyr Gly
Val Asp Pro Lys Leu 355 360 365Ser
Thr Glu Ile Asp Phe Asp Phe Lys Asn Pro Asp Ser Glu Lys Thr 370
375 380Gln Arg Arg Pro Ser Pro Lys Gly His Leu
Thr Ala Cys Arg Ile Thr385 390 395
400Ser Glu Asp Pro Gly Glu Gly Phe Lys Pro Ser Asn Gly Val Met
His 405 410 415Glu Leu Asn
Phe Arg Ser Ser Ser Asn Val Trp Gly Tyr Phe Ser Val 420
425 430Gly Thr Gln Gly Gly Ile His Ser Phe Ser
Asp Ser Gln Phe Gly His 435 440
445Ile Phe Ala Tyr Gly Glu Asn Arg Ser Ala Ser Arg Lys His Met Val 450
455 460Ile Ala Leu Lys Glu Leu Ser Ile
Arg Gly Asp Phe Arg Thr Thr Val465 470
475 480Glu Tyr Leu Ile Lys Leu Leu Glu Thr Glu Ala Phe
Glu Glu Asn Thr 485 490
495Ile Thr Thr Gly Trp 50067491PRTMagnaporthe
griseaMISC_FEATURE(1)..(491)N- and C-terminal deleted ACCase BC domain
(AAs 72-562) 67Thr Asn Val Leu Ile Ala Asn Asn Gly Ile Ala Ala Val Lys
Glu Ile1 5 10 15Arg Ser
Val Arg Lys Trp Ala Tyr Glu Thr Phe Gly Asp Glu Arg Ala 20
25 30Ile Gln Phe Thr Val Met Ala Thr Pro
Glu Asp Leu Gln Ala Asn Ala 35 40
45Asp Tyr Ile Arg Met Ala Asp His Tyr Val Glu Val Pro Gly Gly Thr 50
55 60Asn Asn Asn Asn Tyr Ala Asn Val Glu
Leu Ile Val Asp Val Ala Glu65 70 75
80Arg Met Asn Val His Ala Val Trp Ala Gly Trp Gly His Ala
Ser Glu 85 90 95Asn Pro
Lys Leu Pro Glu Ser Leu Ala Ala Ser Pro Lys Lys Ile Ile 100
105 110Phe Ile Gly Pro Pro Gly Ser Ala Met
Arg Ser Leu Gly Asp Lys Ile 115 120
125Ser Ser Thr Ile Val Ala Gln His Ala Gln Val Pro Cys Ile Pro Trp
130 135 140Ser Gly Thr Gly Val Asp Ala
Val Gln Ile Asp Lys Lys Gly Ile Val145 150
155 160Thr Val Asp Asp Asp Thr Tyr Ala Lys Gly Cys Val
Thr Ser Trp Gln 165 170
175Glu Gly Leu Glu Lys Ala Arg Gln Ile Gly Phe Pro Val Met Ile Lys
180 185 190Ala Ser Glu Gly Gly Gly
Gly Lys Gly Ile Arg Lys Ala Val Ser Glu 195 200
205Glu Gly Phe Glu Glu Leu Tyr Lys Ala Ala Ala Ser Glu Ile
Pro Gly 210 215 220Ser Pro Ile Phe Ile
Met Lys Leu Ala Gly Asn Ala Arg His Leu Glu225 230
235 240Val Gln Leu Leu Ala Asp Gln Tyr Gly Asn
Asn Ile Ser Leu Phe Gly 245 250
255Arg Asp Cys Ser Val Gln Arg Arg His Gln Lys Ile Ile Glu Glu Ala
260 265 270Pro Val Thr Ile Ala
Lys Pro Asp Thr Phe Lys Ala Met Glu Glu Ala 275
280 285Ala Val Arg Leu Gly Arg Leu Val Gly Tyr Val Ser
Ala Gly Thr Val 290 295 300Glu Tyr Leu
Tyr Ser His Ala Asp Asp Lys Phe Tyr Phe Leu Glu Leu305
310 315 320Asn Pro Arg Leu Gln Val Glu
His Pro Thr Thr Glu Gly Val Ser Gly 325
330 335Val Asn Leu Pro Ala Ser Gln Leu Gln Ile Ala Met
Gly Ile Pro Leu 340 345 350His
Arg Ile Ser Asp Ile Arg Leu Leu Tyr Gly Val Asp Pro Lys Leu 355
360 365Ser Thr Glu Ile Asp Phe Asp Phe Lys
Asn Pro Asp Ser Glu Lys Thr 370 375
380Gln Arg Arg Pro Ser Pro Lys Gly His Leu Thr Ala Cys Arg Ile Thr385
390 395 400Ser Glu Asp Pro
Gly Glu Gly Phe Lys Pro Ser Asn Gly Val Met His 405
410 415Glu Leu Asn Phe Arg Ser Ser Ser Asn Val
Trp Gly Tyr Phe Ser Val 420 425
430Gly Thr Gln Gly Gly Ile His Ser Phe Ser Asp Ser Gln Phe Gly His
435 440 445Ile Phe Ala Tyr Gly Glu Asn
Arg Ser Ala Ser Arg Lys His Met Val 450 455
460Ile Ala Leu Lys Glu Leu Ser Ile Arg Gly Asp Phe Arg Thr Thr
Val465 470 475 480Glu Tyr
Leu Ile Lys Leu Leu Glu Thr Glu Ala 485
49068525PRTSaccharomyces cerevisiaeMISC_FEATURE(1)..(525)N-terminal
deleted Yeast ACCase BC domain (AAs--57-581) 68Thr Val Ile Ser Lys
Ile Leu Ile Ala Asn Asn Gly Ile Ala Ala Val1 5
10 15Lys Glu Ile Arg Ser Val Arg Lys Trp Ala Tyr
Glu Thr Phe Gly Asp 20 25
30Asp Arg Thr Val Gln Phe Val Ala Met Ala Thr Pro Glu Asp Leu Glu
35 40 45Ala Asn Ala Glu Tyr Ile Arg Met
Ala Asp Gln Tyr Ile Glu Val Pro 50 55
60Gly Gly Thr Asn Asn Asn Asn Tyr Ala Asn Val Asp Leu Ile Val Asp65
70 75 80Ile Ala Glu Arg Ala
Asp Val Asp Ala Val Trp Ala Gly Trp Gly His 85
90 95Ala Ser Glu Asn Pro Leu Leu Pro Glu Lys Leu
Ser Gln Ser Lys Arg 100 105
110Lys Val Ile Phe Ile Gly Pro Pro Gly Asn Ala Met Arg Ser Leu Gly
115 120 125Asp Lys Ile Ser Ser Thr Ile
Val Ala Gln Ser Ala Lys Val Pro Cys 130 135
140Ile Pro Trp Ser Gly Thr Gly Val Asp Thr Val His Val Asp Glu
Lys145 150 155 160Thr Gly
Leu Val Ser Val Asp Asp Asp Ile Tyr Gln Lys Gly Cys Cys
165 170 175Thr Ser Pro Glu Asp Gly Leu
Gln Lys Ala Lys Arg Ile Gly Phe Pro 180 185
190Val Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys Gly Ile
Arg Gln 195 200 205Val Glu Arg Glu
Glu Asp Phe Ile Ala Leu Tyr His Gln Ala Ala Asn 210
215 220Glu Ile Pro Gly Ser Pro Ile Phe Ile Met Lys Leu
Ala Gly Arg Ala225 230 235
240Arg His Leu Glu Val Gln Leu Leu Ala Asp Gln Tyr Gly Thr Asn Ile
245 250 255Ser Leu Phe Gly Arg
Asp Cys Ser Val Gln Arg Arg His Gln Lys Ile 260
265 270Ile Glu Glu Ala Pro Val Thr Ile Ala Lys Ala Glu
Thr Phe His Glu 275 280 285Met Glu
Lys Ala Ala Val Arg Leu Gly Lys Leu Val Gly Tyr Val Ser 290
295 300Ala Gly Thr Val Glu Tyr Leu Tyr Ser His Asp
Asp Gly Lys Phe Tyr305 310 315
320Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro Thr Thr Glu
325 330 335Met Val Ser Gly
Val Asn Leu Pro Ala Ala Gln Leu Gln Ile Ala Met 340
345 350Gly Ile Pro Met His Arg Ile Ser Asp Ile Arg
Thr Leu Tyr Gly Met 355 360 365Asn
Pro His Ser Ala Ser Glu Ile Asp Phe Glu Phe Lys Thr Gln Asp 370
375 380Ala Thr Lys Lys Gln Arg Arg Pro Ile Pro
Lys Gly His Cys Thr Ala385 390 395
400Cys Arg Ile Thr Ser Glu Asp Pro Asn Asp Gly Phe Lys Pro Ser
Gly 405 410 415Gly Thr Leu
His Glu Leu Asn Phe Arg Ser Ser Ser Asn Val Trp Gly 420
425 430Tyr Phe Ser Val Gly Asn Asn Gly Asn Ile
His Ser Phe Ser Asp Ser 435 440
445Gln Phe Gly His Ile Phe Ala Phe Gly Glu Asn Arg Gln Ala Ser Arg 450
455 460Lys His Met Val Val Ala Leu Lys
Glu Leu Ser Ile Arg Gly Asp Phe465 470
475 480Arg Thr Thr Val Glu Tyr Leu Ile Lys Leu Leu Glu
Thr Glu Asp Phe 485 490
495Glu Asp Asn Thr Ile Thr Thr Gly Trp Leu Asp Asp Leu Ile Thr His
500 505 510Lys Met Thr Ala Glu Lys
Pro Asp Pro Thr Leu Ala Val 515 520
52569515PRTSaccharomyces cerevisiaeMISC_FEATURE(1)..(515)N- and
C-terminal deleted Yeast ACCase BC domain (AAs 57-571) 69Thr Val
Ile Ser Lys Ile Leu Ile Ala Asn Asn Gly Ile Ala Ala Val1 5
10 15Lys Glu Ile Arg Ser Val Arg Lys
Trp Ala Tyr Glu Thr Phe Gly Asp 20 25
30Asp Arg Thr Val Gln Phe Val Ala Met Ala Thr Pro Glu Asp Leu
Glu 35 40 45Ala Asn Ala Glu Tyr
Ile Arg Met Ala Asp Gln Tyr Ile Glu Val Pro 50 55
60Gly Gly Thr Asn Asn Asn Asn Tyr Ala Asn Val Asp Leu Ile
Val Asp65 70 75 80Ile
Ala Glu Arg Ala Asp Val Asp Ala Val Trp Ala Gly Trp Gly His
85 90 95Ala Ser Glu Asn Pro Leu Leu
Pro Glu Lys Leu Ser Gln Ser Lys Arg 100 105
110Lys Val Ile Phe Ile Gly Pro Pro Gly Asn Ala Met Arg Ser
Leu Gly 115 120 125Asp Lys Ile Ser
Ser Thr Ile Val Ala Gln Ser Ala Lys Val Pro Cys 130
135 140Ile Pro Trp Ser Gly Thr Gly Val Asp Thr Val His
Val Asp Glu Lys145 150 155
160Thr Gly Leu Val Ser Val Asp Asp Asp Ile Tyr Gln Lys Gly Cys Cys
165 170 175Thr Ser Pro Glu Asp
Gly Leu Gln Lys Ala Lys Arg Ile Gly Phe Pro 180
185 190Val Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys
Gly Ile Arg Gln 195 200 205Val Glu
Arg Glu Glu Asp Phe Ile Ala Leu Tyr His Gln Ala Ala Asn 210
215 220Glu Ile Pro Gly Ser Pro Ile Phe Ile Met Lys
Leu Ala Gly Arg Ala225 230 235
240Arg His Leu Glu Val Gln Leu Leu Ala Asp Gln Tyr Gly Thr Asn Ile
245 250 255Ser Leu Phe Gly
Arg Asp Cys Ser Val Gln Arg Arg His Gln Lys Ile 260
265 270Ile Glu Glu Ala Pro Val Thr Ile Ala Lys Ala
Glu Thr Phe His Glu 275 280 285Met
Glu Lys Ala Ala Val Arg Leu Gly Lys Leu Val Gly Tyr Val Ser 290
295 300Ala Gly Thr Val Glu Tyr Leu Tyr Ser His
Asp Asp Gly Lys Phe Tyr305 310 315
320Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro Thr Thr
Glu 325 330 335Met Val Ser
Gly Val Asn Leu Pro Ala Ala Gln Leu Gln Ile Ala Met 340
345 350Gly Ile Pro Met His Arg Ile Ser Asp Ile
Arg Thr Leu Tyr Gly Met 355 360
365Asn Pro His Ser Ala Ser Glu Ile Asp Phe Glu Phe Lys Thr Gln Asp 370
375 380Ala Thr Lys Lys Gln Arg Arg Pro
Ile Pro Lys Gly His Cys Thr Ala385 390
395 400Cys Arg Ile Thr Ser Glu Asp Pro Asn Asp Gly Phe
Lys Pro Ser Gly 405 410
415Gly Thr Leu His Glu Leu Asn Phe Arg Ser Ser Ser Asn Val Trp Gly
420 425 430Tyr Phe Ser Val Gly Asn
Asn Gly Asn Ile His Ser Phe Ser Asp Ser 435 440
445Gln Phe Gly His Ile Phe Ala Phe Gly Glu Asn Arg Gln Ala
Ser Arg 450 455 460Lys His Met Val Val
Ala Leu Lys Glu Leu Ser Ile Arg Gly Asp Phe465 470
475 480Arg Thr Thr Val Glu Tyr Leu Ile Lys Leu
Leu Glu Thr Glu Asp Phe 485 490
495Glu Asp Asn Thr Ile Thr Thr Gly Trp Leu Asp Asp Leu Ile Thr His
500 505 510Lys Met Thr
51570505PRTSaccharomyces cerevisiaeMISC_FEATURE(1)..(505)N- and
C-terminal deleted Yeast ACCase BC domain (AAs 57-561) 70Thr Val
Ile Ser Lys Ile Leu Ile Ala Asn Asn Gly Ile Ala Ala Val1 5
10 15Lys Glu Ile Arg Ser Val Arg Lys
Trp Ala Tyr Glu Thr Phe Gly Asp 20 25
30Asp Arg Thr Val Gln Phe Val Ala Met Ala Thr Pro Glu Asp Leu
Glu 35 40 45Ala Asn Ala Glu Tyr
Ile Arg Met Ala Asp Gln Tyr Ile Glu Val Pro 50 55
60Gly Gly Thr Asn Asn Asn Asn Tyr Ala Asn Val Asp Leu Ile
Val Asp65 70 75 80Ile
Ala Glu Arg Ala Asp Val Asp Ala Val Trp Ala Gly Trp Gly His
85 90 95Ala Ser Glu Asn Pro Leu Leu
Pro Glu Lys Leu Ser Gln Ser Lys Arg 100 105
110Lys Val Ile Phe Ile Gly Pro Pro Gly Asn Ala Met Arg Ser
Leu Gly 115 120 125Asp Lys Ile Ser
Ser Thr Ile Val Ala Gln Ser Ala Lys Val Pro Cys 130
135 140Ile Pro Trp Ser Gly Thr Gly Val Asp Thr Val His
Val Asp Glu Lys145 150 155
160Thr Gly Leu Val Ser Val Asp Asp Asp Ile Tyr Gln Lys Gly Cys Cys
165 170 175Thr Ser Pro Glu Asp
Gly Leu Gln Lys Ala Lys Arg Ile Gly Phe Pro 180
185 190Val Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys
Gly Ile Arg Gln 195 200 205Val Glu
Arg Glu Glu Asp Phe Ile Ala Leu Tyr His Gln Ala Ala Asn 210
215 220Glu Ile Pro Gly Ser Pro Ile Phe Ile Met Lys
Leu Ala Gly Arg Ala225 230 235
240Arg His Leu Glu Val Gln Leu Leu Ala Asp Gln Tyr Gly Thr Asn Ile
245 250 255Ser Leu Phe Gly
Arg Asp Cys Ser Val Gln Arg Arg His Gln Lys Ile 260
265 270Ile Glu Glu Ala Pro Val Thr Ile Ala Lys Ala
Glu Thr Phe His Glu 275 280 285Met
Glu Lys Ala Ala Val Arg Leu Gly Lys Leu Val Gly Tyr Val Ser 290
295 300Ala Gly Thr Val Glu Tyr Leu Tyr Ser His
Asp Asp Gly Lys Phe Tyr305 310 315
320Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro Thr Thr
Glu 325 330 335Met Val Ser
Gly Val Asn Leu Pro Ala Ala Gln Leu Gln Ile Ala Met 340
345 350Gly Ile Pro Met His Arg Ile Ser Asp Ile
Arg Thr Leu Tyr Gly Met 355 360
365Asn Pro His Ser Ala Ser Glu Ile Asp Phe Glu Phe Lys Thr Gln Asp 370
375 380Ala Thr Lys Lys Gln Arg Arg Pro
Ile Pro Lys Gly His Cys Thr Ala385 390
395 400Cys Arg Ile Thr Ser Glu Asp Pro Asn Asp Gly Phe
Lys Pro Ser Gly 405 410
415Gly Thr Leu His Glu Leu Asn Phe Arg Ser Ser Ser Asn Val Trp Gly
420 425 430Tyr Phe Ser Val Gly Asn
Asn Gly Asn Ile His Ser Phe Ser Asp Ser 435 440
445Gln Phe Gly His Ile Phe Ala Phe Gly Glu Asn Arg Gln Ala
Ser Arg 450 455 460Lys His Met Val Val
Ala Leu Lys Glu Leu Ser Ile Arg Gly Asp Phe465 470
475 480Arg Thr Thr Val Glu Tyr Leu Ile Lys Leu
Leu Glu Thr Glu Asp Phe 485 490
495Glu Asp Asn Thr Ile Thr Thr Gly Trp 500
50571495PRTSaccharomyces cerevisiaeMISC_FEATURE(1)..(495)N- and
C-terminal deleted Yeast ACCase BC domain (AAs 57-551) 71Thr Val
Ile Ser Lys Ile Leu Ile Ala Asn Asn Gly Ile Ala Ala Val1 5
10 15Lys Glu Ile Arg Ser Val Arg Lys
Trp Ala Tyr Glu Thr Phe Gly Asp 20 25
30Asp Arg Thr Val Gln Phe Val Ala Met Ala Thr Pro Glu Asp Leu
Glu 35 40 45Ala Asn Ala Glu Tyr
Ile Arg Met Ala Asp Gln Tyr Ile Glu Val Pro 50 55
60Gly Gly Thr Asn Asn Asn Asn Tyr Ala Asn Val Asp Leu Ile
Val Asp65 70 75 80Ile
Ala Glu Arg Ala Asp Val Asp Ala Val Trp Ala Gly Trp Gly His
85 90 95Ala Ser Glu Asn Pro Leu Leu
Pro Glu Lys Leu Ser Gln Ser Lys Arg 100 105
110Lys Val Ile Phe Ile Gly Pro Pro Gly Asn Ala Met Arg Ser
Leu Gly 115 120 125Asp Lys Ile Ser
Ser Thr Ile Val Ala Gln Ser Ala Lys Val Pro Cys 130
135 140Ile Pro Trp Ser Gly Thr Gly Val Asp Thr Val His
Val Asp Glu Lys145 150 155
160Thr Gly Leu Val Ser Val Asp Asp Asp Ile Tyr Gln Lys Gly Cys Cys
165 170 175Thr Ser Pro Glu Asp
Gly Leu Gln Lys Ala Lys Arg Ile Gly Phe Pro 180
185 190Val Met Ile Lys Ala Ser Glu Gly Gly Gly Gly Lys
Gly Ile Arg Gln 195 200 205Val Glu
Arg Glu Glu Asp Phe Ile Ala Leu Tyr His Gln Ala Ala Asn 210
215 220Glu Ile Pro Gly Ser Pro Ile Phe Ile Met Lys
Leu Ala Gly Arg Ala225 230 235
240Arg His Leu Glu Val Gln Leu Leu Ala Asp Gln Tyr Gly Thr Asn Ile
245 250 255Ser Leu Phe Gly
Arg Asp Cys Ser Val Gln Arg Arg His Gln Lys Ile 260
265 270Ile Glu Glu Ala Pro Val Thr Ile Ala Lys Ala
Glu Thr Phe His Glu 275 280 285Met
Glu Lys Ala Ala Val Arg Leu Gly Lys Leu Val Gly Tyr Val Ser 290
295 300Ala Gly Thr Val Glu Tyr Leu Tyr Ser His
Asp Asp Gly Lys Phe Tyr305 310 315
320Phe Leu Glu Leu Asn Pro Arg Leu Gln Val Glu His Pro Thr Thr
Glu 325 330 335Met Val Ser
Gly Val Asn Leu Pro Ala Ala Gln Leu Gln Ile Ala Met 340
345 350Gly Ile Pro Met His Arg Ile Ser Asp Ile
Arg Thr Leu Tyr Gly Met 355 360
365Asn Pro His Ser Ala Ser Glu Ile Asp Phe Glu Phe Lys Thr Gln Asp 370
375 380Ala Thr Lys Lys Gln Arg Arg Pro
Ile Pro Lys Gly His Cys Thr Ala385 390
395 400Cys Arg Ile Thr Ser Glu Asp Pro Asn Asp Gly Phe
Lys Pro Ser Gly 405 410
415Gly Thr Leu His Glu Leu Asn Phe Arg Ser Ser Ser Asn Val Trp Gly
420 425 430Tyr Phe Ser Val Gly Asn
Asn Gly Asn Ile His Ser Phe Ser Asp Ser 435 440
445Gln Phe Gly His Ile Phe Ala Phe Gly Glu Asn Arg Gln Ala
Ser Arg 450 455 460Lys His Met Val Val
Ala Leu Lys Glu Leu Ser Ile Arg Gly Asp Phe465 470
475 480Arg Thr Thr Val Glu Tyr Leu Ile Lys Leu
Leu Glu Thr Glu Asp 485 490
495
User Contributions:
comments("1"); ?> comment_form("1"); ?>Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
Usenet FAQ Index |
Documents |
Other FAQs |
User Contributions:
Comment about this patent or add new information about this topic: